,doi,tweets,archive,subject-area,covid,title,authors,abstract,posted
0,10.1101/2021.04.27.441510,1661,bioRxiv,Microbiology,True,Aerosol Exposure of Cynomolgus Macaques to SARS-CoV-2 Results in More Severe Pathology than Existing Models,"[{'given': 'Sandra L.', 'family': 'Bixler', 'sequence': 'first', 'affiliation': []}, {'given': 'Christopher P.', 'family': 'Stefan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexandra', 'family': 'Jay', 'sequence': 'additional', 'affiliation': []}, {'given': 'Franco', 'family': 'Rossi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Keersten M.', 'family': 'Ricks', 'sequence': 'additional', 'affiliation': []}, {'given': 'Charles J.', 'family': 'Shoemaker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alicia M.', 'family': 'Moreau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiankun', 'family': 'Zeng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jay W.', 'family': 'Hooper', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Dyer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ondraya', 'family': 'Frick', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jeffrey W.', 'family': 'Koehler', 'sequence': 'additional', 'affiliation': []}, {'given': 'Brian', 'family': 'Kearney', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nina', 'family': 'DiPinto', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jun', 'family': 'Liu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Samantha', 'family': 'Tostenson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tamara L.', 'family': 'Clements', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jeffrey M.', 'family': 'Smith', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joshua A.', 'family': 'Johnson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kerry', 'family': 'Berrier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Heather', 'family': 'Esham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Korey L.', 'family': 'Delp', 'sequence': 'additional', 'affiliation': []}, {'given': 'Susan R.', 'family': 'Coyne', 'sequence': 'additional', 'affiliation': []}, {'given': 'Holly', 'family': 'Bloomfield', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'Kuehnert', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kristen', 'family': 'Akers', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kathleen', 'family': 'Gibson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Timothy D.', 'family': 'Minogue', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aysegul', 'family': 'Nalca', 'sequence': 'additional', 'affiliation': []}, {'given': 'Margaret L. M.', 'family': 'Pitt', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The emergence of SARS-CoV-2 pandemic has highlighted the need for animal models that faithfully recapitulate the salient features of COVID-19 disease in humans; these models are necessary for the rapid down-selection, testing, and evaluation of medical countermeasures. Here we performed a direct comparison of two distinct routes of SARS-CoV-2 exposure, combined intratracheal/intranasal and small particle aerosol, in two nonhuman primate species: rhesus and cynomolgus macaques. While all four experimental groups displayed very few outward clinical signs, evidence of mild to moderate respiratory disease was present on radiographs and at the time of necropsy. Cynomolgus macaques exposed via the aerosol route also developed the most consistent fever responses and had the most severe respiratory disease and pathology. This study demonstrates that while all four models were suitable representations of mild COVID-like illness, aerosol exposure of cynomolgus macaques to SARS-CoV-2 produced the most severe disease, which may provide additional clinical endpoints for evaluating therapeutics and vaccines.</jats:p>",2021-04-27
1,10.1101/2021.02.27.433180,640,bioRxiv,Immunology,True,"Negligible impact of SARS-CoV-2 variants on CD4+ and
                        CD8+ T cell reactivity in COVID-19 exposed donors and
                    vaccinees","[{'given': 'Alison', 'family': 'Tarke', 'sequence': 'first', 'affiliation': []}, {'given': 'John', 'family': 'Sidney', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nils', 'family': 'Methot', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1180-275X', 'authenticated-orcid': False, 'given': 'Yun', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jennifer M.', 'family': 'Dan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benjamin', 'family': 'Goodwin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'Rubiro', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aaron', 'family': 'Sutherland', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9785-5272', 'authenticated-orcid': False, 'given': 'Ricardo', 'family': 'da Silva Antunes', 'sequence': 'additional', 'affiliation': []}, {'given': 'April', 'family': 'Frazier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stephen A.', 'family': 'Rawlings', 'sequence': 'additional', 'affiliation': []}, {'given': 'Davey M.', 'family': 'Smith', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bjoern', 'family': 'Peters', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard H.', 'family': 'Scheuermann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniela', 'family': 'Weiskopf', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6484-6262', 'authenticated-orcid': False, 'given': 'Shane', 'family': 'Crotty', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2209-5966', 'authenticated-orcid': False, 'given': 'Alba', 'family': 'Grifoni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alessandro', 'family': 'Sette', 'sequence': 'additional', 'affiliation': []}]","<jats:title>SUMMARY</jats:title>
                <jats:p>The emergence of SARS-CoV-2 variants highlighted the need to better
                    understand adaptive immune responses to this virus. It is important to address
                    whether also CD4+ and CD8+ T cell responses are affected, because of the role
                    they play in disease resolution and modulation of COVID-19 disease severity.
                    Here we performed a comprehensive analysis of SARS-CoV-2-specific CD4+ and CD8+
                    T cell responses from COVID-19 convalescent subjects recognizing the ancestral
                    strain, compared to variant lineages B.1.1.7, B.1.351, P.1, and CAL.20C as well
                    as recipients of the Moderna (mRNA-1273) or Pfizer/BioNTech (BNT162b2) COVID-19
                    vaccines. Similarly, we demonstrate that the sequences of the vast majority of
                    SARS-CoV-2 T cell epitopes are not affected by the mutations found in the
                    variants analyzed. Overall, the results demonstrate that CD4+ and CD8+ T cell
                    responses in convalescent COVID-19 subjects or COVID-19 mRNA vaccinees are not
                    substantially affected by mutations found in the SARS-CoV-2 variants.</jats:p>",2021-03-01
2,10.1101/2021.01.29.21250653,615,medRxiv,Allergy and Immunology,True,Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine,"[{'given': 'Florian', 'family': 'Krammer', 'sequence': 'first', 'affiliation': []}, {'given': 'Komal', 'family': 'Srivastava', 'sequence': 'additional', 'affiliation': []}, {'given': 'Viviana', 'family': 'Simon', 'sequence': 'additional', 'affiliation': []}, {'name': 'the PARIS team', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>An important question is arising as COVID-19 vaccines are getting rolled out: Should individuals who already had a SARS-CoV-2 infection receive one or two shots of the currently authorized mRNA vaccines. In this short report, we show that the antibody response to the first vaccine dose in individuals with pre-existing immunity is equal to or even exceeds the titers found in naïve individuals after the second dose. We also show that the reactogenicity is significantly higher in individuals who have been infected with SARS-CoV-2 in the past. Changing the policy to give these individuals only one dose of vaccine would not negatively impact on their antibody titers, spare them from unnecessary pain and free up many urgently needed vaccine doses.</jats:p>",2021-02-01
3,10.1101/2021.04.21.440862,566,bioRxiv,Immunology,True,Rapid induction of antigen-specific CD4+ T cells guides coordinated humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination,"[{'ORCID': 'http://orcid.org/0000-0002-0180-2748', 'authenticated-orcid': False, 'given': 'Mark M.', 'family': 'Painter', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8323-7358', 'authenticated-orcid': False, 'given': 'Divij', 'family': 'Mathew', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1715-5191', 'authenticated-orcid': False, 'given': 'Rishi R.', 'family': 'Goel', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0224-0097', 'authenticated-orcid': False, 'given': 'Sokratis A.', 'family': 'Apostolidis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ajinkya', 'family': 'Pattekar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Oliva', 'family': 'Kuthuru', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amy E.', 'family': 'Baxter', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ramin S.', 'family': 'Herati', 'sequence': 'additional', 'affiliation': []}, {'given': 'Derek A.', 'family': 'Oldridge', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7853-8340', 'authenticated-orcid': False, 'given': 'Sigrid', 'family': 'Gouma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philip', 'family': 'Hicks', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sarah', 'family': 'Dysinger', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kendall A.', 'family': 'Lundgreen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2432-9500', 'authenticated-orcid': False, 'given': 'Leticia', 'family': 'Kuri-Cervantes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sharon', 'family': 'Adamski', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amanda', 'family': 'Hicks', 'sequence': 'additional', 'affiliation': []}, {'given': 'Scott', 'family': 'Korte', 'sequence': 'additional', 'affiliation': []}, {'given': 'Josephine R.', 'family': 'Giles', 'sequence': 'additional', 'affiliation': []}, {'given': 'Madison E.', 'family': 'Weirick', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher M.', 'family': 'McAllister', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jeanette', 'family': 'Dougherty', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sherea', 'family': 'Long', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kurt', 'family': 'D’Andrea', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jacob T.', 'family': 'Hamilton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael R.', 'family': 'Betts', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'Bates', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2928-7506', 'authenticated-orcid': False, 'given': 'Scott E.', 'family': 'Hensley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alba', 'family': 'Grifoni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniela', 'family': 'Weiskopf', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alessandro', 'family': 'Sette', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2614-3072', 'authenticated-orcid': False, 'given': 'Allison R.', 'family': 'Greenplate', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0477-1956', 'authenticated-orcid': False, 'given': 'E. John', 'family': 'Wherry', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary</jats:title><jats:p>The SARS-CoV-2 mRNA vaccines have shown remarkable clinical efficacy, but questions remain about the nature and kinetics of T cell priming. We performed longitudinal antigen-specific T cell analyses in healthy individuals following mRNA vaccination. Vaccination induced rapid near-maximal antigen-specific CD4<jats:sup>+</jats:sup> T cell responses in all subjects after the first vaccine dose. CD8<jats:sup>+</jats:sup> T cell responses developed gradually after the first and second dose and were variable. Vaccine-induced T cells had central memory characteristics and included both Tfh and Th1 subsets, similar to natural infection. Th1 and Tfh responses following the first dose predicted post-boost CD8<jats:sup>+</jats:sup> T cell and neutralizing antibody levels, respectively. Integrated analysis of 26 antigen-specific T cell and humoral responses revealed coordinated features of the immune response to vaccination. Lastly, whereas booster vaccination improved CD4<jats:sup>+</jats:sup> and CD8<jats:sup>+</jats:sup> T cell responses in SARS-CoV-2 naïve subjects, the second vaccine dose had little effect on T cell responses in SARS-CoV-2 recovered individuals. Thus, longitudinal analysis revealed robust T cell responses to mRNA vaccination and highlighted early induction of antigen-specific CD4<jats:sup>+</jats:sup> T cells.</jats:p><jats:sec><jats:title>Graphical Abstract</jats:title><jats:fig id=""ufig1"" position=""float"" fig-type=""figure"" orientation=""portrait""><jats:graphic xmlns:xlink=""http://www.w3.org/1999/xlink"" xlink:href=""440862v1_ufig1"" position=""float"" orientation=""portrait"" /></jats:fig></jats:sec>",2021-04-22
4,10.1101/2021.04.10.21255248,471,medRxiv,Infectious Diseases (except HIV/AIDS),True,Retrospective cohort study of Ivermectin as a SARS-CoV-2 pre-exposure prophylaxis method in Healthcare Workers,"[{'given': 'Jose', 'family': 'Morgenstern', 'sequence': 'first', 'affiliation': []}, {'given': 'Jose Natalio', 'family': 'Redondo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alvaro', 'family': 'Olavarria', 'sequence': 'additional', 'affiliation': []}, {'given': 'Isis', 'family': 'Rondon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Santiago', 'family': 'Roca', 'sequence': 'additional', 'affiliation': []}, {'given': 'Albida', 'family': 'De Leon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Juan Manuel', 'family': 'Canela', 'sequence': 'additional', 'affiliation': []}, {'given': 'Johnny', 'family': 'Tavares', 'sequence': 'additional', 'affiliation': []}, {'given': 'Miguelina', 'family': 'Minaya', 'sequence': 'additional', 'affiliation': []}, {'given': 'Oscar', 'family': 'Lopez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana', 'family': 'Castillo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana Maria', 'family': 'Placido', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rafael', 'family': 'Pena Cruz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yudelka', 'family': 'Merette', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marlenin', 'family': 'Toribio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Juan Asmir', 'family': 'Francisco', 'sequence': 'additional', 'affiliation': []}]","<jats:p>This observational and retrospective cohort study, carried out in two medical centers, Centro Medico Bournigal (CMBO) in Puerto Plata and Centro Medico Punta Cana (CMPC) in Punta Cana, Dominican Republic, sought to determine whether Ivermectin, at a weekly oral (PO) dose of 0.2 mg/kg, is an effective pre-exposure prophylaxis (PrEP) method preventing the spread of Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2), in the healthcare workers.
The study began on June 29, 2020 and ended on July 26, 2020, where 713 active healthcare personnel were included for the analysis, from which 326 healthcare personnel adhered to a weekly prophylactic program with Ivermectin for Coronavirus Disease-19 (COVID-19), designed by Grupo Rescue task force, that runs both medical centers, and 387 healthcare personnel who did not adhere to the program and were assigned as control group. A SPSS Propensity Score Matching procedure was applied in a 1:1 ratio to homogeneously evaluate the groups that were made up of 271 participants each.
In 28 days of follow-up, a significant protection of Ivermectin as a PrEP method preventing the infection from SARS-CoV-2 was observed 1.8% compared to those who did not take it 6.6%, (p-value = 0.006) with a risk reduction of a positive Chain Reaction of Real-Time Polymerase Transcription (RT-PCR) COVID-19 test by 74% (HR 0.26, 95% CI [0.10,0.71]). These results support the use of weekly Ivermectin as a compassionate preventive method in the healthcare personnel.</jats:p>",2021-04-17
5,10.1101/2021.04.26.441389,327,bioRxiv,Microbiology,False,Antiviral defense via nucleotide depletion in bacteria,"[{'ORCID': 'http://orcid.org/0000-0003-3113-6755', 'authenticated-orcid': False, 'given': 'Nitzan', 'family': 'Tal', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6844-7613', 'authenticated-orcid': False, 'given': 'Adi', 'family': 'Millman', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2869-5401', 'authenticated-orcid': False, 'given': 'Avigail', 'family': 'Stokar-Avihail', 'sequence': 'additional', 'affiliation': []}, {'given': 'Taya', 'family': 'Fedorenko', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9137-9543', 'authenticated-orcid': False, 'given': 'Azita', 'family': 'Leavitt', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0604-3605', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Melamed', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1907-9244', 'authenticated-orcid': False, 'given': 'Erez', 'family': 'Yirmiya', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carmel', 'family': 'Abraham', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2954-2503', 'authenticated-orcid': False, 'given': 'Gil', 'family': 'Amitai', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3872-4982', 'authenticated-orcid': False, 'given': 'Rotem', 'family': 'Sorek', 'sequence': 'additional', 'affiliation': []}]","<jats:p>DNA viruses and retroviruses need to consume large quantities of deoxynucleotides (dNTPs) when replicating within infected cells. The human antiviral factor SAMHD1 takes advantage of this vulnerability in the viral life cycle, and inhibits viral replication by degrading dNTPs into their constituent deoxynucleosides and inorganic phosphate. In this study we report that bacteria employ a similar strategy to defend against phage infection. We found a family of defensive dCTP deaminase proteins that, in response to phage infection, convert dCTP into deoxy-uracil nucleotides. A second family of phage resistance genes encode dGTPase enzymes, which degrade dGTP into phosphate-free deoxy-guanosine (dG) and are distant homologs of the human SAMHD1. Our results show that the defensive proteins completely eliminate the specific deoxynucleotide (either dCTP or dGTP) from the nucleotide pool during phage infection, thus starving the phage of an essential DNA building block and halting its replication. Both defensive genes are found in a diverse set of bacterial species and are specifically enriched in Vibrio genomes. Our study demonstrates that manipulation of the deoxynucleotide pool is a potent antiviral strategy shared by both prokaryotes and eukaryotes.</jats:p>",2021-04-26
6,10.1101/2021.04.21.21255873,262,medRxiv,Infectious Diseases (except HIV/AIDS),True,Real World Effectiveness of COVID-19 mRNA Vaccines against Hospitalizations and Deaths in the United States,"[{'ORCID': 'http://orcid.org/0000-0002-3464-2111', 'authenticated-orcid': False, 'given': 'Farhaan S.', 'family': 'Vahidy', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7697-0084', 'authenticated-orcid': False, 'given': 'Lauren', 'family': 'Pischel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mauricio E.', 'family': 'Tano', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alan P.', 'family': 'Pan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marc L.', 'family': 'Boom', 'sequence': 'additional', 'affiliation': []}, {'given': 'Henry Dirk', 'family': 'Sostman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Khurram', 'family': 'Nasir', 'sequence': 'additional', 'affiliation': []}, {'given': 'Saad B.', 'family': 'Omer', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Covid-19 has caused significant global mortality. Multiple vaccines have demonstrated efficacy in clinical trials though real-world effectiveness of vaccines against Covid-19 mortality in clinically and demographically diverse populations has not yet been reported.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We used a retrospective cohort assembled from a cross-institution comprehensive data repository. Established patients of the health care system were categorized as not immunized, partially immunized, or fully immunized against SARS-CoV-2 with an mRNA vaccine through April 4, 2021. Outcomes were Covid-19 related hospitalization and death.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of the 91,134 established patients, 70.2% were not immunized, 4.5% were partially immunized and 25.4% were fully immunized. Among the fully immunized 0.7% had a Covid-19 hospitalization, whereas 3.4% among the partially immunized and 2.7% non-immunized individuals were hospitalized with Covid-19. Of the 225 deaths among Covid-19 hospitalizations, 219 (97.3%) were in the not immunized, 5 (2.2%) in the partially immunized, and 1 (0.0041%) in the fully immunized group. mRNA vaccines were 96% (95%CI: 95 — 99) effective at preventing Covid-19 related hospitalization and 98.7% (95%CI: 91.0 — 99.8) effective at preventing Covid-19 related death when participants were fully vaccinated. Partial vaccination was 77% (95%CI: 71 — 82) effective at preventing hospitalization and 64.2% (95%CI: 13.0 — 85.2) effective at preventing death. Vaccine effectiveness at preventing hospitalization was conserved across subgroups of age, race, ethnicity, Area Deprivation Index, and Charlson Comorbidity Index.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>In a large, diverse cohort in the United States, full immunization with mRNA vaccines was highly effective in the real-world scenario at preventing Covid-19 related hospitalization and death.</jats:p></jats:sec>",2021-04-23
7,10.1101/2021.02.17.21251946,198,medRxiv,Infectious Diseases (except HIV/AIDS),True,Estimating the Failure Risk of Quarantine Systems for Preventing COVID-19 Outbreaks in Australia and New Zealand,"[{'ORCID': 'http://orcid.org/0000-0002-4427-7314', 'authenticated-orcid': False, 'given': 'Leah M', 'family': 'Grout', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7373-0520', 'authenticated-orcid': False, 'given': 'Ameera', 'family': 'Katar', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7715-2561', 'authenticated-orcid': False, 'given': 'Driss', 'family': 'Ait Ouakrim', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3156-0479', 'authenticated-orcid': False, 'given': 'Jennifer A', 'family': 'Summers', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4184-001X', 'authenticated-orcid': False, 'given': 'Amanda', 'family': 'Kvalsvig', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1865-1536', 'authenticated-orcid': False, 'given': 'Michael G', 'family': 'Baker', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6995-4369', 'authenticated-orcid': False, 'given': 'Tony', 'family': 'Blakely', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5118-0676', 'authenticated-orcid': False, 'given': 'Nick', 'family': 'Wilson', 'sequence': 'additional', 'affiliation': []}]","<jats:p><jats:bold>Objectives:</jats:bold> To identify COVID-19 outbreaks and border control failures associated with quarantine systems in Australia and New Zealand and to estimate the failure risks. 
<jats:bold>Design, setting, participants:</jats:bold> Observational epidemiological study of travellers transiting quarantine in Australia and New Zealand up to 31 March 2021.
<jats:bold>Main outcome measures:</jats:bold> The incidence of COVID-19 related failures arising from quarantine, and the failure risk for those transiting quarantine, estimated both per 100,000 travellers and per 1000 SARS-CoV-2 positive cases.
<jats:bold>Results:</jats:bold> Australia and New Zealand had 22 COVID-19 related failures arising from quarantine systems up to 31 March 2021 (12 and 10, respectively). One resultant outbreak involved an estimated 800 deaths and quarantine failures instigated nine lockdowns. The failure risk for those transiting quarantine was estimated at 5.7 failures per 100,000 travellers and 5.3 failures (95%CI: 3.1 to 7.5) per 1000 SARS-CoV-2 positive cases. The latter risk was almost four-fold higher in New Zealand compared with Australia. Approximately 54% of quarantine system failures could likely have been prevented with the full vaccination of frontline border workers, for 70% effectiveness at preventing transmission.
<jats:bold>Conclusions:</jats:bold> Quarantine system failures can be costly in terms of lives and economic impacts such as lockdowns. Ongoing improvements or alternatives to hotel-based quarantine are required.</jats:p>",2021-02-19
8,10.1101/2021.04.06.21254882,193,medRxiv,Epidemiology,True,Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals,"[{'given': 'Talia', 'family': 'Kustin', 'sequence': 'first', 'affiliation': []}, {'given': 'Noam', 'family': 'Harel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Uriah', 'family': 'Finkel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shay', 'family': 'Perchik', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sheri', 'family': 'Harari', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maayan', 'family': 'Tahor', 'sequence': 'additional', 'affiliation': []}, {'given': 'Itamar', 'family': 'Caspi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rachel', 'family': 'Levy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael', 'family': 'Leschinsky', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shifra Ken', 'family': 'Dror', 'sequence': 'additional', 'affiliation': []}, {'given': 'Galit', 'family': 'Bergerzon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hala', 'family': 'Gadban', 'sequence': 'additional', 'affiliation': []}, {'given': 'Faten', 'family': 'Gadban', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eti', 'family': 'Eliassian', 'sequence': 'additional', 'affiliation': []}, {'given': 'Orit', 'family': 'Shimron', 'sequence': 'additional', 'affiliation': []}, {'given': 'Loulou', 'family': 'Saleh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Haim', 'family': 'Ben-Zvi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Doron', 'family': 'Amichay', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anat', 'family': 'Ben-Dor', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dana', 'family': 'Sagas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Merav', 'family': 'Strauss', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yonat Shemer', 'family': 'Avni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amit', 'family': 'Huppert', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eldad', 'family': 'Kepten', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ran D.', 'family': 'Balicer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Doron', 'family': 'Nezer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shay', 'family': 'Ben-Shachar', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2919-3542', 'authenticated-orcid': False, 'given': 'Adi', 'family': 'Stern', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary</jats:title><jats:p>The SARS-CoV-2 pandemic has been raging for over a year, creating global detrimental impact. The BNT162b2 mRNA vaccine has demonstrated high protection levels, yet apprehension exists that several variants of concerns (VOCs) can surmount the immune defenses generated by the vaccines. Neutralization assays have revealed some reduction in neutralization of VOCs B.1.1.7 and B.1.351, but the relevance of these assays in real life remains unclear. We performed a case-control study that examined the distribution of SARS-CoV-2 variants observed in infections of vaccinated individuals (“breakthrough cases”) and matched infections of unvaccinated individuals. We hypothesized that if there is lower vaccine effectiveness against one of the VOCs, its proportion among the breakthrough cases should be higher than among unvaccinated cases. Our results show that vaccinees that tested positive at least a week after the second dose were indeed disproportionally infected with B.1.351, as compared with unvaccinated individuals (odds ratio of 8:1). Those who tested positive between two weeks after the first dose and one week after the second dose, were disproportionally infected by B.1.1.7 (odds ratio of 26:10), suggesting reduced vaccine effectiveness against both VOCs at particular time windows following vaccination. Nevertheless, the B.1.351 incidence in Israel to-date remains low and vaccine effectiveness remains high among those fully vaccinated. These results overall suggest that vaccine breakthrough infection may be more frequent with both VOCs, yet a combination of mass-vaccination with two doses coupled with non-pharmaceutical interventions control and contain their spread.</jats:p>",2021-04-09
9,10.1101/2020.08.21.20179671,168,medRxiv,Epidemiology,True,Evidence for treatment with estradiol for women with SARS-CoV-2 infection,"[{'ORCID': 'http://orcid.org/0000-0002-1979-386X', 'authenticated-orcid': False, 'given': 'Ute', 'family': 'Seeland', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7184-5519', 'authenticated-orcid': False, 'given': 'Flaminia', 'family': 'Coluzzi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4164-1472', 'authenticated-orcid': False, 'given': 'Maurizio', 'family': 'Simmaco', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7985-2561', 'authenticated-orcid': False, 'given': 'Cameron', 'family': 'Mura', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7618-7292', 'authenticated-orcid': False, 'given': 'Philip E.', 'family': 'Bourne', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4987-2913', 'authenticated-orcid': False, 'given': 'Max', 'family': 'Heiland', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2407-1087', 'authenticated-orcid': False, 'given': 'Robert', 'family': 'Preissner', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3672-0283', 'authenticated-orcid': False, 'given': 'Saskia', 'family': 'Preissner', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Given that an individual’s age and gender are strongly predictive of COVID-19 outcomes, do such factors imply anything about preferable therapeutic options?</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>An analysis of electronic health records for a large (68,466-case), international COVID-19 cohort, in five-year age strata, revealed age-dependent sex differences. In particular, we surveyed the effects of systemic hormone administration in women. The primary outcome for estradiol therapy was death. Odds Ratios (ORs) and Kaplan-Meier survival curves were analyzed for 37,086 COVID-19 women in two age groups: pre- (15-49 years) and post-menopausal (&gt;50 years).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The incidence of SARS-CoV-2 infection is higher in women than men (about +15%) and, in contrast, the fatality rate is higher in men (about +50%). Interestingly, the relationships between these quantities are also linked to age. Pre-adolescent girls had the same risk of infection and fatality rate as boys. Adult premenopausal women had a significantly higher risk of infection than men in the same five-year age stratum (about 16,000 vs. 12,000 cases). This ratio changed again in postmenopausal women, with infection susceptibility converging with men. While fatality rates increased continuously with age for both sexes, at 50 years there was a steeper increase for men. Thus far, these types of intricacies have been largely neglected. Because the hormone 17ß-estradiol has a positive effect on expression of the human ACE2 protein—which plays an essential role for SARS-CoV-2 cellular entry—propensity score matching was performed for the women’s sub-cohort, comparing users versus non-users of estradiol. This retrospective study of hormone therapy in female COVID-19 patients shows that the fatality risk for women &gt;50 yrs receiving estradiol therapy (user group) is reduced by more than 50%; the OR was 0.33, 95 % CI [0.18, 0.62] and the Hazard Ratio was 0.29, 95% CI[0.11,0.76]. For younger, pre-menopausal women (15-49 yrs), the risk of COVID-19 fatality is the same irrespective of estradiol treatment, probably because of higher endogenous estradiol levels.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>As of this writing, still no effective drug treatment is available for COVID-19; since estradiol shows such a strong improvement regarding fatality in COVID-19, we suggest prospective studies on the potentially more broadly protective roles of this naturally occurring hormone.</jats:p></jats:sec>",2020-08-24
10,10.1101/2021.01.28.428665,167,bioRxiv,Immunology,True,Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce robust immune responses in mice,"[{'ORCID': 'http://orcid.org/0000-0001-7958-6961', 'authenticated-orcid': False, 'given': 'Alexandra J', 'family': 'Spencer', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5195-6254', 'authenticated-orcid': False, 'given': 'Paul F', 'family': 'McKay', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8637-3785', 'authenticated-orcid': False, 'given': 'Sandra', 'family': 'Belij-Rammerstorfer', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4288-2892', 'authenticated-orcid': False, 'given': 'Marta', 'family': 'Ulaszewska', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3345-663X', 'authenticated-orcid': False, 'given': 'Cameron D', 'family': 'Bissett', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kai', 'family': 'Hu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Karnyart', 'family': 'Samnuan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna K.', 'family': 'Blakney', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8114-1838', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Wright', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1194-2429', 'authenticated-orcid': False, 'given': 'Hannah R', 'family': 'Sharpe', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6883-666X', 'authenticated-orcid': False, 'given': 'Ciaran', 'family': 'Gilbride', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adam', 'family': 'Truby', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6406-4834', 'authenticated-orcid': False, 'given': 'Elizabeth R', 'family': 'Allen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6823-9750', 'authenticated-orcid': False, 'given': 'Sarah C', 'family': 'Gilbert', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4936-1718', 'authenticated-orcid': False, 'given': 'Robin J', 'family': 'Shattock', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7711-897X', 'authenticated-orcid': False, 'given': 'Teresa', 'family': 'Lambe', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Several vaccines have demonstrated efficacy against SARS-CoV-2 mediated disease, yet there is limited data on the immune response induced by heterologous vaccination regimens using alternate vaccine modalities. Here, we present a detailed description of the immune response, in mice, following vaccination with a self-amplifying RNA (saRNA) vaccine and an adenoviral vectored vaccine (ChAdOx1 nCoV-19/AZD1222) against SARS-CoV-2. We demonstrate that antibody responses are higher in two dose heterologous vaccination regimens than single dose regimens. Neutralising titres after heterologous prime-boost were at least comparable or higher than the titres measured after homologous prime boost vaccination with viral vectors. Importantly, the cellular immune response after a heterologous regimen is dominated by cytotoxic T cells and Th1<jats:sup>+</jats:sup> CD4 T cells which is superior to the response induced in homologous vaccination regimens in mice. These results underpin the need for clinical trials to investigate the immunogenicity of heterologous regimens with alternate vaccine technologies.</jats:p>",2021-01-29
11,10.1101/2020.10.29.20220426,143,medRxiv,Infectious Diseases (except HIV/AIDS),True,Occupational risk of COVID-19 in the 1st vs 2nd wave of infection,"[{'ORCID': 'http://orcid.org/0000-0003-4851-5794', 'authenticated-orcid': False, 'given': 'Karin', 'family': 'Magnusson', 'sequence': 'first', 'affiliation': []}, {'given': 'Karin', 'family': 'Nygård', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fredrik', 'family': 'Methi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Line', 'family': 'Vold', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kjetil', 'family': 'Telle', 'sequence': 'additional', 'affiliation': []}]","<jats:sec><jats:title>Aim</jats:title><jats:p>To study whether employees in occupations that typically imply close contact with other people are tested more and at higher risk of confirmed SARS-CoV-2 infection (COVID-19) and related hospitalization, in the 1<jats:sup>st</jats:sup> and 2<jats:sup>nd</jats:sup> wave of infection in Norway.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In all 3 559 694 residents of Norway on January 1<jats:sup>st</jats:sup> 2020 aged 20-70 (with mean [SD] age 44.1 [14.3] years and 51% men), we studied COVID-19 testing patterns sorted by occupation (using Standard Classification of Occupations [ISCO-08]). We also studied whether selected occupations had a higher risk of 1) confirmed COVID-19 and 2) hospitalization with COVID-19, compared to everyone else aged 20-70 years using logistic regression adjusted for age, sex, testing behavior, and own and maternal country of birth.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Occupations with high frequency of testing (e.g. health personnel and teachers) had a low frequency of positive tests. Nurses, physicians, dentists, physiotherapists, bus/tram and taxi drivers had 1.1-4 times the odds of COVID-19 during the 1<jats:sup>st</jats:sup> wave, whereas bartenders, waiters, transport conductors and travel stewards had 1.1-3 times the odds of COVID-19 during the 2<jats:sup>nd</jats:sup> wave (when compared to everyone else). Teachers had moderately increased odds of COVID-19. Occupation may be of limited relevance for hospitalization with the disease.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Studying the entire Norwegian population using international standardized codes of occupations, our findings may be of relevance to national and regional authorities in handling the pandemic. Also, our findings provide a knowledge foundation for the more targeted future studies of lockdown, testing strategies and disease control measures.</jats:p></jats:sec>",2020-11-03
12,10.1101/2021.01.26.21250543,140,medRxiv,Infectious Diseases (except HIV/AIDS),True,The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera,"[{'given': 'Sonia', 'family': 'Jangra', 'sequence': 'first', 'affiliation': []}, {'given': 'Chengjin', 'family': 'Ye', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raveen', 'family': 'Rathnasinghe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel', 'family': 'Stadlbauer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Florian', 'family': 'Krammer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Viviana', 'family': 'Simon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luis', 'family': 'Martinez-Sobrido', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adolfo', 'family': 'García-Sastre', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael', 'family': 'Schotsaert', 'sequence': 'additional', 'affiliation': []}, {'name': 'PVI study group', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>One year in the coronavirus disease 2019 (COVID-19) pandemic, the first vaccines are being rolled out under emergency use authorizations. It is of great concern that newly emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can escape antibody-mediated protection induced by previous infection or vaccination through mutations in the spike protein. The glutamate (E) to Lysine (K) substitution at position 484 (E484K) in the receptor binding domain (RBD) of the spike protein is present in the rapidly spreading variants of concern belonging to the B.1.351 and P.1 lineages. We performed <jats:italic>in vitro</jats:italic> microneutralization assays with both the USA-WA1/2020 virus and a recombinant (r)SARS-CoV-2 virus that is identical to USA-WA1/2020 except for the E484K mutation introduced in the spike RBD. We selected 34 sera from study participants based on their SARS-CoV-2 spike ELISA antibody titer (negative [N=4] versus weak [N=8], moderate [N=11] or strong positive [N=11]). In addition, we included sera from five individuals who received two doses of the Pfizer SARS-CoV-2 vaccine BNT162b2. Serum neutralization efficiency was lower against the E484K rSARS-CoV-2 (vaccination samples: 3.4 fold; convalescent low IgG: 2.4 fold, moderate IgG: 4.2 fold and high IgG: 2.6 fold) compared to USA-WA1/2020. For some of the convalescent donor sera with low or moderate IgG against the SARS-CoV-2 spike, the drop in neutralization efficiency resulted in neutralization ID<jats:sub>50</jats:sub> values similar to negative control samples, with low or even absence of neutralization of the E484K rSARS-CoV-2. However, human sera with high neutralization titers against the USA-WA1/2020 strain were still able to neutralize the E484K rSARS-CoV-2. Therefore, it is important to aim for the highest titers possible induced by vaccination to enhance protection against newly emerging SARS-CoV-2 variants. Two vaccine doses may be needed for induction of high antibody titers against SARS-CoV-2. Postponing the second vaccination is suggested by some public health authorities in order to provide more individuals with a primer vaccination. Our data suggests that this may leave vaccinees less protected against newly emerging variants.</jats:p>",2021-01-29
13,10.1101/2021.02.27.21252597,140,medRxiv,Epidemiology,True,Household COVID-19 risk and in-person schooling,"[{'ORCID': 'http://orcid.org/0000-0002-9741-8109', 'authenticated-orcid': False, 'given': 'Justin', 'family': 'Lessler', 'sequence': 'first', 'affiliation': []}, {'given': 'M. Kate', 'family': 'Grabowski', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kyra H.', 'family': 'Grantz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elena', 'family': 'Badillo-Goicoechea', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3166-7521', 'authenticated-orcid': False, 'given': 'C. Jessica E.', 'family': 'Metcalf', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carly', 'family': 'Lupton-Smith', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8662-9077', 'authenticated-orcid': False, 'given': 'Andrew S.', 'family': 'Azman', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9042-8611', 'authenticated-orcid': False, 'given': 'Elizabeth A.', 'family': 'Stuart', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>In-person schooling has proved contentious and difficult to study throughout the SARS-CoV-2 pandemic. Data from a massive online survey in the United States indicates an increased risk of COVID-19-related outcomes among respondents living with a child attending school in-person. School-based mitigation measures are associated with significant reductions in risk, particularly daily symptoms screens, teacher masking, and closure of extra-curricular activities. With seven or more mitigation measures, the association between in-person schooling and COVID-19-related outcomes all but disappears. Teachers working outside the home were more likely to report COVID-19-related outcomes, but this association is similar to other occupations (e.g., healthcare, office work). In-person schooling is associated with household COVID-19 risk, but this risk can likely be controlled with properly implemented school-based mitigation measures.</jats:p><jats:sec><jats:title>One sentence summary</jats:title><jats:p>Living with children attending in-person school is linked to a higher risk of COVID-19 outcomes, which school-based interventions can mitigate.</jats:p></jats:sec>",2021-03-01
14,10.1101/2021.03.03.433755,138,bioRxiv,Plant Biology,False,Large scale genomic rearrangements in selectedArabidopsis thalianaT-DNA lines are caused by T-DNA insertion mutagenesis,"[{'ORCID': 'http://orcid.org/0000-0002-3321-7471', 'authenticated-orcid': False, 'given': 'Boas', 'family': 'Pucker', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9124-5203', 'authenticated-orcid': False, 'given': 'Nils', 'family': 'Kleinbölting', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7635-3473', 'authenticated-orcid': False, 'given': 'Bernd', 'family': 'Weisshaar', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Experimental proof of gene function assignments in plants is heavily based on mutant analyses. T- DNA insertion lines provided an invaluable resource of mutants and enabled systematic reverse genetics-based investigation of the functions of<jats:italic>Arabidopsis thaliana</jats:italic>genes during the last decades.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We sequenced the genomes of 14<jats:italic>A. thaliana</jats:italic>GABI-Kat T-DNA insertion lines, which eluded flanking sequence tag-based attempts to characterize their insertion loci, with Oxford Nanopore Technologies (ONT) long reads. Complex T-DNA insertions were resolved and 11 previously unknown T-DNA loci identified, suggesting that the number of T-DNA insertions per line was underestimated. T-DNA mutagenesis caused fusions of chromosomes along with compensating translocations to keep the gene set complete throughout meiosis. Also, an inverted duplication of 800 kbp was detected. About 10% of GABI-Kat lines might be affected by chromosomal rearrangements, some of which do not involve T-DNA. Local assembly of selected reads was shown to be a computationally effective method to resolve the structure of T-DNA insertion loci. We developed an automated workflow to support investigation of long read data from T-DNA insertion lines. All steps from DNA extraction to assembly of T-DNA loci can be completed within days.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Long read sequencing was demonstrated to be a very effective way to resolve complex T-DNA insertions and chromosome fusions. Many T-DNA insertions comprise not just a single T-DNA, but complex arrays of multiple T-DNAs. It is becoming obvious that T-DNA insertion alleles must be characterized by exact identification of both T-DNA::genome junctions to generate clear genotype- to-phenotype relations.</jats:p></jats:sec>",2021-03-04
15,10.1101/2021.04.26.21256152,137,medRxiv,Infectious Diseases (except HIV/AIDS),False,Effectiveness of portable air filtration on reducing indoor aerosol counts: preclinical observational trials,"[{'given': 'Junghoon', 'family': 'Lee', 'sequence': 'first', 'affiliation': []}, {'given': 'Max', 'family': 'Rounds', 'sequence': 'additional', 'affiliation': []}, {'given': 'Forbes', 'family': 'McGain', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robyn', 'family': 'Schofield', 'sequence': 'additional', 'affiliation': []}, {'given': 'Grant', 'family': 'Skidmore', 'sequence': 'additional', 'affiliation': []}, {'given': 'Imogen', 'family': 'Wadlow', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kevin', 'family': 'Kevin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ashley', 'family': 'Stevens', 'sequence': 'additional', 'affiliation': []}, {'given': 'Caroline', 'family': 'Marshall', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lou', 'family': 'Irving', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marion', 'family': 'Kainer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kirsty', 'family': 'Buising', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jason', 'family': 'Monty', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Objective: To assess the effectiveness of aerosol filtration by portable air cleaning devices with high efficiency particulate air (HEPA) filters used in addition to standard building heating ventilation and air-conditioning (HVAC).

Methods: Test rooms, including a hospital single-patient room, were filled with test aerosol to simulate aerosol movement. Aerosol counts were measured over time with various portable air cleaning devices and room ventilation systems to quantify the aerosol concentration reduction rate and overall clearance rate.

Results: Portable air cleaners were very effective in removing aerosols, especially for the devices with high flow rate. In a small control room, the aerosols were cleared 4 to 5 times faster with portable air cleaners than the room with HVAC alone. A single bed hospital room equipped with an excellent ventilation rate (~ 14 air changes per hour) can clear the aerosols in 20 minutes. However, with the addition of two air cleaners, the clearance time became 3 times faster (in 6 minutes and 30 seconds).

Conclusions: Portable air cleaning devices with HEPA filtration were highly effective at removing aerosols. To clear aerosols (above 90% clearance) in under 10 minutes requires around 25 air changes per hour; readily feasible with air cleaners. Inexpensive portable air cleaning devices should be considered for small and enclosed spaces in health care settings such as inpatient rooms, personal protective equipment donning/doffing stations, and staff tea rooms. Portable air cleaners are particularly important where there is limited ability to reduce aerosol transmission with building HVAC ventilation.</jats:p>",2021-04-28
16,10.1101/2020.08.18.256594,119,bioRxiv,Neuroscience,False,"A Practical Alzheimer Disease Classifier via Brain Imaging-Based Deep Learning on 85,721 Samples","[{'given': 'Bin', 'family': 'Lu', 'sequence': 'first', 'affiliation': []}, {'given': 'Hui-Xian', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zhi-Kai', 'family': 'Chang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Le', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ning-Xuan', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zhi-Chen', 'family': 'Zhu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hui-Xia', 'family': 'Zhou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xue-Ying', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yu-Wei', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shi-Xian', 'family': 'Cui', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zhao-Yu', 'family': 'Deng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zhen', 'family': 'Fan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hong', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiao', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4720-8867', 'authenticated-orcid': False, 'given': 'Paul M.', 'family': 'Thompson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Francisco Xavier', 'family': 'Castellanos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chao-Gan', 'family': 'Yan', 'sequence': 'additional', 'affiliation': []}, {'name': 'for the Alzheimer’s Disease Neuroimaging Initiative', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Beyond detecting brain lesions or tumors, comparatively little success has been attained in identifying brain disorders such as Alzheimer’s disease (AD), based on magnetic resonance imaging (MRI). Many machine learning algorithms to detect AD have been trained using limited training data, meaning they often generalize poorly when applied to scans from previously unseen populations. Here we aimed to build a practical brain imaging-based AD diagnostic classifier using deep learning/transfer learning on dataset of unprecedented size and diversity. We pooled MRI data from more than 217 sites/scanners to constitute the largest brain MRI sample to date (85,721 scans from 50,876 participants). Next, we applied a state-of-the-art deep convolutional neural network, Inception-ResNet-V2, to build a sex classifier with high generalization capability. The sex classifier achieved 94.9% accuracy and served as a base model in transfer learning for the objective diagnosis of AD. After transfer learning, the model fine-tuned for AD classification achieved 91.3% accuracy in leave-sites-out cross-validation on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset and 94.2%/87.9% accuracy for direct tests on two unseen independent datasets (AIBL/OASIS). When this AD classifier was tested on brain images from unseen mild cognitive impairment (MCI) patients, MCI patients who finally converted to AD were 3 times more likely to be predicted as AD than MCI patients who did not convert (65.2% vs 20.6%). Predicted scores from the AD classifier showed significant correlations with illness severity. In sum, the proposed AD classifier could offer a medical-grade biomarker that could be integrated into AD diagnostic practice. Our trained model, code and preprocessed data are freely available to the research community.</jats:p>",2020-08-20
17,10.1101/2021.03.08.21252200,109,medRxiv,Epidemiology,True,Vaccine effectiveness after 1st and 2nd dose of the BNT162b2 mRNA Covid-19 Vaccine in long-term care facility residents and healthcare workers – a Danish cohort study,"[{'given': 'Ida Rask', 'family': 'Moustsen-Helms', 'sequence': 'first', 'affiliation': []}, {'given': 'Hanne-Dorthe', 'family': 'Emborg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jens', 'family': 'Nielsen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katrine Finderup', 'family': 'Nielsen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tyra Grove', 'family': 'Krause', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kåre', 'family': 'Mølbak', 'sequence': 'additional', 'affiliation': []}, {'given': 'Karina Lauenborg', 'family': 'Møller', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ann-Sofie Nicole', 'family': 'Berthelsen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Palle', 'family': 'Valentiner-Branth', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>At the end of 2020, Denmark launched an immunization program against SARS-CoV-2. The Danish health authorities prioritized persons currently living in long-term care facilities (LTCF residents) and frontline healthcare workers (HCW) as the first receivers of vaccination. Here we present preliminary population based vaccine effectiveness (VE) estimates in these two target groups.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The study was designed as a retrospective registry- and population-based observational cohort study including all LTCF residents and all HWC. The outcome was a polymerase chain reaction confirmed SARS-CoV-2, and VE was estimated for different periods following first and second dose. We used Poisson and Cox regressions to estimate respectively crude and calendar time-adjusted VE for the BNT162b2 mRNA Covid-19 Vaccine from Pfizer/BioNTech with 95% confidence intervals (CI) for vaccinated versus unvaccinated.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A total of 39,040 LTCF residents (median age at first dose; 84 years, Interquartile range (IQR): 77-90) and 331,039 HCW (median age at first dose; 47 years, IQR: 36-57) were included. Among LTCF residents, 95.2% and 86.0% received first and second dose from 27 December 2020 until 18 February 2021, for HWC the proportion was 27.8% and 24.4%. During a median follow-up of 53 days, there were 488 and 5,663 confirmed SARS-CoV-2 cases in the unvaccinated groups, whereas there were 57 and 52 in LTCF residents and HCW within the first 7 days after the second dose and 27 and 10 cases beyond seven days of second dose. No protective effect was observed for LTCF residents after first dose. In HCW, VE was 17% (95% CI; 4-28) in the &gt; 14 days after first dose (before second dose). Furthermore, the VE in LTCF residents at day 0-7 of second dose was 52% (95% CI; 27-69) and 46% (95% CI; 28-59) in HCW. Beyond seven days of second dose, VE increased to 64% (95% CI; 14-84) and 90% (95% CI; 82-95) in the two groups, respectively.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The results were promising regarding the VE both within and beyond seven days of second vaccination with the BNT162b2 mRNA Covid-19 Vaccine currently used in many countries to help mitigate the global SARS-CoV-2 pandemic.</jats:p></jats:sec><jats:sec><jats:title>Impact of the research</jats:title><jats:p>So far, observational studies of the real-word effectiveness of the mRNA Vaccine BNT162b2 has been limited to the period after the administration of the first dose. This is the first report to date to present vaccine effectiveness (VE) estimates after the second BNT162b2 mRNA Covid-19 Vaccine. We estimated a VE of 52% and 46% in LTCF residents and HCW within seven days, which increased to 64% and 90% in the two groups respectively beyond seven days of immunization. These findings supports maintaining a two-dose schedule of the BNT162b2 mRNA Covid-19 Vaccine.</jats:p></jats:sec>",2021-03-09
18,10.1101/2021.04.26.21256136,105,medRxiv,Infectious Diseases (except HIV/AIDS),True,Detecting in-school transmission of SARS-CoV-2 from case ratios and documented clusters,"[{'ORCID': 'http://orcid.org/0000-0001-8011-0012', 'authenticated-orcid': False, 'given': 'Kaitlyn', 'family': 'Johnson', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1086-9717', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Lachmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Madison', 'family': 'Stoddard', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9321-6876', 'authenticated-orcid': False, 'given': 'Remy', 'family': 'Pasco', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1969-3778', 'authenticated-orcid': False, 'given': 'Spencer J', 'family': 'Fox', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5828-8874', 'authenticated-orcid': False, 'given': 'Lauren Ancel', 'family': 'Meyers', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arijit', 'family': 'Chakravarty', 'sequence': 'additional', 'affiliation': []}]",<jats:p>Claims that in-person schooling has not amplified SARS-CoV-2 transmission are based on similar infection rates in schools and their surrounding communities and limited numbers of documented in-school transmission events. Simulations assuming high in-school transmission suggest that these metrics cannot exclude the possibility that transmission in schools exacerbated overall pandemic risks.</jats:p>,2021-04-28
19,10.1101/2021.03.01.21252652,105,medRxiv,Infectious Diseases (except HIV/AIDS),True,"Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England","[{'given': 'Jamie Lopez', 'family': 'Bernal', 'sequence': 'first', 'affiliation': []}, {'given': 'Nick', 'family': 'Andrews', 'sequence': 'additional', 'affiliation': []}, {'given': 'Charlotte', 'family': 'Gower', 'sequence': 'additional', 'affiliation': []}, {'given': 'Julia', 'family': 'Stowe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chris', 'family': 'Robertson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elise', 'family': 'Tessier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ruth', 'family': 'Simmons', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simon', 'family': 'Cottrell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard', 'family': 'Roberts', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mark', 'family': 'O’Doherty', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kevin', 'family': 'Brown', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claire', 'family': 'Cameron', 'sequence': 'additional', 'affiliation': []}, {'given': 'Diane', 'family': 'Stockton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jim', 'family': 'McMenamin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mary', 'family': 'Ramsay', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Objectives</jats:title><jats:p>To estimate the real-world effectiveness of the Pfizer/BioNTech BNT162b2 vaccine and Astrazeneca ChAdOx1 vaccine against Confirmed COVID-19, hospitalisations and deaths. To estimate effectiveness on the UK variant of concern.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Test negative case control design</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>Community COVID-19 PCR testing in England</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>All adults in England aged 70 years and older (over 7.5 million). All COVID-19 testing in the community among eligible individuals who reported symptoms between 8<jats:sup>th</jats:sup>December 2020 and 19<jats:sup>th</jats:sup>February 2021 was included in the analysis.</jats:p></jats:sec><jats:sec><jats:title>Interventions</jats:title><jats:p>One and two doses of BNT162b2 vaccine. One dose of ChAdOx1 vaccine.</jats:p></jats:sec><jats:sec><jats:title>Main outcome measures</jats:title><jats:p>Symptomatic PCR confirmed SARS-CoV-2 infection, hospitalisations and deaths with COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Individuals aged &gt;=80 years vaccinated with BNT162b2 prior to 4<jats:sup>th</jats:sup>January, had a higher odds of testing positive in the first 9 days after vaccination (odds ratio up to 1.48, 95%CI 1.23-1.77), indicating that those initially targeted had a higher underlying risk of infection. Vaccine effectiveness was therefore estimated relative to the baseline post-vaccination period. Vaccine effects were noted from 10-13 days after vaccination, reaching an effectiveness of 70% (95% CI 59-78%) from 28-34 days, then plateauing. From 14 days after the second dose a vaccine effectiveness of 89% (95%CI: 85-93%) was seen.</jats:p><jats:p>Individuals aged &gt;=70 years vaccinated from 4<jats:sup>th</jats:sup>January had a similar underlying risk of COVID-19 to unvaccinated individuals. With BNT162b2, vaccine effectiveness reached 61% (95%CI 51-69%) from 28-34 days after vaccination then plateaued. With the ChAdOx1 vaccine, vaccine effects were seen from 14-20 days after vaccination reaching an effectiveness of 60% (95%CI 41-73%) from 28-34 days and further increasing to 73% (95%CI 27-90%) from day 35 onwards.</jats:p><jats:p>On top of the protection against symptomatic disease, cases who had been vaccinated with one dose of BNT162b2 had an additional 43% (95%CI 33-52%) lower risk of emergency hospitalisation and an additional 51% (95%CI 37-62%) lower risk of death. Cases who had been vaccinated with one dose of ChAdOx1 had an additional 37% (95% CI 3-59%) lower risk of emergency hospitalisation. There was insufficient follow-up to assess the effect of ChAdOx1 on mortality due to the later rollout of this vaccine. Combined with the effect against symptomatic disease, this indicates that a single dose of either vaccine is approximately 80% effective at preventing hospitalisation and a single dose of BNT162b2 is 85% effective at preventing death with COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Vaccination with either a single dose of BNT162b2 or ChAdOx1 COVID-19 vaccination was associated with a significant reduction in symptomatic SARS-CoV2 positive cases in older adults with even greater protection against severe disease. Both vaccines show similar effects. Protection was maintained for the duration of follow-up (&gt;6 weeks). A second dose of BNT162b2 provides further protection against symptomatic disease but second doses of ChAdOx1 have not yet been rolled out in England. There is a clear effect of the vaccines against the UK variant of concern.</jats:p></jats:sec>",2021-03-02
20,10.1101/2021.03.29.21254554,101,medRxiv,Primary Care Research,True,IVERMECTIN REPROPOSING FOR COVID-19 TREATMENT OUTPATIENTS IN MILD STAGE IN PRIMARY HEALTH CARE CENTERS,"[{'given': 'Rossana Elena', 'family': 'Chahla', 'sequence': 'first', 'affiliation': []}, {'given': 'Luis', 'family': 'Medina Ruiz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Teresa', 'family': 'Mena', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yolanda', 'family': 'Brepe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paola', 'family': 'Terranova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eugenia Silvana', 'family': 'Ortega', 'sequence': 'additional', 'affiliation': []}, {'given': 'Guillermo Gabriel', 'family': 'Barrenechea', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5454-9873', 'authenticated-orcid': False, 'given': 'Daniel Gustavo', 'family': 'Goroso', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria de los Angeles', 'family': 'Peral de Bruno', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The emergence of COVID-19 requires alternative treatments based on the reuse of drugs as a strategy to prevent the progression of the disease in patients infected with SARS-COV-2. The goal was to evaluate the use of ivermectin in mild stage outpatients to heal and / or reverse the progression of COVID-19 disease towards the development of moderate or severe stages.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Cluster Assigned Clinical Trial (2:1) in outpatients, n = 234. The subjects were divided into experimental (EG: n = 110) and control groups (CG: n = 62). The EG received ivermectin orally 4 drops of 6 mg = 24 mg every 7 days for 4 weeks. All participants were diagnosed by positive RT-PCR for COVID-19 and were evaluated by clinical examination, at the beginning and the end of protocol. Data analyzed were applied the proportion, bivariate, and logical regression tests with level significance p &lt; 0·05. This study was registered at <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""uri"" xlink:href=""http://ClinicalTrials.gov"">ClinicalTrials.gov</jats:ext-link> Identifier <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""clintrialgov"" xlink:href=""NCT04784481"">NCT04784481</jats:ext-link>.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Both groups were similar in age, sex, and comorbidities (EG: 56F, median age= 40·0, range: 18·0 - 75·0; CG: 34F, median age = 37·5, range: 18·0 - 71·0). A significant reduction in the symptom numbers was observed in the EG when the medical examination was performed from 5<jats:sup>th</jats:sup> to 9<jats:sup>th</jats:sup> days, after starting treatment (<jats:italic>p</jats:italic> = 0·0026). Although, medical examination from 10<jats:sup>th</jats:sup> to 14<jats:sup>th</jats:sup> day, showed a progressive reduction of the percentage symptom numbers, these were not significative in both groups. A higher proportion of medical release was observed in EG (98·2%) vs CG (87·1%) (<jats:italic>p</jats:italic> = 0·003). EG showed 8 times more chance of receiving medical release than CG (OR 7·99, 95% CI: 1·64 −38·97, <jats:italic>p</jats:italic> = 0·003). The treatment effect with ivermectin to obtain medical release was analyzed by the logistic regression model based in the following control variables: sex, age, and comorbidities. Then, the chance to obtain medical release was maintained in EG (OR 10·37, 95% CI: 2·05 - 52·04, <jats:italic>p</jats:italic> = 0·005).</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>Treatment with ivermectin in outpatients with mild stage COVID-19 disease managed to slightly reduce the symptom numbers. Also, this treatment improved the clinical state to obtain medical release, even in the presence of comorbidities. The treatment with ivermectin could significantly prevent the evolution to serious stages since the EG did not present any patient with referral to critical hospitalization.</jats:p><jats:p><jats:italic>Clinical Trials</jats:italic> registry number is <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""clintrialgov"" xlink:href=""NCT04784481"">NCT04784481</jats:ext-link></jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>Ministry of Public Health. Tucumán, Argentina.</jats:p></jats:sec><jats:sec><jats:title>Research in Context</jats:title><jats:sec><jats:title>Evidence before this study</jats:title><jats:p>Currently there are no specific therapies approved for COVID-19 treatment by the FDA, that is why different repositionable drugs are being studied in clinical trials and compassionate use protocols based on <jats:italic>in vitro</jats:italic> activity. ivermectin is a broad spectrum antiparasitic agent that has been shown to have antiviral activity against a wide range of viruses. A study by Caly et al. (2020) suggested thatnuclear transport inhibitory activity of ivermectin may be effective against SARS-CoV-2. Since the publication of that work, numerous clinical trials were started to study ivermectin potential for COVID-19 treatment. At the end of March 2021, there were about 60 studies registered in <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""uri"" xlink:href=""https://www.clinicaltrials.gov"">https://www.clinicaltrials.gov</jats:ext-link>, and 43 studies listened <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""uri"" xlink:href=""https://www.who.int/clinical-trials-registry-platform"">https://www.who.int/clinical-trials-registry-platform</jats:ext-link> about the safety and effectiveness of ivermectin in COVID-19 patients, for treatment and prophylaxis. Most of these studies are from developing countries, which shows the need of emerging economies to find alternative therapies to contain the spread of the disease and the collapse of health systems.</jats:p></jats:sec><jats:sec><jats:title>Added value of this study</jats:title><jats:p>We found that an early intervention with ivermectin has impacted on the score of symptoms related to COVID-19 in ambulatory patients, between the 5<jats:sup>th</jats:sup> and 9<jats:sup>th</jats:sup> day. The patients who received the treatment changed from score 2 to score 1 in the WHO ordinal scale. In any case, patients evolved to higher scores. Also the treatment increased the probability to obtain medical release, even in the presence of comorbidities.</jats:p></jats:sec><jats:sec><jats:title>Implications of all available evidence</jats:title><jats:p>According to the <jats:underline>COVID-19 Treatment Guidelines by the NIH</jats:underline>, most trials have several limitations. It needs results from adequately powered and well-designed clinical trials to provide evidence-based guidance on the role of ivermectin in the treatment of COVID-19. However, our study shows overlaps in benefits with other authors, and taking together, these results are encouraging for further study about repurposing ivermectin for the treatment of COVID-19.</jats:p></jats:sec></jats:sec>",2021-03-30
21,10.1101/2021.03.27.21254453,100,medRxiv,Epidemiology,True,How unequal vaccine distribution promotes the evolution of vaccine escape,"[{'given': 'Philip J', 'family': 'Gerrish', 'sequence': 'first', 'affiliation': []}, {'given': 'Fernando', 'family': 'Saldaña', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benjamin', 'family': 'Galeota-Sprung', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexandre', 'family': 'Colato', 'sequence': 'additional', 'affiliation': []}, {'given': 'Erika E', 'family': 'Rodriguez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jorge X Velasco', 'family': 'Hernández', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Health officials warn that SARS-CoV-2 vaccines must be uniformly distributed within and among countries if we are to quell the ongoing pandemic. Yet there has been little critical assessment of the underlying reasons for this warning. Here, we explicitly show why vaccine equity is necessary. Perhaps counter-intuitively, we find that vaccine escape mutants are less likely to come from highly vaccinated regions where there is strong selection pressure favoring vaccine escape and more likely to come from neighboring unvaccinated regions where there is no selection favoring escape. Unvaccinated geographic regions thus provide evolutionary reservoirs from which new strains can arise and cause new epidemics within neighboring vaccinated regions and beyond. Our findings have timely implications for vaccine rollout strategies and public health policy.</jats:p>",2021-03-28
22,10.1101/2021.04.27.441464,93,bioRxiv,Biophysics,False,Stochastic dynamics of single molecules across phase boundaries,"[{'ORCID': 'http://orcid.org/0000-0002-2738-867X', 'authenticated-orcid': False, 'given': 'Stefano', 'family': 'Bo', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1934-7437', 'authenticated-orcid': False, 'given': 'Lars', 'family': 'Hubatsch', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0301-7655', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Bauermann', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6279-0405', 'authenticated-orcid': False, 'given': 'Christoph A.', 'family': 'Weber', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4731-9185', 'authenticated-orcid': False, 'given': 'Frank', 'family': 'Julicher', 'sequence': 'additional', 'affiliation': []}]","<jats:p>We discuss the stochastic trajectories of single molecules in a phase-separated liquid, when a dense and a dilute phase coexist. Starting from a continuum theory of macroscopic phase separation we derive a stochastic Langevin equation for molecular trajectories that takes into account thermal fluctuations. We find that molecular trajectories can be described as diffusion with drift in an effective potential, which has a steep gradient at phase boundaries. We discuss how the physics of phase coexistence affects the statistics of molecular trajectories and in particular the statistics of displacements of molecules crossing a phase boundary. At thermodynamic equilibrium detailed balance imposes that the distributions of displacements crossing the phase boundary from the dense or from the dilute phase are the same. Our theory can be used to infer key phase separation parameters from the statistics of single-molecule trajectories. For simple Brownian motion, there is no drift in the presence of a concentration gradient. We show that interactions in the fluid give rise to an average drift velocity in concentration gradients. Interestingly, under non-equilibrium conditions, single molecules tend to drift uphill the concentration gradient. Thus, our work bridges between single-molecule dynamics and collective dynamics at macroscopic scales and provides a framework to study single-molecule dynamics in phase-separating systems.</jats:p>",2021-04-27
23,10.1101/839977,93,bioRxiv,Ecology,False,The minimum land area requiring conservation attention to safeguard biodiversity,"[{'ORCID': 'http://orcid.org/0000-0001-6322-0172', 'authenticated-orcid': False, 'given': 'James R.', 'family': 'Allan', 'sequence': 'first', 'affiliation': []}, {'given': 'Hugh P.', 'family': 'Possingham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Scott C.', 'family': 'Atkinson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anthony', 'family': 'Waldron', 'sequence': 'additional', 'affiliation': []}, {'given': 'Moreno', 'family': 'Di Marco', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3509-7901', 'authenticated-orcid': False, 'given': 'Vanessa M.', 'family': 'Adams', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stuart H. M.', 'family': 'Butchart', 'sequence': 'additional', 'affiliation': []}, {'given': 'W. Daniel', 'family': 'Kissling', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Worsdell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gwili', 'family': 'Gibbon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kundan', 'family': 'Kumar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Piyush', 'family': 'Mehta', 'sequence': 'additional', 'affiliation': []}, {'given': 'Martine', 'family': 'Maron', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0692-7507', 'authenticated-orcid': False, 'given': 'Brooke A.', 'family': 'Williams', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kendall R.', 'family': 'Jones', 'sequence': 'additional', 'affiliation': []}, {'given': 'Brendan A.', 'family': 'Wintle', 'sequence': 'additional', 'affiliation': []}, {'given': 'April E.', 'family': 'Reside', 'sequence': 'additional', 'affiliation': []}, {'given': 'James E.M.', 'family': 'Watson', 'sequence': 'additional', 'affiliation': []}]","<jats:p>More ambitious conservation efforts are needed to stop the global biodiversity crisis. Here, we estimate the minimum land area to secure important sites for terrestrial fauna, ecologically intact areas, and the optimal locations for representation of species ranges and ecoregions. We discover that at least 64 million km<jats:sup>2</jats:sup> (44% of terrestrial area) requires conservation attention. Over 1.8 billion people live on these lands so responses that promote agency, self-determination, equity, and sustainable management for safeguarding biodiversity are essential. Spatially explicit land-use scenarios suggest that 1.3 million km<jats:sup>2</jats:sup> of land requiring conservation could be lost to intensive human land-uses by 2030, which requires immediate attention. However, there is a seven-fold difference between the amount of habitat converted under optimistic and pessimistic scenarios, highlighting an opportunity to avert this crisis. Appropriate targets in the post-2020 Global Biodiversity Framework to ensure conservation of the identified land would contribute substantially to safeguarding biodiversity.</jats:p>",2019-11-12
24,10.1101/2020.12.16.20248134,91,medRxiv,Infectious Diseases (except HIV/AIDS),True,No evidence of association between schools and SARS-CoV-2 second wave in Italy,"[{'ORCID': 'http://orcid.org/0000-0002-1348-4548', 'authenticated-orcid': False, 'given': 'Sara', 'family': 'Gandini', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4450-5751', 'authenticated-orcid': False, 'given': 'Maurizio', 'family': 'Rainisio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria Luisa', 'family': 'Iannuzzo', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5956-4340', 'authenticated-orcid': False, 'given': 'Federica', 'family': 'Bellerba', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5614-4359', 'authenticated-orcid': False, 'given': 'Francesco', 'family': 'Cecconi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8515-8928', 'authenticated-orcid': False, 'given': 'Luca', 'family': 'Scorrano', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>During the Covid19 pandemic, school closure has been mandated in analogy to its known effect against influenza, but it is unclear whether schools are early amplifiers of Covid19 cases.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We performed a cross-sectional and prospective cohort study in Italy. We used databases from the Italian Ministry of Education containing the number of new positive SARS-CoV-2 cases per school from September 20 to November 8, 2020 to calculate incidence among students and staff. We calculated incidence across each age group using databases from the Veneto Region system of SARS-CoV-2 cases notification in the period August 26- November 24, 2020. We used a database from the Veneto Region system of SARS-CoV-2 secondary cases tracing in Verona province schools to estimate number of tests, the frequency of secondary infections at school by type of index case and the ratio positive cases/ number of tests per school institute using an adjusted multivariable generalized linear regression model. We estimated the reproduction number R<jats:sub>t</jats:sub>at the regional level from the Italian Civil Protection of regional SARS-CoV-2 cases notification database in the period 6 August-2 December 2020.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>From September 12 to November 7 2020, SARS-CoV-2 incidence among students was lower than that in the general population of all but two Italian regions. Secondary infections were &lt;1%, and clusters of &gt;2 secondary cases per school were 5-7% in a representative November week. Incidence among teachers was greater than in the general population. However, when compared with incidence among similar age groups, the difference was not significant (P=0.23). Secondary infections among teachers were more frequent when the index case was a teacher than a student (38% vs. 11%, P=0.007). From August 28 to October 25 in Veneto where school reopened on September 14, the growth of SARS-CoV- 2 incidence was lower in school age individuals, maximal in 20-29 and 45-49 years old individuals. The delay between the different school opening dates in the different Italian regions and the increase in the regional Covid19 reproduction number R<jats:sub>t</jats:sub>was not uniform. Reciprocally, school closures in two regions where they were implemented before other measures did not affect the rate of R<jats:sub>t</jats:sub>decline.</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>Our analysis does not support a role for school opening as a driver of the second wave of SARS-CoV-2 epidemics in Italy, a large European country with high SARS-CoV-2 incidence.</jats:p></jats:sec><jats:sec><jats:title>Research in context</jats:title><jats:sec><jats:title>Evidence before this study</jats:title><jats:p>The role of schools and at large of children as amplifiers of the Covid19 pandemics is debated. Despite biological and epidemiological evidence that children play a marginal role in Sars-CoV-2 spread, policies of school closures have been predicated, mostly based on the temporal coincidence between school reopening in certain countries and Covid19 outbreaks. Whether schools contributed to the so called “second wave” of Covid19 is uncertain. Italy’s regionalized calendar of school reopening and databases of positivity at school allows to estimate the impact of schools on the increase of Sars-CoV-2 that occurred in autumn 2020.</jats:p></jats:sec><jats:sec><jats:title>Added value of this study</jats:title><jats:p>We found that incidence among students is lower than in the general population and that whereas incidence among teachers appears higher than that in the general population, it is comparable to that among individuals of the same age bracket. Moreover, secondary infections at school are rare and clusters even less common. The index case of a secondary teacher case is more frequently a teacher than a student. In Veneto, during the first phase of the second wave incidence among school age individuals was low as opposed to the sustained incidence among individuals of 45-49 years. Finally, the time lag between school opening and Rt increase was not uniform across different Italian regions with different school opening dates, with lag times shorter in regions where schools opened later.</jats:p></jats:sec><jats:sec><jats:title>Implications of the available evidence</jats:title><jats:p>These findings contribute to indicate that Covid19 infections rarely occur at school and that transmission from students to teachers is very rare. Moreover, they fail to support a role for school age individuals and school openings as a driver of the Covid19 second wave. Overall, our findings could help inform policy initiatives of school openings during the current Covid19 pandemic.</jats:p></jats:sec></jats:sec>",2020-12-18
25,10.1101/2021.03.31.21254502,89,medRxiv,Infectious Diseases (except HIV/AIDS),True,Increased household secondary attacks rates with Variant of Concern SARS-CoV-2 index cases,"[{'given': 'Sarah A.', 'family': 'Buchan', 'sequence': 'first', 'affiliation': []}, {'given': 'Semra', 'family': 'Tibebu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nick', 'family': 'Daneman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael', 'family': 'Whelan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thuva', 'family': 'Vanniyasingam', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michelle', 'family': 'Murti', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kevin A.', 'family': 'Brown', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>IMPORTANCE</jats:title><jats:p>Higher secondary attack rates related to variant of concern (VOC) index cases have been reported, but have not been explored within households, which continue to be an important source of coronavirus disease 2019 (COVID-19) transmission</jats:p></jats:sec><jats:sec><jats:title>OBJECTIVE</jats:title><jats:p>To compare secondary attack rates in households with VOC versus non-VOC index cases.</jats:p></jats:sec><jats:sec><jats:title>DESIGN</jats:title><jats:p>A retrospective cohort study of household index cases reported from February 7 – 27, 2021. A propensity-score matched cohort was derived to calculate adjusted estimates.</jats:p></jats:sec><jats:sec><jats:title>SETTING</jats:title><jats:p>Ontario, Canada.</jats:p></jats:sec><jats:sec><jats:title>PARTICIPANTS</jats:title><jats:p>A population-based cohort of all private households with index cases. We excluded cases in congregate settings, as well as households with one individual or with &gt;1 case with the same earliest symptom onset date.</jats:p></jats:sec><jats:sec><jats:title>EXPOSURE</jats:title><jats:p>VOC status, defined as either individuals confirmed as B.1.1.7 using whole genome sequencing or those that screened positive for the N501Y mutation using real-time PCR.</jats:p></jats:sec><jats:sec><jats:title>MAIN OUTCOME AND MEASURE</jats:title><jats:p>Household secondary attack rate, defined as the number of household secondary cases that occurred 1-14 days after the index case divided by the total number of household secondary contacts.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>We included 1,259 index VOC and non-VOC cases in the propensity score-matched analysis. The secondary attack rate for VOC index cases in this matched cohort was 1.31 times higher than non-VOC index cases (RR=1.31, 95%CI 1.14-1.49), similar to the unadjusted estimate. In stratified analyses, the higher secondary attack rate for VOC compared to non-VOC index cases was accentuated for asymptomatic index cases (RR=1.91, 95% CI 0.96-3.80) and presymptomatic cases (RR=3.41, 95%CI 1.13-10.26)</jats:p></jats:sec><jats:sec><jats:title>CONCLUSIONS AND RELEVANCE</jats:title><jats:p>This study provides strong evidence of increased transmissibility in households due to VOCs and suggests that asymptomatic and pre-symptomatic transmission may be of particular importance for VOCs. Our study suggests that more aggressive public health measures will be needed to control VOCs and that ongoing research is needed to understand mechanisms of VOC transmissibility to curb their associated morbidity and mortality.</jats:p></jats:sec>",2021-04-05
26,10.1101/2020.07.31.20166116,87,medRxiv,Epidemiology,False,Face masks to prevent transmission of respiratory diseases: Systematic review and meta-analysis of randomized controlled trials*,"[{'ORCID': 'http://orcid.org/0000-0002-5302-6429', 'authenticated-orcid': False, 'given': 'Hanna M.', 'family': 'Ollila', 'sequence': 'first', 'affiliation': []}, {'given': 'Markku', 'family': 'Partinen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jukka', 'family': 'Koskela', 'sequence': 'additional', 'affiliation': []}, {'given': 'Riikka', 'family': 'Savolainen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna', 'family': 'Rotkirch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Liisa T.', 'family': 'Laine', 'sequence': 'additional', 'affiliation': []}]","<jats:title>A<jats:sc>bstract</jats:sc></jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>To examine the effect of face mask intervention in respiratory infections across different exposure settings and age groups.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Systematic review and meta-analysis.</jats:p></jats:sec><jats:sec><jats:title>Data sources</jats:title><jats:p>PubMed, Cochrane Central Register of Controlled Trials, and Web of Science were searched for randomized controlled trials investigating the effect of face masks on respiratory infections published by November 18th, 2020. We followed PRISMA guidelines.</jats:p></jats:sec><jats:sec><jats:title>Eligibility criteria for selecting studies</jats:title><jats:p>Randomized controlled trials investigating face masks in respiratory infections across different exposure settings. Two reviewers performed the search, extracted data, and assessed the risk of bias. Random effects meta-analysis with risk ratio, adjusted odds ratios, and number needed to treat were performed. Findings by source control or wearer protection, age groups, exposure settings, and role of non-compliance were evaluated.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Seventeen studies were included, (N=11,601 cases and N=10,286 controls, follow-up from 4 days to 19 months). Fourteen trials included adults and children and three trials included children only. Twelve studies showed non-compliance in treatment and eleven in control group. Four studies supported the use of face masks. Meta-analysis across all studies with risk ratios found no association with number of infections (RR=0.957 [0.810 − 1.131], p=0.608). Meta-analysis using odds ratios adjusted for age, sex, and vaccination (when available) showed protective effect of face masks (OR=0.850 [0.736 − 0.982], p=0.027). Subgroup meta-analysis with adjusted odds ratios found a decrease in respiratory infections among adults (14 studies, OR = 0.829 [0.709 − 0.969], p=0.019) in source control setting (OR = 0.845 [0.7375 − 0.969], p=0.0159) and when face masks were used together with hand hygiene OR = 0.690 [0.568 − 0.838], p=0.0002). Overall between-study heterogeneity was large also in the subgroup analyses.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Despite the large between study heterogeneity, compliance bias and differences by environmental settings, the findings support the use of face masks to prevent respiratory infections. <jats:italic>PROSPERO registration number CRD42020205523</jats:italic>.</jats:p></jats:sec>",2020-08-04
27,10.1101/2021.04.28.441626,86,bioRxiv,Evolutionary Biology,False,"A re-analysis of the data in Sharkey et al.'s (2021) minimalist revision reveals that BINs do not deserve names, but BOLD Systems needs a stronger commitment to open science","[{'ORCID': 'http://orcid.org/0000-0002-4452-2885', 'authenticated-orcid': False, 'given': 'Rudolf', 'family': 'Meier', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8961-9998', 'authenticated-orcid': False, 'given': 'Bonnie', 'family': 'Blaimer', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5265-815X', 'authenticated-orcid': False, 'given': 'Eliana', 'family': 'Buenaventura', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8598-9844', 'authenticated-orcid': False, 'given': 'Emily', 'family': 'Hartop', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6253-3078', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'von Rintelen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7988-3437', 'authenticated-orcid': False, 'given': 'Amrita', 'family': 'Srivathsan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1888-7482', 'authenticated-orcid': False, 'given': 'Darren', 'family': 'Yeo', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Halting biodiversity decline is one of the most critical challenges for humanity, but biodiversity assessment and monitoring are hampered by taxonomic impediments. We here distinguish between a ""dark taxon impediment"" caused by a large number of undescribed species and a ""superficial description impediment"" caused by species descriptions so imprecise that type specimens have to be consulted in order to resolve species identities. Recently, Sharkey et al. (2021) proposed to address the dark taxon impediment for Costa Rican braconid wasps by describing 403 species based on barcode clusters (""BINs"") computed by BOLD Systems. The default assumption of the revision is that BIN=Species (e.g., BOLD:ACM9419 becomes Bracon federicomatarritai Sharkey, sp. nov.) and therefore the diagnoses of most species consist only of a consensus barcode. We here argue that this type of ""minimalist revision"" is unnecessary and undesirable. It is unnecessary because barcode clusters (e.g. BINs) already provide grouping statements that overcome many of the obstacles associated with dark taxon impediments. However, minimalist revisions are also undesirable and problematic because the diagnoses are only based on one character system - that in the case of Sharkey et al. was poorly analyzed. Furthermore, the revision relies on units that violate basic rules of reproducibility because the BINs were delimited by a proprietary algorithm (RESL) that is applied to a mixture of public and private data. Here, we illustrate that many of the BINs described as species are unstable when the available public data are reanalyzed, reiterate that COI mostly measures time of divergence, and that BOLD Systems violates key principles of open science. We conclude by urging authors, reviewers, editors, and grantors to only publish and fund projects that adhere to modern standards of reproducibility.</jats:p>",2021-04-29
28,10.1101/2021.04.08.21255106,80,medRxiv,Neurology,False,Adipose tissue distribution from body MRI is associated with cross-sectional and longitudinal brain age in adults,"[{'ORCID': 'http://orcid.org/0000-0002-0974-9304', 'authenticated-orcid': False, 'given': 'Dani', 'family': 'Beck', 'sequence': 'first', 'affiliation': []}, {'given': 'Ann-Marie G.', 'family': 'de Lange', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7361-5418', 'authenticated-orcid': False, 'given': 'Dag', 'family': 'Alnæs', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ivan I.', 'family': 'Maximov', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5240-7783', 'authenticated-orcid': False, 'given': 'Mads L.', 'family': 'Pedersen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Olof Dahlqvist', 'family': 'Leinhard', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7399-8375', 'authenticated-orcid': False, 'given': 'Jennifer', 'family': 'Linge', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rozalyn', 'family': 'Simon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Geneviève', 'family': 'Richard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kristine M.', 'family': 'Ulrichsen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Erlend S.', 'family': 'Dørum', 'sequence': 'additional', 'affiliation': []}, {'given': 'Knut K.', 'family': 'Kolskår', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anne-Marthe', 'family': 'Sanders', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adriano', 'family': 'Winterton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tiril P.', 'family': 'Gurholt', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4003-1018', 'authenticated-orcid': False, 'given': 'Tobias', 'family': 'Kaufmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nils Eiel', 'family': 'Steen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jan Egil', 'family': 'Nordvik', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4461-3568', 'authenticated-orcid': False, 'given': 'Ole A.', 'family': 'Andreassen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8644-956X', 'authenticated-orcid': False, 'given': 'Lars T.', 'family': 'Westlye', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>There is an intimate body-brain connection in ageing, and obesity is a key risk factor for poor cardiometabolic health and neurodegenerative conditions. Although research has demonstrated deleterious effects of obesity on brain structure and function, the majority of studies have used conventional measures such as waist-to-hip ratio, waist circumference, and body mass index. While sensitive to gross features of body composition, such global anthropomorphic features fail to describe regional differences in body fat distribution and composition, and to determine visceral adiposity, which is related to a range of metabolic conditions. In this mixed cross-sectional and longitudinal design (interval mean and standard deviation = 19.7 ± 0.5 months), including 790 healthy individuals (mean (range) age = 46.7 (18-94) years, 53% women), we investigated cross-sectional body magnetic resonance imaging (MRI, n = 286) measures of adipose tissue distribution in relation to longitudinal brain structure using MRI-based morphometry and diffusion tensor imaging (DTI). We estimated tissue-specific brain age at two time points and performed Bayesian multilevel modelling to investigate the associations between adipose measures at follow-up and brain age gap (BAG) at baseline and follow-up. We also tested for interactions between BAG and both time and age on each adipose measure. The results showed credible associations between T1-based BAG and liver fat, muscle fat infiltration (MFI), and weight-to-muscle ratio (WMR), indicating older-appearing brains in people with higher measures of adipose tissue. Longitudinal evidence supported interaction effects between time and MFI and WMR on T1-based BAG, indicating accelerated ageing over the course of the study period in people with higher measures of adipose tissue. The results show that specific measures of fat distribution are associated with brain ageing and that different compartments of adipose tissue may be differentially linked with increased brain ageing, with potential to identify key processes involved in age-related transdiagnostic disease processes.</jats:p>",2021-04-15
29,10.1101/2021.01.27.21250617,80,medRxiv,Infectious Diseases (except HIV/AIDS),True,More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis,"[{'ORCID': 'http://orcid.org/0000-0001-7504-3441', 'authenticated-orcid': False, 'given': 'Sandra', 'family': 'Lopez-Leon', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3207-6697', 'authenticated-orcid': False, 'given': 'Talia', 'family': 'Wegman-Ostrosky', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0111-1154', 'authenticated-orcid': False, 'given': 'Carol', 'family': 'Perelman', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1146-9552', 'authenticated-orcid': False, 'given': 'Rosalinda', 'family': 'Sepulveda', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9808-063X', 'authenticated-orcid': False, 'given': 'Paulina A', 'family': 'Rebolledo', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9451-1914', 'authenticated-orcid': False, 'given': 'Angelica', 'family': 'Cuapio', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6174-4113', 'authenticated-orcid': False, 'given': 'Sonia', 'family': 'Villapol', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>COVID-19, caused by SARS-CoV-2, can involve sequelae and other medical complications that last weeks to months after initial recovery, which has come to be called Long-COVID or COVID long-haulers. This systematic review and meta-analysis aims to identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage. LitCOVID (PubMed and Medline) and Embase were searched by two independent researchers. All articles with original data for detecting long-term COVID-19 published before 1<jats:sup>st</jats:sup> of January 2021 and with a minimum of 100 patients were included. For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. Heterogeneity was assessed using <jats:italic>I</jats:italic><jats:sup>2</jats:sup> statistics. This systematic review followed Preferred Reporting Items for Systematic Reviewers and Meta-analysis (PRISMA) guidelines, although the study protocol was not registered. A total of 18,251 publications were identified, of which 15 met the inclusion criteria. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included. The follow-up time ranged from 14 to 110 days post-viral infection. The age of the study participants ranged between 17 and 87 years. It was estimated that 80% (95% CI 65-92) of the patients that were infected with SARS-CoV-2 developed one or more long-term symptoms. The five most common symptoms were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). All meta-analyses showed medium (n=2) to high heterogeneity (n=13). In order to have a better understanding, future studies need to stratify by sex, age, previous comorbidities, severity of COVID-19 (ranging from asymptomatic to severe), and duration of each symptom. From the clinical perspective, multi-disciplinary teams are crucial to developing preventive measures, rehabilitation techniques, and clinical management strategies with whole-patient perspectives designed to address long COVID-19 care.</jats:p>",2021-01-29
30,10.1101/2021.01.28.21250706,78,medRxiv,Infectious Diseases (except HIV/AIDS),True,Early Multidrug Outpatient Treatment of SARS-CoV-2 Infection (COVID-19) and Reduced Mortality Among Nursing Home Residents,"[{'given': 'Paul E', 'family': 'Alexander', 'sequence': 'first', 'affiliation': []}, {'given': 'Robin', 'family': 'Armstrong', 'sequence': 'additional', 'affiliation': []}, {'given': 'George', 'family': 'Fareed', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kulvinder K.', 'family': 'Gill', 'sequence': 'additional', 'affiliation': []}, {'given': 'John', 'family': 'Lotus', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ramin', 'family': 'Oskoui', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chad', 'family': 'Prodromos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Harvey A.', 'family': 'Risch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Howard C', 'family': 'Tenenbaum', 'sequence': 'additional', 'affiliation': []}, {'given': 'Craig M.', 'family': 'Wax', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peter A.', 'family': 'McCullough', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The outbreak of COVID-19 from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread all over the world with tremendous morbidity and mortality in the elderly. In-hospital treatment addresses the multifaceted nature of the illness including viral replication, cytokine storm, and endothelial injury with thrombosis. We identified nine reports of early treatment outcomes in COVID-19 nursing home patients. Multi-drug therapy including hydroxychloroquine with one or more anti-infectives, corticosteroids, and antithrombotic agents can be extended to seniors in the nursing home setting without hospitalization. Data from nine studies found multidrug regimens relying on the use of hydroxychloroquine as well as other agents including doxycycline were associated with a statistically significant and &gt;60% reductions in mortality. Going forward, we theorize and based on the evidence, that early empiric treatment for the elderly with COVID-19 in the nursing home setting (or similar congregated settings with elderly residents/patients) has a genuine probability of success and acceptable safety. This group remains our highest at-risk group and warrants acute treatment focus that will prevent the development and/or worsening of problems associated with COVID-19, most particularly isolation, hospitalization, and death. In fact, with the rapidity and severity of SARS-CoV-2 outbreaks in nursing homes, in-center treatment of patients with acute COVID-19 is possibly the most rational and importantly <jats:italic>feasible</jats:italic> strategy to reduce the risks of hospitalization and death. If the approach remains ‘wait-and-see’ and elderly high-risk patients in such congregated nursing room type settings are allowed to worsen with no early treatment, they may be too sick and fragile to benefit from in-hospital therapeutics and are at risk for pulmonary failure, life-ending micro-thrombi of the lungs, kidneys etc. We put forth the notion that the most important factor in this regard, is making available early therapeutic intervention as described here. These drugs include and under supervision by skilled doctors, combination/sequenced ivermectin, hydroxychloroquine, colchicine, azithromycin, doxycycline, bromhexine hydrochloride, and favipiravir (outside the US), along with inhaled steroids such as budesonide and oral steroids including dexamethasone and prednisone, and anti-thrombotic anti-clotting drugs such as heparin). As the clinical trials data on treatments for COVID-19 mature, this early treatment therapeutic option deserves serious, urgent, and sober consideration by the medical establishment and respective decision-makers.</jats:p>",2021-02-01
31,10.1101/2020.07.18.210161,76,bioRxiv,Immunology,True,An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19,"[{'ORCID': 'http://orcid.org/0000-0003-0684-7635', 'authenticated-orcid': False, 'given': 'Reuben', 'family': 'McGregor', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8343-0860', 'authenticated-orcid': False, 'given': 'Daniel', 'family': 'Chauss', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4759-717X', 'authenticated-orcid': False, 'given': 'Tilo', 'family': 'Freiwald', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4429-8200', 'authenticated-orcid': False, 'given': 'Bingyu', 'family': 'Yan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5758-4092', 'authenticated-orcid': False, 'given': 'Luopin', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7673-0013', 'authenticated-orcid': False, 'given': 'Estefania', 'family': 'Nova-Lamperti', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zonghao', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Heather', 'family': 'Teague', 'sequence': 'additional', 'affiliation': []}, {'given': 'Erin E', 'family': 'West', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0875-446X', 'authenticated-orcid': False, 'given': 'Jack', 'family': 'Bibby', 'sequence': 'additional', 'affiliation': []}, {'given': 'Audrey', 'family': 'Kelly', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amna', 'family': 'Malik', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexandra F', 'family': 'Freeman', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1660-8438', 'authenticated-orcid': False, 'given': 'Daniella', 'family': 'Schwartz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Didier', 'family': 'Portilla', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5620-1982', 'authenticated-orcid': False, 'given': 'Susan', 'family': 'John', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'Lavender', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4994-9500', 'authenticated-orcid': False, 'given': 'Michail S', 'family': 'Lionakis', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4939-5130', 'authenticated-orcid': False, 'given': 'Nehal N', 'family': 'Mehta', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4196-1417', 'authenticated-orcid': False, 'given': 'Claudia', 'family': 'Kemper', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9845-8292', 'authenticated-orcid': False, 'given': 'Nichola', 'family': 'Cooper', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4496-3215', 'authenticated-orcid': False, 'given': 'Giovanna', 'family': 'Lombardi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0942-8292', 'authenticated-orcid': False, 'given': 'Arian', 'family': 'Laurence', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7080-8820', 'authenticated-orcid': False, 'given': 'Majid', 'family': 'Kazemian', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2968-1156', 'authenticated-orcid': False, 'given': 'Behdad', 'family': 'Afzali', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Pro-inflammatory immune responses are necessary for effective pathogen clearance, but cause severe tissue damage if not shut down in a timely manner<jats:sup>1,2</jats:sup>. Excessive complement and IFN-γ-associated responses are known drivers of immunopathogenesis<jats:sup>3</jats:sup> and are among the most highly induced immune programs in hyper-inflammatory SARS-CoV2 lung infection<jats:sup>4</jats:sup>. The molecular mechanisms that govern orderly shutdown and retraction of these responses remain poorly understood. Here, we show that complement triggers contraction of IFN-γ producing CD4<jats:sup>+</jats:sup> T helper (Th) 1 cell responses by inducing expression of the vitamin D (VitD) receptor (VDR) and CYP27B1, the enzyme that activates VitD, permitting T cells to both activate and respond to VitD. VitD then initiates the transition from pro-inflammatory IFN-γ<jats:sup>+</jats:sup> Th1 cells to suppressive IL-10<jats:sup>+</jats:sup> Th1 cells. This process is primed by dynamic changes in the epigenetic landscape of CD4<jats:sup>+</jats:sup> T cells, generating superenhancers and recruiting c-JUN and BACH2, a key immunoregulatory transcription factor<jats:sup>5–7</jats:sup>. Accordingly, cells in psoriatic skin treated with VitD increased BACH2 expression, and BACH2 haplo-insufficient CD4<jats:sup>+</jats:sup> T cells were defective in IL-10 production. As proof-of-concept, we show that CD4<jats:sup>+</jats:sup> T cells in the bronchoalveolar lavage fluid (BALF) of patients with COVID-19 are Th1-skewed and that VDR is among the top regulators of genes induced by SARS-CoV2. Importantly, genes normally down-regulated by VitD were de-repressed in CD4<jats:sup>+</jats:sup> BALF T cells of COVID-19, indicating that the VitD-driven shutdown program is impaired in this setting. The active metabolite of VitD, alfacalcidol, and cortico-steroids were among the top predicted pharmaceuticals that could normalize SARS-CoV2 induced genes. These data indicate that adjunct therapy with VitD in the context of other immunomodulatory drugs may be a beneficial strategy to dampen hyperinflammation in severe COVID-19.</jats:p>",2020-07-19
32,10.1101/2021.04.26.441518,73,bioRxiv,Immunology,True,Nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity,"[{'ORCID': 'http://orcid.org/0000-0001-7515-2226', 'authenticated-orcid': False, 'given': 'William E.', 'family': 'Matchett', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0723-3347', 'authenticated-orcid': False, 'given': 'Vineet', 'family': 'Joag', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4321-6413', 'authenticated-orcid': False, 'given': 'J. Michael', 'family': 'Stolley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Frances K.', 'family': 'Shepherd', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clare F.', 'family': 'Quarnstrom', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clayton K.', 'family': 'Mickelson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8819-2654', 'authenticated-orcid': False, 'given': 'Sathi', 'family': 'Wijeyesinghe', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7291-8433', 'authenticated-orcid': False, 'given': 'Andrew G.', 'family': 'Soerens', 'sequence': 'additional', 'affiliation': []}, {'given': 'Samuel', 'family': 'Becker', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6603-281X', 'authenticated-orcid': False, 'given': 'Joshua M.', 'family': 'Thiede', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eyob', 'family': 'Weyu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stephen', 'family': 'O’Flanagan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jennifer A.', 'family': 'Walter', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michelle N.', 'family': 'Vu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8803-7606', 'authenticated-orcid': False, 'given': 'Vineet D.', 'family': 'Menachery', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7360-6546', 'authenticated-orcid': False, 'given': 'Tyler D.', 'family': 'Bold', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2520-809X', 'authenticated-orcid': False, 'given': 'Vaiva', 'family': 'Vezys', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8009-7655', 'authenticated-orcid': False, 'given': 'Marc K.', 'family': 'Jenkins', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0515-571X', 'authenticated-orcid': False, 'given': 'Ryan A.', 'family': 'Langlois', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9440-3884', 'authenticated-orcid': False, 'given': 'David', 'family': 'Masopust', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the COVID-19 pandemic. Neutralizing antibodies target the receptor binding domain of the spike (S) protein, a focus of successful vaccine efforts. Concerns have arisen that S-specific vaccine immunity may fail to neutralize emerging variants. We show that vaccination with HAd5 expressing the nucleocapsid (N) protein can establish protective immunity, defined by reduced weight loss and viral load, in both Syrian hamsters and k18-hACE2 mice. Challenge of vaccinated mice was associated with rapid N-specific T cell recall responses in the respiratory mucosa. This study supports the rationale for including additional viral antigens, even if they are not a target of neutralizing antibodies, to broaden epitope coverage and immune effector mechanisms.</jats:p>",2021-04-27
33,10.1101/2021.04.26.21255788,67,medRxiv,Public and Global Health,True,Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study,"[{'ORCID': 'http://orcid.org/0000-0003-4915-0715', 'authenticated-orcid': False, 'given': 'Katherine', 'family': 'Woolf', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3510-4814', 'authenticated-orcid': False, 'given': 'Ian Christopher', 'family': 'McManus', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2337-4799', 'authenticated-orcid': False, 'given': 'Christopher A', 'family': 'Martin', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2534-6951', 'authenticated-orcid': False, 'given': 'Laura B', 'family': 'Nellums', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1860-6337', 'authenticated-orcid': False, 'given': 'Anna Louise', 'family': 'Guyatt', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7216-4547', 'authenticated-orcid': False, 'given': 'Carl', 'family': 'Melbourne', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5231-4851', 'authenticated-orcid': False, 'given': 'Luke', 'family': 'Bryant', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3355-4259', 'authenticated-orcid': False, 'given': 'Mayuri', 'family': 'Gogoi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2880-8277', 'authenticated-orcid': False, 'given': 'Fatimah', 'family': 'Wobi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amani', 'family': 'Al-Oraibi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Osama B', 'family': 'Hassan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amit', 'family': 'Gupta', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6057-2073', 'authenticated-orcid': False, 'given': 'Catherine', 'family': 'John', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3596-7874', 'authenticated-orcid': False, 'given': 'Martin D', 'family': 'Tobin', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3726-3560', 'authenticated-orcid': False, 'given': 'Susan', 'family': 'Carr', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sandra', 'family': 'Simpson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6825-6753', 'authenticated-orcid': False, 'given': 'Bindu', 'family': 'Gregary', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0859-5550', 'authenticated-orcid': False, 'given': 'Avinash', 'family': 'Aujayeb', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stephen', 'family': 'Zingwe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rubina', 'family': 'Reza', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9284-9321', 'authenticated-orcid': False, 'given': 'Laura J', 'family': 'Gray', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2343-7099', 'authenticated-orcid': False, 'given': 'Kamlesh', 'family': 'Khunti', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1521-9964', 'authenticated-orcid': False, 'given': 'Manish', 'family': 'Pareek', 'sequence': 'additional', 'affiliation': []}, {'name': 'UK-REACH Study Collaborative Group', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Background
In most countries, healthcare workers (HCWs) represent a priority group for vaccination against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) due to their elevated risk of COVID-19 and potential contribution to nosocomial SARS-CoV-2 transmission. Concerns have been raised that HCWs from ethnic minority groups are more likely to be vaccine hesitant (defined by the World Health Organisation as refusing or delaying a vaccination) than those of White ethnicity, but there are limited data on SARS-CoV-2 vaccine hesitancy and its predictors in UK HCWs.
Methods
Nationwide prospective cohort study and qualitative study in a multi-ethnic cohort of clinical and non-clinical UK HCWs. We analysed ethnic differences in SARS-CoV-2 vaccine hesitancy adjusting for demographics, vaccine trust, and perceived risk of COVID-19. We explored reasons for hesitancy in qualitative data using a framework analysis. 
Findings
11,584 HCWs were included in the cohort analysis. 23% (2704) reported vaccine hesitancy. Compared to White British HCWs (21.3% hesitant), HCWs from Black Caribbean (54.2%), Mixed White and Black Caribbean (38.1%), Black African (34.4%), Chinese (33.1%), Pakistani (30.4%), and White Other (28.7%) ethnic groups were significantly more likely to be hesitant. In adjusted analysis, Black Caribbean (aOR 3.37, 95% CI 2.11 - 5.37), Black African (aOR 2.05, 95% CI 1.49 - 2.82), White Other ethnic groups (aOR 1.48, 95% CI 1.19 - 1.84) were significantly more likely to be hesitant. Other independent predictors of hesitancy were younger age, female sex, higher score on a COVID-19 conspiracy beliefs scale, lower trust in employer, lack of influenza vaccine uptake in the previous season, previous COVID-19, and pregnancy. Qualitative data from 99 participants identified the following contributors to hesitancy: lack of trust in government and employers, safety concerns due to the speed of vaccine development, lack of ethnic diversity in vaccine studies, and confusing and conflicting information. Participants felt uptake in ethnic minority communities might be improved through inclusive communication, involving HCWs in the vaccine rollout, and promoting vaccination through trusted networks.
Interpretation
Despite increased risk of COVID-19, HCWs from some ethnic minority groups are more likely to be vaccine hesitant than their White British colleagues. Strategies to build trust and dispel myths surrounding the COVID-19 vaccine in these communities are urgently required. Public health communications should be inclusive, non-stigmatising and utilise trusted networks. 
Funding
MRC-UK Research and Innovation (MR/V027549/1), the Department of Health and Social Care through the National Institute for Health Research (NIHR), and NIHR Biomedical Research Centres and NIHR Applied Research Collaboration East Midlands.</jats:p>",2021-04-28
34,10.1101/2021.04.27.441667,66,bioRxiv,Evolutionary Biology,False,Enhanced lipogenesis through Pparγ helps cavefish adapt to food scarcity.,"[{'given': 'Shaolei', 'family': 'Xiong', 'sequence': 'first', 'affiliation': []}, {'given': 'Wei', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexander', 'family': 'Kenzior', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luke', 'family': 'Olsen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jaya', 'family': 'Krishnan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jenna', 'family': 'Persons', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kyle', 'family': 'Medley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robert', 'family': 'Peuss', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yongfu', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shiyuan', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ning', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nancy', 'family': 'Thomas', 'sequence': 'additional', 'affiliation': []}, {'given': 'John', 'family': 'Miles', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1966-6959', 'authenticated-orcid': False, 'given': 'Alejandro', 'family': 'Sanchez Alvarado', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3248-2772', 'authenticated-orcid': False, 'given': 'Nicolas', 'family': 'Rohner', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Nutrient availability varies seasonally and spatially in the wild. The resulting nutrient limitation or restricted access to nutrients pose a major challenge for every organism. While many animals, such as hibernating animals, evolved strategies to overcome periods of nutrient scarcity, the cellular mechanisms of these strategies are poorly understood. Cave environments represent an extreme example of nutrient deprived environments since the lack of sunlight and therefore primary energy production drastically diminishes the nutrient availability. Here, we used Astyanax mexicanus, which includes river-dwelling surface fish and cave adapted cavefish populations to study the genetic adaptation to nutrient limitations. We show that cavefish populations store large amounts of fat in different body regions when fed ad libitum in the lab. We found higher expression of lipogenesis genes in cavefish livers when fed the same amount of food as surface fish, suggesting an improved ability of cavefish to use lipogenesis to convert available energy into triglycerides for storage into adipose tissue. Moreover, the lipid metabolism regulator, Peroxisome proliferator-activated receptor γ (Pparγ), is upregulated at both transcript and protein levels in cavefish livers. Chromatin Immunoprecipitation sequencing (ChIP seq) showed that Pparγ binds cavefish promoter regions of genes to a higher extent than surface fish. Finally, we identified two possible regulatory mechanisms of Pparγ in cavefish: higher amounts of ligands of the nuclear receptor, and nonsense mutations in per2, a known repressor of Pparγ. Taken together, our study reveals that upregulated Pparγ promotes higher levels of lipogenesis in the liver and contributes to higher body fat accumulation in cavefish populations, an important adaptation to nutrient limited environments.</jats:p>",2021-04-28
35,10.1101/2021.01.28.21250486,62,medRxiv,Infectious Diseases (except HIV/AIDS),True,PCR assay to enhance global surveillance for SARS-CoV-2 variants of concern,"[{'given': 'Chantal B.F.', 'family': 'Vogels', 'sequence': 'first', 'affiliation': []}, {'given': 'Mallery I.', 'family': 'Breban', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tara', 'family': 'Alpert', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mary E.', 'family': 'Petrone', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anne E.', 'family': 'Watkins', 'sequence': 'additional', 'affiliation': []}, {'given': 'Isabel M.', 'family': 'Ott', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jaqueline Goes', 'family': 'de Jesus', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ingra Morales', 'family': 'Claro', 'sequence': 'additional', 'affiliation': []}, {'given': 'Giulia', 'family': 'Magalhães Ferreira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Myuki A.E.', 'family': 'Crispim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lavanya', 'family': 'Singh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Houriiyah', 'family': 'Tegally', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ugochukwu J.', 'family': 'Anyaneji', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emma B.', 'family': 'Hodcroft', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher E.', 'family': 'Mason', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gaurav', 'family': 'Khullar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jessica', 'family': 'Metti', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joel T.', 'family': 'Dudley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthew J.', 'family': 'MacKay', 'sequence': 'additional', 'affiliation': []}, {'given': 'Megan', 'family': 'Nash', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jianhui', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chen', 'family': 'Liu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pei', 'family': 'Hui', 'sequence': 'additional', 'affiliation': []}, {'given': 'Steven', 'family': 'Murphy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Caleb', 'family': 'Neal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eva', 'family': 'Laszlo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marie L.', 'family': 'Landry', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anthony', 'family': 'Muyombwe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Randy', 'family': 'Downing', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jafar', 'family': 'Razeq', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tulio', 'family': 'de Oliveira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nuno R.', 'family': 'Faria', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ester C.', 'family': 'Sabino', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard A.', 'family': 'Neher', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joseph R.', 'family': 'Fauver', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nathan D.', 'family': 'Grubaugh', 'sequence': 'additional', 'affiliation': []}, {'name': 'Brazil-UK CADDE Genomic Network', 'sequence': 'additional', 'affiliation': []}, {'name': 'NGS-SA', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>With the emergence of SARS-CoV-2 variants that may increase transmissibility and/or cause escape from immune responses<jats:sup>1–3</jats:sup>, there is an urgent need for the targeted surveillance of circulating lineages. It was found that the B.1.1.7 (also 501Y.V1) variant first detected in the UK<jats:sup>4,5</jats:sup> could be serendipitously detected by the ThermoFisher TaqPath COVID-19 PCR assay because a key deletion in these viruses, spike Δ69-70, would cause a “spike gene target failure” (SGTF) result. However, a SGTF result is not definitive for B.1.1.7, and this assay cannot detect other variants of concern that lack spike Δ69-70, such as B.1.351 (also 501Y.V2) detected in South Africa<jats:sup>6</jats:sup> and P.1 (also 501Y.V3) recently detected in Brazil<jats:sup>7</jats:sup>. We identified a deletion in the ORF1a gene (ORF1a Δ3675-3677) in all three variants, which has not yet been widely detected in other SARS-CoV-2 lineages. Using ORF1a Δ3675-3677 as the primary target and spike Δ69-70 to differentiate, we designed and validated an open source PCR assay to detect SARS-CoV-2 variants of concern<jats:sup>8</jats:sup>. Our assay can be rapidly deployed in laboratories around the world to enhance surveillance for the local emergence spread of B.1.1.7, B.1.351, and P.1.</jats:p>",2021-02-01
36,10.1101/2021.03.05.21252960,62,medRxiv,Infectious Diseases (except HIV/AIDS),True,SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19,"[{'given': 'Lize M.', 'family': 'Grobbelaar', 'sequence': 'first', 'affiliation': []}, {'given': 'Chantelle', 'family': 'Venter', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mare', 'family': 'Vlok', 'sequence': 'additional', 'affiliation': []}, {'given': 'Malebogo', 'family': 'Ngoepe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gert Jacobus', 'family': 'Laubscher', 'sequence': 'additional', 'affiliation': []}, {'given': 'Petrus Johannes', 'family': 'Lourens', 'sequence': 'additional', 'affiliation': []}, {'given': 'Janami', 'family': 'Steenkamp', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5838-7963', 'authenticated-orcid': False, 'given': 'Douglas B.', 'family': 'Kell', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9108-2384', 'authenticated-orcid': False, 'given': 'Etheresia', 'family': 'Pretorius', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-induced infection, the cause of coronavirus disease 2019 (COVID-19), is characterized by unprecedented clinical pathologies. One of the most important pathologies, is hypercoagulation and microclots in the lungs of patients. Here we study the effect of isolated SARS-CoV-2 spike protein S1 subunit as potential inflammagen <jats:italic>sui generis</jats:italic>. Using scanning electron and fluorescence microscopy as well as mass spectrometry, we investigate the potential of this inflammagen to interact with platelets and fibrin(ogen) directly to cause blood hypercoagulation. Using platelet poor plasma (PPP), we show that spike protein may interfere with blood flow. Mass spectrometry also showed that when spike protein S1 is added to healthy PPP, it results in structural changes to β and γ fibrin(ogen), complement 3, and prothrombin. These proteins were substantially resistant to trypsinization, in the presence of spike protein S1. Here we suggest that, in part, the presence of spike protein in circulation may contribute to the hypercoagulation in COVID-19 positive patients and may cause substantial impairment of fibrinolysis. Such lytic impairment may result in the persistent large microclots we have noted here and previously in plasma samples of COVID-19 patients. This observation may have important clinical relevance in the treatment of hypercoagulability in COVID-19 patients.</jats:p>",2021-03-08
37,10.1101/2021.04.23.441199,59,bioRxiv,Neuroscience,False,"Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons","[{'ORCID': 'http://orcid.org/0000-0002-3884-0596', 'authenticated-orcid': False, 'given': 'Xinyi Jenny', 'family': 'He', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8140-9347', 'authenticated-orcid': False, 'given': 'Janki', 'family': 'Patel', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2597-9636', 'authenticated-orcid': False, 'given': 'Connor E.', 'family': 'Weiss', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9164-8608', 'authenticated-orcid': False, 'given': 'Xiang', 'family': 'Ma', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4797-9119', 'authenticated-orcid': False, 'given': 'Brenda L.', 'family': 'Bloodgood', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7248-2932', 'authenticated-orcid': False, 'given': 'Matthew R.', 'family': 'Banghart', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Functional interactions between G protein-coupled receptors are poised to enhance neuronal sensitivity to neuromodulators and therapeutic drugs. Mu and Delta opioid receptors (MORs and DORs) can interact when overexpressed in the same cells, but whether co-expression of endogenous MORs and DORs in neurons leads to functional interactions is unclear. Here, we show that both MORs and DORs inhibit parvalbumin-expressing basket cells (PV-BCs) in hippocampal CA1 through partially occlusive signaling pathways that terminate on somato-dendritic potassium channels and presynaptic calcium channels. Using photoactivatable opioid neuropeptides, we find that DORs dominate the response to enkephalin in terms of both ligand-sensitivity and kinetics, which may be due to relatively low expression levels of MOR. Opioid-activated potassium channels do not show heterologous desensitization, indicating that MORs and DORs signal independently. In a direct test for heteromeric functional interactions, the DOR antagonist TIPP-Psi does not alter the kinetics or potency of either the potassium channel or synaptic responses to photorelease of the MOR agonist DAMGO. Thus, despite largely redundant and convergent signaling, MORs and DORs do not functionally interact in PV-BCs. These findings imply that crosstalk between MORs and DORs, either in the form of physical interactions or synergistic intracellular signaling, is not a preordained outcome of co-expression in neurons.</jats:p>",2021-04-24
38,10.1101/2021.03.26.21254394,58,medRxiv,Infectious Diseases (except HIV/AIDS),True,SARS-CoV-2 infection risk among unvaccinated is negatively associated with community-level vaccination rates,"[{'given': 'Oren', 'family': 'Milman', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2515-4113', 'authenticated-orcid': False, 'given': 'Idan', 'family': 'Yelin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Noga', 'family': 'Aharony', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rachel', 'family': 'Katz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Esma', 'family': 'Herzel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amir', 'family': 'Ben-Tov', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jacob', 'family': 'Kuint', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sivan', 'family': 'Gazit', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gabriel', 'family': 'Chodick', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tal', 'family': 'Patalon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Roy', 'family': 'Kishony', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Mass vaccination has the potential to curb the current COVID-19 pandemic by protecting vaccinees from the disease and possibly lowering the chance of transmission to unvaccinated individuals. The high effectiveness of the widely-administered BNT162b vaccine in preventing not only the disease but also infection suggests a potential for a population-level effect, critical for disease eradication. However, this putative effect is difficult to observe, especially in light of highly fluctuating spatio-temporal epidemic dynamics. Here, analyzing vaccination records and test results collected during a rapid vaccine rollout for a large population from 223 geographically defined communities, we find that the rates of vaccination in each community are highly correlated with a later decline in infections among a cohort of under 16 years old which are unvaccinated. These results provide observational evidence that vaccination not only protects individual vaccinees but also provides cross-protection to unvaccinated individuals in the community.</jats:p>",2021-03-29
39,10.1101/2021.04.26.441525,53,bioRxiv,Microbiology,False,Inositol lipid synthesis is widespread in host-associated Bacteroidetes,"[{'given': 'S. L.', 'family': 'Heaver', 'sequence': 'first', 'affiliation': []}, {'given': 'H. H.', 'family': 'Le', 'sequence': 'additional', 'affiliation': []}, {'given': 'P.', 'family': 'Tang', 'sequence': 'additional', 'affiliation': []}, {'given': 'A.', 'family': 'Baslé', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9156-3284', 'authenticated-orcid': False, 'given': 'J.', 'family': 'Marles-Wright', 'sequence': 'additional', 'affiliation': []}, {'given': 'E. L.', 'family': 'Johnson', 'sequence': 'additional', 'affiliation': []}, {'given': 'D. J.', 'family': 'Campopiano', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9087-1672', 'authenticated-orcid': False, 'given': 'R. E.', 'family': 'Ley', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Ubiquitous in eukaryotes, inositol lipids have finely tuned roles in cellular signaling and membrane homeostasis. In Bacteria, however, inositol lipid production is rare. Recently, the prominent human gut bacterium <jats:italic>Bacteroides thetaiotaomicron</jats:italic> (BT) was reported to produce inositol lipids, including inositol sphingolipids, but the pathways remain ambiguous and their prevalence unclear. Here, we investigated the gene cluster responsible for inositol lipid synthesis in BT using a novel strain with inducible control of sphingolipid synthesis. We characterized the biosynthetic pathway from <jats:italic>myo-</jats:italic>inositol-phosphate (MIP) synthesis to phosphoinositol-dihydroceramide, including structural and kinetic studies of the enzyme MIP synthase (MIPS). We determined the crystal structure of recombinant BT MIPS with bound NAD cofactor at 2.0 Å resolution, and identified the first reported phosphatase for the conversion of bacterially-derived phosphatidylinositol phosphate (PIP) to phosphatidylinositol (PI). Transcriptomic analysis indicated inositol production is nonessential but its loss alters BT capsule expression. Bioinformatic and lipidomic comparisons of Bacteroidetes species revealed a novel second putative pathway for bacterial PI synthesis without a PIP intermediate. Our results indicate that inositol sphingolipid production, via one of the two pathways, is widespread in host-associated Bacteroidetes, and may be implicated in host interactions both indirectly via the capsule and directly through inositol lipid provisioning.</jats:p>",2021-04-27
40,10.1101/2021.02.26.21252096,53,medRxiv,Public and Global Health,True,Self-reported real-world safety and reactogenicity of COVID-19 vaccines: An international vaccine-recipient survey,"[{'given': 'Alexander G.', 'family': 'Mathioudakis', 'sequence': 'first', 'affiliation': []}, {'given': 'Murad', 'family': 'Ghrew', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew', 'family': 'Ustianowski', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shazaad', 'family': 'Ahmad', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ray', 'family': 'Borrow', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lida Pieretta', 'family': 'Papavasileiou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dimitrios', 'family': 'Petrakis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nawar Diar', 'family': 'Bakerly', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The safety of COVID-19 vaccines has been demonstrated in selected populations in recent studies, but more data in specific groups is needed to inform vaccine choice and health policy.</jats:p></jats:sec><jats:sec><jats:title>Objectives</jats:title><jats:p>An international, online survey was conducted to compare the safety, tolerability and reactogenicity of available COVID-19 vaccines in different recipient groups.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>This survey was launched in February 2021, for 11 days. Recipients of a first COVID-19 vaccine dose ≥7 days prior to survey completion were eligible. The incidence and severity of vaccination side effects were assessed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Survey was completed by 2,002 respondents, of whom 26.6% had prior COVID-19 infection (68.8% laboratory confirmed). Prior COVID-19 infection was associated with increased risk of any side effect (risk ratio 1.08, 95% confidence intervals [1.05-1.11]), fever (2.24 [1.86-2.70]), breathlessness (2.05 [1.28-3.29]), flu-like illness (1.78 [1.51-2.10]), fatigue (1.34 [1.20-1.49]) and local reactions (1.10 [1.06-1.15]). It was also associated with increased risk of severe side effects, leading to hospital care (1.56 [1.14-2.12]).</jats:p><jats:p>While mRNA vaccines were associated with a higher incidence of any side effect (1.06 [1.01-1.11]) compared to viral vector-based vaccines, these were generally milder (p&lt;0.001), mostly local reactions. Importantly, mRNA vaccine-recipients reported considerably lower incidence of systemic reactions (RR&lt;0.6) including anaphylaxis, swelling, flu-like illness, breathlessness and fatigue, and of side effects requiring hospital care (0.42 [0.31-0.58]).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>For the first time, our study links prior COVID-19 illness with increased incidence of vaccination side effects and demonstrates that mRNA vaccines cause milder, less frequent systemic side effects, but more local reactions.</jats:p></jats:sec><jats:sec><jats:title>Key messages</jats:title><jats:list list-type=""simple""><jats:list-item><jats:label>–</jats:label><jats:p>People with prior COVID-19 illness appear to experience significantly increased incidence and severity of side effects after receiving the COVID-19 vaccine.</jats:p></jats:list-item><jats:list-item><jats:label>–</jats:label><jats:p>In this first head-to-head comparison of the safety and reactogenicity of different types of vaccines, it was demonstrated that mRNA vaccines cause milder, less frequent systemic side effects, compared to viral vector vaccines, but more local reactions.</jats:p></jats:list-item></jats:list></jats:sec><jats:sec><jats:title>Tweetable Summary</jats:title><jats:p>A survey of &gt;2000 COVID-19 vaccine-recipients links prior COVID-19 illness with increased incidence of vaccination side effects; mRNA vaccines cause milder, less frequent systemic side effects, but more local reactions.</jats:p></jats:sec>",2021-03-08
41,10.1101/2021.04.11.439381,53,bioRxiv,Genetics,False,Why most Principal Component Analyses (PCA) in population genetic studies are wrong,"[{'ORCID': 'http://orcid.org/0000-0003-4795-1084', 'authenticated-orcid': False, 'given': 'Eran', 'family': 'Elhaik', 'sequence': 'first', 'affiliation': []}]","<jats:p>Principal Component Analysis (PCA) is a multivariate analysis that allows reduction of the complexity of datasets while preserving data's covariance and visualizing the information on colorful scatterplots, ideally with only a minimal loss of information. PCA applications are extensively used as the foremost analyses in population genetics and related fields (e.g., animal and plant or medical genetics), implemented in well-cited packages like EIGENSOFT and PLINK. PCA outcomes are used to shape study design, identify and characterize individuals and populations, and draw historical and ethnobiological conclusions on origins, evolution, whereabouts, and relatedness. The replicability crisis in science has prompted us to evaluate whether PCA results are reliable, robust, and replicable. We employed an intuitive color-based model alongside human population data for eleven common test cases. We demonstrate that PCA results are artifacts of the data and that they can be easily manipulated to generate desired outcomes. PCA results may not be reliable, robust, or replicable as the field assumes. Our findings raise concerns on the validity of results reported in the literature of population genetics and related fields that place a disproportionate reliance upon PCA outcomes and the insights derived from them. We conclude that PCA may have a biasing role in genetic investigations. An alternative mixed-admixture population genetic model is discussed.</jats:p>",2021-04-12
42,10.1101/2021.04.16.440017,52,bioRxiv,Genomics,False,Telomere-to-telomere gapless chromosomes of banana using nanopore sequencing,"[{'ORCID': 'http://orcid.org/0000-0002-8108-9910', 'authenticated-orcid': False, 'given': 'Caroline', 'family': 'Belser', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5219-8771', 'authenticated-orcid': False, 'given': 'Franc-Christophe', 'family': 'Baurens', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5830-3253', 'authenticated-orcid': False, 'given': 'Benjamin', 'family': 'Noel', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1801-7500', 'authenticated-orcid': False, 'given': 'Guillaume', 'family': 'Martin', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4752-7278', 'authenticated-orcid': False, 'given': 'Corinne', 'family': 'Cruaud', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1042-4803', 'authenticated-orcid': False, 'given': 'Benjamin', 'family': 'Istace', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nabila', 'family': 'Yahiaoui', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7467-8509', 'authenticated-orcid': False, 'given': 'Karine', 'family': 'Labadie', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6868-4344', 'authenticated-orcid': False, 'given': 'Eva', 'family': 'Hřibová', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6263-0492', 'authenticated-orcid': False, 'given': 'Jaroslav', 'family': 'Doležel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arnaud', 'family': 'Lemainque', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7562-3454', 'authenticated-orcid': False, 'given': 'Patrick', 'family': 'Wincker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Angélique', 'family': 'D’Hont', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1718-3010', 'authenticated-orcid': False, 'given': 'Jean-Marc', 'family': 'Aury', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Long-read technologies hold the promise to obtain more complete genome assemblies and to make them easier. Coupled with long-range technologies, they can reveal the architecture of complex regions, like centromeres or rDNA clusters. These technologies also make it possible to know the complete organization of chromosomes, which remained complicated before even when using genetic maps. However, generating a gapless and telomere-to-telomere assembly is still not trivial, and requires a combination of several technologies and the choice of suitable software. Here, we report a chromosome-scale assembly of a banana genome (<jats:italic>Musa acuminata</jats:italic>) generated using Oxford Nanopore long-reads. We generated a genome coverage of 177X from a single PromethION flowcell with near 17X with reads longer than 75Kb. From the 11 chromosomes, 5 were entirely reconstructed in a single contig from telomere to telomere, revealing for the first time the content of complex regions like centromeres or clusters of paralogous genes.</jats:p>",2021-04-17
43,10.1101/2021.04.27.441512,52,bioRxiv,Microbiology,True,Iota-carrageenan prevents the replication of SARS-CoV-2 on an in vitro respiratory epithelium model,"[{'ORCID': 'http://orcid.org/0000-0002-3129-2048', 'authenticated-orcid': False, 'given': 'Augusto', 'family': 'Varese', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4564-7361', 'authenticated-orcid': False, 'given': 'Ana', 'family': 'Ceballos', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3368-0538', 'authenticated-orcid': False, 'given': 'Carlos', 'family': 'Palacios', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5680-1486', 'authenticated-orcid': False, 'given': 'Juan Manuel', 'family': 'Figueroa', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0187-0548', 'authenticated-orcid': False, 'given': 'Andrea Vanesa', 'family': 'Dugour', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>There are, except for remdesivir, no approved antivirals for the treatment or prevention of SARS-CoV-2 infections. Iota-carrageenan formulated into a nasal spray has already been proven safe and effective in viral respiratory infections. We explored this antiviral activity in Calu-3, a human respiratory model cell line. A formula of iota-carrageenan and sodium chloride, as a nasal spray, already approved for human use, effectively inhibited SARS-CoV-2 infection in vitro, providing a more substantial reference for further clinical studies or developments.</jats:p>",2021-04-27
44,10.1101/2021.04.27.440989,51,bioRxiv,Neuroscience,False,Perceived and mentally rotated contents are differentially represented in cortical depth of V1,"[{'given': 'Polina', 'family': 'Iamshchinina', 'sequence': 'first', 'affiliation': []}, {'given': 'Daniel', 'family': 'Kaiser', 'sequence': 'additional', 'affiliation': []}, {'given': 'Renat', 'family': 'Yakupov', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel', 'family': 'Haenelt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alessandro', 'family': 'Sciarra', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hendrik', 'family': 'Mattern', 'sequence': 'additional', 'affiliation': []}, {'given': 'Falk', 'family': 'Luesebrink', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emrah', 'family': 'Duezel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Oliver', 'family': 'Speck', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nikolaus', 'family': 'Weiskopf', 'sequence': 'additional', 'affiliation': []}, {'given': 'Radoslaw Martin', 'family': 'Cichy', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Primary visual cortex (V1) in humans is known to represent both veridically perceived external input and internally-generated contents underlying imagery and mental rotation. However, it is unknown how the brain keeps these contents separate thus avoiding a mixture of the perceived and the imagined which could lead to potentially detrimental consequences. Inspired by neuroanatomical studies showing that feedforward and feedback connections in V1 terminate in different cortical layers, we hypothesized that this anatomical compartmentalization underlies functional segregation of external and internally-generated visual contents, respectively. We used high-resolution layer-specific fMRI to test this hypothesis in a mental rotation task. We found that rotated contents were predominant at outer cortical depth bins (i.e. superficial and deep). At the same time perceived contents were represented stronger at the middle cortical bin. These results identify how through cortical depth compartmentalization V1 functionally segregates rather than confuses external from internally-generated visual contents. These results indicate that feedforward and feedback manifest in distinct subdivisions of the early visual cortex, thereby reflecting a general strategy for implementing multiple cognitive functions within a single brain region.</jats:p>",2021-04-28
45,10.1101/2021.04.27.441613,51,bioRxiv,Biophysics,False,"tdLanYFP, a yellow, bright, photostable and pH insensitive fluorescent protein for live cell imaging and FRET-based sensing strategies","[{'given': 'Y.', 'family': 'Bousmah', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4585-4862', 'authenticated-orcid': False, 'given': 'H.', 'family': 'Valenta', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7359-5733', 'authenticated-orcid': False, 'given': 'G.', 'family': 'Bertolin', 'sequence': 'additional', 'affiliation': []}, {'given': 'U.', 'family': 'Singh', 'sequence': 'additional', 'affiliation': []}, {'given': 'V.', 'family': 'Nicolas', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7543-3976', 'authenticated-orcid': False, 'given': 'H.', 'family': 'Pasquier', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8200-6446', 'authenticated-orcid': False, 'given': 'M.', 'family': 'Tramier', 'sequence': 'additional', 'affiliation': []}, {'given': 'F.', 'family': 'Merola', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4063-365X', 'authenticated-orcid': False, 'given': 'M.', 'family': 'Erard', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Yellow fluorescent proteins (YFP) are widely used as optical reporters in Förster Resonance Energy Transfer (FRET) based biosensors. Although great improvements have been done, the sensitivity of the biosensors is still limited by the low photostability and the poor fluorescence performances of YFPs at acidic pHs. In fact, today, there is no yellow variant derived from the EYFP with a pK<jats:sub>1/2</jats:sub> below ∼5.5. Here, we characterize a new yellow fluorescent protein, tdLanYFP, derived from the tetrameric protein from the cephalochordate <jats:italic>B. lanceolatum</jats:italic>, LanYFP. With a quantum yield of 0.92 and an extinction coefficient of 133 000 mol<jats:sup>−1</jats:sup>.L.cm<jats:sup>−1</jats:sup>, it is, to our knowledge, the brightest dimeric fluorescent protein available, and brighter than most of the monomeric YFPs. Contrasting with EYFP and its derivatives, tdLanYFP has a very high photostability <jats:italic>in vitro</jats:italic> and preserves this property in live cells. As a consequence, tdLanYFP allows the imaging of cellular structures with sub-diffraction resolution with STED nanoscopy. We also demonstrate that the combination of high brightness and strong photostability is compatible with the use of spectro-microscopies in single molecule regimes. Its very low pK<jats:sub>1/2</jats:sub> of 3.9 makes tdLanYFP an excellent tag even at acidic pHs. Finally, we show that tdLanYFP can be a FRET partner either as donor or acceptor in different biosensing modalities. Altogether, these assets make tdLanYFPa very attractive yellow fluorescent protein for long-term or single-molecule live-cell imaging that is also suitable for FRET experiment including at acidic pH.</jats:p>",2021-04-27
46,10.1101/2021.04.21.21255807,51,medRxiv,Infectious Diseases (except HIV/AIDS),True,A randomised clinical trial of azithromycin versus standard care in ambulatory COVID-19 – the ATOMIC2 trial,"[{'ORCID': 'http://orcid.org/0000-0003-0699-2373', 'authenticated-orcid': False, 'given': 'Timothy SC', 'family': 'Hinks', 'sequence': 'first', 'affiliation': []}, {'given': 'Lucy', 'family': 'Cureton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ruth', 'family': 'Knight', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ariel', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jennifer L', 'family': 'Cane', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vicki S', 'family': 'Barber', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joanna', 'family': 'Black', 'sequence': 'additional', 'affiliation': []}, {'given': 'Susan J', 'family': 'Dutton', 'sequence': 'additional', 'affiliation': []}, {'given': 'James', 'family': 'Melhorn', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maisha', 'family': 'Jabeen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Phil', 'family': 'Moss', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rajendar', 'family': 'Garlapati', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tanya', 'family': 'Baron', 'sequence': 'additional', 'affiliation': []}, {'given': 'Graham', 'family': 'Johnson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fleur', 'family': 'Cantle', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Clarke', 'sequence': 'additional', 'affiliation': []}, {'given': 'Samer', 'family': 'Elkhodair', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jonathan', 'family': 'Underwood', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel', 'family': 'Lasserson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ian D', 'family': 'Pavord', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sophie', 'family': 'Morgan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Duncan', 'family': 'Richards', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The antibacterial, anti-inflammatory and antiviral properties of azithromycin suggest therapeutic potential against COVID-19. Randomised data in mild-moderate disease are lacking. We assessed whether azithromycin is effective in reducing hospitalisation in patients with mild-moderate COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>This open-label, randomised superiority clinical trial at 19 centres in the United Kingdom enrolled adults, ≥18 years, presenting to hospitals with clinically-diagnosed highly-probable or confirmed COVID-19 infection, with &lt;14 days symptoms, considered suitable for initial ambulatory management. Patients were randomised (1:1) to azithromycin (500 mg daily orally for 14 days) or to standard care without macrolides. The primary outcome was the difference in proportion of participants with death or hospital admission from any cause over the 28 days from randomisation, assessed according to intention-to-treat (ITT). Trial registration: ClinicalTrials.gov, <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""clintrialgov"" xlink:href=""NCT04381962"">NCT04381962</jats:ext-link>, Study closed.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>298 participants were enrolled from 3<jats:sup>rd</jats:sup> June 2020 to 29<jats:sup>th</jats:sup> January 2021. The primary outcome was assessed in 292 participants. The primary endpoint was not significantly different between the azithromycin and control groups (Adjusted OR 0·91 [95% CI 0·43-1·92], p=0·80). Rates of respiratory failure, progression to pneumonia, all-cause mortality, and adverse events, including serious cardiovascular events, were not significantly different between groups.</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>In patients with mild-moderate COVID-19 managed without hospital admission, adding azithromycin to standard care treatment did not reduce the risk of subsequent hospitalisation or death. Our findings do not support the use of azithromycin in patients with mild-moderate COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>NIHR Oxford BRC, University of Oxford and Pfizer Inc.</jats:p></jats:sec><jats:sec><jats:title>Research in context</jats:title><jats:sec><jats:title>Evidence before this study</jats:title><jats:p>We searched MEDLINE and the Cochrane Central register of Controlled Trials (CENTRAL) with the terms (“azithromycin”) AND (“COVID” OR “COVID-19”) AND (“clinical trials”), until March 25, 2021, with no language restrictions. We identified 42 studies, among which there were four completed randomised trials of azithromycin (with or without hydroxychloroquine) in hospitalised patients with severe disease, and three completed randomised trials of azithromycin in mild COVID-19 in primary care. The four trials in hospitalised patients randomised 8,988 participants to azithromycin or standard care or hydroxychloroquine and found no evidence of a difference in mortality, duration of hospital stay or peak disease severity. Of the three trials in primary care, these randomised participants with early disease to 3 or 5 days of therapy, of which only one assessed azithromycin as standalone therapy. This large, adaptive platform trial in the UK randomised 540 participants in primary care to 3 days treatment with azithromycin versus 875 to standard care alone and found no meaningful difference in time to first reported recovery, or of rates of hospitalisation (3% versus 3%) and there were no deaths. We did not identify any randomised trials in patients with COVID-19 managed in ambulatory care.</jats:p></jats:sec><jats:sec><jats:title>Added value of this study</jats:title><jats:p>The ATOMIC2 trial was uniquely-designed to assess azithromycin as a standalone therapy in those with mild-moderately COVID-19 presenting to emergency care, but assessed as appropriate for initial ambulatory management without hospital admission. ATOMIC2 also uniquely assessed high-dose, long-duration treatment to investigate the efficacy of putative anti-inflammatory effects. We found that azithromycin 500 mg daily for 14 days did not reduce the proportion of participants who died or required hospital admission from any cause over the 28 days from randomisation.</jats:p></jats:sec><jats:sec><jats:title>Implications of all the available evidence</jats:title><jats:p>Our findings, taken together with existing data, suggest there is no evidence that azithromycin reduces hospitalisation, respiratory failure or death compared with standard care, either in early disease in the community, or those hospitalised with severe disease, or in those with moderate disease managed on an ambulatory pathway.</jats:p></jats:sec></jats:sec>",2021-04-27
47,10.1101/2020.07.23.20160820,51,medRxiv,Infectious Diseases (except HIV/AIDS),True,"Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts","[{'ORCID': 'http://orcid.org/0000-0001-7915-4974', 'authenticated-orcid': False, 'given': 'Anne M.', 'family': 'Neilan', 'sequence': 'first', 'affiliation': []}, {'given': 'Elena', 'family': 'Losina', 'sequence': 'additional', 'affiliation': []}, {'given': 'Audrey C.', 'family': 'Bangs', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clare', 'family': 'Flanagan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher', 'family': 'Panella', 'sequence': 'additional', 'affiliation': []}, {'given': 'G. Ege', 'family': 'Eskibozkurt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amir', 'family': 'Mohareb', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emily P.', 'family': 'Hyle', 'sequence': 'additional', 'affiliation': []}, {'given': 'Justine A.', 'family': 'Scott', 'sequence': 'additional', 'affiliation': []}, {'given': 'Milton C.', 'family': 'Weinstein', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mark J.', 'family': 'Siedner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Krishna P.', 'family': 'Reddy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Guy', 'family': 'Harling', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kenneth A.', 'family': 'Freedberg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fatma M.', 'family': 'Shebl', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pooyan', 'family': 'Kazemian', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrea L.', 'family': 'Ciaranello', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>We projected the clinical and economic impact of alternative testing strategies on COVID-19 incidence and mortality in Massachusetts using a microsimulation model.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We compared five testing strategies: 1) PCR-severe-only: PCR testing only patients with severe/critical symptoms; 2) Self-screen: PCR-severe-only plus self-assessment of COVID-19-consistent symptoms with self-isolation if positive; 3) PCR-any-symptom: PCR for any COVID-19-consistent symptoms with self-isolation if positive; 4) PCR-all: PCR-any-symptom and one-time PCR for the entire population; and, 5) PCR-all-repeat: PCR-all with monthly re-testing. We examined effective reproduction numbers (R<jats:sub>e</jats:sub>, 0.9-2.0) at which policy conclusions would change. We used published data on disease progression and mortality, transmission, PCR sensitivity/specificity (70/100%) and costs. Model-projected outcomes included infections, deaths, tests performed, hospital-days, and costs over 180-days, as well as incremental cost-effectiveness ratios (ICERs, $/quality-adjusted life-year [QALY]).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In all scenarios, PCR-all-repeat would lead to the best clinical outcomes and PCR-severe-only would lead to the worst; at R<jats:sub>e</jats:sub> 0.9, PCR-all-repeat vs. PCR-severe-only resulted in a 63% reduction in infections and a 44% reduction in deaths, but required &gt;65-fold more tests/day with 4-fold higher costs. PCR-all-repeat had an ICER &lt;$100,000/QALY only when R<jats:sub>e</jats:sub> ≥1.8. At all R<jats:sub>e</jats:sub> values, PCR-any-symptom was cost-saving compared to other strategies.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Testing people with any COVID-19-consistent symptoms would be cost-saving compared to restricting testing to only those with symptoms severe enough to warrant hospital care. Expanding PCR testing to asymptomatic people would decrease infections, deaths, and hospitalizations. Universal screening would be cost-effective when paired with monthly retesting in settings where the COVID-19 pandemic is surging.</jats:p></jats:sec>",2020-07-24
48,10.1101/2021.04.27.441365,48,bioRxiv,Bioinformatics,False,Prediction of RNA-protein interactions using a nucleotide language model,"[{'ORCID': 'http://orcid.org/0000-0003-1256-9299', 'authenticated-orcid': False, 'given': 'Keisuke', 'family': 'Yamada', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9466-1034', 'authenticated-orcid': False, 'given': 'Michiaki', 'family': 'Hamada', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Motivation:The accumulation of sequencing data has enabled researchers to predict the interactions between RNA sequencesand RNA-binding proteins (RBPs) using novel machine learning techniques.  However, existing models are often difficult tointerpret and require additional information to sequences.  Bidirectional encoder representations from Transformer (BERT)is a language-based deep learning model that is highly interpretable.  Therefore, a model based on BERT architecture canpotentially overcome such limitations.Results:Here, we propose BERT-RBP as a model to predict RNA-RBP interactions by adapting the BERT architecture pre-trained on a human reference genome.  Our model outperformed state-of-the-art prediction models using the eCLIP-seq data of154 RBPs.  The detailed analysis further revealed that BERT-RBP could recognize both the transcript region type and RNAsecondary structure only from sequential information.  Overall, the results provide insights into the fine-tuning mechanism ofBERT in biological contexts and provide evidence of the applicability of the model to other RNA-related problems.Availability:Python source codes are freely available at https://github.com/kkyamada/bert-rbp.</jats:p>",2021-04-28
49,10.1101/2021.04.26.21256141,45,medRxiv,Genetic and Genomic Medicine,False,Response to Polygenic Risk: Results of the MyGeneRank Mobile Application-Based Coronary Artery Disease Study,"[{'given': 'Evan D', 'family': 'Muse', 'sequence': 'first', 'affiliation': []}, {'given': 'Shaun', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shuchen', 'family': 'Liu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Brianna', 'family': 'Fernandez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Brian', 'family': 'Schrader', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bhuvan', 'family': 'Molparia', 'sequence': 'additional', 'affiliation': []}, {'given': 'André Nicolás', 'family': 'León', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raymond', 'family': 'Lee', 'sequence': 'additional', 'affiliation': []}, {'given': 'Neha', 'family': 'Pubbi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nolan', 'family': 'Mejia', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christina', 'family': 'Ren', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ahmed', 'family': 'El-kalliny', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ernesto Prado', 'family': 'Montes de Oca', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hector O', 'family': 'Aguilar-Fraga', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arjun', 'family': 'Ghoshal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raquel', 'family': 'Dias', 'sequence': 'additional', 'affiliation': []}, {'given': 'Doug', 'family': 'Evans', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kai-Yu', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paris', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nathan E', 'family': 'Wineinger', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emily', 'family': 'Spencer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eric J', 'family': 'Topol', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0232-8053', 'authenticated-orcid': False, 'given': 'Ali', 'family': 'Torkamani', 'sequence': 'additional', 'affiliation': []}]","<jats:p>The degree to which polygenic risk scores (PRS) influence preventive health is the subject of debate, with few prospective studies completed to date. We developed a smartphone application for the prospective and automated generation, communication, and electronic capture of response to a PRS for coronary artery disease (CAD). We evaluated self-reported actions taken in response to personal CAD PRS information, with special interest in the initiation of lipid lowering therapy (<jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""clintrialgov"" xlink:href=""NCT03277365"">NCT03277365</jats:ext-link>). 20% of high genetic risk (n=95) vs 7.9% of low genetic risk individuals (n=101) initiated lipid lowering therapy at follow-up (p-value = 0.002). The initiation of both statin and non-statin lipid lowering therapy was associated with degree of genetic risk: 15.2% (n=92) vs 6.0% (n=100) for statins (p-value = 0.018) and 6.8% (n=118) vs 1.6% (n=123) for non-statins (p-value = 0.022) in high vs low genetic risk, respectively. Overall, degree of genetic risk was associated with use of any lipid lowering therapy at follow-up: 42.4% (n=132) vs 28.5% (n=130) (p-value = 0.009). We also find that CAD PRS information is perceived to be understandable, actionable, and does not induce health anxiety.</jats:p>",2021-04-28
50,10.1101/2021.04.23.441091,44,bioRxiv,Cell Biology,False,Endomembranes promote chromosome missegregation by ensheathing misaligned chromosomes,"[{'ORCID': 'http://orcid.org/0000-0002-7410-3470', 'authenticated-orcid': False, 'given': 'Nuria', 'family': 'Ferrandiz', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9039-942X', 'authenticated-orcid': False, 'given': 'Laura', 'family': 'Downie', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9485-8603', 'authenticated-orcid': False, 'given': 'Georgina P.', 'family': 'Starling', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8927-6967', 'authenticated-orcid': False, 'given': 'Stephen J.', 'family': 'Royle', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Errors in mitosis that cause chromosome missegregation lead to aneuploidy and micronuclei formation which are associated with cancer. Accurate segregation requires the alignment of all chromosomes by the mitotic spindle at the metaphase plate, and any misalignment must be corrected before anaphase is triggered. The spindle is situated in a membrane-free “exclusion zone”, beyond this zone, endomembranes (endoplasmic reticulum, nuclear envelope and other organelles) are densely packed. We asked what happens to misaligned chromosomes that find themselves beyond the exclusion zone? Here we show that such chromosomes become ensheathed in multiple layers of endomembranes. Chromosome ensheathing delays mitosis and increases the frequency of chromosome missegregation and subsequent micronuclei formation. We use an induced organelle relocalization strategy in live cells to show that clearance of endomembranes allows for the rescue of chromosomes that were destined for missegregation. Our findings indicate that endomembranes promote the missegregation of misaligned chromosomes that are outside the exclusion zone, and therefore constitute a novel pathway to aneuploidy.</jats:p>",2021-04-23
51,10.1101/2021.04.08.438862,44,bioRxiv,Bioinformatics,False,Genomic sequence characteristics and the empiric accuracy of short-read sequencing,"[{'ORCID': 'http://orcid.org/0000-0002-9108-3328', 'authenticated-orcid': False, 'given': 'Maximillian', 'family': 'Marin', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7116-5211', 'authenticated-orcid': False, 'suffix': 'Jr', 'given': 'Roger', 'family': 'Vargas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael', 'family': 'Harris', 'sequence': 'additional', 'affiliation': []}, {'given': 'Brendan', 'family': 'Jeffrey', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6715-1001', 'authenticated-orcid': False, 'given': 'L. Elaine', 'family': 'Epperson', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Durbin', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3247-6260', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Strong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Max', 'family': 'Salfinger', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8466-7547', 'authenticated-orcid': False, 'given': 'Zamin', 'family': 'Iqbal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Irada', 'family': 'Akhundova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sergo', 'family': 'Vashakidze', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5059-8002', 'authenticated-orcid': False, 'given': 'Valeriu', 'family': 'Crudu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4190-9045', 'authenticated-orcid': False, 'given': 'Alex', 'family': 'Rosenthal', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3871-5760', 'authenticated-orcid': False, 'given': 'Maha Reda', 'family': 'Farhat', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Short-read whole genome sequencing (WGS) is a vital tool for clinical applications and basic research. Genetic divergence from the reference genome, repetitive sequences, and sequencing bias, reduce the performance of variant calling using short-read alignment, but the loss in recall and specificity has not been adequately characterized. For the clonal pathogen Mycobacterium tuberculosis (Mtb), researchers frequently exclude 10.7% of the genome believed to be repetitive and prone to erroneous variant calls. To benchmark short-read variant calling, we used 36 diverse clinical Mtb isolates dually sequenced with Illumina short-reads and PacBio long-reads. We systematically study the short-read variant calling accuracy and the influence of sequence uniqueness, reference bias, and GC content.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Reference based Illumina variant calling had a recall ≥89.0% and precision ≥98.5% across parameters evaluated. The best balance between precision and recall was achieved by tuning the mapping quality (MQ) threshold, i.e. confidence of the read mapping (recall 85.8%, precision 99.1% at MQ ≥ 40). Masking repetitive sequence content is an alternative conservative approach to variant calling that maintains high precision (recall 70.2%, precision 99.6% at MQ≥40). Of the genomic positions typically excluded for Mtb, 68% are accurately called using Illumina WGS including 52 of the 168 PE/PPE genes (34.5%). We present a refined list of low confidence regions and examine the largest sources of variant calling error.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Our improved approach to variant calling has broad implications for the use of WGS in the study of Mtb biology, inference of transmission in public health surveillance systems, and more generally for WGS applications in other organisms.</jats:p></jats:sec>",2021-04-11
52,10.1101/2021.04.25.21255890,44,medRxiv,Infectious Diseases (except HIV/AIDS),True,Stimulation of vascular organoids with SARS-CoV-2 antigens increases endothelial permeability and regulates vasculopathy,"[{'ORCID': 'http://orcid.org/0000-0003-0825-3179', 'authenticated-orcid': False, 'given': 'Abdullah O.', 'family': 'Khan', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3247-9186', 'authenticated-orcid': False, 'given': 'Jasmeet S.', 'family': 'Reyat', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4442-5767', 'authenticated-orcid': False, 'given': 'Joshua H.', 'family': 'Bourne', 'sequence': 'additional', 'affiliation': []}, {'given': 'Martina', 'family': 'Colicchia', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0624-245X', 'authenticated-orcid': False, 'given': 'Maddy L.', 'family': 'Newby', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2547-968X', 'authenticated-orcid': False, 'given': 'Joel D.', 'family': 'Allen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1072-2694', 'authenticated-orcid': False, 'given': 'Max', 'family': 'Crispin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Esther', 'family': 'Youd', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul G.', 'family': 'Murray', 'sequence': 'additional', 'affiliation': []}, {'given': 'Graham', 'family': 'Taylor', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3823-4497', 'authenticated-orcid': False, 'given': 'Zania', 'family': 'Stamataki', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2885-1299', 'authenticated-orcid': False, 'given': 'Alex G.', 'family': 'Richter', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adam F.', 'family': 'Cunningham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthew', 'family': 'Pugh', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0499-6880', 'authenticated-orcid': False, 'given': 'Julie', 'family': 'Rayes', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>Thrombotic complications and vasculopathy have been extensively associated with severe COVID-19 infection, however the mechanisms by which endotheliitis is induced remain poorly understood. Here we investigate vascular permeability in the context of SARS-CoV-2-mediated endotheliitis in patient samples and a vascular organoid model.</jats:p></jats:sec><jats:sec><jats:title>Methods and Results</jats:title><jats:p>We report the presence of the Spike glycoprotein in pericytes associated with pericyte activation and increased endothelial permeability in post-mortem COVID-19 lung autopsies. A pronounced decrease in the expression of the adhesion molecule VE-cadherin is observed in patients with thrombotic complications. Interestingly, fibrin-rich thrombi did not contain platelets, did not colocalize with tissue factor and have heterogenous levels of Von Willebrand factor, suggesting a biomarker-guided therapy might be required to target thrombosis in severe patients. Using a 3D vascular organoid model, we observe that ACE2 is primarily expressed in pericytes adjacent to vascular networks, consistent with patient data, indicating a preferential uptake of the S glycoprotein by these cells. Exposure of vascular organoids to SARS-CoV-2 or its antigens, recombinant trimeric Spike glycoprotein and Nucleocapsid protein, reduced endothelial cell and pericyte viability as well as CD144 expression with no additive effect upon endothelial activation via IL-1β.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Our data suggest that pericyte uptake of SARS-CoV-2 or Spike glycoprotein contributes to vasculopathy by altering endothelial permeability increasing the risk of thrombotic complications.</jats:p></jats:sec>",2021-04-27
53,10.1101/2021.04.23.441128,43,bioRxiv,Neuroscience,False,Rich and lazy learning of task representations in brains and neural networks,"[{'ORCID': 'http://orcid.org/0000-0002-1843-9156', 'authenticated-orcid': False, 'given': 'Timo', 'family': 'Flesch', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7887-175X', 'authenticated-orcid': False, 'given': 'Keno', 'family': 'Juechems', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tsvetomira', 'family': 'Dumbalska', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9831-8812', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Saxe', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2941-2653', 'authenticated-orcid': False, 'given': 'Christopher', 'family': 'Summerfield', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>How do neural populations code for multiple, potentially conflicting tasks? Here, we used computational simulations involving neural networks to define “lazy” and “rich” coding solutions to this multitasking problem, which trade off learning speed for robustness. During lazy learning the input dimensionality is expanded by random projections to the network hidden layer, whereas in rich learning hidden units acquire structured representations that privilege relevant over irrelevant features. For context-dependent decision-making, one rich solution is to project task representations onto low-dimensional and orthogonal manifolds. Using behavioural testing and neuroimaging in humans, and analysis of neural signals from macaque prefrontal cortex, we report evidence for neural coding patterns in biological brains whose dimensionality and neural geometry are consistent with the rich learning regime.</jats:p>",2021-04-23
54,10.1101/2020.01.30.927871,43,bioRxiv,Evolutionary Biology,False,Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag,"[{'given': 'Prashant', 'family': 'Pradhan', 'sequence': 'first', 'affiliation': []}, {'given': 'Ashutosh Kumar', 'family': 'Pandey', 'sequence': 'additional', 'affiliation': []}, {'given': 'Akhilesh', 'family': 'Mishra', 'sequence': 'additional', 'affiliation': []}, {'given': 'Parul', 'family': 'Gupta', 'sequence': 'additional', 'affiliation': []}, {'given': 'Praveen Kumar', 'family': 'Tripathi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Manoj Balakrishnan', 'family': 'Menon', 'sequence': 'additional', 'affiliation': []}, {'given': 'James', 'family': 'Gomes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Perumal', 'family': 'Vivekanandan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bishwajit', 'family': 'Kundu', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>We are currently witnessing a major epidemic caused by the 2019 novel coronavirus (2019-nCoV). The evolution of 2019-nCoV remains elusive. We found 4 insertions in the spike glycoprotein (S) which are unique to the 2019-nCoV and are not present in other coronaviruses. Importantly, amino acid residues in all the 4 inserts have identity or similarity to those in the HIV-1 gp120 or HIV-1 Gag. Interestingly, despite the inserts being discontinuous on the primary amino acid sequence, 3D-modelling of the 2019-nCoV suggests that they converge to constitute the receptor binding site. The finding of 4 unique inserts in the 2019-nCoV, all of which have identity /similarity to amino acid residues in key structural proteins of HIV-1 is unlikely to be fortuitous in nature. This work provides yet unknown insights on 2019-nCoV and sheds light on the evolution and pathogenicity of this virus with important implications for diagnosis of this virus.</jats:p>",2020-01-31
55,10.1101/2020.11.20.391987,43,bioRxiv,Neuroscience,False,A Cre-dependent CRISPR/dCas9 system for gene expression regulation in neurons,"[{'ORCID': 'http://orcid.org/0000-0001-9197-5046', 'authenticated-orcid': False, 'given': 'Nancy V.N.', 'family': 'Carullo', 'sequence': 'first', 'affiliation': []}, {'given': 'Jenna E', 'family': 'Hinds', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3637-9705', 'authenticated-orcid': False, 'given': 'Jasmin S.', 'family': 'Revanna', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8798-4545', 'authenticated-orcid': False, 'given': 'Jennifer J', 'family': 'Tuscher', 'sequence': 'additional', 'affiliation': []}, {'given': 'Allison J', 'family': 'Bauman', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7361-3399', 'authenticated-orcid': False, 'given': 'Jeremy J', 'family': 'Day', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Site-specific genetic and epigenetic targeting of distinct cell populations is a central goal in molecular neuroscience and is crucial to understand the gene regulatory mechanisms that underlie complex phenotypes and behaviors. While recent technological advances have enabled unprecedented control over gene expression, many of these approaches are focused on selected model organisms and/or require labor-intensive customization for different applications. The simplicity and modularity of CRISPR-based systems have transformed this aspect of genome editing, providing a variety of possible applications and targets. However, there are currently few available tools for cell-selective CRISPR regulation in neurons. Here, we designed, validated, and optimized CRISPR activation (CRISPRa) and CRISPR interference (CRISPRi) systems for Cre recombinase-dependent gene regulation. Unexpectedly, CRISPRa systems based on a traditional double-floxed inverted open reading frame (DIO) strategy exhibited leaky target gene induction in the absence of Cre. Therefore, we developed an intron-containing Cre-dependent CRISPRa system (SVI-DIO-dCas9-VPR) that alleviated leaky gene induction and outperformed the traditional DIO system at endogenous genes in both HEK293T cells and rat primary neuron cultures. Using gene-specific CRISPR sgRNAs, we demonstrate that SVI-DIO-dCas9-VPR can activate highly inducible genes (GRM2, Tent5b, and Fos) as well as moderately inducible genes (Sstr2 and Gadd45b) in a Cre-specific manner. Furthermore, to illustrate the versatility of this tool, we created a parallel CRISPRi construct that successfully inhibited expression from of a luciferase reporter in HEK293T cells only in the presence of Cre. These results provide a robust framework for Cre-dependent CRISPR-dCas9 approaches across different model systems, and will enable cell-specific targeting when combined with common Cre driver lines or Cre delivery via viral vectors.</jats:p>",2020-11-20
56,10.1101/806505,43,bioRxiv,Immunology,False,Lymphoid follicle formation and human vaccination responses recapitulated in an organ-on-a-chip,"[{'ORCID': 'http://orcid.org/0000-0002-2163-2205', 'authenticated-orcid': False, 'given': 'Girija', 'family': 'Goyal', 'sequence': 'first', 'affiliation': []}, {'given': 'Pranav', 'family': 'Prabhala', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gautam', 'family': 'Mahajan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bruce', 'family': 'Bausk', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tal', 'family': 'Gilboa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Liangxia', 'family': 'Xie', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yunhao', 'family': 'Zhai', 'sequence': 'additional', 'affiliation': []}, {'given': 'Roey', 'family': 'Lazarovits', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adam', 'family': 'Mansour', 'sequence': 'additional', 'affiliation': []}, {'given': 'Min Sun', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Danielle', 'family': 'Curran', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jaclyn', 'family': 'Long', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sanjay', 'family': 'Sharma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Limor', 'family': 'Cohen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Oren', 'family': 'Levy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rachelle', 'family': 'Prantil-Baun', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5524-7348', 'authenticated-orcid': False, 'given': 'David R', 'family': 'Walt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Donald E', 'family': 'Ingber', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Lymphoid follicles (LFs) are responsible for generation of adaptive immune responses in secondary lymphoid organs and form ectopically during chronic inflammation. A human model of LF formation would provide a tool to understand LF development and an alternative to non-human primate models for preclinical evaluation of vaccines.  Here, we show that primary human blood B- and T-lymphocytes autonomously assemble into ectopic LFs when cultured in a three-dimensional (3D) extracellular matrix gel within an organ-on-a-chip microfluidic device. Dynamic fluid flow is required for LF formation and prevention of lymphocyte autoactivation. These germinal center-like LFs contain B cells expressing Activation-Induced Cytidine Deaminase and exhibit plasma cell (PC) differentiation upon activation. To explore their utility for vaccine testing, autologous monocyte-derived dendritic cells were integrated into LF Chips. The human LF chips demonstrated improved antibody responses to split virion influenza vaccination compared to 2D cultures, which were enhanced by addition of a squalene-in-water emulsion adjuvant, and this was accompanied by increases in LF size and number. When inoculated with commercial influenza vaccine, PC formation and production of anti-hemagglutinin IgG were observed, as well as secretion of cytokines similar to those observed in vaccinated humans over clinically relevant timescales.</jats:p>",2019-10-16
57,10.1101/2021.04.26.440876,42,bioRxiv,Microbiology,False,Fluoxetine targets an allosteric site in the enterovirus 2C AAA+ ATPase and stabilizes the hexameric complex,"[{'ORCID': 'http://orcid.org/0000-0003-3834-5808', 'authenticated-orcid': False, 'given': 'Daniel L.', 'family': 'Hurdiss', 'sequence': 'first', 'affiliation': []}, {'given': 'Priscila', 'family': 'El Kazzi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lisa', 'family': 'Bauer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicolas', 'family': 'Papageorgiou', 'sequence': 'additional', 'affiliation': []}, {'given': 'François P.', 'family': 'Ferron', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tim', 'family': 'Donselaar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arno L.W.', 'family': 'van Vliet', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4924-1991', 'authenticated-orcid': False, 'given': 'Bruno', 'family': 'Canard', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6046-024X', 'authenticated-orcid': False, 'given': 'Etienne', 'family': 'Decroly', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9728-3419', 'authenticated-orcid': False, 'given': 'Andrea', 'family': 'Brancale', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tzviya', 'family': 'Zeev-Ben-Mordehai', 'sequence': 'additional', 'affiliation': []}, {'given': 'Friedrich', 'family': 'Förster', 'sequence': 'additional', 'affiliation': []}, {'given': 'Frank J.M.', 'family': 'van Kuppeveld', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2859-7123', 'authenticated-orcid': False, 'given': 'Bruno', 'family': 'Coutard', 'sequence': 'additional', 'affiliation': []}]","<jats:p>The enterovirus genus encompasses many clinically important human pathogens such as poliovirus, coxsackieviruses, echoviruses, numbered enteroviruses and rhinoviruses. These viruses are the etiological agents of several human diseases, including hand-foot-and-mouth disease, neonatal sepsis, encephalitis, meningitis, paralysis and respiratory infections. There is an unmet need for antivirals to treat these diseases. The non-structural protein 2C is a AAA+ ATPase, with reported helicase activity, and plays a key role in viral replication. As such, it is an attractive target for antiviral drug development. Several repurposing screens with FDA-approved drugs have identified 2C-targeting compounds such as fluoxetine and dibucaine, but the molecular basis of 2C inhibition has remained enigmatic. Here we present the 1.5 Å resolution crystal structure of the soluble fragment of coxsackievirus B3 2C protein in complex with (S)-fluoxetine (SFX), which reveals a conserved, hydrophobic drug-binding pocket which is distal to the ATP binding site. To decipher the molecular mechanism of inhibition by fluoxetine and other 2C-targeting compounds, we engineered a soluble, hexameric and ATPase competent 2C protein. Using this system, we show that SFX, dibucaine, HBB and guanidine hydrochloride inhibit 2C ATPase activity in a dose-dependent manner. Moreover, using cryo-EM analysis, we demonstrate that SFX and dibucaine stabilize 2C in a defined hexameric conformation, rationalising their mode of inhibiton and allowing us to generate the first reconstruction of the oligomeric complex. Taken together, these results provide important structural and mechanistic insights into 2C inhibition and provide a robust engineering strategy which can be used for structural, functional and drug-screening analysis of 2C proteins from current or future enteroviruses.</jats:p>",2021-04-26
58,10.1101/2021.04.12.439463,41,bioRxiv,Pharmacology and Toxicology,False,"In-depth comparative toxicogenomics of glyphosate and Roundup herbicides: histopathology, transcriptome and epigenome signatures, and DNA damage","[{'given': 'Robin', 'family': 'Mesnage', 'sequence': 'first', 'affiliation': []}, {'given': 'Mariam', 'family': 'Ibragim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniele', 'family': 'Mandrioli', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Falcioni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fiorella', 'family': 'Belpoggi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Inger', 'family': 'Brandsma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emma', 'family': 'Bourne', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emanuel', 'family': 'Savage', 'sequence': 'additional', 'affiliation': []}, {'given': 'Charles A', 'family': 'Mein', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael N', 'family': 'Antoniou', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Health effects from exposure to glyphosate-based herbicides is an intense matter of debate. Toxicity including genotoxicity of glyphosate alone has been repeatedly tested over the last 40 years. Contrastingly, few studies have conducted comparative investigations between glyphosate and its commercial herbicide formulations, such as Roundup. We thus performed the first in-depth comparative toxicogenomic evaluation of glyphosate and a typical European Union Roundup formulation by determining alterations in transcriptome and epigenome profiles.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Glyphosate and the European Union reference commercial formulation Roundup MON 52276 (both at 0.5, 50, 175 mg/kg bw/day glyphosate equivalent concentration) were administered to rats in a subchronic 90-day toxicity study. Standard clinical biochemistry and kidney and liver histopathology was performed. In addition, transcriptomics and DNA methylation profiling of liver and selective gene expression analysis of kidneys was conducted. Furthermore, a panel of six mouse embryonic reporter stem cell lines validated to identify carcinogenic outcomes (DNA damage, oxidative stress, and protein misfolding) were used to provide insight into the mechanisms underlying the toxicity of glyphosate and 3 Roundup formulations.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Histopathology and serum biochemistry analysis showed that MON 52276 but not glyphosate treatment was associated with a statistically significant increase in hepatic steatosis and necrosis. Similar lesions were also present in the liver of glyphosate-treated groups but not in the control group. MON 52276 altered the expression of 96 genes in liver, with the most affected biological functions being TP53 activation by DNA damage and oxidative stress as well as the regulation of circadian rhythms. The most affected genes in liver also had their expression similarly altered in kidneys. DNA methylation profiling of liver revealed 5,727 and 4,496 differentially methylated CpG sites between the control group and the group of rats exposed to glyphosate and MON 52276, respectively. Direct DNA damage measurement by apurinic/apyrimidinic lesion formation in liver was increased with glyphosate exposure. Mechanistic evaluations showed that two Roundup herbicides but not glyphosate activated oxidative stress and misfolded protein responses.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Taken together, the results of our study show that Roundup herbicides are more toxic than glyphosate, activating mechanisms involved in cellular carcinogenesis and causing gene expression changes reflecting DNA damage. This further highlights the power of high-throughput ‘omics’ methods to detect metabolic changes, which would be missed by relying solely on conventional biochemical and histopathological measurements. Our study paves the way for future investigations by reporting a panel of gene expression changes and DNA methylation sites, which can serve as biomarkers and potential predictors of negative health outcomes resulting from exposure to glyphosate-based herbicides.</jats:p></jats:sec>",2021-04-13
59,10.1101/2021.04.24.441253,40,bioRxiv,Genomics,False,Transposable element profiles reveal cell line identity and loss of heterozygosity in Drosophila cell culture,"[{'ORCID': 'http://orcid.org/0000-0002-8605-7547', 'authenticated-orcid': False, 'given': 'Shunhua', 'family': 'Han', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9290-8339', 'authenticated-orcid': False, 'given': 'Preston J.', 'family': 'Basting', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1459-3148', 'authenticated-orcid': False, 'given': 'Guilherme', 'family': 'Dias', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5249-6587', 'authenticated-orcid': False, 'given': 'Arthur', 'family': 'Luhur', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew C.', 'family': 'Zelhof', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5462-9854', 'authenticated-orcid': False, 'given': 'Casey M.', 'family': 'Bergman', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Cell culture systems allow key insights into biological mechanisms yet suffer from irreproducible outcomes in part because of cross-contamination or mislabelling of cell lines. Cell line misidentification can be mitigated by the use of genotyping protocols, which have been developed for human cell lines but are lacking for many important model species. Here we leverage the classical observation that transposable elements (TEs) proliferate in cultured <jats:italic>Drosophila</jats:italic> cells to demonstrate that genome-wide TE insertion profiles can reveal the identity and provenance of <jats:italic>Drosophila</jats:italic> cell lines. We identify multiple cases where TE profiles clarify the origin of <jats:italic>Drosophila</jats:italic> cell lines (Sg4, mbn2, and OSS_E) relative to published reports, and also provide evidence that insertions from only a subset of LTR retrotransposon families are necessary to mark <jats:italic>Drosophila</jats:italic> cell line identity. We also develop a new bioinformatics approach to detect TE insertions and estimate intra-sample allele frequencies in legacy whole-genome shotgun sequencing data (called ngs_te_mapper2), which revealed copy-neutral loss of heterozygosity as a mechanism shaping the unique TE profiles that identify <jats:italic>Drosophila</jats:italic> cell lines. Our work contributes to the general understanding of the forces impacting metazoan genomes as they evolve in cell culture and paves the way for high-throughput protocols that use TE insertions to authenticate cell lines in <jats:italic>Drosophila</jats:italic> and other organisms.</jats:p>",2021-04-24
60,10.1101/2021.03.03.21252706,40,medRxiv,Infectious Diseases (except HIV/AIDS),True,Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant,"[{'ORCID': 'http://orcid.org/0000-0002-2828-8558', 'authenticated-orcid': False, 'given': 'Renato Mendes', 'family': 'Coutinho', 'sequence': 'first', 'affiliation': []}, {'given': 'Flavia Maria Darcie', 'family': 'Marquitti', 'sequence': 'additional', 'affiliation': []}, {'given': 'Leonardo Souto', 'family': 'Ferreira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marcelo Eduardo', 'family': 'Borges', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rafael Lopes', 'family': 'Paixão da Silva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Otavio', 'family': 'Canton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tatiana P.', 'family': 'Portella', 'sequence': 'additional', 'affiliation': []}, {'given': 'Silas', 'family': 'Poloni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Caroline', 'family': 'Franco', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mateusz M.', 'family': 'Plucinski', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fernanda C.', 'family': 'Lessa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Antônio Augusto', 'family': 'Moura da Silva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Roberto Andre', 'family': 'Kraenkel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria Amélia', 'family': 'de Sousa Mascena Veras', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paulo', 'family': 'Inácio Prado', 'sequence': 'additional', 'affiliation': []}]","<jats:p>The variant of concern (VOC) P.1 emerged in the Amazonas state (Brazil) in November-2020. It contains a constellation of mutations, ten of them in the spike protein. Consequences of these specific mutations at the population level have been little studied so far, despite the detection of P.1 variant in 26 countries, with local transmission in at least four other countries in the Americas and Europe. Here, we estimate P.1’s transmissibility and reinfection using a model-based approach, by fitting data from the Brazilian national health surveillance of hospitalized individuals and frequency of the P.1 variant in Manaus from December 2020 to February 2021, when the city was devastated by four times more cases than in the previous peak (April 2020). The new variant was found to be about 2.6 times more transmissible (95% Confidence Interval (CI): 2.4–2.8) than previous circulating variant(s). The city already had a high prevalence of individuals previously affected by the SARS-CoV-2 virus (estimated as 78%, CI:73–83%), and the fitted model attributed 28% of the cases during the period to reinfections by the variant P.1. Our estimates rank P.1 as the most transmissible among the current identified SARS-CoV-2 VOCs, posing a serious threat and requiring urgent measures to control its global spread.</jats:p>",2021-03-05
61,10.1101/2021.04.26.441537,39,bioRxiv,Bioengineering,False,Genomically Mined Acoustic Reporter Genes Enable On-Demand In Vivo Monitoring of Tumor-Homing Bacteria,"[{'ORCID': 'http://orcid.org/0000-0002-4347-6901', 'authenticated-orcid': False, 'given': 'Robert C.', 'family': 'Hurt', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4266-9197', 'authenticated-orcid': False, 'given': 'Marjorie T.', 'family': 'Buss', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katie', 'family': 'Wong', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2926-191X', 'authenticated-orcid': False, 'given': 'Daniel P.', 'family': 'Sawyer', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9610-0687', 'authenticated-orcid': False, 'given': 'Margaret B.', 'family': 'Swift', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3819-1618', 'authenticated-orcid': False, 'given': 'Przemysław', 'family': 'Dutka', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8747-0483', 'authenticated-orcid': False, 'given': 'David R.', 'family': 'Mittelstein', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4411-6991', 'authenticated-orcid': False, 'given': 'Zhiyang', 'family': 'Jin', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9717-6288', 'authenticated-orcid': False, 'given': 'Mohamad H.', 'family': 'Abedi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ramya', 'family': 'Deshpande', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0291-4215', 'authenticated-orcid': False, 'given': 'Mikhail G.', 'family': 'Shapiro', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>A major outstanding challenge in the fields of biological research, synthetic biology and cell-based medicine is the difficulty of visualizing the function of natural and engineered cells noninvasively inside opaque organisms. Ultrasound imaging has the potential to address this challenge as a widely available technique with a tissue penetration of several centimeters and a spatial resolution below 100 μm. Recently, the first genetically encoded reporter molecules were developed based on bacterial gas vesicles to link ultrasound signals to molecular and cellular function. However, the properties of these first-generation acoustic reporter genes (ARGs) resulted in limited sensitivity and specificity for imaging in the <jats:italic>in vivo</jats:italic> context. Here, we describe second-generation ARGs with greatly improved acoustic properties and expression characteristics. We identified these ARGs through a systematic phylogenetic screen of candidate gas vesicle gene clusters from diverse bacteria and archaea. The resulting constructs offer major qualitative and quantitative improvements, including the ability to produce nonlinear ultrasound contrast to distinguish their signals from those of background tissues, and a reduced burden of expression in probiotic hosts. We demonstrate the utility of these next-generation ARGs by imaging the <jats:italic>in situ</jats:italic> gene expression of tumor-homing probiotic bacteria, revealing the unique spatial distribution of tumor colonization by these cells noninvasively in living subjects.</jats:p>",2021-04-27
62,10.1101/2020.06.03.20121145,37,medRxiv,Infectious Diseases (except HIV/AIDS),True,"The role of children in the spread of COVID-19: Using household data from Bnei Brak, Israel, to estimate the relative susceptibility and infectivity of children","[{'ORCID': 'http://orcid.org/0000-0001-5316-8964', 'authenticated-orcid': False, 'given': 'Itai', 'family': 'Dattner', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4544-0910', 'authenticated-orcid': False, 'given': 'Yair', 'family': 'Goldberg', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7411-4789', 'authenticated-orcid': False, 'given': 'Guy', 'family': 'Katriel', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8808-8937', 'authenticated-orcid': False, 'given': 'Rami', 'family': 'Yaari', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nurit', 'family': 'Gal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yoav', 'family': 'Miron', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1147-8686', 'authenticated-orcid': False, 'given': 'Arnona', 'family': 'Ziv', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yoram', 'family': 'Hamo', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3306-185X', 'authenticated-orcid': False, 'given': 'Amit', 'family': 'Huppert', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>One of the significant unanswered questions about COVID-19 epidemiology relates to the role of children in transmission. In this study we estimate susceptibility and infectivity of children compared to those of adults. Understanding the age-structured transmission dynamics of the outbreak provides precious and timely information to guide epidemic modelling and public health policy.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Data were collected from households in the city of Bnei Brak, Israel, in which all household members were tested for COVID-19 using PCR. To estimate relative transmission parameters in the absence of data on who infected whom, we developed an estimation method based on a discrete stochastic dynamic model of the spread of the epidemic within a household. The model describes the propagation of the disease between household members allowing for susceptibility and infectivity parameters to vary among two age groups. The parameter estimates are obtained by a maximum likelihood method, where the likelihood function is computed based on the stochastic model via simulations.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Inspection of the data reveals that children are less likely to become infected compared to adults (25% of children infected over all households, 44% of adults infected over all households, excluding index cases), and the chances of becoming infected increases with age. An interesting exception is that infants up to age one year are more likely to be infected than children between one and four. Using our modelling approach, we estimate that the susceptibility of children (under 20 years old) is 45% [40%, 55%] of the susceptibility of adults. The infectivity of children was estimated to be 85% [65%, 110%] relative to that of adults.</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>It is widely observed that the percentage of children within confirmed cases is low. A common explanation is that children who are infected are less likely to develop symptoms than adults, and thus are less likely to be tested. We estimate that children are less susceptible to infection, which is an additional factor explaining their relatively low rate of occurrence within confirmed cases. Moreover, our results indicate that children, when infected, are somewhat less prone to infect others compared to adults; however, this result is not statistically significant.</jats:p><jats:p>The resulting estimates of susceptibility and infectivity of children compared to adults are crucial for deciding on appropriate interventions, and for controlling the epidemic outbreak and its progress. These estimates can guide age-dependent public health policy such as school closure and opening. However, while our estimates of children’s susceptibility and infectivity are lower than those of adults within a household, it is important to bear in mind that their role in the spread of COVID-19 outside the household, is also affected by different contact patterns and hygiene habits.</jats:p></jats:sec>",2020-06-05
63,10.1101/2020.06.16.20132597,36,medRxiv,Pharmacology and Therapeutics,True,"Hydroxychloroquine with or without azithromycin and in-hospital mortality or discharge in patients hospitalized for COVID-19 infection: a cohort study of 4,642 in-patients in France","[{'ORCID': 'http://orcid.org/0000-0002-1267-5270', 'authenticated-orcid': False, 'given': 'Emilie', 'family': 'Sbidian', 'sequence': 'first', 'affiliation': []}, {'given': 'Julie', 'family': 'Josse', 'sequence': 'additional', 'affiliation': []}, {'given': 'Guillaume', 'family': 'Lemaitre', 'sequence': 'additional', 'affiliation': []}, {'given': 'Imke', 'family': 'Meyer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mélodie', 'family': 'Bernaux', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexandre', 'family': 'Gramfort', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nathanaël', 'family': 'Lapidus', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicolas', 'family': 'Paris', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7142-6728', 'authenticated-orcid': False, 'given': 'Antoine', 'family': 'Neuraz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ivan', 'family': 'Lerner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicolas', 'family': 'Garcelon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bastien', 'family': 'Rance', 'sequence': 'additional', 'affiliation': []}, {'given': 'Olivier', 'family': 'Grisel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Moreau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ali', 'family': 'Bellamine', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pierre', 'family': 'Wolkenstein', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gaël', 'family': 'Varoquaux', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eric', 'family': 'Caumes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marc', 'family': 'Lavielle', 'sequence': 'additional', 'affiliation': []}, {'given': 'Armand Mekontso', 'family': 'Dessap', 'sequence': 'additional', 'affiliation': []}, {'given': 'Etienne', 'family': 'Audureau', 'sequence': 'additional', 'affiliation': []}, {'name': 'AP-HP Covid CDR Initiative and ‘Entrepôt de Données de Santé’ AP-HP consortium', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>To assess the clinical effectiveness of oral hydroxychloroquine (HCQ) with or without azithromycin (AZI) in preventing death or leading to hospital discharge.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Retrospective cohort study.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>An analysis of data from electronic medical records and administrative claim data from the French Assistance Publique - Hôpitaux de Paris (AP-HP) data warehouse, in 39 public hospitals, Ile-de-France, France.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>All adult inpatients with at least one PCR-documented SARS-CoV-2 RNA from a nasopharyngeal sample between February 1<jats:sup>st</jats:sup>, 2020 and April 6<jats:sup>th</jats:sup>, 2020 were eligible for analysis. The study population was restricted to patients who did not receive COVID-19 treatments assessed in ongoing trials, including antivirals and immunosuppressive drugs. End of follow-up was defined as the date of death, discharge home, day 28 after admission, whichever occurred first, or administrative censoring on May 4, 2020.</jats:p></jats:sec><jats:sec><jats:title>Intervention</jats:title><jats:p>Patients were further classified into 3 groups: (i) receiving HCQ alone, (ii) receiving HCQ together with AZI, and (iii) receiving neither HCQ nor AZI. Exposure to a HCQ/AZI combination was defined as a simultaneous prescription of the 2 treatments (more or less one day).</jats:p></jats:sec><jats:sec><jats:title>Main outcome measures</jats:title><jats:p>The primary outcome was all-cause 28-day mortality as a time-to-event endpoint under a competing risks survival analysis framework. The secondary outcome was 28-day discharge home. Augmented inverse probability of treatment weighted (AIPTW) estimates of the average treatment effect (ATE) were computed to account for confounding.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A total of 4,642 patients (mean age: 66.1 ± 18; males: 2,738 (59%)) were included, of whom 623 (13.4%) received HCQ alone, 227 (5.9%) received HCQ plus AZI, and 3,792 (81.7%) neither drug. Patients receiving ‘HCQ alone’ or ‘HCQ plus AZI’ were more likely younger, males, current smokers and overall presented with slightly more co-morbidities (obesity, diabetes, any chronic pulmonary diseases, liver diseases), while no major difference was apparent in biological parameters. After accounting for confounding, no statistically significant difference was observed between the ‘HCQ’ and ‘Neither drug’ groups for 28-day mortality: AIPTW absolute difference in ATE was +1.24% (−5.63 to 8.12), ratio in ATE 1.05 (0.77 to 1.33). 28-day discharge rates were statistically significantly higher in the ‘HCQ’ group: AIPTW absolute difference in ATE (+11.1% [3.30 to 18.9]), ratio in ATE (1.25 [1.07 to 1.42]). As for the ‘HCQ+AZI’ vs neither drug, trends for significant differences and ratios in AIPTW ATE were found suggesting higher mortality rates in the former group (difference in ATE +9.83% [-0.51 to 20.17], ratio in ATE 1.40 [0.98 to 1.81];p=0.062).</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Using a large non-selected population of inpatients hospitalized for COVID-19 infection in 39 hospitals in France and robust methodological approaches, we found no evidence for efficacy of HCQ or HCQ combined with AZI on 28-day mortality. Our results suggested a possible excess risk of mortality associated with HCQ combined with AZI, but not with HCQ alone. Significantly higher rates of discharge home were observed in patients treated by HCQ, a novel finding warranting further confirmation in replicative studies. Altogether, our findings further support the need to complete currently undergoing randomized clinical trials.</jats:p></jats:sec><jats:sec><jats:title>WHAT THIS PAPER ADDS?</jats:title><jats:sec><jats:title>What is already known on this subject</jats:title><jats:list list-type=""simple""><jats:list-item><jats:label>-</jats:label><jats:p>The use of Hydroxychloroquine (HCQ) or HCQ with azithromycin (AZI) has been associated with viral load reduction at 6 days in COVID-19 infected patients</jats:p></jats:list-item><jats:list-item><jats:label>-</jats:label><jats:p>No difference between HCQ and no-HCQ groups in terms of risk of death or need for mechanical ventilation was found in two large cohorts of hospitalized COVID-19 infected patients</jats:p></jats:list-item></jats:list></jats:sec><jats:sec><jats:title>What this study adds</jats:title><jats:list list-type=""simple""><jats:list-item><jats:label>-</jats:label><jats:p>Using a large non-selected population of inpatients hospitalized for COVID-19 infection in 39 hospitals in France and robust methodological approaches, we found no evidence for efficacy of HCQ on 28-day mortality</jats:p></jats:list-item><jats:list-item><jats:label>-</jats:label><jats:p>Our results suggest an excess risk of mortality in patients treated by a combination of HCQ and AZI, but not with HCQ alone</jats:p></jats:list-item><jats:list-item><jats:label>-</jats:label><jats:p>Significantly higher rates of discharge home were observed in patients treated by HCQ, a novel finding warranting further confirmation in replicative studies</jats:p></jats:list-item></jats:list></jats:sec></jats:sec>",2020-06-19
64,10.1101/2021.03.25.21254335,36,medRxiv,Gastroenterology,True,Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines,"[{'given': 'Nicholas A', 'family': 'Kennedy', 'sequence': 'first', 'affiliation': []}, {'given': 'Simeng', 'family': 'Lin', 'sequence': 'additional', 'affiliation': []}, {'given': 'James R', 'family': 'Goodhand', 'sequence': 'additional', 'affiliation': []}, {'given': 'Neil', 'family': 'Chanchlani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ben', 'family': 'Hamilton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claire', 'family': 'Bewshea', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rachel', 'family': 'Nice', 'sequence': 'additional', 'affiliation': []}, {'given': 'Desmond', 'family': 'Chee', 'sequence': 'additional', 'affiliation': []}, {'given': 'JR Fraser', 'family': 'Cummings', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aileen', 'family': 'Fraser', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peter M', 'family': 'Irving', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nikolaos', 'family': 'Kamperidis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Klaartje B', 'family': 'Kok', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher A', 'family': 'Lamb', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jonathan', 'family': 'Macdonald', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shameer J', 'family': 'Mehta', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard CG', 'family': 'Pollok', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tim', 'family': 'Raine', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philip J', 'family': 'Smith', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ajay M', 'family': 'Verma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Timothy J', 'family': 'McDonald', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shaji', 'family': 'Sebastian', 'sequence': 'additional', 'affiliation': []}, {'given': 'Charlie W', 'family': 'Lees', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nick', 'family': 'Powell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tariq', 'family': 'Ahmad', 'sequence': 'additional', 'affiliation': []}, {'name': 'Contributors to the CLARITY IBD study', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Delayed second-dose SARS-CoV-2 vaccination trades maximal effectiveness for a lower level of immunity across more of the population. We investigated whether patients with inflammatory bowel disease treated with infliximab have attenuated serological responses to a single-dose of a SARS-CoV-2 vaccine.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Antibody responses and seroconversion rates in infliximab-treated patients (n=865) were compared to a cohort treated with vedolizumab (n=428), a gut-selective anti-integrin α4β7 monoclonal antibody. Our primary outcome was anti-SARS-CoV-2 spike (S) antibody concentrations 3-10 weeks after vaccination in patients without evidence of prior infection. Secondary outcomes were seroconversion rates, and antibody responses following past infection or a second dose of the BNT162b2 vaccine.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Geometric mean [SD] anti-SARS-CoV-2 antibody concentrations were lower in patients treated with infliximab than vedolizumab, following BNT162b2 (6.0 U/mL [5.9] vs 28.8 U/mL [5.4] P&lt;0.0001) and ChAdOx1 nCoV-19 (4.7 U/mL [4.9]) vs 13.8 U/mL [5.9] P&lt;0.0001) vaccines. In our multivariable models, antibody concentrations were lower in infliximab-compared to vedolizumab-treated patients who received the BNT162b2 (fold change [FC] 0.29 [95% CI 0.21, 0.40], p&lt;0.0001) and ChAdOx1 nCoV-19 (FC 0.39 [95% CI 0.30, 0.51], p&lt;0.0001) vaccines. In both models, age ≥ 60 years, immunomodulator use, Crohn’s disease, and smoking were associated with lower, whilst non-white ethnicity was associated with higher, anti-SARS-CoV-2 antibody concentrations. Seroconversion rates after a single-dose of either vaccine were higher in patients with prior SARS-CoV-2 infection and after two doses of BNT162b2 vaccine.</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>Infliximab is associated with attenuated immunogenicity to a single-dose of the BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines. Vaccination after SARS-CoV-2 infection, or a second dose of vaccine, led to seroconversion in most patients. Delayed second dosing should be avoided in patients treated with infliximab.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>Royal Devon and Exeter and Hull University Hospital Foundation NHS Trusts. Unrestricted educational grants: F. Hoffmann-La Roche AG (Switzerland), Biogen GmbH (Switzerland), Celltrion Healthcare (South Korea) and Galapagos NV (Belgium).</jats:p></jats:sec><jats:sec><jats:title>Research in context</jats:title><jats:sec><jats:title>Evidence before this study</jats:title><jats:p>Faced with further surges of SARS-CoV-2 infection, a growing number of countries, including the UK, have opted to delay second vaccine doses for all people. This strategy trades maximal effectiveness against a lower level of protective immunity across more of the at-risk population.</jats:p><jats:p>We have previously shown that seroprevalence, seroconversion in PCR-confirmed cases, and the magnitude of anti-SARS-CoV-2 antibodies following SARS-CoV-2 infection are reduced in infliximab-compared with vedolizumab-treated patients. Whether single-doses of vaccines are effective in patients treated with anti-TNF therapies is unknown.</jats:p><jats:p>We searched PubMed from 25 November 2019 to 23 March 2021 with the terms “anti-tumour necrosis factor” or “anti-integrin” or “infliximab” or “adalimumab” or “vedolizumab” or “biological therapy” or “biologic therapy” AND “SARS-CoV-2” or “coronavirus” or “COVID-19” or AND “seroprevalence” or “seroconversion” or “antibody” or “antibody response” or “magnitude” or “immunogenicity” AND “vaccine” or “vaccination” or “immunisation” or “immunization” or “ChAdOx1 nCoV-19” or “BNT162b2” or “mRNA-1273”, without restriction on language.</jats:p><jats:p>Serological responses to SARS-CoV-2 vaccines have been reported in registration trials and small observational cohorts of healthy volunteers. Two small studies, including one unpublished preprint, found that COVID-19 vaccine immunogenicity rates were lower in transplant recipients and patients with malignancy receiving immunosuppressive therapy, and fewer patients treated with potent immunosuppressants seroconverted than healthy controls. No studies have assessed the effect of anti-TNF therapy on immunogenicity following SARS-CoV-2 vaccination.</jats:p></jats:sec><jats:sec><jats:title>Added value of this study</jats:title><jats:p>To test if anti-TNF drugs attenuate serological responses to primary SARS-CoV-2 vaccines, we analysed anti-SARS-CoV-2 spike (S) antibody concentrations and seroconversion rates in 1293 patients with inflammatory bowel disease who received primary vaccinations with either the ChAdOx1 nCoV-19 or BNT162b2 vaccines. 865 were treated with the anti-TNF drug infliximab and outcomes were compared to a reference cohort of 428 patients treated with vedolizumab, a gut selective anti-integrin α4β7 monoclonal antibody that is not associated with impaired systemic immune responses.</jats:p><jats:p>Anti-SARS-CoV-2 antibody levels and rates of seroconversion were lower following primary vaccination with both the BNT162b2 and ChAdOx1 nCoV-19 vaccines in patients with IBD treated with infliximab compared to vedolizumab. Older age, immunomodulator use, Crohn’s disease (versus ulcerative colitis or inflammatory bowel disease unclassified), and current smoking were associated with lower anti-SARS-CoV-2 antibody concentrations, irrespective of vaccine type. Non-white ethnicity was associated with higher anti-SARS-CoV-2 (S) antibody concentrations following primary vaccination with both vaccines. Antibody concentrations and seroconversion rates were higher in patients with past SARS-CoV-2 infection prior to a single-dose of either vaccine, and after 2 doses of the BNT162b2 vaccine.</jats:p></jats:sec><jats:sec><jats:title>Implications of the available evidence</jats:title><jats:p>Our findings have important implications for patients treated with anti-TNF therapy, particularly for those also treated with an immunomodulator. Poor antibody responses to a single-dose of vaccine exposes these patients to a potential increased risk of SARS-CoV-2 infection. However, higher rates of seroconversion in patients with two exposures to SARS-CoV-2 antigen, even in the presence of TNF blockade, suggest that all patients receiving these drugs should be prioritized for optimally timed second doses. Until patients receive a second vaccine dose, they should consider that they are not protected from SARS-CoV-2 infection and continue to practice enhanced physical distancing and shielding if appropriate. Even after two antigen exposures, a small subset of patients failed to mount an antibody response. Antibody testing and adapted vaccine schedules should be considered to protect these at-risk patients.</jats:p></jats:sec></jats:sec>",2021-03-28
65,10.1101/2020.08.13.249797,35,bioRxiv,Neuroscience,False,Comparing spatial null models for brain maps,"[{'ORCID': 'http://orcid.org/0000-0003-1057-1336', 'authenticated-orcid': False, 'given': 'Ross D.', 'family': 'Markello', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0307-2862', 'authenticated-orcid': False, 'given': 'Bratislav', 'family': 'Misic', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Technological and data sharing advances have led to a proliferation of high-resolution structural and functional maps of the brain. Modern neuroimaging research increasingly depends on identifying correspondences between the topographies of these maps; however, most standard methods for statistical inference fail to account for their spatial properties. Recently, multiple methods have been developed to generate null distributions that preserve the spatial autocorrelation of brain maps and yield more accurate statistical estimates. Here, we comprehensively assess the performance of ten published null frameworks in statistical analyses of neuroimaging data. To test the efficacy of these frameworks in situations with a known ground truth, we first apply them to a series of controlled simulations and examine the impact of data resolution and spatial autocorrelation on their family-wise error rates. Next, we use each framework with two empirical neuroimaging datasets, investigating their performance when testing (1) the correspondence between brain maps (e.g., correlating two activation maps) and (2) the spatial distribution of a feature within a partition (e.g., quantifying the specificity of an activation map within an intrinsic functional network). Finally, we investigate how differences in the implementation of these null models may impact their performance. In agreement with previous reports, we find that naive null models that do not preserve spatial autocorrelation consistently yield elevated false positive rates and unrealistically liberal statistical estimates. While spatially-constrained null models yielded more realistic, conservative estimates, even these frameworks suffer from inflated false positive rates and variable performance across analyses. Throughout our results, we observe minimal impact of parcellation and resolution on null model performance. Altogether, our findings highlight the need for continued development of statistically-rigorous methods for comparing brain maps. The present report provides a harmonised framework for benchmarking and comparing future advancements.</jats:p>",2020-08-14
66,10.1101/2020.09.22.309229,35,bioRxiv,Developmental Biology,False,"High-Resolution, Large Imaging Volume, and Multi-View Single Objective Light-Sheet Microscopy","[{'ORCID': 'http://orcid.org/0000-0001-5138-4663', 'authenticated-orcid': False, 'given': 'Bin', 'family': 'Yang', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0534-4374', 'authenticated-orcid': False, 'given': 'Merlin', 'family': 'Lange', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alfred', 'family': 'Millett-Sikking', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ahmet Can', 'family': 'Solak', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6679-1261', 'authenticated-orcid': False, 'given': 'Shruthi Vijay', 'family': 'Kumar', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9971-895X', 'authenticated-orcid': False, 'given': 'Wanpeng', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hirofumi', 'family': 'Kobayashi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7080-3210', 'authenticated-orcid': False, 'given': 'Matthew N.', 'family': 'McCarroll', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4388-9642', 'authenticated-orcid': False, 'given': 'Lachlan W.', 'family': 'Whitehead', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4636-5000', 'authenticated-orcid': False, 'given': 'Reto P.', 'family': 'Fiolka', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas B.', 'family': 'Kornberg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew G.', 'family': 'York', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9991-9724', 'authenticated-orcid': False, 'given': 'Loic A.', 'family': 'Royer', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Recent developments in Oblique Plane Microscopy (OPM) have shown that it can achieve high spatio-temporal resolution. Here we describe a single objective light-sheet microscope based on oblique plane illumination that achieves: (i) large field of view and high-resolution imaging via a custom remote focusing objective; (ii) fast volumetric imaging by means of <jats:italic>light-sheet stabilised stage scanning</jats:italic> – a novel scanning modality that extends the imaging volume without compromising imaging speed nor quality; (iii) multi-view imaging by alternating the orientation of light-sheet illumination and detection to improve the image quality on large samples; (iv) simpler design and ergonomics by remote placement of coverslips to allow inverted imaging, enabling imaging across scales in a high-throughput format. Overall, we achieved a resolution of 450 nm laterally and 2 μm axially and a field of view of 3000 μm × 800 μm × 300 μm. We demonstrate the speed, field of view, resolution and versatility of our novel instrument by imaging various systems, including zebrafish whole brain activity, <jats:italic>Drosophila</jats:italic> egg chamber development, and zebrafish development – up to nine embryos simultaneously.</jats:p>",2020-09-24
67,10.1101/2021.04.23.441075,34,bioRxiv,Pharmacology and Toxicology,False,In vivo KRAS G12D/V Degradation Mediated by CANDDY Using a Modified Proteasome Inhibitor,"[{'given': 'Satoshi', 'family': 'Imanishi', 'sequence': 'first', 'affiliation': []}, {'given': 'Lijuan', 'family': 'Huang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shoko', 'family': 'Itakura', 'sequence': 'additional', 'affiliation': []}, {'given': 'Masamichi', 'family': 'Ishizaka', 'sequence': 'additional', 'affiliation': []}, {'given': 'Megumi', 'family': 'Tsukamoto', 'sequence': 'additional', 'affiliation': []}, {'given': 'Megumi', 'family': 'Saito', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yoichi', 'family': 'Iwasaki', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tomohiro', 'family': 'Yamaguchi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Etsuko', 'family': 'Miyamoto-Sato', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary paragraph</jats:title><jats:p>“Undruggable” proteins, such as RAS proteins, remain problematic despite efforts to discover inhibitors against them. KRAS mutants are prevalent in human cancers. Although KRAS G12C inhibitors have been developed recently, there are no effective inhibitors for KRAS G12D/V. Here, we described the development of a novel chemical knockdown strategy, termed CANDDY (<jats:underline>Chemical knockdown</jats:underline> with <jats:underline>A</jats:underline>ffinity aNd <jats:underline>D</jats:underline>egradation <jats:underline>DY</jats:underline>namics). This strategy, which is not an inhibition strategy, involves a CANDDY tag modified from a proteasome inhibitor. The tag induces direct proteasomal degradation. We constructed TUS-007 as a multispecific small molecule tethered from a KRAS interactor and CANDDY tag to target KRAS G12D/V. TUS-007 successfully suppressed tumors due to the degradation of KRAS G12D/V. We confirmed that the CANDDY tag-induced degradation was independent of target ubiquitination. The CANDDY technology could represent a simple and practical way to degrade currently “undruggable” proteins.</jats:p>",2021-04-23
68,10.1101/2021.04.16.21255616,34,medRxiv,Infectious Diseases (except HIV/AIDS),True,Prevalence and Transmission of SARS-CoV-2 in Childcare Facilities: A Longitudinal Study,"[{'given': 'Luise', 'family': 'Haag', 'sequence': 'first', 'affiliation': []}, {'given': 'Judith', 'family': 'Blankenburg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Manja', 'family': 'Unrath', 'sequence': 'additional', 'affiliation': []}, {'given': 'Johanna', 'family': 'Grabietz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elisabeth', 'family': 'Kahre', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lukas', 'family': 'Galow', 'sequence': 'additional', 'affiliation': []}, {'given': 'Josephine', 'family': 'Schneider', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexander H.', 'family': 'Dalpke', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christian', 'family': 'Lück', 'sequence': 'additional', 'affiliation': []}, {'given': 'Leo', 'family': 'Büttner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Reinhard', 'family': 'Berner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jakob P.', 'family': 'Armann', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Objectives</jats:title><jats:p>Previous data indicate that children might play a less crucial role in SARS-CoV-2 transmission than initially assumed. We conducted a study to gain further knowledge on prevalence, transmission and spread of SARS-CoV-2 among preschool children, their parents and caretakers.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Children, their parents and care givers in 14 childcare facilities in Dresden, Saxony/ Germany were invited to participate in the KiTaCoviDD19-study between July 2020 and January 2021. Seroprevalence of SARS-CoV-2 antibodies was assessed up to 4 times during the study period in all participating adults and personal characteristics as well as epidemiological information of personal SARS-CoV-2 history were obtained. Stool viral shedding of SARS-CoV-2 was analyzed every 2-4 weeks in all participating children.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In total, 318 children, 299 parents and 233 childcare workers were enrolled. The percentage of seropositive adults and SARS-CoV-2 positive detected children rose considerably by January 2021. However, the rate of SARS-CoV-2 positive children was considerably lower than the rate of seropositive adults. Overall, we detected a maximum of three connected cases in children. About 50% of SARS-CoV-2 infections in children could not be connected to a secondary case within our study population.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The study could not provide evidence for a relevant asymptomatic (“silent”) spread of SARS-CoV-2 in childcare facilities, neither in a low nor a high prevalence setting. This finding adds to the evidence that childcare and educational settings do not play a crucial role in driving the SARS-CoV-2 pandemic.</jats:p></jats:sec><jats:sec><jats:title>Table of Contents Summary</jats:title><jats:p>This longitudinal study among children, parents and childcare workers provides further insight on SARS-CoV-2 prevalence and transmission within childcare facilities.</jats:p></jats:sec><jats:sec><jats:title>What’s Known on This Subject</jats:title><jats:p>Based on age distribution of SARS-CoV-2 infections and previous data of very limited spread of COVID-19 among primary and secondary schools there is reason to believe that children play a less crucial role in SARS-CoV-2 transmission than initially assumed.</jats:p></jats:sec><jats:sec><jats:title>What This Study Adds</jats:title><jats:p>Previously published studies focus mainly on SARS-CoV-2 transmission in schools. This longitudinal study provides information on prevalence, transmission and spread of SARS-CoV-2 within childcare facilities during low- and high-prevalence settings.</jats:p></jats:sec>",2021-04-18
69,10.1101/2021.04.27.441629,33,bioRxiv,Neuroscience,False,ElectroEncephaloGraphy robust linear modelling using weights reflecting single trials' dynamics,"[{'given': 'Cyril R', 'family': 'Pernet', 'sequence': 'first', 'affiliation': []}, {'given': 'Guillaume A', 'family': 'Rousselet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ignacio', 'family': 'Suay Mas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ramon', 'family': 'Martinez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rand', 'family': 'Wilcox', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arnaud A', 'family': 'Delorme', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Being able to remove or weigh down the influence of outlier data is desirable for any statistical models. While Magnetic and ElectroEncephaloGraphic (MEEG) data are often averaged across trials per condition, it is becoming common practice to use information from all trials to build linear models. Individual trials can, however, have considerable weight and thus bias inferential results. Here, rather than looking for univariate outliers, defined independently at each measurement point, we apply the principal component projection (PCP) method at each channel, deriving a single weight per trial at each channel independently. Using both synthetic data and open EEG data, we show (1) that PCP is efficient at detecting a large variety of outlying trials; (2) how PCP-based weights can be implemented in the context of the general linear model with accurate control of type 1 family-wise error rate; and (3) that our PCP-based Weighted Least Square (WLS) approach increases the statistical power of group analyses as well as a much slower Iterative Reweighted Least Squares (IRLS), although the weighting scheme is markedly different. Together, our results show that WLS based on PCP weights derived from whole trial profiles is an efficient method to weigh down the influence of outlier EEG data in linear models.</jats:p>",2021-04-28
70,10.1101/2021.03.11.21253275,33,medRxiv,Public and Global Health,True,Effect of vaccination on transmission of COVID-19: an observational study in healthcare workers and their households,"[{'ORCID': 'http://orcid.org/0000-0002-2825-3419', 'authenticated-orcid': False, 'given': 'Anoop S', 'family': 'V Shah', 'sequence': 'first', 'affiliation': []}, {'given': 'Ciara', 'family': 'Gribben', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jennifer', 'family': 'Bishop', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peter', 'family': 'Hanlon', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Caldwell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rachael', 'family': 'Wood', 'sequence': 'additional', 'affiliation': []}, {'given': 'Martin', 'family': 'Reid', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jim', 'family': 'McMenamin', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Goldberg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Diane', 'family': 'Stockton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sharon', 'family': 'Hutchinson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chris', 'family': 'Robertson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul M', 'family': 'McKeigue', 'sequence': 'additional', 'affiliation': []}, {'given': 'Helen M', 'family': 'Colhoun', 'sequence': 'additional', 'affiliation': []}, {'given': 'David A', 'family': 'McAllister', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The effect of vaccination for COVID-19 on onward transmission is unknown.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A national record linkage study determined documented COVID-19 cases and hospitalisations in unvaccinated household members of vaccinated and unvaccinated healthcare workers from 8<jats:sup>th</jats:sup> December 2020 to 3<jats:sup>rd</jats:sup> March 2021. The primary endpoint was COVID-19 14 days following the first dose.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The cohort comprised of 194,362 household members (mean age 31·1 ± 20·9 years) and 144,525 healthcare workers (mean age 44·4 ± 11·4 years). 113,253 (78·3%) of healthcare workers received at least one dose of the BNT162b2 mRNA or ChAdOx1 nCoV-19 vaccine and 36,227 (25·1%) received a second dose. There were 3,123 and 4,343 documented COVID-19 cases and 175 and 177 COVID-19 hospitalisations in household members of healthcare workers and healthcare workers respectively. Household members of vaccinated healthcare workers had a lower risk of COVID-19 case compared to household members of unvaccinated healthcare worker (rate per 100 person-years 9·40 <jats:italic>versus</jats:italic> 5·93; HR 0·70, 95% confidence interval [CI] 0·63 to 0·78). The effect size for COVID-19 hospitalisation was similar, with the confidence interval crossing the null (HR 0·77 [95% CI 0·53 to 1·10]). The rate per 100 person years was lower in vaccinated compared to unvaccinated healthcare workers for documented (20·13 <jats:italic>versus</jats:italic> 8·51; HR 0·45 [95% CI 0·42 to 0·49]) and hospitalized COVID-19 (0·97 versus 0·14; HR 0·16 [95% CI 0·09 to 0·27]). Compared to the period before the first dose, the risk of documented COVID-19 case was lower at ≥ 14 days after the second dose for household members (HR 0·46 [95% CI 0·30to 0·70]) and healthcare workers (HR 0·08 [95% CI 0·04 to 0·17]).</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>Vaccination of health care workers was associated with a substantial reduction in COVID-19 cases in household contacts consistent with an effect of vaccination on transmission.</jats:p></jats:sec>",2021-03-21
71,10.1101/2021.04.26.441441,33,bioRxiv,Cell Biology,False,The TPLATE complex mediates membrane bending during plant clathrin-mediated endocytosis,"[{'ORCID': 'http://orcid.org/0000-0002-2739-8843', 'authenticated-orcid': False, 'given': 'Alexander', 'family': 'Johnson', 'sequence': 'first', 'affiliation': []}, {'given': 'Dana A', 'family': 'Dahhan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2198-0509', 'authenticated-orcid': False, 'given': 'Nataliia', 'family': 'Gnyliukh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Walter A', 'family': 'Kaufmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vanessa', 'family': 'Zheden', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tommaso', 'family': 'Costanzo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pierre', 'family': 'Mahou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mónika', 'family': 'Hrtyan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jie', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Juan', 'family': 'Aguilera-Servin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniël', 'family': 'van Damme', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emmanuel', 'family': 'Beaurepaire', 'sequence': 'additional', 'affiliation': []}, {'given': 'Martin', 'family': 'Loose', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sebastian Y', 'family': 'Bednarek', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jiri', 'family': 'Friml', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Clathrin-mediated endocytosis in plants is an essential process but the underlying mechanisms are poorly understood, not least because of the extreme intracellular turgor pressure acting against the formation of endocytic vesicles. In contrast to other models, plant endocytosis is independent of actin, indicating a mechanistically distinct solution. Here, by using biochemical and advanced microscopy approaches, we show that the plant-specific TPLATE complex acts outside of endocytic vesicles as a mediator of membrane bending. Cells with disrupted TPLATE fail to generate spherical vesicles, and <jats:italic>in vitro</jats:italic> biophysical assays identified protein domains with membrane bending capability. These results redefine the role of the TPLATE complex as a key component of the evolutionarily distinct mechanism mediating membrane bending against high turgor pressure to drive endocytosis in plant cells.</jats:p><jats:sec><jats:title>One Sentence Summary</jats:title><jats:p>While plant CME is actin independent, we identify that the evolutionarily ancient octameric TPLATE complex mediates membrane bending against high turgor pressure in plant clathrin-mediated endocytosis.</jats:p></jats:sec>",2021-04-27
72,10.1101/2021.04.27.441467,33,bioRxiv,Genomics,False,The genomic basis of domestic colonisation and dispersal in Chagas disease vectors,"[{'ORCID': 'http://orcid.org/0000-0002-2342-1655', 'authenticated-orcid': False, 'given': 'Luis E', 'family': 'Hernandez-Castro', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4537-3532', 'authenticated-orcid': False, 'given': 'Anita G', 'family': 'Villacís', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7635-5447', 'authenticated-orcid': False, 'given': 'Arne', 'family': 'Jacobs', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0325-823X', 'authenticated-orcid': False, 'given': 'Bachar', 'family': 'Cheaib', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6096-3448', 'authenticated-orcid': False, 'given': 'Casey C', 'family': 'Day', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3861-9784', 'authenticated-orcid': False, 'given': 'Sofía', 'family': 'Ocaña-Mayorga', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2857-3922', 'authenticated-orcid': False, 'given': 'Cesar A', 'family': 'Yumiseva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Antonella', 'family': 'Bacigalupo', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4624-0259', 'authenticated-orcid': False, 'given': 'Björn', 'family': 'Andersson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4420-8367', 'authenticated-orcid': False, 'given': 'Louise', 'family': 'Matthews', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7044-346X', 'authenticated-orcid': False, 'given': 'Erin L', 'family': 'Landguth', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9418-6640', 'authenticated-orcid': False, 'given': 'Jaime A', 'family': 'Costales', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9856-1591', 'authenticated-orcid': False, 'given': 'Martin S', 'family': 'Llewellyn', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1964-1425', 'authenticated-orcid': False, 'given': 'Mario J', 'family': 'Grijalva', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The biology of vector adaptation to the human habitat remains poorly understood for many arthropod-borne diseases but underpins effective and sustainable disease control. We adopted a landscape genomics approach to investigate gene flow, signatures of local adaptation, and drivers of population structure among multiple linked wild and domestic population pairs in <jats:italic>Rhodnius ecuadoriensis</jats:italic>, an important vector of Chagas Disease. Evidence of high triatomine gene flow (F<jats:sub>ST</jats:sub>) between wild and domestic ecotopes at sites throughout the study area indicate insecticide-based control will be hindered by constant re-infestation of houses. Genome scans revealed genetic loci with strong signal of local adaptation to the domestic setting, which we mapped to annotated regions in the <jats:italic>Rhodnius prolixus</jats:italic> genome. Our landscape genomic mixed effects models showed <jats:italic>Rhodnius ecuadoriensis</jats:italic> population structure and connectivity is driven by landscape elevation at a regional scale. Our ecologically- and spatially-explicit vector dispersal model enables targeted vector control and recommends spatially discrete, periodic interventions to local authorities as more efficacious than current, haphazard approaches. In tandem, evidence for parallel genomic adaptation to colonisation of the domestic environment at multiple sites sheds new light on the evolutionary basis of adaptation to the human host in arthropod vectors.</jats:p>",2021-04-27
73,10.1101/607390,32,bioRxiv,Genomics,False,Mapping-based genome size estimation,"[{'ORCID': 'http://orcid.org/0000-0002-3321-7471', 'authenticated-orcid': False, 'given': 'Boas', 'family': 'Pucker', 'sequence': 'first', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>While the size of chromosomes can be measured under a microscope, the size of genomes cannot be measured precisely. Biochemical methods and k-mer distribution-based approaches allow only estimations. An alternative approach to predict the genome size based on high contiguity assemblies and short read mappings is presented here and optimized on<jats:italic>Arabidopsis thaliana</jats:italic>and<jats:italic>Beta vulgaris</jats:italic>.<jats:italic>Brachypodium distachyon</jats:italic>,<jats:italic>Solanum lycopersicum</jats:italic>,<jats:italic>Vitis vinifera</jats:italic>, and<jats:italic>Zea mays</jats:italic>were also analyzed to demonstrate the broad applicability of this approach. Mapping-based Genome Size Estimation (MGSE) and additional scripts are available on github:<jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""uri"" xlink:href=""https://github.com/bpucker/MGSE"">https://github.com/bpucker/MGSE</jats:ext-link>.</jats:p>",2019-04-13
74,10.1101/2021.04.11.439311,31,bioRxiv,Scientific Communication and Education,False,"Designing a high-resolution, LEGO-based microscope for an educational setting","[{'ORCID': 'http://orcid.org/0000-0002-4325-6298', 'authenticated-orcid': False, 'given': 'Bart E.', 'family': 'Vos', 'sequence': 'first', 'affiliation': []}, {'given': 'Emil Betz', 'family': 'Blesa', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1548-0655', 'authenticated-orcid': False, 'given': 'Timo', 'family': 'Betz', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Microscopy is an essential tool in many fields of science. However, due to their costs and fragility, the usage of microscopes is limited in classroom settings and nearly absent at home. In this article we present the construction of a microscope using LEGO<jats:sup>®</jats:sup> bricks and low-cost, easily available lenses. We demonstrate that the obtained magnification and resolution are sufficient to resolve micrometer-sized objects and propose a series of experiments that explore various biophysical principles. Finally, a study with students in the age range of 9 to 13 shows that the understanding of microscopy increases significantly after working with the LEGO microscope.</jats:p>",2021-04-11
75,10.1101/2021.04.27.441631,31,bioRxiv,Plant Biology,False,"Plant detection and counting from high-resolution RGB images acquired from UAVs: comparison between deep-learning and handcrafted methods with application to maize, sugar beet, and sunflower crops","[{'ORCID': 'http://orcid.org/0000-0003-1116-5540', 'authenticated-orcid': False, 'given': 'Etienne', 'family': 'David', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8105-2184', 'authenticated-orcid': False, 'given': 'Gaetan', 'family': 'Daubige', 'sequence': 'additional', 'affiliation': []}, {'given': 'Francois', 'family': 'Joudelat', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Burger', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6919-0469', 'authenticated-orcid': False, 'given': 'Alexis', 'family': 'Comar', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6162-2562', 'authenticated-orcid': False, 'given': 'Benoit', 'family': 'De solan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7655-8997', 'authenticated-orcid': False, 'given': 'Frederic', 'family': 'Baret', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Plants density is a key information on crop growth. Usually done manually, this task can beneficiate from advances in image analysis technics. Automated detection of individual plants in images is a key step to estimate this density. To develop and evaluate dedicated processing technics, high resolution RGB images were acquired from UAVs during several years and experiments over maize, sugar beet and sunflower crops at early stages. A total of 16247 plants have been labelled interactively. We compared the performances of handcrafted method (HC) to those of deep-learning (DL). HC method consists in segmenting the image into green and background pixels, identifying rows, then objects corresponding to plants thanks to knowledge of the sowing pattern as prior information. DL method is based on  the Faster RCNN model trained over 2/3 of the images selected to represent a good balance between plant development stage and sessions. One model is trained for each crop.
Results show that DL generally outperforms HC, particularly for maize and sunflower crops. The quality of images appears mandatory for HC methods where image blur and complex background induce difficulties for the segmentation step. Performances of DL methods are also limited by image quality as well as the presence of weeds. An hybrid method (HY) was proposed to eliminate weeds between the rows using the rules used for the HC method. HY improves slightly DL performances in the case of high weed infestation. A significant level of variability of plant detection performances is observed between the several experiments. This was explained by the variability of image acquisition conditions including illumination, plant development stage, background complexity and weed infestation. We tested an active learning approach where few images corresponding to the conditions of the testing dataset were complementing the training dataset for DL. Results show a drastic increase of performances for all crops, with relative RMSE below 5% for the estimation of the plant density.</jats:p>",2021-04-28
76,10.1101/2020.10.02.20202614,31,medRxiv,Infectious Diseases (except HIV/AIDS),True,Combined Metabolic Activators accelerates recovery in mild-to-moderate COVID-19,"[{'given': 'Ozlem', 'family': 'Altay', 'sequence': 'first', 'affiliation': []}, {'given': 'Muhammad', 'family': 'Arif', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiangyu', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hong', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mehtap', 'family': 'Aydın', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gizem', 'family': 'Alkurt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Woonghee', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dogukan', 'family': 'Akyol', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cheng', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gizem', 'family': 'Dinler-Doganay', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hasan', 'family': 'Turkez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Saeed', 'family': 'Shoaie', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jens', 'family': 'Nielsen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jan', 'family': 'Borén', 'sequence': 'additional', 'affiliation': []}, {'given': 'Oktay', 'family': 'Olmuscelik', 'sequence': 'additional', 'affiliation': []}, {'given': 'Levent', 'family': 'Doganay', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mathias', 'family': 'Uhlén', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adil', 'family': 'Mardinoglu', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>There is a need to treat COVID-19 patients suffering from respiratory problems, resulting in decreased oxygen levels and thus leading to mitochondrial dysfunction and metabolic abnormalities. Here, we investigated if a high oral dose of a mixture of Combined Metabolic Activators (CMA) can restore metabolic function and thus aid the recovery of COVID-19 patients. We conducted a placebo-controlled, open-label phase 2 study and a double-blinded phase 3 clinical trials to investigate the time of symptom-free recovery on ambulatory patients using a mixture of CMA consisting of NAD+ and glutathione precursors. The results of both studies showed that the time to complete recovery was significantly shorter in the CMA group (6.6 vs 9.3 days) in phase 2 and (5.7 vs 9.2 days) in phase 3 trials. A comprehensive analysis of the blood metabolome and proteome showed that the plasma levels of proteins and metabolites associated with inflammation and antioxidant metabolism are significantly improved in patients treated with the metabolic activators as compared to placebo. The results show that treating patients infected with COVID-19 with a high dose of CMAs leads to a more rapid symptom-free recovery, suggesting a role for such a therapeutic regime in the treatment of infections leading to respiratory problems.</jats:p>",2020-10-05
77,10.1101/2021.04.22.21255947,30,medRxiv,Public and Global Health,False,To what extent is the altitude at which we live associated with 10-year cardiovascular risk?,"[{'given': 'Andrea Cevallos', 'family': 'Guerrero', 'sequence': 'first', 'affiliation': []}, {'given': 'Heidi Angela', 'family': 'Fernández', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ángela', 'family': 'León-Cáceres', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luciana', 'family': 'Armijos-Acurio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carlos', 'family': 'Erazo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ruth', 'family': 'Jimbo-Sotomayor', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hugo', 'family': 'Pereira-Olmos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Henry', 'family': 'Pineda-Abarca', 'sequence': 'additional', 'affiliation': []}, {'given': 'Erika', 'family': 'Quishpe-Narváez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xavier', 'family': 'Sánchez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carmenza', 'family': 'Sevilla', 'sequence': 'additional', 'affiliation': []}, {'given': 'Betzabé', 'family': 'Tello', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana', 'family': 'Torres-Castillo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tatiana', 'family': 'Villacrés', 'sequence': 'additional', 'affiliation': []}, {'given': 'Iván', 'family': 'Dueñas-Espín', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>There is evidence that demonstrates lower incidence rates of cardiometabolic factors at the highlands. There are no studies which correlate the altitude with formally calculated cardiovascular risk by a meter-by-meter approach. Under the hypothesis that cardiovascular risk is inversely associated with altitude, this study was aimed to assess such association.</jats:p></jats:sec><jats:sec><jats:title>Materials and methods</jats:title><jats:p>Cross sectional study using data from the Ecuadorian National Health Survey of 2012. We analyzed available information of adults of ≥ 40 to 60 years old who have sociodemographic, anthropometric, cardiovascular risk factors, and laboratory biomarkers that were included in the survey. We assessed the independent association between altitude of the housing in which survey participants lived at, on a meter-by-meter approach, and cardiovascular health risk at ten years, formally calculated by Framingham equations.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Linear regression model showed that participants had 0.0005 % less probability of developing cardiovascular disease at 10 years <jats:italic>per</jats:italic> each increase in a meter in the altitude that participants live at (p&lt;0.001), adjusted for sex, age, ethnicity, educational level, availability of social security, immigrants in family, area, income quintile, overcrowding (≥ 7 inhabitants in the house), any alcohol consumption, history of hypertension, body mass index, hematocrit, and triglycerides.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>From a public health perspective, altitude at which individuals live is an important health determinant of cardiovascular risk. Specifically, <jats:italic>per</jats:italic> each increase of 1000 m in the altitude that people live at, there is a reduction of almost half a percentual point in the cardiovascular risk at 10 years.</jats:p></jats:sec>",2021-04-23
78,10.1101/2020.10.16.341883,30,bioRxiv,Microbiology,True,Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses,"[{'ORCID': 'http://orcid.org/0000-0002-3655-406X', 'authenticated-orcid': False, 'given': 'Dylan H.', 'family': 'Morris', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5195-5478', 'authenticated-orcid': False, 'given': 'Kwe Claude', 'family': 'Yinda', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5430-9124', 'authenticated-orcid': False, 'given': 'Amandine', 'family': 'Gamble', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6481-5845', 'authenticated-orcid': False, 'given': 'Fernando W.', 'family': 'Rossine', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8493-5799', 'authenticated-orcid': False, 'given': 'Qishen', 'family': 'Huang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Trenton', 'family': 'Bushmaker', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1816-472X', 'authenticated-orcid': False, 'given': 'Robert J.', 'family': 'Fischer', 'sequence': 'additional', 'affiliation': []}, {'given': 'M. Jeremiah', 'family': 'Matson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4368-6359', 'authenticated-orcid': False, 'given': 'Neeltje van', 'family': 'Doremalen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2654-5132', 'authenticated-orcid': False, 'given': 'Peter J.', 'family': 'Vikesland', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3628-6891', 'authenticated-orcid': False, 'given': 'Linsey C.', 'family': 'Marr', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2288-3196', 'authenticated-orcid': False, 'given': 'Vincent J.', 'family': 'Munster', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7941-502X', 'authenticated-orcid': False, 'given': 'James O.', 'family': 'Lloyd-Smith', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Environmental conditions affect virus inactivation rate and transmission potential. Understanding those effects is critical for anticipating and mitigating epidemic spread. Ambient temperature and humidity strongly affect the inactivation rate of enveloped viruses, but a mechanistic, quantitative theory of those effects has been elusive. We measure the stability of the enveloped respiratory virus SARS-CoV-2 on an inert surface at nine temperature and humidity conditions and develop a mechanistic model to explain and predict how temperature and humidity alter virus inactivation. We find SARS-CoV-2 survives longest at low temperatures and extreme relative humidities; median estimated virus half-life is over 24 hours at 10 °C and 40 % RH, but approximately 1.5 hours at 27 °C and 65 % RH. Our mechanistic model uses simple chemistry to explain the increase in virus inactivation rate with increased temperature and the U-shaped dependence of inactivation rate on relative humidity. The model accurately predicts quantitative measurements from existing studies of five different human coronaviruses (including SARS-CoV-2), suggesting that shared mechanisms may determine environmental stability for many enveloped viruses. Our results indicate scenarios of particular transmission risk, point to pandemic mitigation strategies, and open new frontiers in the mechanistic study of virus transmission.</jats:p>",2020-10-16
79,10.1101/2020.12.18.423358,29,bioRxiv,Microbiology,True,An infectivity-enhancing site on the SARS-CoV-2 spike protein is targeted by COVID-19 patient antibodies,"[{'given': 'Yafei', 'family': 'Liu', 'sequence': 'first', 'affiliation': []}, {'given': 'Wai Tuck', 'family': 'Soh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Asa', 'family': 'Tada', 'sequence': 'additional', 'affiliation': []}, {'given': 'Akemi', 'family': 'Arakawa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sumiko', 'family': 'Matsuoka', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emi E.', 'family': 'Nakayama', 'sequence': 'additional', 'affiliation': []}, {'given': 'Songling', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chikako', 'family': 'Ono', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shiho', 'family': 'Torii', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kazuki', 'family': 'Kishida', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hui', 'family': 'Jin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Wataru', 'family': 'Nakai', 'sequence': 'additional', 'affiliation': []}, {'given': 'Noriko', 'family': 'Arase', 'sequence': 'additional', 'affiliation': []}, {'given': 'Atsushi', 'family': 'Nakagawa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yasuhiro', 'family': 'Shindo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Masako', 'family': 'Kohyama', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hironori', 'family': 'Nakagami', 'sequence': 'additional', 'affiliation': []}, {'given': 'Keisuke', 'family': 'Tomii', 'sequence': 'additional', 'affiliation': []}, {'given': 'Koichiro', 'family': 'Ohmura', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shiro', 'family': 'Ohshima', 'sequence': 'additional', 'affiliation': []}, {'given': 'Masato', 'family': 'Okada', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9091-8285', 'authenticated-orcid': False, 'given': 'Yoshiharu', 'family': 'Matsuura', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daron M.', 'family': 'Standley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tatsuo', 'family': 'Shioda', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1153-3166', 'authenticated-orcid': False, 'given': 'Hisashi', 'family': 'Arase', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>SARS-CoV-2 infection causes severe symptoms in a subset of patients, suggesting the presence of certain unknown risk factors. Although antibodies against the receptor-binding domain (RBD) of the SARS-CoV-2 spike have been shown prevent SARS-CoV-2 infection, the effects of antibodies against other spike protein domains are largely unknown. Here, we screened a series of anti-spike monoclonal antibodies from COVID-19 patients, and found that some of antibodies against the N-terminal domain (NTD) dramatically enhanced the binding capacity of the spike protein to ACE2, and thus increased SARS-CoV2 infectivity. Surprisingly, mutational analysis revealed that all the infectivity-enhancing antibodies recognized a specific site on the surface of the NTD. The antibodies against this infectivity-enhancing site were detected in all samples of hospitalized COVID-19 patients in the study. However, the ratio of infectivity-enhancing antibodies to neutralizing antibodies differed among patients. Furthermore, the antibodies against the infectivity-enhancing site were detected in 3 out of 48 uninfected donors, albeit at low levels. These findings suggest that the production of antibodies against SARS-CoV-2 infectivity-enhancing site could be considered as a possible exacerbating factors for COVID-19 and that a spike protein lacking such antibody epitopes may be required for safe vaccine development, especially for individuals with pre-existing enhancing antibodies.</jats:p>",2020-12-18
80,10.1101/2021.04.24.21256040,28,medRxiv,Infectious Diseases (except HIV/AIDS),True,The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients,"[{'ORCID': 'http://orcid.org/0000-0002-2899-1489', 'authenticated-orcid': False, 'given': 'Giorgia', 'family': 'Caruana', 'sequence': 'first', 'affiliation': []}, {'given': 'Laure-Line', 'family': 'Lebrun', 'sequence': 'additional', 'affiliation': []}, {'given': 'Oriane', 'family': 'Aebischer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Onya', 'family': 'Opota', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luis', 'family': 'Urbano', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mikael', 'family': 'de Rham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Oscar', 'family': 'Marchetti', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gilbert', 'family': 'Greub', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Most of the reports describing SARS-CoV-2 rapid antigen tests (RATs) performances derive from COVID-19 symptomatic subjects in outpatient settings during periods of highest incidence of infections and high rates of hospital admissions. Here we investigated the role of RATs in an Emergency Department, as a screening tool before admission for COVID-19 asymptomatic patients. Each patient was screened with two simultaneous nasopharyngeal swabs: one immediately analyzed at the bedside using RAT and the other sent to the laboratory for RT-PCR analysis. A total of 116 patients were screened at hospital admission in a 250-bed community hospital in Morges (EHC), Switzerland. With a disease prevalence of 6% based on RT-PCR results, RAT detected only two out of seven RT-PCR positive patients (sensitivity 28.6%) and delivered two false positive results (specificity 98.2%), thus resulting not fiable enough to be used as a screening method in this clinical scenario.</jats:p>",2021-04-27
81,10.1101/2021.04.02.438288,28,bioRxiv,Microbiology,True,An emerging SARS-CoV-2 mutant evading cellular immunity and increasing viral infectivity,"[{'given': 'Chihiro', 'family': 'Motozono', 'sequence': 'first', 'affiliation': []}, {'given': 'Mako', 'family': 'Toyoda', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jiri', 'family': 'Zahradnik', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2869-9450', 'authenticated-orcid': False, 'given': 'Terumasa', 'family': 'Ikeda', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2792-4399', 'authenticated-orcid': False, 'given': 'Akatsuki', 'family': 'Saito', 'sequence': 'additional', 'affiliation': []}, {'given': 'Toong Seng', 'family': 'Tan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Isaac', 'family': 'Ngare', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9163-1665', 'authenticated-orcid': False, 'given': 'Hesham', 'family': 'Nasser', 'sequence': 'additional', 'affiliation': []}, {'given': 'Izumi', 'family': 'Kimura', 'sequence': 'additional', 'affiliation': []}, {'given': 'Keiya', 'family': 'Uriu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yusuke', 'family': 'Kosugi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shiho', 'family': 'Torii', 'sequence': 'additional', 'affiliation': []}, {'given': 'Akiko', 'family': 'Yonekawa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nobuyuki', 'family': 'Shimono', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yoji', 'family': 'Nagasaki', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rumi', 'family': 'Minami', 'sequence': 'additional', 'affiliation': []}, {'given': 'Takashi', 'family': 'Toya', 'sequence': 'additional', 'affiliation': []}, {'given': 'Noritaka', 'family': 'Sekiya', 'sequence': 'additional', 'affiliation': []}, {'given': 'Takasuke', 'family': 'Fukuhara', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9091-8285', 'authenticated-orcid': False, 'given': 'Yoshiharu', 'family': 'Matsuura', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gideon', 'family': 'Schreiber', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1760-3839', 'authenticated-orcid': False, 'given': 'So', 'family': 'Nakagawa', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4852-4236', 'authenticated-orcid': False, 'given': 'Takamasa', 'family': 'Ueno', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4431-1380', 'authenticated-orcid': False, 'given': 'Kei', 'family': 'Sato', 'sequence': 'additional', 'affiliation': []}, {'name': 'The Genotype to Phenotype Japan (G2P-Japan) consortium', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary</jats:title><jats:p>During the current SARS-CoV-2 pandemic that is devastating the modern societies worldwide, many variants that naturally acquire multiple mutations have emerged. Emerging mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has recently been investigated, that to human leukocyte antigen (HLA)-restricted cellular immunity remains unaddressed. Here we demonstrate that two recently emerging mutants in the receptor binding domain of the SARS-CoV-2 spike protein, L452R (in B.1.427/429) and Y453F (in B.1.298), can escape from the HLA-24-restricted cellular immunity. These mutations reinforce the affinity to viral receptor ACE2, and notably, the L452R mutation increases protein stability, viral infectivity, and potentially promotes viral replication. Our data suggest that the HLA-restricted cellular immunity potentially affects the evolution of viral phenotypes, and the escape from cellular immunity can be a further threat of the SARS-CoV-2 pandemic.</jats:p><jats:sec><jats:title>Graphical Abstract</jats:title><jats:fig id=""ufig1"" position=""float"" orientation=""portrait"" fig-type=""figure""><jats:graphic xmlns:xlink=""http://www.w3.org/1999/xlink"" xlink:href=""438288v1_ufig1"" position=""float"" orientation=""portrait"" /></jats:fig></jats:sec>",2021-04-05
82,10.1101/2021.03.11.21253207,28,medRxiv,Infectious Diseases (except HIV/AIDS),True,Recovered not restored: Long-term health consequences after mild COVID-19 in non-hospitalized patients,"[{'given': 'Max', 'family': 'Augustin', 'sequence': 'first', 'affiliation': []}, {'given': 'Philipp', 'family': 'Schommers', 'sequence': 'additional', 'affiliation': []}, {'given': 'Melanie', 'family': 'Stecher', 'sequence': 'additional', 'affiliation': []}, {'given': 'Felix', 'family': 'Dewald', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lutz', 'family': 'Gieselmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Henning', 'family': 'Gruell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carola', 'family': 'Horn', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kanika', 'family': 'Vanshylla', 'sequence': 'additional', 'affiliation': []}, {'given': 'Veronica Di', 'family': 'Cristanziano', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luise', 'family': 'Osebold', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria', 'family': 'Roventa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Toqeer', 'family': 'Riaz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nikolai', 'family': 'Tschernoster', 'sequence': 'additional', 'affiliation': []}, {'given': 'Janine', 'family': 'Altmueller', 'sequence': 'additional', 'affiliation': []}, {'given': 'Leonard', 'family': 'Rose', 'sequence': 'additional', 'affiliation': []}, {'given': 'Susanne', 'family': 'Salomon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vanessa', 'family': 'Priesner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jan Christoffer', 'family': 'Luers', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christian', 'family': 'Albus', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stephan', 'family': 'Rosenkranz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Birgit', 'family': 'Gathof', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gerd', 'family': 'Fätkenheuer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael', 'family': 'Hallek', 'sequence': 'additional', 'affiliation': []}, {'given': 'Florian', 'family': 'Klein', 'sequence': 'additional', 'affiliation': []}, {'given': 'Isabelle', 'family': 'Suárez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clara', 'family': 'Lehmann', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>While the leading symptoms during coronavirus disease 2019 (COVID-19) are acute and the majority of patients fully recover, a significant fraction of patients now increasingly experience long-term health consequences. However, most data available focus on health-related events after severe infection and hospitalization. We present a longitudinal, prospective analysis of health consequences in patients who initially presented with no or minor symptoms of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection. Hence we focus on mild COVID-19 in non-hospitalized patients.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We included 958 patients with confirmed SARS-CoV-2 infection in this study. Patients were observed for seven months from April 6<jats:sup>th</jats:sup> to December 2<jats:sup>nd</jats:sup> 2020 for long-term symptoms and SARS-CoV-2 antibodies. We identified anosmia, ageusia, fatigue or shortness of breath as most common, persisting symptoms at month 4 and 7 and summarized presence of such long-term health consequences as post-COVID syndrome (PCS). Predictors of long-term symptoms were assessed using an uni- and multivariable logistic regression model.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>We observed 442 and 353 patients over four and seven months after symptom onset, respectively. Four months post SARS-CoV-2 infection, 8.6% (38/442) of patients presented with shortness of breath, 12.4% (55/442) with anosmia, 11.1% (49/442) with ageusia and 9.7% (43/442) with fatigue. At least one of these characteristic symptoms was present in 27.8% (123/442) and 34.8% (123/353) at month 4 and 7 post-infection, respectively. This corresponds to 12.8% patients with long-lasting symptoms relative to the initial total cohort (123/958). A lower baseline level of SARS-CoV-2 IgG, anosmia and diarrhea during acute COVID-19 were associated with higher risk to develop long-term symptoms.</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>The on-going presence of either shortness of breath, anosmia, ageusia or fatigue as long-lasting symptoms even in non-hospitalized patients was observed at four and seven months post-infection and summarized as post-COVID syndrome (PCS). The continued assessment of patients with PCS will become a major task to define and mitigate the socioeconomic and medical long-term effects of COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>COVIM:„NaFoUniMedCovid19”(FKZ: 01KX2021)</jats:p></jats:sec><jats:sec><jats:title>Research in context</jats:title><jats:sec><jats:title>Evidence before this study</jats:title><jats:p>Data about long-term health consequences after SARS-CoV-2 infection and COVID-19 is scarce and most available data describe health consequences in hospitalized patients during acute COVID-19. However, these studies do not take into account the vast majority of patients with a milder course of infection (WHO score1-3).</jats:p></jats:sec><jats:sec><jats:title>Added value of this study</jats:title><jats:p>Our cohort consists of mostly mild COVID-19 cases that have been prospectively followed for a median time of 6.8 months. At least one trained physician critically reviewed the patients’ reported symptoms at each visit. We assessed SARS-CoV-2 IgG at each visit to correlate reported symptoms with serological data. At 4 months after SARS-CoV-2 infection, shortness of breath occurred in 8.6% (38/442), anosmia in 12.4% (55/442), ageusia in 11.1% (49/442), and fatigue in 9.7% (43/442) of patients. At least one characteristic symptom was present in 27.8% (123/442) and 34.8% (123/353) at months 4 and 7 post-infection, respectively. Symptoms were summarized as post-COVID syndrome (PCS). Relative to our initial total cohort (123/958), this corresponds to 12.8% patients with long-lasting symptoms. Lower baseline level of SARS-CoV-2 IgG, anosmia and diarrhea during acute COVID-19 were associated with higher risk of developing long-term symptoms.</jats:p></jats:sec><jats:sec><jats:title>Implications of all available evidence</jats:title><jats:p>We believe that our findings have important implications for the fields of infectious diseases and public health, because we show long-term health consequences may occur even after very mild COVID-19 in the outpatient setting. As up to 81% of all SARS-CoV-2 infected patients present with mild disease, it can be expected that PCS will affect a larger number of individuals than initially assumed, posing major medical, social and economic challenges.</jats:p></jats:sec></jats:sec>",2021-03-12
83,10.1101/2021.01.29.21250759,28,medRxiv,Infectious Diseases (except HIV/AIDS),True,Genetically predicted serum vitamin D and COVID-19: a Mendelian randomization study,"[{'ORCID': 'http://orcid.org/0000-0003-3361-6744', 'authenticated-orcid': False, 'given': 'Bonnie K', 'family': 'Patchen', 'sequence': 'first', 'affiliation': []}, {'given': 'Andrew G', 'family': 'Clark', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2240-3604', 'authenticated-orcid': False, 'given': 'Dana B', 'family': 'Hancock', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5205-7138', 'authenticated-orcid': False, 'given': 'Nathan', 'family': 'Gaddis', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4827-5073', 'authenticated-orcid': False, 'given': 'Patricia A', 'family': 'Cassano', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Objectives</jats:title><jats:p>To investigate causality of the association of serum vitamin D with the risk and severity of COVID-19 infection.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Two-sample Mendelian randomization study.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>Summary data from genome-wide analyses in the population-based UK Biobank and SUNLIGHT Consortium, applied to meta-analyzed results of genome-wide analyses in the COVID-19 Host Genetics Initiative.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>17,965 COVID-19 cases including 11,085 laboratory or physician confirmed cases, 7,885 hospitalized cases, and 4,336 severe respiratory cases, and 1,370,547 controls, primarily of European ancestry.</jats:p></jats:sec><jats:sec><jats:title>Exposures</jats:title><jats:p>Genetically predicted variation in serum vitamin D status, based on genome-wide significant single nucleotide polymorphisms (SNPs) associated with serum vitamin D or risk of vitamin D deficiency/insufficiency.</jats:p></jats:sec><jats:sec><jats:title>Main outcome measures</jats:title><jats:p>Susceptibility to and severity of COVID-19 infection, including severe respiratory infection and hospitalization.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Mendelian randomization analysis, powered to detect moderate effects comparable to those seen in observational studies, provided little to no evidence for an effect of genetically predicted serum vitamin D on susceptibility to or severity of COVID-19 infection. Using SNPs in loci related to vitamin D metabolism as proxies for serum vitamin D concentration, the odds ratio for a standard deviation increase in serum vitamin D was 1.04 (95% confidence interval 0.92 to 1.18) for any COVID-19 infection versus population controls, 1.05 (0.84-1.31) for hospitalized COVID-19 versus population controls, 0.96 (0.64 to 1.43) for severe respiratory COVID-19 versus population controls, 1.15 (0.99 to 1.35) for COVID-19 positive versus COVID-19 negative, and 1.44 (0.75 to 2.78) for hospitalized COVID-19 versus non-hospitalized COVID-19. Results were similar in analyses that used all SNPs with genome-wide significant associations with serum vitamin D (i.e., including SNPs in loci with no known relationship to vitamin D metabolism) and in analyses using SNPs with genome-wide significant associations with risk of vitamin D deficiency or insufficiency.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>These findings suggest that genetically predicted differences in long-term vitamin D nutritional status do not causally affect susceptibility to and severity of COVID-19 infection, and that associations observed in previous studies may have been driven by confounding. These results do not exclude the possibility of low-magnitude causal effects, nor do they preclude potential causal effects of acute responses to therapeutic doses of vitamin D. Future directions include extension of this work to non-European ancestry populations, and high-risk populations, for example persons with comorbid disease.</jats:p></jats:sec>",2021-02-01
84,10.1101/2020.04.04.20053058,27,medRxiv,Infectious Diseases (except HIV/AIDS),True,Indoor transmission of SARS-CoV-2,"[{'given': 'Hua', 'family': 'Qian', 'sequence': 'first', 'affiliation': []}, {'given': 'Te', 'family': 'Miao', 'sequence': 'additional', 'affiliation': []}, {'given': 'Li', 'family': 'Liu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaohong', 'family': 'Zheng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Danting', 'family': 'Luo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yuguo', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>By early April 2020, the COVID-19 pandemic had infected nearly one million people and had spread to nearly all countries worldwide. It is essential to understand where and how SARS-CoV-2 is transmitted.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Case reports were extracted from the local Municipal Health Commissions of 320 prefectural cities (municipalities) in China, not including Hubei province, between 4 January and 11 February 2020. We identified all outbreaks involving three or more cases and reviewed the major characteristics of the enclosed spaces in which the outbreaks were reported and associated indoor environmental issues.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Three hundred and eighteen outbreaks with three or more cases were identified, involving 1245 confirmed cases in 120 prefectural cities. We divided the venues in which the outbreaks occurred into six categories: homes, transport, food, entertainment, shopping, and miscellaneous. Among the identified outbreaks, 53·8% involved three cases, 26·4% involved four cases, and only 1·6% involved ten or more cases. Home outbreaks were the dominant category (254 of 318 outbreaks; 79·9%), followed by transport (108; 34·0%; note that many outbreaks involved more than one venue category). Most home outbreaks involved three to five cases. We identified only a single outbreak in an outdoor environment, which involved two cases.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>All identified outbreaks of three or more cases occurred in an indoor environment, which confirms that sharing indoor space is a major SARS-CoV-2 infection risk.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>The work was supported by the Research Grants Council of Hong (no 17202719, C7025-16G), and National Natural Science Foundation of China (no 41977370).</jats:p></jats:sec>",2020-04-07
85,10.1101/2021.03.10.432967,27,bioRxiv,Microbiology,True,Cannabidiol Inhibits SARS-CoV-2 Replication and Promotes the Host Innate Immune Response,"[{'given': 'Long Chi', 'family': 'Nguyen', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8343-5477', 'authenticated-orcid': False, 'given': 'Dongbo', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vlad', 'family': 'Nicolaescu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas J.', 'family': 'Best', 'sequence': 'additional', 'affiliation': []}, {'given': 'Takashi', 'family': 'Ohtsuki', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shao-Nong', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'J. Brent', 'family': 'Friesen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4460-9558', 'authenticated-orcid': False, 'given': 'Nir', 'family': 'Drayman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adil', 'family': 'Mohamed', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4027-4885', 'authenticated-orcid': False, 'given': 'Christopher', 'family': 'Dann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Diane', 'family': 'Silva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Haley', 'family': 'Gula', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0711-5516', 'authenticated-orcid': False, 'given': 'Krysten A.', 'family': 'Jones', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5361-5776', 'authenticated-orcid': False, 'given': 'J. Michael', 'family': 'Millis', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9616-1911', 'authenticated-orcid': False, 'given': 'Bryan C.', 'family': 'Dickinson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Savaş', 'family': 'Tay', 'sequence': 'additional', 'affiliation': []}, {'given': 'Scott A.', 'family': 'Oakes', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1022-4326', 'authenticated-orcid': False, 'given': 'Guido F.', 'family': 'Pauli', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2790-7393', 'authenticated-orcid': False, 'given': 'David O.', 'family': 'Meltzer', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7417-3615', 'authenticated-orcid': False, 'given': 'Glenn', 'family': 'Randall', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6586-8335', 'authenticated-orcid': False, 'given': 'Marsha Rich', 'family': 'Rosner', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>The rapid spread of COVID-19 underscores the need for new treatments. Here we report that cannabidiol (CBD), a compound produced by the cannabis plant, inhibits SARS-CoV-2 infection. CBD and its metabolite, 7-OH-CBD, but not congeneric cannabinoids, potently block SARS-CoV-2 replication in lung epithelial cells. CBD acts after cellular infection, inhibiting viral gene expression and reversing many effects of SARS-CoV-2 on host gene transcription. CBD induces interferon expression and up-regulates its antiviral signaling pathway. A cohort of human patients previously taking CBD had significantly lower SARS-CoV-2 infection incidence of up to an order of magnitude relative to matched pairs or the general population. This study highlights CBD, and its active metabolite, 7-OH-CBD, as potential preventative agents and therapeutic treatments for SARS-CoV-2 at early stages of infection.</jats:p>",2021-03-10
86,10.1101/2020.12.01.404681,27,bioRxiv,Genomics,False,Epigenetic scores for the circulating proteome replicate protein-disease predictions as tools for biomarker discovery,"[{'ORCID': 'http://orcid.org/0000-0001-6398-5407', 'authenticated-orcid': False, 'given': 'Danni A', 'family': 'Gadd', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2595-552X', 'authenticated-orcid': False, 'given': 'Robert F', 'family': 'Hillary', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3242-0360', 'authenticated-orcid': False, 'given': 'Daniel L', 'family': 'McCartney', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9132-8030', 'authenticated-orcid': False, 'given': 'Shaza B', 'family': 'Zaghlool', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0435-3562', 'authenticated-orcid': False, 'given': 'Anna J', 'family': 'Stevenson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cliff', 'family': 'Nangle', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0198-5078', 'authenticated-orcid': False, 'given': 'Archie', 'family': 'Campbell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robin', 'family': 'Flaig', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sarah E', 'family': 'Harris', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1060-4479', 'authenticated-orcid': False, 'given': 'Rosie M', 'family': 'Walker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Liu', 'family': 'Shi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5599-6237', 'authenticated-orcid': False, 'given': 'Elliot M', 'family': 'Tucker-Drob', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christian', 'family': 'Gieger', 'sequence': 'additional', 'affiliation': []}, {'given': 'Annette', 'family': 'Peters', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0583-5093', 'authenticated-orcid': False, 'given': 'Melanie', 'family': 'Waldenberger', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3015-5850', 'authenticated-orcid': False, 'given': 'Johannes', 'family': 'Graumann', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5286-5485', 'authenticated-orcid': False, 'given': 'Allan F', 'family': 'McRae', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1733-263X', 'authenticated-orcid': False, 'given': 'Ian J', 'family': 'Deary', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1249-6106', 'authenticated-orcid': False, 'given': 'David J', 'family': 'Porteous', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9405-9550', 'authenticated-orcid': False, 'given': 'Caroline', 'family': 'Hayward', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2143-8760', 'authenticated-orcid': False, 'given': 'Peter M', 'family': 'Visscher', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4036-3642', 'authenticated-orcid': False, 'given': 'Simon R', 'family': 'Cox', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7884-5877', 'authenticated-orcid': False, 'given': 'Kathryn L', 'family': 'Evans', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0198-4588', 'authenticated-orcid': False, 'given': 'Andrew M', 'family': 'McIntosh', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9638-3912', 'authenticated-orcid': False, 'given': 'Karsten', 'family': 'Suhre', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4430-4260', 'authenticated-orcid': False, 'given': 'Riccardo E', 'family': 'Marioni', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Polygenic scores capture the genetic predisposition to complex disease and are powerful tools for risk stratification. However, such diseases are also largely influenced by environmental insults and lifestyle factors, which are thought to be captured by epigenetic modifications. DNA methylation encodes information on the epigenetic landscape of an individual, regulates gene transcription, and can be reflected in the variability of the proteome. Protein biomarkers that predict or correlate with disease onset have been identified across many age-related morbidities; however, the extent of epigenetic influence in these pathways is often unclear. Here, we report a comprehensive epigenome-wide study of the circulating proteome. Using data from four independent cohort studies, we train and test epigenetic scores (EpiScores) for 953 plasma proteins, identifying 109 robust signatures that explain between 1% and 58% of the variance after adjusting for genetic effects. These EpiScores are then linked to the incidence of 12 leading morbidities over 14 years of follow up in the Generation Scotland cohort (n=9,537). After adjustment for common risk factors, 137 EpiScore - incident disease associations are revealed, several of which are confirmed by previously identified associations with measured protein levels. Notably, 21 EpiScores that associate with incident diabetes replicate previous protein associations with incident (n=12 proteins) and prevalent (n=21 proteins) diabetes. Complementary to polygenic scores, these epigenetic scores for protein levels are therefore likely to capture the environmental components of disease risk and can be a valuable resource for disease prediction, stratification and biomarker discovery.</jats:p>",2020-12-02
87,10.1101/2021.04.20.21255830,26,medRxiv,Public and Global Health,True,Miami-Dade: A Case Study of Domestic Violence Arrests During the COVID-19 Pandemic,"[{'ORCID': 'http://orcid.org/0000-0001-9546-4307', 'authenticated-orcid': False, 'given': 'Justin', 'family': 'Kurland', 'sequence': 'first', 'affiliation': []}, {'given': 'Alex R.', 'family': 'Piquero', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicole Leeper', 'family': 'Piquero', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The global health crisis that started early in 2020 has triggered a surge of interest in the effect (if any) of COVID-19 on patterns of domestic violence.<jats:sup>1</jats:sup> The first systematic review and meta-analysis examining domestic violence during the pandemic revealed quite a lot of diversity in the approaches used to measure potential effects. Drawing on the time series forecasting literature, this brief report contributes to the growing body of evidence around the issue of domestic violence during the pandemic. Arrest data from Miami-Dade County (US) are leveraged along with a robust approach towards model identification, which is used to generate a suitably accurate forecast against which the observed pandemic period domestic violence data can be compared. The pattern uncovered for Miami-Dade County was similar what was found in other U.S. cities that during the pandemic experienced spikes (+95 CI) in the level of domestic violence arrests that were greater than expected. Interestingly these spikes appeared shortly after dips (−95 CI) in observed arrests fell below the expected level.</jats:p>",2021-04-27
88,10.1101/2021.04.21.440861,25,bioRxiv,Bioinformatics,True,InterARTIC: an interactive web application for whole-genome nanopore sequencing analysis of SARS-CoV-2 and other viruses,"[{'ORCID': 'http://orcid.org/0000-0002-6192-6937', 'authenticated-orcid': False, 'given': 'James M.', 'family': 'Ferguson', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9034-9905', 'authenticated-orcid': False, 'given': 'Hasindu', 'family': 'Gamaarachchi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1687-2359', 'authenticated-orcid': False, 'given': 'Thanh', 'family': 'Nguyen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3916-040X', 'authenticated-orcid': False, 'given': 'Alyne', 'family': 'Gollon', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4160-6335', 'authenticated-orcid': False, 'given': 'Stephanie', 'family': 'Tong', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2708-5879', 'authenticated-orcid': False, 'given': 'Chiara', 'family': 'Aquilina-Reid', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9062-3644', 'authenticated-orcid': False, 'given': 'Rachel', 'family': 'Bowen-James', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3861-0472', 'authenticated-orcid': False, 'given': 'Ira W.', 'family': 'Deveson', 'sequence': 'additional', 'affiliation': []}]","<jats:label>1.</jats:label><jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Motivation</jats:title><jats:p><jats:italic>InterARTIC</jats:italic> is an interactive web application for the analysis of viral whole-genome sequencing (WGS) data generated on Oxford Nanopore Technologies (ONT) devices. A graphical interface enables users with no bioinformatics expertise to analyse WGS experiments and reconstruct consensus genome sequences from individual isolates of viruses, such as SARS-CoV-2. <jats:italic>InterARTIC</jats:italic> is intended to facilitate widespread adoption and standardisation of ONT sequencing for viral surveillance and molecular epidemiology.</jats:p></jats:sec><jats:sec><jats:title>Worked example</jats:title><jats:p>We demonstrate the use of <jats:italic>InterARTIC</jats:italic> for the analysis of ONT viral WGS data from SARS-CoV-2 and Ebola virus, using a laptop computer or the internal computer on an ONT GridlON sequencing device. We showcase the intuitive graphical interface, workflow customization capabilities and job-scheduling system that facilitate execution of small- and large-scale WGS projects on any virus.</jats:p></jats:sec><jats:sec><jats:title>Implementation &amp; availability</jats:title><jats:p><jats:italic>InterARTIC</jats:italic> is a free, open-source web application implemented in Python. The application can be downloaded as a set of pre-compiled binaries that are compatible with all common Ubuntu distributions or built from source. For further details please visit: <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""uri"" xlink:href=""https://github.com/Psy-Fer/interARTIC/"">https://github.com/Psy-Fer/interARTIC/</jats:ext-link>.</jats:p></jats:sec>",2021-04-22
89,10.1101/2021.04.16.440189,25,bioRxiv,Evolutionary Biology,False,Genomic analysis reveals a polygenic architecture of antler morphology in wild red deer (Cervus elaphus),"[{'given': 'Lucy', 'family': 'Peters', 'sequence': 'first', 'affiliation': []}, {'given': 'Jisca', 'family': 'Huisman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Loeske E.B.', 'family': 'Kruuk', 'sequence': 'additional', 'affiliation': []}, {'given': 'Josephine M.', 'family': 'Pemberton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Susan E.', 'family': 'Johnston', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Sexually-selected traits show large variation and rapid evolution across the animal kingdom, yet genetic variation often persists within populations despite apparent directional selection. A key step in solving this long-standing paradox is to determine the genetic architecture of sexually-selected traits to understand evolutionary drivers and constraints at the genomic level. Antlers are a form of sexual weaponry in male red deer. On the island of Rum, Scotland, males with larger antlers have increased breeding success, yet there has been no response to selection observed at the genetic level. To better understand the underlying mechanisms of this observation, we investigate the genetic architecture of ten antler traits and their principle components using genomic data from &gt;38,000 SNPs. We estimate the heritabilities and genetic correlations of the antler traits using a genomic relatedness approach. We then use genome-wide association and haplotype-based regional heritability to identify regions of the genome underlying antler morphology, and an Empirical Bayes approach to estimate the underlying distributions of allele effect sizes. We show that antler morphology is heritable with a polygenic architecture, highly repeatable over an individual’s lifetime, and that almost all aspects are positively genetically correlated with some loci identified as having pleiotropic effects. Our findings suggest that a large mutational target and pleiotropy with traits sharing similar complex polygenic architectures are likely to contribute to the maintenance of genetic variation in antler morphology in this population.</jats:p>",2021-04-18
90,10.1101/2020.09.18.20192815,25,medRxiv,Genetic and Genomic Medicine,False,Exome sequencing identifies rare coding variants in 10 genes which confer substantial risk for schizophrenia,"[{'ORCID': 'http://orcid.org/0000-0003-0601-6815', 'authenticated-orcid': False, 'given': 'Tarjinder', 'family': 'Singh', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1513-6077', 'authenticated-orcid': False, 'given': 'Benjamin M.', 'family': 'Neale', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0949-8752', 'authenticated-orcid': False, 'given': 'Mark J.', 'family': 'Daly', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>By meta-analyzing the whole-exomes of 24,248 cases and 97,322 controls, we implicate ultra-rare coding variants (URVs) in ten genes as conferring substantial risk for schizophrenia (odds ratios 3 - 50, P &lt; 2.14 × 10<jats:sup>-6</jats:sup>), and 32 genes at a FDR &lt; 5%. These genes have the greatest expression in central nervous system neurons and have diverse molecular functions that include the formation, structure, and function of the synapse. The associations of NMDA receptor subunit <jats:italic>GRIN2A</jats:italic> and AMPA receptor subunit <jats:italic>GRIA3</jats:italic> provide support for the dysfunction of the glutamatergic system as a mechanistic hypothesis in the pathogenesis of schizophrenia. We find significant evidence for an overlap of rare variant risk between schizophrenia, autism spectrum disorders (ASD), and severe neurodevelopmental disorders (DD/ID), supporting a neurodevelopmental etiology for schizophrenia. We show that protein-truncating variants in <jats:italic>GRIN2A, TRIO</jats:italic>, and <jats:italic>CACNA1G</jats:italic> confer risk for schizophrenia whereas specific missense mutations in these genes confer risk for DD/ID. Nevertheless, few of the strongly associated schizophrenia genes appear to confer risk for DD/ID. We demonstrate that genes prioritized from common variant analyses of schizophrenia are enriched in rare variant risk, suggesting that common and rare genetic risk factors at least partially converge on the same underlying pathogenic biological processes. Even after excluding significantly associated genes, schizophrenia cases still carry a substantial excess of URVs, implying that more schizophrenia risk genes await discovery using this approach.</jats:p>",2020-09-18
91,10.1101/2021.04.26.21256081,25,medRxiv,Infectious Diseases (except HIV/AIDS),True,Clinical validation of RCSMS: a rapid and sensitive CRISPR-Cas12a test for the molecular detection of SARS-CoV-2 from saliva,"[{'ORCID': 'http://orcid.org/0000-0002-1157-8452', 'authenticated-orcid': False, 'given': 'Joaquín', 'family': 'Abugattás Núñez del Prado', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3555-4017', 'authenticated-orcid': False, 'given': 'Angélica', 'family': 'Quintana Reyes', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9763-1682', 'authenticated-orcid': False, 'given': 'Juan', 'family': 'Blume La Torre', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6466-5288', 'authenticated-orcid': False, 'given': 'Renzo', 'family': 'Gutiérrez-Loli', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alejandro', 'family': 'Pinzón Olejua', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5040-0641', 'authenticated-orcid': False, 'given': 'Elena', 'family': 'Chamorro Chirinos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Félix Antonio', 'family': 'Loza Mauricio', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4136-7795', 'authenticated-orcid': False, 'given': 'Jorge L', 'family': 'Maguiña', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1113-4544', 'authenticated-orcid': False, 'given': 'Julio', 'family': 'Leon', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3828-4235', 'authenticated-orcid': False, 'given': 'Piere', 'family': 'Rodriguez-Aliaga', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6230-0832', 'authenticated-orcid': False, 'given': 'Edward', 'family': 'Málaga-Trillo', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Early detection of SARS-CoV-2 using molecular techniques is paramount to the fight against COVID-19. Due to its high sensitivity and specificity, RT-qPCR is the 'gold standard' method for this purpose. However, its technical requirements, processing time and elevated costs hamper its use towards massive and timely molecular testing for COVID-19 in rural and socioeconomically deprived areas of Latin America. The advent and rapid evolution of CRISPR-Cas technology has boosted the development of new pathogen detection methodologies. Recently, DETECTR-a combination of isothermal RT-LAMP amplification and Cas12a-mediated enzymatic detection- has been successfully validated in the Netherlands and the USA as a rapid and low-cost alternative to RT-qPCR for the detection of SARS-CoV-2 from nasopharyngeal swabs. Here, we evaluated the performance of RCSMS, a locally adapted variant of DETECTR, to ascertain the presence of SARS-CoV-2 in saliva samples from 276 patients in two hospitals in Lima, Peru (current status over a total of 350 samples). We show that a low-cost thermochemical treatment with TCEP/EDTA is sufficient to inactivate viral particles and cellular nucleases in saliva, eliminating the need to extract viral RNA with commercial kits, as well as the cumbersome nasopharyngeal swab procedure and the requirement of biosafety level 2 laboratories for molecular analyses. Our clinical validation shows that RCSMS detects up to 5 viral copies per reaction in 40 min, with sensitivity and specificity of 93.8% and 99.0% in the field, respectively, relative to RT-qPCR. Since CRISPR-Cas biosensors can be easily reprogrammed by using different guide RNA molecules, RCSMS has the potential to be quickly adapted for the detection of new SARS-CoV-2 variants. Notably, estimation of its negative and positive predictive values suggests that RCSMS can be confidently deployed in both high and low prevalence settings. Furthermore, our field study validates the use of lateral flow strips to easily visualize the presence of SARS-CoV-2, which paves the way to deploy RCSMS as a 'point of care' test in environments with limited access to state-of-the-art diagnostic laboratories. In sum, RCSMS is a fast, efficient and inexpensive alternative to RT-qPCR for expanding COVID-19 testing capacity in low- and middle-income countries.</jats:p>",2021-04-27
92,10.1101/2020.11.21.392720,25,bioRxiv,Evolutionary Biology,False,A conserved strategy for inducing appendage regeneration,"[{'ORCID': 'http://orcid.org/0000-0003-1864-1706', 'authenticated-orcid': False, 'given': 'Michael J.', 'family': 'Abrams', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2160-5311', 'authenticated-orcid': False, 'given': 'Fayth', 'family': 'Tan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ty', 'family': 'Basinger', 'sequence': 'additional', 'affiliation': []}, {'given': 'Martin', 'family': 'Heithe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yutian', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, {'given': 'Misha', 'family': 'Raffiee', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patrick', 'family': 'Leahy', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6722-9008', 'authenticated-orcid': False, 'given': 'John O.', 'family': 'Dabiri', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0135-4022', 'authenticated-orcid': False, 'given': 'David A.', 'family': 'Gold', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3904-0195', 'authenticated-orcid': False, 'given': 'Lea', 'family': 'Goentoro', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Can limb regeneration be induced? Few have pursued this question, and an evolutionarily conserved strategy has yet to emerge. This study reports a strategy for inducing regenerative response in appendages, which works across three species that span the animal phylogeny. In Cnidaria, the frequency of appendage regeneration in the moon jellyfish <jats:italic>Aurelia</jats:italic> was increased by feeding with the amino acid L-leucine and the growth hormone insulin. In insects, the same strategy induced tibia regeneration in adult <jats:italic>Drosophila</jats:italic>. Finally, in mammals, L-leucine and sucrose administration induced digit regeneration in adult mice, including dramatically from mid-phalangeal amputation. The conserved effect of L-leucine and insulin/sugar suggests a key role for energetic parameters in regeneration induction. The simplicity by which nutrient supplementation can induce appendage regeneration provides a testable hypothesis across animals.</jats:p>",2020-11-22
93,10.1101/2021.04.22.441027,25,bioRxiv,Cell Biology,False,A comprehensive analysis of gene expression changes in a high replicate and open-source dataset of differentiating hiPSC-derived cardiomyocytes,"[{'given': 'Tanya', 'family': 'Grancharova', 'sequence': 'first', 'affiliation': []}, {'given': 'Kaytlyn A.', 'family': 'Gerbin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexander B.', 'family': 'Rosenberg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Charles M.', 'family': 'Roco', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joy', 'family': 'Arakaki', 'sequence': 'additional', 'affiliation': []}, {'given': 'Colette', 'family': 'DeLizzo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stephanie Q.', 'family': 'Dinh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rory', 'family': 'Donovan-Maiye', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthew', 'family': 'Hirano', 'sequence': 'additional', 'affiliation': []}, {'given': 'Angelique', 'family': 'Nelson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joyce', 'family': 'Tang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Julie A.', 'family': 'Theriot', 'sequence': 'additional', 'affiliation': []}, {'given': 'Calysta', 'family': 'Yan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vilas', 'family': 'Menon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sean P.', 'family': 'Palecek', 'sequence': 'additional', 'affiliation': []}, {'given': 'Georg', 'family': 'Seelig', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ruwanthi N.', 'family': 'Gunawardane', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>We performed a comprehensive analysis of the transcriptional changes within and across cell populations during human induced pluripotent stem cell (hiPSC) differentiation to cardiomyocytes. Using the single cell RNA-seq combinatorial barcoding method SPLiT-seq, we sequenced &gt;20,000 single cells from 55 independent samples representing two differentiation protocols and multiple hiPSC lines. Samples included experimental replicates ranging from undifferentiated hiPSCs to mixed populations of cells at D90 post-differentiation. As expected, differentiated cell populations clustered by time point, with differential expression analysis revealing markers of cardiomyocyte differentiation and maturation changing from D12 to D90. We next performed a complementary cluster-independent sparse regression analysis to identify and rank genes that best assigned cells to differentiation time points. The two highest ranked genes between D12 and D24 (<jats:italic>MYH7</jats:italic> and <jats:italic>MYH6</jats:italic>) resulted in an accuracy of 0.84, and the three highest ranked genes between D24 and D90 (<jats:italic>A2M, H19, IGF2</jats:italic>) resulted in an accuracy of 0.94, revealing that low dimensional gene features can identify differentiation or maturation stages in differentiating cardiomyocytes. Expression levels of select genes were validated using RNA FISH. Finally, we interrogated differences in differentiation population composition and cardiac gene expression resulting from two differentiation protocols, experimental replicates, and three hiPSC lines in the WTC-11 background to identify sources of variation across these experimental variables.</jats:p>",2021-04-23
94,10.1101/2021.04.06.21254963,24,medRxiv,Transplantation,True,Impaired Humoral and Cellular Immunity after SARS-CoV2 BNT162b2 (Tozinameran) Prime-Boost Vaccination in Kidney Transplant Recipients,"[{'ORCID': 'http://orcid.org/0000-0003-2572-5641', 'authenticated-orcid': False, 'given': 'Arne', 'family': 'Sattler', 'sequence': 'first', 'affiliation': []}, {'given': 'Eva', 'family': 'Schrezenmeier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ulrike', 'family': 'Weber', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexander', 'family': 'Potekhin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Friederike', 'family': 'Bachmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Klemens', 'family': 'Budde', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elena', 'family': 'Storz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vanessa', 'family': 'Proß', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yasmin', 'family': 'Bergmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Linda', 'family': 'Thole', 'sequence': 'additional', 'affiliation': []}, {'given': 'Caroline', 'family': 'Tizian', 'sequence': 'additional', 'affiliation': []}, {'given': 'Oliver', 'family': 'Hölsken', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andreas', 'family': 'Diefenbach', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hubert', 'family': 'Schrezenmeier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bernd', 'family': 'Jahrsdörfer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tomasz', 'family': 'Zemojtel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katharina', 'family': 'Jechow', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christian', 'family': 'Conrad', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7045-6327', 'authenticated-orcid': False, 'given': 'Sören', 'family': 'Lukassen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Diana', 'family': 'Stauch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nils', 'family': 'Lachmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mira', 'family': 'Choi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fabian', 'family': 'Halleck', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katja', 'family': 'Kotsch', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Novel mRNA-based vaccines have been proven powerful tools to combat the global pandemic caused by SARS-CoV2 with BNT162b2 efficiently protecting individuals from COVID-19 across a broad age range. Still, it remains largely unknown how renal insufficiency and immunosuppressive medication affect development of vaccine induced immunity. We therefore comprehensively analyzed humoral and cellular responses in kidney transplant recipients after prime-boost vaccination with BNT162b2. As opposed to all healthy vaccinees and the majority of hemodialysis patients, only 4/39 and 1/39 transplanted individuals showed IgA and IgG seroconversion at day 8±1 after booster immunization with minor changes until day 23±5, respectively. Although most transplanted patients mounted spike-specific T helper cell responses, frequencies were significantly reduced compared to controls and dialysis patients, accompanied by a broad impairment in effector cytokine production, memory differentiation and activation-related signatures. Spike-specific CD8<jats:sup>+</jats:sup> T cell responses were less abundant than their CD4<jats:sup>+</jats:sup> counterparts in healthy controls and hemodialysis patients and almost undetectable in transplant patients. Signs of alloreactivity promoted by BNT162b2 were not documented within the observation period. In summary, our data strongly suggest revised vaccination approaches in immunosuppressed patients, including individual immune monitoring for protection of this vulnerable group at risk to develop severe COVID-19.</jats:p>",2021-04-07
95,10.1101/2021.04.28.441736,24,bioRxiv,Synthetic Biology,False,Bioremediation of industrial pollutants by insects expressing a fungal laccase,"[{'given': 'Michael', 'family': 'Clark', 'sequence': 'first', 'affiliation': []}, {'given': 'Kate', 'family': 'Tepper', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4400-8712', 'authenticated-orcid': False, 'given': 'Kerstin', 'family': 'Petroll', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7483-4273', 'authenticated-orcid': False, 'given': 'Sheemal', 'family': 'Kumar', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1467-9937', 'authenticated-orcid': False, 'given': 'Anwar', 'family': 'Sunna', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7831-848X', 'authenticated-orcid': False, 'given': 'Maciej', 'family': 'Maselko', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Inadequate management of household and industrial wastes pose major challenges to human and environmental health.  Advances in synthetic biology may help address these challenges by engineering biological systems to perform new functions such as biomanufacturing of high-value compounds from low-value waste streams and bioremediation of industrial pollutants. However, the current emphasis on microbial systems for biomanufacturing, which often require highly pre-processed inputs and sophisticated infrastructure, is not feasible for many waste streams. Meanwhile, concerns about transgene biocontainment have limited the release of engineered microbes or plants for bioremediation.
Engineering animals may provide opportunities for utilizing various waste streams that are not suitable for microbial biomanufacturing while effective transgene biocontainment options should enable in situ bioremediation. Here, we engineer the model insect Drosophila melanogaster to express a functional laccase from the fungus Trametes trogii. Laccase expressing flies reduced bisphenol A by more than 50% when present in their growth media, while a lyophilized powder made from engineered adult flies degraded more than 90% of bisphenol A and indigo carmine in aqueous solutions. Our results demonstrate that transgenic animals may be used to bioremediate environmental contaminants in vivo and serve as novel production platforms for industrial enzymes. These results support further development of insects, and possibly other animals, as bioproduction platforms and their potential use in bioremediation.</jats:p>",2021-04-28
96,10.1101/2021.03.02.21252734,24,medRxiv,Epidemiology,True,Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study,"[{'ORCID': 'http://orcid.org/0000-0002-5217-1034', 'authenticated-orcid': False, 'given': 'Paul M', 'family': 'McKeigue', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3550-1764', 'authenticated-orcid': False, 'given': 'David A', 'family': 'McAllister', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Caldwell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ciara', 'family': 'Gribben', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jen', 'family': 'Bishop', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3292-4633', 'authenticated-orcid': False, 'given': 'Stuart', 'family': 'McGurnaghan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthew', 'family': 'Armstrong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joke', 'family': 'Delvaux', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sam', 'family': 'Colville', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6891-6758', 'authenticated-orcid': False, 'given': 'Sharon', 'family': 'Hutchinson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6848-5241', 'authenticated-orcid': False, 'given': 'Chris', 'family': 'Robertson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2707-2779', 'authenticated-orcid': False, 'given': 'Nazir', 'family': 'Lone', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jim', 'family': 'McMenamin', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Goldberg', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8345-3288', 'authenticated-orcid': False, 'given': 'Helen M', 'family': 'Colhoun', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Clinically vulnerable individuals have been advised to shield themselves during the COVID-19 epidemic. The objectives of this study were to investigate: (1) the risk of severe COVID-19 in those eligible for shielding, and (2) the relation of severe COVID-19 to transmission-related factors in those in shielding and the general population.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>All 178578 diagnosed cases of COVID-19 in Scotland from 1 March 2020 to 18 February 2021 were matched for age, sex and primary care practice to 1744283 controls from the general population. This dataset (REACT-SCOT) was linked to the list of 212702 individuals identified as eligible for shielding. Severe COVID-19 was defined as cases that entered critical care or were fatal.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>With those without risk conditions as reference category, the univariate rate ratio for severe COVID-19 was 3.21 (95% CI 3.01 to 3.41) in those with moderate risk conditions and 6.3 (95% CI 5.8 to 6.8) in those eligible for shielding. The highest rate was in solid organ transplant recipients: rate ratio 13.4 (95% CI 9.6 to 18.8). Risk of severe COVID-19 increased with the number of adults but decreased with the number of school-age children in the household. Severe COVID-19 was strongly associated with recent exposure to hospital (defined as 5 to 14 days before presentation date): rate ratio 12.3 (95% CI 11.5 to 13.2) overall. To test for causality, a case-crossover analysis was undertaken; with less recent exposure only (15 to 24 days before first testing positive) as reference category, the rate ratio associated with recent exposure only was 5.9 (95% CI 3.6 to 9.7). The population attributable risk fraction for recent exposure to hospital peaked at 50% in May 2020 and again at 65% in December 2020.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The effectiveness of shielding vulnerable individuals was limited by the inability to control transmission in hospital and from other adults in the household. For solid organ transplant recipients, in whom the efficacy of vaccines is uncertain, these results support a policy of offering vaccination to household contacts. Mitigating the impact of the epidemic requires control of nosocomial transmission.</jats:p></jats:sec>",2021-03-03
97,10.1101/2021.03.25.21254330,23,medRxiv,Epidemiology,True,Understanding the effectiveness of government interventions in Europe’s second wave of COVID-19,"[{'given': 'Mrinank', 'family': 'Sharma', 'sequence': 'first', 'affiliation': []}, {'given': 'Sören', 'family': 'Mindermann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Charlie', 'family': 'Rogers-Smith', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gavin', 'family': 'Leech', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benedict', 'family': 'Snodin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Janvi', 'family': 'Ahuja', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jonas B.', 'family': 'Sandbrink', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joshua Teperowski', 'family': 'Monrad', 'sequence': 'additional', 'affiliation': []}, {'given': 'George', 'family': 'Altman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gurpreet', 'family': 'Dhaliwal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lukas', 'family': 'Finnveden', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexander John', 'family': 'Norman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sebastian B.', 'family': 'Oehm', 'sequence': 'additional', 'affiliation': []}, {'given': 'Julia Fabienne', 'family': 'Sandkühler', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Mellan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jan', 'family': 'Kulveit', 'sequence': 'additional', 'affiliation': []}, {'given': 'Leonid', 'family': 'Chindelevitch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Seth', 'family': 'Flaxman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yarin', 'family': 'Gal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Swapnil', 'family': 'Mishra', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jan Markus', 'family': 'Brauner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Samir', 'family': 'Bhatt', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>As European governments face resurging waves of COVID-19, non-pharmaceutical interventions (NPIs) continue to be the primary tool for infection control. However, updated estimates of their relative effectiveness have been absent for Europe’s second wave, largely due to a lack of collated data that considers the increased subnational variation and diversity of NPIs. We collect the largest dataset of NPI implementation dates in Europe, spanning 114 subnational areas in 7 countries, with a systematic categorisation of interventions tailored to the second wave. Using a hierarchical Bayesian transmission model, we estimate the effectiveness of 17 NPIs from local case and death data. We manually validate the data, address limitations in modelling from previous studies, and extensively test the robustness of our estimates. The combined effect of all NPIs was smaller relative to estimates from the first half of 2020, indicating the strong influence of safety measures and individual protective behaviours--such as distancing--that persisted after the first wave. Closing specific businesses was highly effective. Gathering restrictions were highly effective but only for the strictest limits. We find smaller effects for closing educational institutions compared to the first wave, suggesting that safer operation of schools was possible with a set of stringent safety measures including testing and tracing, preventing mixing, and smaller classes. These results underscore that effectiveness estimates from the early stage of an epidemic are measured relative to pre-pandemic behaviour. Updated estimates are required to inform policy in an ongoing pandemic.</jats:p>",2021-03-26
98,10.1101/2021.04.26.441424,23,bioRxiv,Genomics,False,The role of insulators and transcription in 3D chromatin organisation of flies,"[{'given': 'Keerthi T', 'family': 'Chathoth', 'sequence': 'first', 'affiliation': []}, {'given': 'Liudmila A', 'family': 'Mikheeva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gilles', 'family': 'Crevel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jareth C.', 'family': 'Wolfe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ioni', 'family': 'Hunter', 'sequence': 'additional', 'affiliation': []}, {'given': 'Saskia', 'family': 'Beckett-Doyle', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sue', 'family': 'Cotterill', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hongsheng', 'family': 'Dai', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew', 'family': 'Harrison', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9964-6271', 'authenticated-orcid': False, 'given': 'Nicolae Radu', 'family': 'Zabet', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The DNA in many organisms, including humans, is shown to be organised in topologically associating domains (TADs). In <jats:italic>Drosophila</jats:italic>, several architectural proteins are enriched at TAD borders, but it is still unclear whether these proteins play a functional role in the formation and maintenance of TADs. Here, we show that depletion of BEAF-32, Cp190, Chro and Dref leads to changes in TAD organisation and chromatin loops. Their depletion predominantly affects TAD borders located in heterochromatin, while TAD borders located in euchromatin are resilient to these mutants. Furthermore, transcriptomic data has revealed hundreds of genes displaying differential expression in these mutants and showed that the majority of differentially expressed genes are located within reorganised TADs. Our work identifies a novel and functional role for architectural proteins at TAD borders in <jats:italic>Drosophila</jats:italic> and a link between TAD reorganisation and subsequent changes in gene expression.</jats:p>",2021-04-27
99,10.1101/2020.05.01.20087965,23,medRxiv,Epidemiology,True,Evidence Supports a Causal Model for Vitamin D in COVID-19 Outcomes,"[{'ORCID': 'http://orcid.org/0000-0002-8901-0680', 'authenticated-orcid': False, 'given': 'Gareth', 'family': 'Davies', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5920-8760', 'authenticated-orcid': False, 'given': 'Attila R', 'family': 'Garami', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8979-1835', 'authenticated-orcid': False, 'given': 'Joanna', 'family': 'Byers', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The COVID-19 pandemic caused by the coronavirus SARS-CoV-2 seemed to affect locations in the northern hemisphere most severely appearing to overlap with the pattern of seasonal vitamin D deficiency. Integrating available knowledge, we hypothesised that vitamin D could play a causal role in COVID-19 outcomes.</jats:p></jats:sec><jats:sec><jats:title>Objective</jats:title><jats:p>We set out to analyse the relationship between COVID-19 severity and latitude, and construct a causal inference framework to validate this hypothesis.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We analysed global daily reports of fatalities and recoveries from 239 locations from 22nd Jan 2020 to 9th April 2020. We quantified local COVID-19 outbreak severity to clearly distinguish the latitude relationship and identify any outliers breaking this pattern, and analysed the timeline of spread. We then used a causal inference framework to distinguish correlation from cause using observational data with a hypothetico-deductive method of proof. We constructed two contrasting directed acyclic graph (DAG) models, one causal and one acausal with respect to vitamin D and COVID-19 severity, allowing us to make 19 verifiable and falsifiable predictions for each.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Our analysis confirmed a striking correlation between COVID-19 severity and latitude, and ruled out the temporal spread of infection as an explanation. We compared observed severity for 239 locations with our contrasting model. In the causal model, 16 predictions matched observed data and 3 predictions were untestable; in the acausal model, 14 predictions strongly contradicted observed data, 2 appeared to contradict data, and 3 were untestable.</jats:p></jats:sec><jats:sec><jats:title>Discussion</jats:title><jats:p>We show in advance of RCTs that observed data strongly match predictions made by the causal model but contradict those of the acausal model. We present historic evidence that vitamin D supplementation prevented past respiratory virus pandemics. We discuss how molecular mechanisms of vitamin D action can prevent respiratory viral infections and protect against ARDS. We highlight vitamin D’s direct effect on the renin-angiotensin-system (RAS), which in concert with its other effects, can modify host responses thus preventing a cytokine storm and SARS-CoV-2-induced pathological changes. Emerging clinical research confirms striking correlations between hypovitaminosis D and COVID-19 severity, in full alignment with our study.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our novel causal inference analysis of global data supports the hypothesis that vitamin D levels play a key role in COVID-19 outcomes. The data set size, supporting historical, biomolecular, and emerging clinical research evidence altogether suggest that a very high level of confidence is justified. Vitamin D prophylaxis offers a widely available, low-risk, highly-scalable, and cost-effective pandemic management strategy including the mitigation of local outbreaks and a second wave. Timely implementation of vitamin D supplementation programmes worldwide is critical; initial priority should be given to those who are at the highest risk, including the elderly, immobile, homebound, BAME and healthcare professionals. Population-wide vitamin D sufficiency could prevent seasonal respiratory epidemics, decrease our dependence on pharmaceutical solutions, reduce hospitalisations, and thus greatly lower healthcare costs while significantly increasing quality of life.</jats:p></jats:sec>",2020-05-06
100,10.1101/2020.07.21.20159038,23,medRxiv,Infectious Diseases (except HIV/AIDS),True,Stringent thresholds for SARS-CoV-2 IgG assays result in under-detection of cases reporting loss of taste/smell,"[{'given': 'David W', 'family': 'Eyre', 'sequence': 'first', 'affiliation': []}, {'given': 'Sheila F', 'family': 'Lumley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Denise', 'family': 'O’Donnell', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4508-7969', 'authenticated-orcid': False, 'given': 'Nicole E', 'family': 'Stoesser', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippa C', 'family': 'Matthews', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alison', 'family': 'Howarth', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stephanie B', 'family': 'Hatch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Brian D', 'family': 'Marsden', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stuart', 'family': 'Cox', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tim', 'family': 'James', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard J', 'family': 'Cornall', 'sequence': 'additional', 'affiliation': []}, {'given': 'David I', 'family': 'Stuart', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gavin', 'family': 'Screaton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel', 'family': 'Ebner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Derrick W', 'family': 'Crook', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher P', 'family': 'Conlon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katie', 'family': 'Jeffery', 'sequence': 'additional', 'affiliation': []}, {'given': 'Timothy M', 'family': 'Walker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Timothy EA', 'family': 'Peto', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Thresholds for SARS-CoV-2 antibody assays have typically been determined using samples from symptomatic, often hospitalised, patients. Assay performance following mild/asymptomatic infection is unclear. We assessed IgG responses in asymptomatic healthcare workers with a high pre-test probability of Covid-19, e.g. 807/9292(8.9%) reported loss of smell/taste. The proportion reporting anosmia/ageusia increased at antibody titres below diagnostic thresholds for both an in-house ELISA and the Abbott Architect chemiluminescent microparticle immunoassay (CMIA): 424/903(47%) reported anosmia/ageusia with a positive ELISA, 59/387(13.2%) with high-negative titres, and 324/7943(4.1%) with low-negative results. Adjusting for the proportion of staff reporting anosmia/ageusia suggests the sensitivity of both assays is lower than previously reported: Oxford ELISA 90.8% (95%CI 86.1-92.1%) and Abbott CMIA 80.9% (77.5-84.3%). However, the sensitivity may be lower if some anosmia/ageusia in those with low-negative titres is Covid-19-associated. Samples from individuals with mild/asymptomatic infection should be included in SARS-CoV-2 immunoassay evaluations. Reporting equivocal SARS-CoV-2 antibody results should be considered.</jats:p>",2020-07-25
101,10.1101/2020.10.15.341131,22,bioRxiv,Neuroscience,False,Synaptic diversity naturally arises from neural decoding of heterogeneous populations,"[{'given': 'Jacob L', 'family': 'Yates', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9578-7234', 'authenticated-orcid': False, 'given': 'Benjamin', 'family': 'Scholl', 'sequence': 'additional', 'affiliation': []}]","<jats:p>The synaptic inputs to single cortical neurons exhibit substantial diversity in their sensory-driven activity. What this diversity reflects is unclear, and appears counter-productive in generating selective somatic responses to specific stimuli. We propose that synaptic diversity arises because neurons decode information from upstream populations. Focusing on a single sensory variable, orientation, we construct a probabilistic decoder that estimates the stimulus orientation from the responses of a realistic, hypothetical input population of neurons. We provide a straightforward mapping from the decoder weights to real excitatory synapses, and find that optimal decoding requires diverse input weights. Analytically derived weights exhibit diversity whenever upstream input populations consist of noisy, correlated, and heterogeneous neurons, as is typically found in vivo. In fact, in silico weight diversity was necessary to accurately decode orientation and matched the functional heterogeneity of dendritic spines imaged in vivo. Our results indicate that synaptic diversity is a necessary component of information transmission and reframes studies of connectivity through the lens of probabilistic population codes. These results suggest that the mapping from synaptic inputs to somatic selectivity may not be directly interpretable without considering input covariance and highlights the importance of population codes in pursuit of the cortical connectome.</jats:p>",2020-10-15
102,10.1101/2020.06.12.148296,22,bioRxiv,Bioinformatics,True,DeepEMhancer: a deep learning solution for cryo-EM volume post-processing,"[{'ORCID': 'http://orcid.org/0000-0001-6156-3542', 'authenticated-orcid': False, 'given': 'R', 'family': 'Sanchez-Garcia', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6168-3859', 'authenticated-orcid': False, 'given': 'J', 'family': 'Gomez-Blanco', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9414-503X', 'authenticated-orcid': False, 'given': 'A', 'family': 'Cuervo', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0788-8447', 'authenticated-orcid': False, 'given': 'JM', 'family': 'Carazo', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9473-283X', 'authenticated-orcid': False, 'given': 'COS', 'family': 'Sorzano', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7519-6106', 'authenticated-orcid': False, 'given': 'J', 'family': 'Vargas', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Cryo-EM maps are valuable sources of information for protein structure modeling. However, due to the loss of contrast at high frequencies, they generally need to be post-processed to improve their interpretability. Most popular approaches, based on B-factor correction, suffer from limitations. For instance, they ignore the heterogeneity in the map local quality that reconstructions tend to exhibit. Aiming to overcome these problems, we present DeepEMhancer, a deep learning approach designed to perform automatic post-processing of cryo-EM maps. Trained on a dataset of pairs of experimental maps and maps sharpened using their respective atomic models, DeepEMhancer has learned how to post-process experimental maps performing masking-like and sharpening-like operations in a single step. DeepEMhancer was evaluated on a testing set of 20 different experimental maps, showing its ability to obtain much cleaner and more detailed versions of the experimental maps. Additionally, we illustrated the benefits of DeepEMhancer on the structure of the SARS-CoV-2 RNA polymerase.</jats:p>",2020-06-13
103,10.1101/2021.04.27.441137,21,bioRxiv,Genetics,False,Germline loss-of-function variants in the base-excision repair gene MBD4 cause a Mendelian recessive syndrome of adenomatous colorectal polyposis and acute myeloid leukaemia,"[{'given': 'Claire', 'family': 'Palles', 'sequence': 'first', 'affiliation': []}, {'given': 'Edward', 'family': 'Chew', 'sequence': 'additional', 'affiliation': []}, {'given': 'Judith E.', 'family': 'Grolleman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sara', 'family': 'Galavotti', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christoffer', 'family': 'Flensburg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Erik A.M.', 'family': 'Jansen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Helen', 'family': 'Curley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Chegwidden', 'sequence': 'additional', 'affiliation': []}, {'given': 'Edward Arbe', 'family': 'Barnes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ashish', 'family': 'Bajel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kitty', 'family': 'Sherwood', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lynn', 'family': 'Martin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Huw', 'family': 'Thomas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Demetra', 'family': 'Georgiou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Florentia', 'family': 'Fostira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yael', 'family': 'Goldberg', 'sequence': 'additional', 'affiliation': []}, {'given': 'David J.', 'family': 'Adams', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simone A.M.', 'family': 'van der Biezen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael', 'family': 'Christie', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mark', 'family': 'Clendenning', 'sequence': 'additional', 'affiliation': []}, {'given': 'Constantinos', 'family': 'Deltas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aleksandar J.', 'family': 'Dimovski', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dagmara', 'family': 'Dymerska', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jan', 'family': 'Lubinski', 'sequence': 'additional', 'affiliation': []}, {'given': 'Khalid', 'family': 'Mahmood', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rachel S.', 'family': 'van der Post', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mathijs', 'family': 'Sanders', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jürgen', 'family': 'Weitz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jenny C.', 'family': 'Taylor', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clare', 'family': 'Turnbull', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lilian', 'family': 'Vreede', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tom', 'family': 'van Wezel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Celina', 'family': 'Whalley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claudia Arnedo', 'family': 'Pac', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gulio', 'family': 'Caravagna', 'sequence': 'additional', 'affiliation': []}, {'given': 'William', 'family': 'Cross', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel', 'family': 'Chubb', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna', 'family': 'Frangou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andreas', 'family': 'Gruber', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ben', 'family': 'Kinnersley', 'sequence': 'additional', 'affiliation': []}, {'given': 'Boris', 'family': 'Noyvert', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Church', 'sequence': 'additional', 'affiliation': []}, {'given': 'Trevor', 'family': 'Graham', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard', 'family': 'Houlston', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nuria', 'family': 'Lopez-Bigas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrea', 'family': 'Sottoriva', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Wedge', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mark A.', 'family': 'Jenkins', 'sequence': 'additional', 'affiliation': []}, {'given': 'Roland P.', 'family': 'Kuiper', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew W.', 'family': 'Roberts', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marjolijn J.L.', 'family': 'Ligtenberg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicoline', 'family': 'Hoogerbrugge', 'sequence': 'additional', 'affiliation': []}, {'given': 'Viktor H.', 'family': 'Koelzer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andres Dacal', 'family': 'Rivas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ingrid M.', 'family': 'Winship', 'sequence': 'additional', 'affiliation': []}, {'given': 'Clara Ruiz', 'family': 'Ponte', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel D.', 'family': 'Buchanan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ian P.M.', 'family': 'Tomlinson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ian J.', 'family': 'Majewski', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8222-0343', 'authenticated-orcid': False, 'given': 'Richarda M.', 'family': 'de Voer', 'sequence': 'additional', 'affiliation': []}, {'name': 'Genomics England Research Consortium', 'sequence': 'additional', 'affiliation': []}, {'name': 'The CORGI Consortium', 'sequence': 'additional', 'affiliation': []}, {'name': 'WGS500 Consortium', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Inherited defects in base-excision repair (BER) predispose to adenomatous polyposis and colorectal cancer (CRC), yet our understanding of this important DNA repair pathway remains incomplete. By combining detailed clinical, histological and molecular profiling, we reveal biallelic germline loss-of-function (LOF) variants in the BER gene <jats:italic>MBD4</jats:italic> to predispose to adenomatous polyposis and –uniquely amongst CRC predisposition syndromes– to myeloid neoplasms. Neoplasms from MBD4-deficient patients almost exclusively accumulate somatic CpG&gt;TpG mutations, resembling mutational signature SBS1. MBD4-deficient adenomas harbour mutations in known CRC driver genes, although <jats:italic>AMER1</jats:italic> mutations were more common and <jats:italic>KRAS</jats:italic> mutations less frequent. We did not find an increased risk for colorectal tumours in individuals with a monoallelic <jats:italic>MBD4</jats:italic> LOF variant. We suggest that this condition should be termed <jats:italic>MBD4</jats:italic>-associated neoplasia syndrome (MANS) and that <jats:italic>MBD4</jats:italic> is included in testing for the genetic diagnosis of polyposis and/or early-onset AML.</jats:p>",2021-04-28
104,10.1101/2021.02.06.21249256,21,medRxiv,Infectious Diseases (except HIV/AIDS),True,Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany – a first analysis of a prospective observational study,"[{'ORCID': 'http://orcid.org/0000-0001-9361-9213', 'authenticated-orcid': False, 'given': 'C', 'family': 'Kedor', 'sequence': 'first', 'affiliation': []}, {'given': 'H', 'family': 'Freitag', 'sequence': 'additional', 'affiliation': []}, {'given': 'L', 'family': 'Meyer-Arndt', 'sequence': 'additional', 'affiliation': []}, {'given': 'K', 'family': 'Wittke', 'sequence': 'additional', 'affiliation': []}, {'given': 'T', 'family': 'Zoller', 'sequence': 'additional', 'affiliation': []}, {'given': 'F', 'family': 'Steinbeis', 'sequence': 'additional', 'affiliation': []}, {'given': 'M', 'family': 'Haffke', 'sequence': 'additional', 'affiliation': []}, {'given': 'G', 'family': 'Rudolf', 'sequence': 'additional', 'affiliation': []}, {'given': 'B', 'family': 'Heidecker', 'sequence': 'additional', 'affiliation': []}, {'given': 'HD', 'family': 'Volk', 'sequence': 'additional', 'affiliation': []}, {'given': 'C', 'family': 'Skurk', 'sequence': 'additional', 'affiliation': []}, {'given': 'F', 'family': 'Paul', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2615-1643', 'authenticated-orcid': False, 'given': 'J', 'family': 'Bellmann-Strobl', 'sequence': 'additional', 'affiliation': []}, {'given': 'C', 'family': 'Scheibenbogen', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>Characterization of the clinical features of patients with persistent symptoms after mild to moderate COVID-19 infection and exploration of factors associated with the development of Chronic COVID-19 Syndrome (CCS).</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Setting: Charité Fatigue Center with clinical immunologists and rheumatologist, neurologists and cardiologists at Charité University hospital.</jats:p><jats:p>Participants: 42 patients who presented with persistent moderate to severe fatigue six months following a mostly mild SARS-CoV-2 infection at the Charité Fatigue Center from July to November 2020.</jats:p><jats:p>Main outcome measures: The primary outcomes were clinical and paraclinical data and meeting diagnostic criteria for Chronic Fatigue Syndrome (ME/CFS). Relevant neurological and cardiopulmonary morbidity was excluded.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The median age was 36.5, range 22–62, 29 patients were female and 13 male. At six months post acute COVID-19 all patients had fatigue (Chalder Fatigue Score median 25 of 33, range 14–32), the most frequent other symptoms were post exertional malaise (n=41), cognitive symptoms (n=40), headache (n=38), and muscle pain (n=35). Most patients were moderately to severely impaired in daily live with a median Bell disability score of 50 (range 15–90) of 100 (healthy) and Short Form 36 (SF-36) physical function score of 63 (range 15-80) of 100. 19 of 42 patients fulfilled the 2003 Canadian Consensus Criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). These patients reported more fatigue in the Chalder Fatigue Score (p=0.006), more stress intolerance (p=0.042) and more frequent and longer post exertional malaise (PEM) (p=0.003), and hypersensitivity to noise (p=0.029), light (p=0.0143) and temperature (p=0.024) compared to patients not meeting ME/CFS criteria. Handgrip force was diminished in most patients compared to healthy control values, and lower in CCS/CFS compared to non-CFS CCS (Fmax1 p=0.085, Fmax2, p=0.050, Fmean1 p=0.043, Fmean2 p=0.034, mean of 10 repeat handgrips, 29 female patients). Mannose-binding lectin (MBL) deficiency was observed frequently (22% of all patients) and elevated IL-8 levels were found in 43% of patients.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Chronic COVID-19 Syndrome at months 6 is a multisymptomatic frequently debilitating disease fulfilling diagnostic criteria of ME/CFS in about half of the patients in our study. Research in mechanisms and clinical trials are urgently needed.</jats:p></jats:sec>",2021-02-08
105,10.1101/2021.04.21.440693,21,bioRxiv,Systems Biology,False,Daily rhythms in the transcriptomes of the human parasite Schistosoma mansoni,"[{'ORCID': 'http://orcid.org/0000-0001-8297-8405', 'authenticated-orcid': False, 'given': 'Kate A.', 'family': 'Rawlinson', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5926-7768', 'authenticated-orcid': False, 'given': 'Adam J.', 'family': 'Reid', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6553-5944', 'authenticated-orcid': False, 'given': 'Zhigang', 'family': 'Lu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8104-677X', 'authenticated-orcid': False, 'given': 'Patrick', 'family': 'Driguez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna', 'family': 'Wawer', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2775-5951', 'authenticated-orcid': False, 'given': 'Avril', 'family': 'Coghlan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8303-2451', 'authenticated-orcid': False, 'given': 'Geetha', 'family': 'Sankaranarayanan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9506-9259', 'authenticated-orcid': False, 'given': 'Sarah Kay', 'family': 'Buddenborg', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1793-1074', 'authenticated-orcid': False, 'given': 'Carmen Diaz', 'family': 'Soria', 'sequence': 'additional', 'affiliation': []}, {'given': 'Catherine', 'family': 'McCarthy', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2608-7151', 'authenticated-orcid': False, 'given': 'Nancy', 'family': 'Holroyd', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mandy', 'family': 'Sanders', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3932-5502', 'authenticated-orcid': False, 'given': 'Karl', 'family': 'Hoffmann', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5923-4472', 'authenticated-orcid': False, 'given': 'David', 'family': 'Wilcockson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7767-4922', 'authenticated-orcid': False, 'given': 'Gabriel', 'family': 'Rinaldi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9581-0377', 'authenticated-orcid': False, 'given': 'Matt', 'family': 'Berriman', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The consequences of the earth’s daily rotation have led to 24-hour biological rhythms in most organisms. Parasites have daily rhythms, which, when in synchrony with host rhythms, optimize their fitness. Using round-the-clock transcriptomics of male and female <jats:italic>Schistosoma mansoni</jats:italic> blood flukes we have discovered the first 24-hour molecular oscillations in a metazoan parasite, and gained insight into its daily rhythms. We show that expression of ∼2% of its genes followed diel cycles. Rhythmic processes, in synchrony in both sexes, included a night-time stress response and a day-time metabolic ‘rush hour’. These 24hr rhythms may be driven by host rhythms and/or generated by an intrinsic circadian clock. However, canonical core clock genes are lacking, suggesting an unusual oscillatory mechanism or loss of a functional clock. The daily rhythms in biology identified here, may promote within-host survival and between-host transmission, and are important for the development and delivery of therapeutics against schistosomiasis.</jats:p>",2021-04-22
106,10.1101/2021.04.27.441583,21,bioRxiv,Biophysics,False,OCT4 interprets and enhances nucleosome flexibility,"[{'given': 'Caitlin M.', 'family': 'MacCarthy', 'sequence': 'first', 'affiliation': []}, {'given': 'Jan', 'family': 'Huertas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claudia', 'family': 'Ortmeier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hermann', 'family': 'vom Bruch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Deike', 'family': 'Reinke', 'sequence': 'additional', 'affiliation': []}, {'given': 'Astrid', 'family': 'Sander', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tim', 'family': 'Bergbrede', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hans R.', 'family': 'Schöler', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vlad', 'family': 'Cojocaru', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Pioneer transcription factors induce cellular identity transitions by binding to sites on inaccessible DNA wrapped in nuclear chromatin. They contribute to chromatin opening and recruit other factors to regulatory DNA sites. The structural basis of their interaction with the chromatin structural unit, the nucleosome, is still unresolved. From a combination of experiments and molecular simulations we reveal here how Oct4, the master regulator and inducer of cellular pluripotency, interprets and enhances nucleosome structural flexibility. The magnitude of Oct4 impact on nucleosome dynamics depends on the binding site position and the mobility of unstructured tails of nucleosomal histone proteins. Oct4 propagates and stabilizes open nucleosome conformations by specific sequence recognition and unspecific DNA exploration. Our findings provide a structural basis for the versatility of transcription factors in engaging with nucleosomes and have implications for understanding how pioneer factors induce chromatin dynamics.</jats:p>",2021-04-27
107,10.1101/2020.08.02.232710,20,bioRxiv,Animal Behavior and Cognition,False,Permutation tests for hypothesis testing with animal social data: problems and potential solutions,"[{'ORCID': 'http://orcid.org/0000-0003-2208-7613', 'authenticated-orcid': False, 'given': 'Damien R', 'family': 'Farine', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6933-5501', 'authenticated-orcid': False, 'given': 'Gerald G.', 'family': 'Carter', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Permutation tests are widely used to test hypotheses with animal social network data, but suffer from high rates of type I and II error when the permutations do not properly simulate the null hypothesis of interest. Two common types of permutations each have limitations. Pre-network (datastream) permutations can be used to control ""nuisance effects"" like spatial, temporal, or sampling biases, but only when the null hypothesis assumes random social decisions. Node (node-label) permutation tests can test null hypotheses that include nonrandom social structure, but only when the observed network is not shaped by nuisance effects. We propose a new procedure, the double permutation test, that addresses these limitations by combining pre-network and node permutations. We conduct a range of simulations, allowing us to estimate error rates caused by confounding effects of social or non-social structure in the raw data. We show that the double permutation test is less likely to produce elevated error rates relative to node permutations, pre-network permutations, and regression models with control variables, which all exhibit elevated type I errors under at least one set of simulated conditions. In scenarios where type I error rates from pre-network permutation tests exceed 30%, the error rates from double permutation remain close to 5%. The double permutation test provides a potential solution to issues arising from elevated type I and type II error rates when testing hypotheses with social network data. We also discuss other approaches for more robust inferences, including controlled node permutations, testing multiple null hypotheses, and splitting large datasets to generate replicated networks. Finally, we highlight ways that uncertainty can be explicitly considered and carried through the analysis.</jats:p>",2020-08-04
108,10.1101/2021.04.24.21256047,20,medRxiv,Genetic and Genomic Medicine,True,Interleukin-6 receptor genetic variation and tocilizumab treatment response to COVID-19,"[{'given': 'Ammar Ali', 'family': 'Almarzooq', 'sequence': 'first', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Interleukin-6 receptor (IL6R) stimulates the inflammatory pathways as part of the acute-phase response to infection. Tocilizumab is a monoclonal antibody that inhibits both membrane-bound and soluble IL6R and is used to treat inflammatory conditions, including COVID-19. Despite the disproportionate incidence of COVID-19 among underserved, racial, and ethnic minority populations, the efficacy of tocilizumab in hospitalized COVID-19 patients from these populations is unclear. In this work, three genetic markers for the <jats:italic>IL6R</jats:italic> gene were analyzed across diverse ethnic backgrounds to identify population differences in response to tocilizumab treatment. Genetic structure analyses showed that African populations were significantly different from other described populations. In addition, mapped frequencies of these alleles showed that Sub-Saharan African populations were 3.4x more likely to show an impaired response to tocilizumab than East Asian populations, and 1.8x more likely than European ancestry populations. Existing <jats:italic>IL6R</jats:italic> genotype results may identify populations at increased therapeutic failure risk. As results from current clinical trials on the efficacy of tocilizumab treatment for extreme COVID-19 infections are conflicting, more studies are needed across diverse patient backgrounds to better understand the genetic factors necessary to predict treatment efficacy. This work demonstrates how pharmacogenomics studies can elucidate genetic variation on treatment efficacy on COVID-19.</jats:p>",2021-04-27
109,10.1101/2020.08.28.271957,20,bioRxiv,Pharmacology and Toxicology,True,Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2,"[{'given': 'Mohammad M.', 'family': 'Ghahremanpour', 'sequence': 'first', 'affiliation': []}, {'given': 'Julian', 'family': 'Tirado-Rives', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maya', 'family': 'Deshmukh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joseph A.', 'family': 'Ippolito', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chun-Hui', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Israel Cabeza', 'family': 'de Vaca', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria-Elena', 'family': 'Liosi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3433-0780', 'authenticated-orcid': False, 'given': 'Karen S.', 'family': 'Anderson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3993-9520', 'authenticated-orcid': False, 'given': 'William L.', 'family': 'Jorgensen', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>A consensus virtual screening protocol has been applied to ca. 2000 approved drugs to seek inhibitors of the main protease (M<jats:sup>pro</jats:sup>) of SARS-CoV-2, the virus responsible for COVID-19. 42 drugs emerged as top candidates, and after visual analyses of the predicted structures of their complexes with M<jats:sup>pro</jats:sup>, 17 were chosen for evaluation in a kinetic assay for M<jats:sup>pro</jats:sup> inhibition. Remarkably 14 of the compounds at 100-μM concentration were found to reduce the enzymatic activity and 5 provided IC<jats:sub>50</jats:sub> values below 40 μM: manidipine (4.8 μM), boceprevir (5.4 μM), lercanidipine (16.2 μM), bedaquiline (18.7 μM), and efonidipine (38.5 μM). Structural analyses reveal a common cloverleaf pattern for the binding of the active compounds to the P1, P1’, and P2 pockets of M<jats:sup>pro</jats:sup>. Further study of the most active compounds in the context of COVID-19 therapy is warranted, while all of the active compounds may provide a foundation for lead optimization to deliver valuable chemotherapeutics to combat the pandemic.</jats:p>",2020-08-28
110,10.1101/2020.05.20.106591,20,bioRxiv,Cell Biology,False,Spatial organization of transcribed eukaryotic genes,"[{'given': 'Susanne', 'family': 'Leidescher', 'sequence': 'first', 'affiliation': []}, {'given': 'Johannes', 'family': 'Ribisel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simon', 'family': 'Ullrich', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yana', 'family': 'Feodorova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Erica', 'family': 'Hildebrand', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sebastian', 'family': 'Bultmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stephanie', 'family': 'Link', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katharina', 'family': 'Thanisch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher', 'family': 'Mulholland', 'sequence': 'additional', 'affiliation': []}, {'given': 'Job', 'family': 'Dekker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Heinrich', 'family': 'Leonhardt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Leonid', 'family': 'Mirny', 'sequence': 'additional', 'affiliation': []}, {'given': 'Irina', 'family': 'Solovei', 'sequence': 'additional', 'affiliation': []}]","<jats:title>SUMMARY</jats:title><jats:p>Despite the well-established role of nuclear organization in gene expression regulation, little is known about the reverse: how transcription shapes the spatial organization of the genome. Owing to small sizes of most previously studied genes and the limited resolution of microscopy, the structure and spatial arrangement of a single transcribed gene are still poorly understood. Here, we make use of several long highly expressed genes and demonstrate that they form transcription loops with polymerases moving along the loops and carrying nascent RNAs. Transcription loops can span across microns resembling lampbrush loops and polytene puffs. Extension and shape of transcription loops suggest their intrinsic stiffness, which we attribute to decoration with multiple voluminous nascent RNPs. Our data contradict the model of transcription factories and indicate that although microscopically resolvable transcription loops are specific for long highly expressed genes, the mechanisms underlying their formation can represent a general aspect of eukaryotic transcription.</jats:p>",2020-05-21
111,10.1101/2021.04.28.441874,20,bioRxiv,Developmental Biology,False,Temporal single-cell transcriptomes of zebrafish spinal cord pMN progenitors reveal distinct neuronal and glial progenitor populations,"[{'given': 'Kayt', 'family': 'Scott', 'sequence': 'first', 'affiliation': []}, {'given': 'Rebecca', 'family': ""O'Rourke"", 'sequence': 'additional', 'affiliation': []}, {'given': 'Caitlin', 'family': 'Winkler', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christina A', 'family': 'Kearns', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4500-0672', 'authenticated-orcid': False, 'given': 'Bruce', 'family': 'Appel', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Ventral spinal cord progenitor cells, which express the basic helix loop helix transcription factor Olig2, sequentially produce motor neurons and oligodendrocyte precursor cells (OPCs). Following specification some OPCs differentiate as myelinating oligodendrocytes while others persist as OPCs. Though a considerable amount of work has described the molecular profiles that define motor neurons, OPCs, and oligodendrocytes, less is known about the progenitors that produce them. To identify the developmental origins and transcriptional profiles of motor neurons and OPCs, we performed single-cell RNA sequencing on isolated pMN cells from embryonic zebrafish trunk tissue at stages that encompassed motor neurogenesis, OPC specification, and initiation of oligodendrocyte differentiation. Downstream analyses revealed two distinct pMN progenitor populations: one that appears to produce neurons and one that appears to produce OPCs. This latter population, called Pre-OPCs, is marked by expression of GS Homeobox 2 (gsx2), a gene that encodes a homeobox transcription factor. Using fluorescent in situ hybridizations, we identified gsx2-expressing Pre-OPCs in the spinal cord prior to expression of canonical OPC marker genes. Our data therefore reveal heterogeneous gene expression profiles among pMN progenitors, supporting prior fate mapping evidence.</jats:p>",2021-04-29
112,10.1101/2020.11.16.385401,20,bioRxiv,Evolutionary Biology,True,"An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia","[{'ORCID': 'http://orcid.org/0000-0001-7543-4864', 'authenticated-orcid': False, 'given': 'Yassine', 'family': 'Souilmi', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7362-3618', 'authenticated-orcid': False, 'given': 'M. Elise', 'family': 'Lauterbur', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4603-1473', 'authenticated-orcid': False, 'given': 'Ray', 'family': 'Tobler', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christian D.', 'family': 'Huber', 'sequence': 'additional', 'affiliation': []}, {'given': 'Angad S.', 'family': 'Johar', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2634-8016', 'authenticated-orcid': False, 'given': 'David', 'family': 'Enard', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary</jats:title><jats:p>The current SARS-CoV-2 pandemic has emphasized the vulnerability of human populations to novel viral pressures, despite the vast array of epidemiological and biomedical tools now available. Notably, modern human genomes contain evolutionary information tracing back tens of thousands of years, which may help identify the viruses that have impacted our ancestors – pointing to which viruses have future pandemic potential. Here, we apply evolutionary analyses to human genomic datasets to recover selection events involving tens of human genes that interact with coronaviruses, including SARS-CoV-2, that likely started more than 20,000 years ago. These adaptive events were limited to the population ancestral to East Asian populations. Multiple lines of functional evidence support an ancient viral selective pressure, and East Asia is the geographical origin of several modern coronavirus epidemics. An arms race with an ancient coronavirus, or with a different virus that happened to use similar interactions as coronaviruses with human hosts, may thus have taken place in ancestral East Asian populations. By learning more about our ancient viral foes, our study highlights the promise of evolutionary information to better predict the pandemics of the future. Importantly, adaptation to ancient viral epidemics in specific human populations does not necessarily imply any difference in genetic susceptibility between different human populations, and the current evidence points toward an overwhelming impact of socioeconomic factors in the case of COVID-19.</jats:p>",2020-11-16
113,10.1101/2021.01.04.21249236,20,medRxiv,Infectious Diseases (except HIV/AIDS),True,Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality,"[{'ORCID': 'http://orcid.org/0000-0001-8212-7440', 'authenticated-orcid': False, 'given': 'Julio', 'family': 'Silva', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4590-2756', 'authenticated-orcid': False, 'given': 'Carolina', 'family': 'Lucas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria', 'family': 'Sundaram', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benjamin', 'family': 'Israelow', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patrick', 'family': 'Wong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jon', 'family': 'Klein', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9568-9300', 'authenticated-orcid': False, 'given': 'Maria', 'family': 'Tokuyama', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6118-872X', 'authenticated-orcid': False, 'given': 'Peiwen', 'family': 'Lu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Arvind', 'family': 'Venkataraman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Feimei', 'family': 'Liu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9251-8592', 'authenticated-orcid': False, 'given': 'Tianyang', 'family': 'Mao', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2511-7064', 'authenticated-orcid': False, 'given': 'Ji Eun', 'family': 'Oh', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7903-1122', 'authenticated-orcid': False, 'given': 'Annsea', 'family': 'Park', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3301-6143', 'authenticated-orcid': False, 'given': 'Arnau', 'family': 'Casanovas-Massana', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0027-6480', 'authenticated-orcid': False, 'given': 'Chantal B. F.', 'family': 'Vogels', 'sequence': 'additional', 'affiliation': []}, {'given': 'M. Catherine', 'family': 'Muenker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joseph', 'family': 'Zell', 'sequence': 'additional', 'affiliation': []}, {'given': 'John B.', 'family': 'Fournier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Melissa', 'family': 'Campbell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael', 'family': 'Chiorazzi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Edwin Ruiz', 'family': 'Fuentes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mary E', 'family': 'Petrone', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9675-0065', 'authenticated-orcid': False, 'given': 'Chaney C.', 'family': 'Kalinich', 'sequence': 'additional', 'affiliation': []}, {'given': 'Isabel M.', 'family': 'Ott', 'sequence': 'additional', 'affiliation': []}, {'given': 'Annie', 'family': 'Watkins', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adam J.', 'family': 'Moore', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maura', 'family': 'Nakahata', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nathan D.', 'family': 'Grubaugh', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shelli', 'family': 'Farhadian', 'sequence': 'additional', 'affiliation': []}, {'given': 'Charles Dela', 'family': 'Cruz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Albert I.', 'family': 'Ko', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2048-4028', 'authenticated-orcid': False, 'given': 'Wade L.', 'family': 'Schulz', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3699-2446', 'authenticated-orcid': False, 'given': 'Aaron', 'family': 'Ring', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shuangge', 'family': 'Ma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Saad', 'family': 'Omer', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6015-0279', 'authenticated-orcid': False, 'given': 'Anne L', 'family': 'Wyllie', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7824-9856', 'authenticated-orcid': False, 'given': 'Akiko', 'family': 'Iwasaki', 'sequence': 'additional', 'affiliation': []}, {'name': 'Yale IMPACT Team', 'sequence': 'additional', 'affiliation': []}]","<jats:p>While several clinical and immunological parameters correlate with disease severity and mortality in SARS-CoV-2 infection, work remains in identifying unifying correlates of coronavirus disease 2019 (COVID-19) that can be used to guide clinical practice. Here, we examine saliva and nasopharyngeal (NP) viral load over time and correlate them with patient demographics, and cellular and immune profiling. We found that saliva viral load was significantly higher in those with COVID-19 risk factors; that it correlated with increasing levels of disease severity and showed a superior ability over nasopharyngeal viral load as a predictor of mortality over time (AUC=0.90). A comprehensive analysis of immune factors and cell subsets revealed strong predictors of high and low saliva viral load, which were associated with increased disease severity or better overall outcomes, respectively. Saliva viral load was positively associated with many known COVID-19 inflammatory markers such as IL-6, IL-18, IL-10, and CXCL10, as well as type 1 immune response cytokines. Higher saliva viral loads strongly correlated with the progressive depletion of platelets, lymphocytes, and effector T cell subsets including circulating follicular CD4 T cells (cTfh). Anti-spike (S) and anti-receptor binding domain (RBD) IgG levels were negatively correlated with saliva viral load showing a strong temporal association that could help distinguish severity and mortality in COVID-19. Finally, patients with fatal COVID-19 exhibited higher viral loads, which correlated with the depletion of cTfh cells, and lower production of anti-RBD and anti-S IgG levels. Together these results demonstrated that viral load – as measured by saliva but not nasopharyngeal — is a dynamic unifying correlate of disease presentation, severity, and mortality over time.</jats:p>",2021-01-06
114,10.1101/2021.01.10.426133,19,bioRxiv,Plant Biology,False,The Flowering Time Regulator FLK Controls Pathogen Defense in Arabidopsis thaliana,"[{'given': 'Matthew', 'family': 'Fabian', 'sequence': 'first', 'affiliation': []}, {'given': 'Min', 'family': 'Gao', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8650-1356', 'authenticated-orcid': False, 'given': 'Xiao-Ning', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jiangli', 'family': 'Shi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sung-Ha', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Priyank', 'family': 'Patel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna R.', 'family': 'Hu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7496-3200', 'authenticated-orcid': False, 'given': 'Hua', 'family': 'Lu', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Plant disease resistance is a complex process that is maintained in an intricate balance with development. Increasing evidence indicates the importance of post-transcriptional regulation of plant defense by RNA binding proteins. The K homology (KH) repeat is an ancient RNA binding motif found in proteins from diverse organisms. The role of KH domain proteins in pathogen resistance is not well known. From a genetic screen aimed to uncover novel defense genes in Arabidopsis, we identified a new allele of the canonical flowering regulatory gene, <jats:italic>FLOWERING LOCUS KH Domain</jats:italic> (<jats:italic>FLK</jats:italic>), encoding a putative triple KH-repeat protein. In addition to late flowering, the <jats:italic>flk</jats:italic> mutants exhibited decreased resistance to the bacterial pathogen <jats:italic>Pseudomonas syringae</jats:italic> and increased resistance to the necrotrophic fungal pathogen <jats:italic>Botrytis cinerea</jats:italic>. We found that the <jats:italic>flk</jats:italic> mutations compromised basal defense and defense signaling mediated by salicylic acid and led to increased reactive oxygen species (ROS) scavenging, likely through <jats:italic>FLK</jats:italic>’s regulation of the ROS scavenging enzyme catalases. RNA-seq data revealed that major defense signaling genes are regulated by <jats:italic>FLK</jats:italic>, providing a molecular basis for <jats:italic>FLK</jats:italic>’s contribution to pathogen defense. Together our data support that FLK is a multifunctional protein regulating pathogen defense and development of plants.</jats:p>",2021-01-11
115,10.1101/2021.03.10.21252667,19,medRxiv,Infectious Diseases (except HIV/AIDS),True,The Value of Rapid Antigen Tests to Identify Carriers of Viable SARS-CoV-2,"[{'given': 'Elena V.', 'family': 'Shidlovskaya', 'sequence': 'first', 'affiliation': []}, {'given': 'Nadezhda A.', 'family': 'Kuznetsova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elizaveta V.', 'family': 'Divisenko', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria A.', 'family': 'Nikiforova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrei E.', 'family': 'Siniavin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daria A.', 'family': 'Ogarkova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aleksandr V.', 'family': 'Shagaev', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria A.', 'family': 'Semashko', 'sequence': 'additional', 'affiliation': []}, {'given': 'Artem P.', 'family': 'Tkachuk', 'sequence': 'additional', 'affiliation': []}, {'given': 'Olga A.', 'family': 'Burgasova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vladimir A.', 'family': 'Gushchin', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The search for effective methods to detect patients who excrete a viable virus is one of the urgent tasks of modern biomedicine. In the present study, we examined the diagnostic value of two antigen tests BIOCREDIT COVID-19 Ag (RapiGEN Inc., Korea) and SGTI-flex COVID-19 Ag (Sugentech Inc., Korea) for their diagnostic value in identifying patients who excrete viable SARS-CoV-2. As part of the study, we examined samples from 106 patients who had just been admitted to the hospital, who had undergone quantitative RT-PCR and assessment of viability of SARS-CoV-2 using cell culture. Sensitivity was 0.786 (0.492–0.953) for SGTI-flex COVID-19 Ag and 1 (0.768– 1) for Biocredit COVID-19 Ag. Specificity of rapid tests was significantly higher than that of RT-PCR and was 0.663 (0.557–0.758) and 0.674 (0.568–0.768) for SGTI-flex COVID-19 Ag and Biocredit COVID-19 Ag versus 0.304 (0.213–0.409) obtained for PCR. Thus, for tasks of identifying viable SARS-CoV-2 during screening of conditionally healthy people, as well as monitoring those quarantined, rapid tests show significantly better results.</jats:p>",2021-03-12
116,10.1101/2021.04.27.441718,19,bioRxiv,Microbiology,False,A Novel Family of RNA-Binding Proteins Regulate Polysaccharide Metabolism in Bacteroides thetaiotaomicron,"[{'given': 'Amanda ND', 'family': 'Adams', 'sequence': 'first', 'affiliation': []}, {'given': 'Muhammad S', 'family': 'Azam', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zachary A', 'family': 'Costliow', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiangqian', 'family': 'Ma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patrick H', 'family': 'Degnan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carin K', 'family': 'Vanderpool', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Human gut microbiome composition is constantly changing, and diet is a major driver of these changes. Gut microbial species that persist in mammalian hosts for long periods of time must possess mechanisms for sensing and adapting to nutrient shifts to avoid being outcompeted. Global regulatory mechanisms mediated by RNA-binding proteins (RBPs) that govern responses to nutrient shifts have been characterized in Proteobacteria and Firmicutes but remain undiscovered in the Bacteroidetes. Here we report the identification of RBPs that are broadly distributed across the Bacteroidetes, with many genomes encoding multiple copies. Genes encoding these RBPs are highly expressed in many <jats:italic>Bacteroides</jats:italic> species. A purified RBP, RbpB, from <jats:italic>Bacteroides thetaiotaomicron</jats:italic> binds to single-stranded RNA in vitro with an affinity similar to other characterized regulatory RBPs. <jats:italic>B. thetaiotaomicron</jats:italic> mutants lacking RBPs show dramatic shifts in expression of polysaccharide utilization and capsular polysaccharide loci, suggesting that these RBPs may act as global regulators of polysaccharide metabolism. A <jats:italic>B. thetaiotaomicron</jats:italic> Δ<jats:italic>rbpB</jats:italic> mutant shows a growth defect on dietary sugars belonging to the raffinose family of oligosaccharides (RFOs). The Δ<jats:italic>rbpB</jats:italic> mutant had reduced expression of BT1871, encoding a predicted RFO-degrading melibiase, compared to the wild-type strain. Mutation of BT1871 confirmed that the enzyme it encodes is essential for growth on melibiose and promotes growth on the RFOs raffinose and stachyose. Our data reveal that RbpB is required for optimal expression of BT1871 and other polysaccharide-related genes, suggesting that we have identified an important new family of global regulatory proteins in the Bacteroidetes.</jats:p>",2021-04-28
117,10.1101/2021.04.21.21255874,19,medRxiv,Infectious Diseases (except HIV/AIDS),True,"Evaluation of the sensitivity, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production","[{'ORCID': 'http://orcid.org/0000-0002-4154-5782', 'authenticated-orcid': False, 'given': 'Maria-Inti', 'family': 'Metzendorf', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2517-2258', 'authenticated-orcid': False, 'given': 'Robin M.', 'family': 'Featherstone', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>The Cochrane COVID-19 Study Register (CCSR) is a public, continually updated, curated database of COVID-19 study references. The aim of this study-based register is to support rapid and living evidence synthesis, including a project to build an evidence ecosystem of COVID-19 research (CEOsys). In November and December 2020 we conducted an evaluation of the CCSR for CEOsys, measured its performance and identified areas for improvement.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>For the evaluation we generated a purposive sample of 286 studies from 20 reviews to calculate the CCSR’s sensitivity (comprehensiveness), accuracy (correctly classified and linked studies) and currency (time to publish and process references).</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The CCSR had an overall sensitivity of 77.2%, with the highest sensitivity for interventional studies (94.4%) and lowest sensitivity for modelling studies (63.6%). The study register had 100% sensitivity for trial registry records, 86.5% for journal articles and 52.4% for preprints. 98.3% of references were correctly classified with regard to study type, and 93.4% with regard to study aim. 89% of studies were correctly linked. 81.4% of references were published to the register in under 30 days, with 0.5 day (median) for trial registry records, 2 days for journal articles and 56 days for preprints.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The CCSR had high sensitivity, accurate study classifications and short publishing times for journal articles and trial registry records. We identified that the CCSR’s coverage and publishing times for preprints needed improvement. Finally, the evaluation illustrated the value of a study-based register for identifying additional study references for analysis in evidence synthesis.</jats:p></jats:sec>",2021-04-25
118,10.1101/763292,19,bioRxiv,Neuroscience,False,Single Volume Image Generator and Deep Learning-based ASD Classification,"[{'ORCID': 'http://orcid.org/0000-0002-2749-6507', 'authenticated-orcid': False, 'given': 'Md Rishad', 'family': 'Ahmed', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2726-2855', 'authenticated-orcid': False, 'given': 'Yuan', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Omer T.', 'family': 'Inan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3847-9347', 'authenticated-orcid': False, 'given': 'Hongen', 'family': 'Liao', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Autism spectrum disorder (ASD) is an intricate neuropsychiatric brain disorder characterized by social deficits and repetitive behaviors. Associated ASD biomarkers can be supportive of apprehending the underlying roots of the disease and lead the targeted diagnosis as well as treatment. Although deep learning approaches have been applied in functional magnetic resonance imaging (fMRI) based clinical or behavioral identification of ASD, most erstwhile models are inadequate in their capacity to exploit the data richness. Classification techniques often solely rely on region-based summary and/or functional connectivity analysis of one pipeline or unique site dataset. Besides these, biomedical data modeling to analyze big data related to ASD is still perplexing due to its complexity and heterogeneity. Single volume image consideration has not been previously investigated in classification purposes. By deeming these challenges, in this work, firstly, we design an image generator to generate single volume brain images from the whole-brain image of each subject. Secondly, the single volume images are analyzed by evaluating four deep learning approaches comprising one amended volume base Convolutional Neural Network framework to classify ASD and typical control participants. Thirdly, we propose a novel deep ensemble learning classifier using VGG16 as feature extractor to ensure further classification performance. Then, to evaluate the classifier performance across the inter sites, we apply the proposed method on each site individually and validate our findings by comparing literature reports. We showcase our approaches on large-scale multi-site brain imaging dataset (ABIDE) by considering four preprocessing pipelines, and the outcome demonstrates the state-of-the-art performance compared with the literature findings; hence, which are robust and consistent.</jats:p>",2019-09-09
119,10.1101/2021.01.02.21249146,19,medRxiv,Public and Global Health,True,Do school closures and school reopenings affect community transmission of COVID-19? A systematic review of observational studies,"[{'ORCID': 'http://orcid.org/0000-0001-8894-5006', 'authenticated-orcid': False, 'given': 'Sebastian', 'family': 'Walsh', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9817-0603', 'authenticated-orcid': False, 'given': 'Avirup', 'family': 'Chowdhury', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3366-2903', 'authenticated-orcid': False, 'given': 'Vickie', 'family': 'Braithwaite', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simon', 'family': 'Russell', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6292-1647', 'authenticated-orcid': False, 'given': 'Jack', 'family': 'Birch', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7263-8845', 'authenticated-orcid': False, 'given': 'Joseph', 'family': 'Ward', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claire', 'family': 'Waddington', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5307-663X', 'authenticated-orcid': False, 'given': 'Carol', 'family': 'Brayne', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6253-6498', 'authenticated-orcid': False, 'given': 'Chris', 'family': 'Bonell', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3047-2247', 'authenticated-orcid': False, 'given': 'Russell', 'family': 'Viner', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3218-9912', 'authenticated-orcid': False, 'given': 'Oliver', 'family': 'Mytton', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>School closures are associated with significant negative consequences and exacerbate inequalities. They were implemented worldwide to control SARS-CoV-2 in the first half of 2020, but their effectiveness, and the effects of lifting them, remain uncertain. This review summarises observational evidence of the effect of school closures and school reopenings on SARS-CoV-2 community transmission.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The study protocol was registered on Prospero (ID:CRD42020213699). On 07 January 2021 we searched PubMed, Web of Science, Scopus, CINAHL, the WHO Global COVID-19 Research Database, ERIC, the British Education Index, the Australian Education Index, and Google. We included observational studies with quantitative estimates of the effect of school closures/reopenings on SARS-CoV-2 community transmission. We excluded prospective modelling studies and intra-school transmission studies. We performed a narrative synthesis due to data heterogeneity. We used the ROBINS-I tool to assess risk of bias.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>We identified 7,474 articles, of which 40 were included, with data from 150 countries. Of these 32 studies assessed school closures, and 11 examined reopenings. There was substantial heterogeneity between school closure studies, with half of the studies at lower risk of bias reporting reduced community transmission by up to 60%, and half reporting null findings. The majority (n=3 out of 4) of school reopening studies at lower risk of bias reported no associated increases in transmission.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>School closure studies were at risk of confounding and collinearity from other non-pharmacological interventions implemented around the same time as school closures, and the effectiveness of closures remains uncertain. School reopenings, in areas of low transmission and with appropriate mitigation measures, were generally not accompanied by increasing community transmission. With such varied evidence on effectiveness, and the harmful effects, policymakers should take a measured approach before implementing school closures; and should look to reopen schools in times of low transmission, with appropriate mitigation measures.</jats:p></jats:sec>",2021-01-04
120,10.1101/2020.08.04.20167932,18,medRxiv,Epidemiology,True,Viral cultures for COVID-19 infectivity assessment – a systematic review (Update 4),"[{'ORCID': 'http://orcid.org/0000-0002-4778-2949', 'authenticated-orcid': False, 'given': 'T', 'family': 'Jefferson', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9079-8006', 'authenticated-orcid': False, 'given': 'EA', 'family': 'Spencer', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7812-6311', 'authenticated-orcid': False, 'given': 'J', 'family': 'Brassey', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1009-1992', 'authenticated-orcid': False, 'given': 'C', 'family': 'Heneghan', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>to review the evidence from studies comparing SARS-CoV-2 culture, the best indicator of current infection and infectiousness with the results of reverse transcriptase polymerase chain reaction (RT-PCR).</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We searched LitCovid, medRxiv, Google Scholar and the WHO Covid-19 database for Covid-19 using the terms ‘viral culture’ or ‘viral replication’ and associated synonyms up to 10 September 2020. We carried out citation matching and included studies reporting attempts to culture or observe SARS-CoV-2 matching with cutoffs for RT-PCR positivity. One reviewer extracted data for each study and a second reviewer checked end edited the extraction and summarised the narratively by sample: fecal, respiratory, environment or mixed.</jats:p><jats:p>Where necessary we wrote to corresponding authors of the included or background papers for additional information. We assessed quality using a modified QUADAS 2 risk of bias tool.</jats:p><jats:p>This review is part of an <jats:underline>Open Evidence Review</jats:underline> on Transmission Dynamics of COVID-19. Summaries of the included studies and the protocol (v1) are available at: <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""uri"" xlink:href=""https://www.cebm.net/evidence-synthesis/transmission-dynamics-of-covid-19/"">https://www.cebm.net/evidence-synthesis/transmission-dynamics-of-covid-19/</jats:ext-link>. Searches are updated every 2 weeks. This is the fourth version of this review that was first published on the 4th of August and updated on the 21t of August</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We included 29 studies reporting culturing or observing tissue invasion by SARS-CoV in sputum, naso or oropharyngeal, urine, stool, blood and environmental samples from patients diagnosed with Covid-19. The data are suggestive of a relation between the time from collection of a specimen to test, cycle threshold and symptom severity. The quality of the studies was moderate with lack of standardised reporting.</jats:p><jats:p>Twelve studies reported that Ct values were significantly lower and log copies higher in samples producing live virus culture. Five studies reported no growth in samples based on a Ct cut-off value. These values ranged from CT &gt; 24 for no growth to Ct ≥ 34. Two studies report a strong relationship between Ct value and ability to recover infectious virus and that the odds of live virus culture reduced by 33% for every one unit increase in Ct. A cut-off RT-PCR Ct &gt; 30 was associated with non-infectious samples. One study that analysed the NSP, N and E gene fragments of the PCR result reported different cut-off thresholds depending on the gene fragment analysed. The duration of RNA shedding detected by PCR was far longer compared to detection of live culture. Six out of eight studies reported RNA shedding for longer than 14 days. Yet, infectivity declines after day 8 even among cases with ongoing high viral loads. A very small proportion of people re-testing positive after hospital discharge or with high Ct are likely to be infectious.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Prospective routine testing of reference and culture specimens are necessary for each country involved in the pandemic to establish the usefulness and reliability of PCR for Covid-19 and its relation to patients’ factors. Infectivity is related to the date of onset of symptoms and cycle threshold level.</jats:p><jats:p>A binary Yes/No approach to the interpretation RT-PCR unvalidated against viral culture will result in false positives with possible segregation of large numbers of people who are no longer infectious and hence not a threat to public health.</jats:p></jats:sec>",2020-08-04
121,10.1101/2020.10.21.348771,18,bioRxiv,Neuroscience,False,A deep learning algorithm for 3D cell detection in whole mouse brain image datasets,"[{'ORCID': 'http://orcid.org/0000-0003-3225-1130', 'authenticated-orcid': False, 'given': 'Adam L.', 'family': 'Tyson', 'sequence': 'first', 'affiliation': []}, {'given': 'Charly V.', 'family': 'Rousseau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christian J.', 'family': 'Niedworok', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sepiedeh', 'family': 'Keshavarzi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chryssanthi', 'family': 'Tsitoura', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lee', 'family': 'Cossell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Molly', 'family': 'Strom', 'sequence': 'additional', 'affiliation': []}, {'given': 'Troy W.', 'family': 'Margrie', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Understanding the function of the nervous system necessitates mapping the spatial distributions of its constituent cells defined by function, anatomy or gene expression. Recently, developments in tissue preparation and microscopy allow cellular populations to be imaged throughout the entire rodent brain. How-ever, mapping these neurons manually is prone to bias and is often impractically time consuming. Here we present an opensource algorithm for fully automated 3D detection of neuronal somata in mouse whole-brain microscopy images using standard desktop computer hardware. We demonstrate the applicability and power of our approach by mapping the brain-wide locations of large populations of cells labeled with cytoplasmic fluorescent proteins expressed via retrograde trans-synaptic viral infection.</jats:p>",2020-10-21
122,10.1101/2021.01.19.427283,18,bioRxiv,Cancer Biology,False,Oncogenic RAS instructs morphological transformation of human epithelia via differential tissue mechanics.,"[{'ORCID': 'http://orcid.org/0000-0003-3561-5518', 'authenticated-orcid': False, 'given': 'Agata', 'family': 'Nyga', 'sequence': 'first', 'affiliation': []}, {'given': 'Jose', 'family': 'Munoz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Suze', 'family': 'Dercksen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Giulia', 'family': 'Fornabaio', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4124-8048', 'authenticated-orcid': False, 'given': 'Marina', 'family': 'Uroz', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7621-5214', 'authenticated-orcid': False, 'given': 'Xavier', 'family': 'Trepat', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9201-6186', 'authenticated-orcid': False, 'given': 'Buzz', 'family': 'Baum', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6660-9685', 'authenticated-orcid': False, 'given': 'Helen K', 'family': 'Matthews', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7439-2866', 'authenticated-orcid': False, 'given': 'Vito', 'family': 'Conte', 'sequence': 'additional', 'affiliation': []}]","<jats:p>The loss of epithelial homeostasis and the disruption of normal tissue morphology is a hallmark of tumor development. Here, we ask how the uniform activation of an oncogene, RAS, impacts the morphology and tissue mechanics in a normal epithelium. We found that inducible induction of HRAS in confined epithelial monolayers on soft substrates drives a morphological transformation of a 2D monolayer into a compact 3D cell aggregate. This transformation was initiated by the loss of monolayer integrity and formation of two distinct cell layers with differential cell-cell junctions, cell-substrate adhesion, and tensional states. Computational modelling revealed how adhesion and active peripheral tension induces inherent mechanical instability in the system, which drives the 2D to 3D morphological transformation. Consistent with this, removal of epithelial tension through the inhibition of acto-myosin contractility halted the process. These findings reveal the mechanisms by which oncogene activation within an epithelium can induce mechanical instability to drive morphological tissue transformation.</jats:p>",2021-01-20
123,10.1101/2020.10.02.20205633,18,medRxiv,Infectious Diseases (except HIV/AIDS),True,Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2,"[{'ORCID': 'http://orcid.org/0000-0003-3153-4630', 'authenticated-orcid': False, 'given': 'J.', 'family': 'Curtius', 'sequence': 'first', 'affiliation': []}, {'given': 'M.', 'family': 'Granzin', 'sequence': 'additional', 'affiliation': []}, {'given': 'J.', 'family': 'Schrod', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Airborne transmission of SARS-CoV-2 through virus-containing aerosol particles has been established as an important pathway for Covid-19 infection. Suitable measures to prevent such infections are imperative, especially in situations when a high number of persons convene in closed rooms. Here we tested the efficiency and practicability of operating four air purifiers equipped with HEPA filters in a high school classroom while regular classes were taking place. We monitored the aerosol number concentration for particles &gt; 3 nm at two locations in the room, the aerosol size distribution in the range from 10 nm to 10 µm, PM<jats:sub>10</jats:sub> and CO<jats:sub>2</jats:sub> concentration. For comparison, we performed similar measurements in a neighboring classroom without purifiers. In times when classes were conducted with windows and door closed, the aerosol concentration was reduced by more than 90 % within less than 30 minutes when running the purifiers (air exchange rate 5.5 h<jats:sup>-1</jats:sup>). The reduction was homogeneous throughout the room and for all particle sizes. The measurements are supplemented by a calculation estimating the maximum concentration levels of virus-containing aerosol from a highly contagious person speaking in a closed room with and without air purifiers. Measurements and calculation demonstrate that air purifiers potentially represent a well-suited measure to reduce the risks of airborne transmission of SARS-CoV-2 substantially. Staying for two hours in a closed room with a highly infective person, we estimate that the inhaled dose is reduced by a factor of six when using air purifiers with a total air exchange rate of 5.7 h<jats:sup>-1</jats:sup>.</jats:p><jats:sec><jats:title>Information Classification</jats:title><jats:p>General</jats:p></jats:sec>",2020-10-05
124,10.1101/2020.12.04.411710,18,bioRxiv,Genetics,False,Leveraging auxiliary data from arbitrary distributions to boost GWAS discovery with Flexible cFDR,"[{'ORCID': 'http://orcid.org/0000-0002-9224-4410', 'authenticated-orcid': False, 'given': 'Anna', 'family': 'Hutchinson', 'sequence': 'first', 'affiliation': []}, {'given': 'Guillermo', 'family': 'Reales', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Willis', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9755-1703', 'authenticated-orcid': False, 'given': 'Chris', 'family': 'Wallace', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Genome-wide association studies (GWAS) have identified thousands of genetic variants that are associated with complex traits. However, a stringent significance threshold is required to identify robust genetic associations. Leveraging relevant auxiliary covariates has the potential to boost statistical power to exceed the significance threshold. Particularly, abundant pleiotropy and the non-random distribution of SNPs across various functional categories suggests that leveraging GWAS test statistics from related traits and/or functional genomic data may boost GWAS discovery. While type 1 error rate control has become standard in GWAS, control of the false discovery rate can be a more powerful approach. The conditional false discovery rate (cFDR) extends the standard FDR framework by conditioning on auxiliary data to call significant associations, but current implementations are restricted to auxiliary data satisfying specific parametric distributions, typically GWAS $p$-values for related traits. We relax these distributional assumptions, enabling an extension of the cFDR framework that supports auxiliary covariates from arbitrary continuous distributions (""Flexible cFDR""). Our method can be applied iteratively, thereby supporting multi-dimensional covariate data. Through simulations we show that Flexible cFDR increases sensitivity whilst controlling FDR after one or several iterations. We further demonstrate its practical potential through application to an asthma GWAS, leveraging various functional genomic data to find additional genetic associations for asthma, which we validate in the larger, independent, UK Biobank data resource.</jats:p>",2020-12-04
125,10.1101/2021.04.05.21254656,18,medRxiv,Infectious Diseases (except HIV/AIDS),True,Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2,"[{'ORCID': 'http://orcid.org/0000-0002-3436-9784', 'authenticated-orcid': False, 'given': 'Parakkal', 'family': 'Deepak', 'sequence': 'first', 'affiliation': []}, {'given': 'Wooseob', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8724-3176', 'authenticated-orcid': False, 'given': 'Michael A.', 'family': 'Paley', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2693-3648', 'authenticated-orcid': False, 'given': 'Monica', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexander B.', 'family': 'Carvidi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0212-8094', 'authenticated-orcid': False, 'given': 'Alia A.', 'family': 'El-Qunni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alem', 'family': 'Haile', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5013-4790', 'authenticated-orcid': False, 'given': 'Katherine', 'family': 'Huang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Baylee', 'family': 'Kinnett', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mariel J.', 'family': 'Liebeskind', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zhuoming', 'family': 'Liu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2823-5859', 'authenticated-orcid': False, 'given': 'Lily E.', 'family': 'McMorrow', 'sequence': 'additional', 'affiliation': []}, {'given': 'Diana', 'family': 'Paez', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6380-8133', 'authenticated-orcid': False, 'given': 'Dana C.', 'family': 'Perantie', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7430-0626', 'authenticated-orcid': False, 'given': 'Rebecca E.', 'family': 'Schriefer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shannon E.', 'family': 'Sides', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mahima', 'family': 'Thapa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maté', 'family': 'Gergely', 'sequence': 'additional', 'affiliation': []}, {'given': 'Suha', 'family': 'Abushamma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael', 'family': 'Klebert', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lynne', 'family': 'Mitchell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Darren', 'family': 'Nix', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jonathan', 'family': 'Graf', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6848-9074', 'authenticated-orcid': False, 'given': 'Kimberly E.', 'family': 'Taylor', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4115-4300', 'authenticated-orcid': False, 'given': 'Salim', 'family': 'Chahin', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7656-0982', 'authenticated-orcid': False, 'given': 'Matthew A.', 'family': 'Ciorba', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8146-2519', 'authenticated-orcid': False, 'given': 'Patricia', 'family': 'Katz', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6233-985X', 'authenticated-orcid': False, 'given': 'Mehrdad', 'family': 'Matloubian', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8265-9471', 'authenticated-orcid': False, 'given': 'Jane A.', 'family': 'O’Halloran', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5469-0727', 'authenticated-orcid': False, 'given': 'Rachel M.', 'family': 'Presti', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3588-0637', 'authenticated-orcid': False, 'given': 'Gregory F.', 'family': 'Wu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1564-8590', 'authenticated-orcid': False, 'given': 'Sean P.J.', 'family': 'Whelan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6675-6359', 'authenticated-orcid': False, 'given': 'William J.', 'family': 'Buchser', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6314-5336', 'authenticated-orcid': False, 'given': 'Lianne S.', 'family': 'Gensler', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8127-9426', 'authenticated-orcid': False, 'given': 'Mary C.', 'family': 'Nakamura', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6129-2532', 'authenticated-orcid': False, 'given': 'Ali H.', 'family': 'Ellebedy', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4074-0516', 'authenticated-orcid': False, 'given': 'Alfred H.J.', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Individuals with chronic inflammatory diseases (CID) are frequently treated with immunosuppressive medications that can increase their risk of severe COVID-19. While novel mRNA-based SARS-CoV-2 vaccination platforms provide robust protection in immunocompetent individuals, the immunogenicity in CID patients on immunosuppression is not well established. Therefore, determining the effectiveness of SARS-CoV-2 vaccines in the setting of immunosuppression is essential to risk-stratify CID patients with impaired protection and provide clinical guidance regarding medication management.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We conducted a prospective assessment of mRNA-based vaccine immunogenicity in 133 adults with CIDs and 53 immunocompetent controls. Blood from participants over 18 years of age was collected before initial immunization and 1-2 weeks after the second immunization. Serum anti-SARS-CoV-2 spike (S) IgG<jats:sup>+</jats:sup> binding, neutralizing antibody titers, and circulating S-specific plasmablasts were quantified to assess the magnitude and quality of the humoral response following vaccination.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Compared to immunocompetent controls, a three-fold reduction in anti-S IgG titers (P=0.009) and SARS-CoV-2 neutralization (p&lt;0.0001) were observed in CID patients. B cell depletion and glucocorticoids exerted the strongest effect with a 36- and 10-fold reduction in humoral responses, respectively (p&lt;0.0001). Janus kinase inhibitors and antimetabolites, including methotrexate, also blunted antibody titers in multivariate regression analysis (P&lt;0.0001, P=0.0023, respectively). Other targeted therapies, such as TNF inhibitors, IL-12/23 inhibitors, and integrin inhibitors, had only modest impacts on antibody formation and neutralization.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>CID patients treated with immunosuppressive therapies exhibit impaired SARS-CoV-2 vaccine-induced immunity, with glucocorticoids and B cell depletion therapy more severely impeding optimal responses.</jats:p></jats:sec>",2021-04-07
126,10.1101/2020.02.28.20029272,18,medRxiv,Epidemiology,True,Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19),"[{'given': 'Hiroshi', 'family': 'Nishiura', 'sequence': 'first', 'affiliation': []}, {'given': 'Hitoshi', 'family': 'Oshitani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tetsuro', 'family': 'Kobayashi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tomoya', 'family': 'Saito', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tomimasa', 'family': 'Sunagawa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tamano', 'family': 'Matsui', 'sequence': 'additional', 'affiliation': []}, {'given': 'Takaji', 'family': 'Wakita', 'sequence': 'additional', 'affiliation': []}, {'given': 'Motoi', 'family': 'Suzuki', 'sequence': 'additional', 'affiliation': []}, {'name': 'MHLW COVID-19 Response Team', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>To identify common features of cases with novel coronavirus disease (COVID-19) so as to better understand what factors promote secondary transmission including superspreading events.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A total of 110 cases were examined among eleven clusters and sporadic cases, and investigated who acquired infection from whom. The clusters included four in Tokyo and one each in Aichi, Fukuoka, Hokkaido, Ishikawa, Kanagawa and Wakayama prefectures. The number of secondary cases generated by each primary case was calculated using contact tracing data.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of the 110 cases examined, 27 (24.6%) were primary cases who generated secondary cases. The odds that a primary case transmitted COVID-19 in a closed environment was 18.7 times greater compared to an open-air environment (95% confidence interval [CI]: 6.0, 57.9).</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>It is plausible that closed environments contribute to secondary transmission of COVID-19 and promote superspreading events. Our findings are also consistent with the declining incidence of COVID-19 cases in China, as gathering in closed environments was prohibited in the wake of the rapid spread of the disease.</jats:p></jats:sec>",2020-03-03
127,10.1101/2021.04.21.440731,18,bioRxiv,Microbiology,True,"Novel Human Lung Tissue Model for the Study of SARS-CoV-2 Entry, Inflammation and New Therapeutics","[{'given': 'Judith', 'family': 'Grau-Expósito', 'sequence': 'first', 'affiliation': []}, {'given': 'David', 'family': 'Perea', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marina', 'family': 'Suppi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Núria', 'family': 'Massana', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ander', 'family': 'Vergara', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria', 'family': 'José Soler', 'sequence': 'additional', 'affiliation': []}, {'given': 'Javier', 'family': 'García-Pérez', 'sequence': 'additional', 'affiliation': []}, {'given': 'José', 'family': 'Alcamí', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anna', 'family': 'Serrano-Mollar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joel', 'family': 'Rosado', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vicenç', 'family': 'Falcó', 'sequence': 'additional', 'affiliation': []}, {'given': 'Meritxell', 'family': 'Genescà', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4427-9413', 'authenticated-orcid': False, 'given': 'Maria J.', 'family': 'Buzon', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The development of physiological models that reproduce SARS-CoV-2 infection in primary human cells will be instrumental to identify host-pathogen interactions and potential therapeutics. Here, using cell suspensions from primary human lung tissues (HLT), we have developed a platform for the identification of viral targets and the expression of viral entry factors, as well as for the screening of viral entry inhibitors and anti-inflammatory compounds. We show that the HLT model preserves its main cell populations, maintains the expression of proteins required for SARS-CoV-2 infection, and identifies alveolar type II (AT-II) cells as the most susceptible cell targets for SARS-CoV-2 in the human lung. Antiviral testing of 39 drug candidates revealed a highly reproducible system, and provided the identification of new compounds missed by conventional systems such as VeroE6. Using this model, we also show that interferons do not modulate ACE2 expression, and that stimulation of local inflammatory responses can be modulated by different compounds with antiviral activity. Overall, we present a novel and relevant physiological model for the study of SARS-CoV-2.</jats:p><jats:sec><jats:title>Synopsis</jats:title><jats:fig id=""ufig1"" position=""float"" fig-type=""figure"" orientation=""portrait""><jats:graphic xmlns:xlink=""http://www.w3.org/1999/xlink"" xlink:href=""440731v1_ufig1"" position=""float"" orientation=""portrait"" /></jats:fig><jats:p><jats:italic>Ex vivo</jats:italic> physiological systems for the study of SARS-CoV-2-host interactions are scarce. Here, we establish a novel model using primary human lung tissue (HLT) for the analysis of cell tropism and identification of therapeutics.</jats:p><jats:list list-type=""bullet""><jats:list-item><jats:p>The HLT model preserves main cell subpopulations, including alveolar type-2 cells, and expression of SARS-CoV-2 entry factors ACE2, CD147, and TMPRSS2.</jats:p></jats:list-item><jats:list-item><jats:p>The HLT model is readily susceptible to SARS-CoV-2 entry.</jats:p></jats:list-item><jats:list-item><jats:p>Antiviral testing in the HLT model allows the identification of new candidates missed by conventional systems.</jats:p></jats:list-item><jats:list-item><jats:p>Local inflammation is supported in the HLT model and offers the identification of relevant anti-inflammatory compounds for SARS-CoV-2 infection.</jats:p></jats:list-item></jats:list></jats:sec>",2021-04-23
128,10.1101/2021.04.22.440946,18,bioRxiv,Genetics,False,Sex without crossing over in the yeast Saccharomycodes ludwigii,"[{'ORCID': 'http://orcid.org/0000-0002-8055-4024', 'authenticated-orcid': False, 'given': 'Ioannis A.', 'family': 'Papaioannou', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2569-1330', 'authenticated-orcid': False, 'given': 'Fabien', 'family': 'Dutreux', 'sequence': 'additional', 'affiliation': []}, {'given': 'France A.', 'family': 'Peltier', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0175-1610', 'authenticated-orcid': False, 'given': 'Hiromi', 'family': 'Maekawa', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3053-0796', 'authenticated-orcid': False, 'given': 'Nicolas', 'family': 'Delhomme', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amit', 'family': 'Bardhan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anne', 'family': 'Friedrich', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6606-6884', 'authenticated-orcid': False, 'given': 'Joseph', 'family': 'Schacherer', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2566-923X', 'authenticated-orcid': False, 'given': 'Michael', 'family': 'Knop', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Meiotic recombination is a ubiquitous function of sexual reproduction throughout eukaryotes. Here we report that recombination is extremely suppressed during meiosis in the yeast species <jats:italic>Saccharomycodes ludwigii</jats:italic>. DNA double-strand break formation, processing and repair are required for normal meiosis but do not lead to crossing over. Although the species has retained an intact meiotic gene repertoire, genetic and population analyses suggest the exceptionally rare occurrence of meiotic crossovers. We propose that <jats:italic>Sd. ludwigii</jats:italic> has followed a unique evolutionary trajectory that possibly derives fitness benefits from the combination of frequent fertilization within the meiotic tetrad with the absence of meiotic recombination.</jats:p>",2021-04-23
129,10.1101/2021.04.27.441636,18,bioRxiv,Genetics,False,Crafting for a better MAGIC: systematic design and test for multiparental advanced generation inter-cross population,"[{'given': 'Chin Jian', 'family': 'Yang', 'sequence': 'first', 'affiliation': []}, {'given': 'Rodney N.', 'family': 'Edmondson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hans-Peter', 'family': 'Piepho', 'sequence': 'additional', 'affiliation': []}, {'given': 'Wayne', 'family': 'Powell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ian', 'family': 'Mackay', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Multiparental advanced generation inter-cross (MAGIC) populations are valuable crop resources with a wide array of research uses including genetic mapping of complex traits, management of genetic resources and breeding of new varieties. Multiple founders are crossed to create a rich mosaic of highly recombined founder genomes in the MAGIC recombinant inbred lines (RILs). Many variations of MAGIC population designs exist; however, a large proportion of the currently available populations have been created empirically and based on similar designs. In our evaluations of five MAGIC populations, we found that the choice of designs has a large impact on the recombination landscape in the RILs. The most popular design used in many MAGIC populations has been shown to have a bias in recombinant haplotypes and low level of unique recombinant haplotypes, and therefore is not recommended. To address this problem and provide a remedy for the future, we have developed the “magicdesign” R package for creating and testing any MAGIC population design via simulation. A Shiny app version of the package is available as well. Our “magicdesign” package provides a unifying tool and a framework for creativity and innovation in MAGIC population designs. For example, using this package, we demonstrate that MAGIC population designs can be found which are very effective in creating haplotype diversity without the requirement for very large crossing programmes. Further, we show that interspersing cycles of crossing with cycles of selfing is effective in increasing haplotype diversity. These approaches are applicable in species which are hard to cross or in which resources are limited.</jats:p>",2021-04-27
130,10.1101/2021.04.29.441952,18,bioRxiv,Synthetic Biology,False,Biomolecular mechanisms for signal differentiation,"[{'given': 'Emmanouil', 'family': 'Alexis', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7574-6259', 'authenticated-orcid': False, 'given': 'Carolin C. M.', 'family': 'Schulte', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8705-8488', 'authenticated-orcid': False, 'given': 'Luca', 'family': 'Cardelli', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3565-8967', 'authenticated-orcid': False, 'given': 'Antonis', 'family': 'Papachristodoulou', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Cells can sense temporal changes of molecular signals, allowing them to predict environmental variations and modulate their behaviour. This paper elucidates the underlying biomolecular mechanisms of time derivative computation, facilitating the design of reliable synthetic differentiator devices for a variety of applications, ultimately expanding our understanding of cell behaviour. In particular, we describe and analyse three alternative biomolecular topologies that work as signal differentiators of high accuracy to arbitrary input signals around their nominal operation. We propose strategies to preserve their performance even in the presence of high-frequency input signal components, which are detrimental to the performance of most differentiators. We found that the core of the proposed topologies appears in natural regulatory networks and we further discuss their biological relevance. The simple structure of our designs makes them promising tools for realizing derivative control action in synthetic biology.</jats:p>",2021-04-29
131,10.1101/2020.11.13.382374,18,bioRxiv,Neuroscience,False,Functional microstructure of CaV-mediated calcium signaling in the axon initial segment,"[{'given': 'Anna M', 'family': 'Lipkin', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8548-1381', 'authenticated-orcid': False, 'given': 'Margaret M', 'family': 'Cunniff', 'sequence': 'additional', 'affiliation': []}, {'given': 'Perry WE', 'family': 'Spratt', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1721-5425', 'authenticated-orcid': False, 'given': 'Stefan M', 'family': 'Lemke', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7084-1532', 'authenticated-orcid': False, 'given': 'Kevin J', 'family': 'Bender', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>The axon initial segment (AIS) is a specialized neuronal compartment in which synaptic input is converted into action potential output. This process is supported by a diverse complement of sodium, potassium, and calcium channels (Ca<jats:sub>V</jats:sub>). Different classes of sodium and potassium channels are scaffolded at specific sites within the AIS, conferring unique functions, but how calcium channels are functionally distributed within the AIS is unclear. Here, we utilize conventional 2-photon laser scanning and diffraction-limited, high-speed spot 2-photon imaging to resolve action potential-evoked calcium dynamics in the AIS with high spatiotemporal resolution. In mouse layer 5 prefrontal pyramidal neurons, calcium influx was mediated by a mix of Ca<jats:sub>V</jats:sub>2 and Ca<jats:sub>V</jats:sub>3 channels that differentially localized to discrete regions. Ca<jats:sub>V</jats:sub>3 functionally localized to produce nanodomain hotspots of calcium influx that coupled to ryanodine-dependent stores, whereas Ca<jats:sub>V</jats:sub>2 localized to non-hotspot regions. Thus, different pools of Ca<jats:sub>V</jats:sub>s appear to play distinct roles in AIS function.</jats:p>",2020-11-13
132,10.1101/2020.12.12.422516,18,bioRxiv,Genomics,True,SARS-CoV-2 RNA reverse-transcribed and integrated into the human genome,"[{'given': 'Liguo', 'family': 'Zhang', 'sequence': 'first', 'affiliation': []}, {'given': 'Alexsia', 'family': 'Richards', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew', 'family': 'Khalil', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emile', 'family': 'Wogram', 'sequence': 'additional', 'affiliation': []}, {'given': 'Haiting', 'family': 'Ma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard A.', 'family': 'Young', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rudolf', 'family': 'Jaenisch', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary</jats:title><jats:p>Prolonged SARS-CoV-2 RNA shedding and recurrence of PCR-positive tests have been widely reported in patients after recovery, yet these patients most commonly are non-infectious<jats:sup>1–14</jats:sup>. Here we investigated the possibility that SARS-CoV-2 RNAs can be reverse-transcribed and integrated into the human genome and that transcription of the integrated sequences might account for PCR-positive tests. In support of this hypothesis, we found chimeric transcripts consisting of viral fused to cellular sequences in published data sets of SARS-CoV-2 infected cultured cells and primary cells of patients, consistent with the transcription of viral sequences integrated into the genome. To experimentally corroborate the possibility of viral retro-integration, we describe evidence that SARS-CoV-2 RNAs can be reverse transcribed in human cells by reverse transcriptase (RT) from LINE-1 elements or by HIV-1 RT, and that these DNA sequences can be integrated into the cell genome and subsequently be transcribed. Human endogenous LINE-1 expression was induced upon SARS-CoV-2 infection or by cytokine exposure in cultured cells, suggesting a molecular mechanism for SARS-CoV-2 retro-integration in patients. This novel feature of SARS-CoV-2 infection may explain why patients can continue to produce viral RNA after recovery and suggests a new aspect of RNA virus replication.</jats:p>",2020-12-13
133,10.1101/2021.02.19.431964,18,bioRxiv,Microbiology,False,Recoding enhances the metabolic capabilities of two novel methylotrophic Asgardarchaeota lineages,"[{'given': 'Jiarui', 'family': 'Sun', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5995-2602', 'authenticated-orcid': False, 'given': 'Paul N.', 'family': 'Evans', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0877-7802', 'authenticated-orcid': False, 'given': 'Emma J.', 'family': 'Gagen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0670-7480', 'authenticated-orcid': False, 'given': 'Ben J.', 'family': 'Woodcroft', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8530-0448', 'authenticated-orcid': False, 'given': 'Brian P.', 'family': 'Hedlund', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9485-5637', 'authenticated-orcid': False, 'given': 'Tanja', 'family': 'Woyke', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5386-7925', 'authenticated-orcid': False, 'given': 'Philip', 'family': 'Hugenholtz', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4632-1187', 'authenticated-orcid': False, 'given': 'Christian', 'family': 'Rinke', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Asgardarchaeota have been proposed as the closest living relatives to eukaryotes, and a total of 72 metagenome-assembled genomes (MAGs) representing six primary lineages in this archaeal phylum have thus far been described. These organisms are predicted to be fermentative organoheterotrophs contributing to carbon cycling in sediment ecosystems. Here, we double the genomic catalogue of Asgardarchaeota by obtaining 71 MAGs from a range of habitats around the globe, including deep subsurface, shallow lake, and geothermal spring sediments. Phylogenomic inferences followed by taxonomic rank normalisation confirmed previously established Asgardarchaeota classes and revealed four novel lineages, two of which were consistently recovered as monophyletic classes. We therefore propose the names <jats:italic>Candidatus</jats:italic> Hodarchaeia class nov. and <jats:italic>Cand.</jats:italic> Jordarchaeia class nov., derived from the gods Hod and Jord in Norse mythology. Metabolic inference suggests that both novel classes represent methylotrophic acetogens, encoding the transfer of methyl groups, such as methylated amines, to coenzyme M with acetate as the end product in remnants of a methanogen-derived core metabolism. This inferred mode of energy conservation is predicted to be enhanced by genetic code expansions, i.e. recoding, allowing the incorporation of the rare 21st and 22nd amino acids selenocysteine (Sec) and pyrrolysine (Pyl). We found Sec recoding in Jordarchaeia and all other Asgardarchaeota classes, which likely benefit from increased catalytic activities of Sec-containing enzymes. Pyl recoding on the other hand is restricted to Hodarchaeia in the Asgardarchaeota, making it the first reported non-methanogenic lineage with an inferred complete Pyl machinery, likely providing this class with an efficient mechanism for methylamine utilisation. Furthermore, we identified enzymes for the biosynthesis of ester-type lipids, characteristic of Bacteria and Eukaryotes, in both novel classes, supporting the hypothesis that mixed ether-ester lipids are a shared feature among Asgardarchaeota.</jats:p>",2021-02-19
134,10.1101/2021.04.19.21255768,18,medRxiv,Infectious Diseases (except HIV/AIDS),True,Pharmacovigilance Analysis on Cerebrovascular Accidents and Coronavirus disease 2019 Vaccines,"[{'given': 'Lt. Pushkar', 'family': 'Aggarwal', 'sequence': 'first', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Recently, there have been reports of cerebrovascular accidents (CVA) occurring in individuals who have received the Coronavirus disease 2019 (COVID-19) vaccine.</jats:p></jats:sec><jats:sec><jats:title>Objective</jats:title><jats:p>The objective of this analysis was to determine if a statistically significant signal exists in post-marketing safety reports between CVA and the three COVID-19 vaccines being administered in the United States of America (Pfizer, Moderna, Janssen).</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A pharmacovigilance disproportionality analysis on adverse events reported with COVID-19 vaccines was conducted using data from Vaccine Adverse Event Reporting System.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>A statistically significant signal was found between CVA events and each of the three COVID-19 vaccines (Pfizer/BioNTech’s, Moderna’s and Janssen’s) in the VAERS database. Females and individuals of age 65 or older had higher number of case reports of CVA events with the COVID-19 vaccines. Females had also more COVID-19 adverse event reports in which a CVA was reported and resulted in the patient having permanent disability or death.</jats:p></jats:sec><jats:sec><jats:title>Limitations</jats:title><jats:p>Randomized controlled trials are needed to further analyze this signal.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Patients should be made aware of the risk-benefit and symptoms to watch out for that may indicate the onset of a CVA and informed to seek medical care as soon as possible if they develop these symptoms.</jats:p></jats:sec>",2021-04-27
135,10.1101/2021.04.26.441462,17,bioRxiv,Neuroscience,False,Beta bursting in the retrosplenial cortex is a neurophysiological correlate of environmental novelty which is disrupted in a mouse model of Alzheimer’s disease,"[{'ORCID': 'http://orcid.org/0000-0002-4904-5600', 'authenticated-orcid': False, 'given': 'Callum', 'family': 'Walsh', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8236-9033', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Ridler', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria Garcia', 'family': 'Garrido', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9411-4022', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Witton', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8852-3671', 'authenticated-orcid': False, 'given': 'Andrew D.', 'family': 'Randall', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5269-7661', 'authenticated-orcid': False, 'given': 'Jonathan T.', 'family': 'Brown', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The retrosplenial cortex (RSC) plays a significant role in spatial learning and memory, and is functionally disrupted in the early stages of Alzheimer’s disease. In order to investigate neurophysiological correlates of spatial learning and memory in this region we employed <jats:italic>in vivo</jats:italic> electrophysiology in awake, behaving mice, comparing neural activity between wild-type and J20 mice, a mouse model of Alzheimer’s disease-associated amyloidopathy. To determine the response of the RSC to environmental novelty local field potentials were recorded while mice explored novel and familiar recording arenas. In familiar environments we detected short, phasic bursts of beta (20-30 Hz) oscillations (beta bursts) which arose at a low but steady rate. Exposure to a novel environment rapidly initiated a dramatic increase in the rate, size and duration of beta bursts. Additionally, theta-beta cross-frequency coupling was significantly higher during novelty, and spiking of neurons in the RSC was significantly enhanced during beta bursts. Finally, aberrant beta bursting was seen in J20 mice, including increased beta bursting during novelty and familiarity, yet a loss of coupling between beta bursts and spiking activity. These findings, support the concept that beta bursting may be responsible for the activation and reactivation of neuronal ensembles underpinning the formation and maintenance of cortical representations, and that disruptions to this activity in J20 mice may underlie cognitive impairments seen in these animals.</jats:p>",2021-04-27
136,10.1101/2021.04.10.21254672,17,medRxiv,Primary Care Research,True,Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial,"[{'name': 'PRINCIPLE Collaborative Group', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0331-7364', 'authenticated-orcid': False, 'given': 'Ly-Mee', 'family': 'Yu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9993-2478', 'authenticated-orcid': False, 'given': 'Mona', 'family': 'Bafadhel', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6072-1430', 'authenticated-orcid': False, 'given': 'Jienchi', 'family': 'Dorward', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0852-627X', 'authenticated-orcid': False, 'given': 'Gail', 'family': 'Hayward', 'sequence': 'additional', 'affiliation': []}, {'given': 'Benjamin R', 'family': 'Saville', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2963-4491', 'authenticated-orcid': False, 'given': 'Oghenekome', 'family': 'Gbinigie', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6229-5057', 'authenticated-orcid': False, 'given': 'Oliver', 'family': 'Van Hecke', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7643-572X', 'authenticated-orcid': False, 'given': 'Emma', 'family': 'Ogburn', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5277-3545', 'authenticated-orcid': False, 'given': 'Philip H', 'family': 'Evans', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0460-6870', 'authenticated-orcid': False, 'given': 'Nicholas PB', 'family': 'Thomas', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6703-3542', 'authenticated-orcid': False, 'given': 'Mahendra G', 'family': 'Patel', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8701-3258', 'authenticated-orcid': False, 'given': 'Nicholas', 'family': 'Berry', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2794-1439', 'authenticated-orcid': False, 'given': 'Michelle A.', 'family': 'Detry', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4325-9568', 'authenticated-orcid': False, 'given': 'Christina T.', 'family': 'Saunders', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8912-1663', 'authenticated-orcid': False, 'given': 'Mark', 'family': 'Fitzgerald', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3345-2826', 'authenticated-orcid': False, 'given': 'Victoria', 'family': 'Harris', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8553-2641', 'authenticated-orcid': False, 'given': 'Simon', 'family': 'de Lusignan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0619-1074', 'authenticated-orcid': False, 'given': 'Monique I', 'family': 'Andersson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peter J', 'family': 'Barnes', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3890-7201', 'authenticated-orcid': False, 'given': 'Richard EK', 'family': 'Russell', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7758-226X', 'authenticated-orcid': False, 'suffix': 'Jr.', 'given': 'Dan V', 'family': 'Nicolau', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3003-7918', 'authenticated-orcid': False, 'given': 'Sanjay', 'family': 'Ramakrishnan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7976-7172', 'authenticated-orcid': False, 'given': 'FD Richard', 'family': 'Hobbs', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0102-3453', 'authenticated-orcid': False, 'given': 'Christopher C', 'family': 'Butler', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>BACKGROUND</jats:title><jats:p>Inhaled budesonide has shown efficacy for treating COVID-19 in the community but has not yet been tested in effectiveness trials.</jats:p></jats:sec><jats:sec><jats:title>METHODS</jats:title><jats:p>We performed a multicenter, open-label, multi-arm, adaptive platform randomized controlled trial involving people aged ≥65 years, or ≥50 years with comorbidities, and unwell ≤14 days with suspected COVID-19 in the community (PRINCIPLE). Participants were randomized to usual care, usual care plus inhaled budesonide (800µg twice daily for 14 days), or usual care plus other interventions. The co-primary endpoints are time to first self-reported recovery, and hospitalization/death related to COVID-19, both measured over 28 days from randomisation and analysed using Bayesian models.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>The trial opened on April 2, 2020. Randomization to inhaled budesonide began on November 27, 2020 and was stopped on March 31, 2021 based on an interim analysis using data from March 4, 2021. Here, we report updated interim analysis data from March 25, 2021, at which point the trial had randomized 4663 participants with suspected COVID-19. Of these, 2617 (56.1%) tested SARS-CoV-2 positive and contributed data to this interim budesonide primary analysis; 751 budesonide, 1028 usual care and 643 to other interventions. Time to first self-reported recovery was shorter in the budesonide group compared to usual care (hazard ratio 1.208 [95% BCI 1.076 – 1.356], probability of superiority 0.999, estimated benefit [95% BCI] of 3.011 [1.134 – 5.41] days). Among those in the interim budesonide primary analysis who had the opportunity to contribute data for 28 days follow up, there were 59/692 (8.5%) COVID-19 related hospitalizations/deaths in the budesonide group vs 100/968 (10.3%) in the usual care group (estimated percentage benefit, 2.1% [95% BCI −0.7% – 4.8%], probability of superiority 0.928).</jats:p></jats:sec><jats:sec><jats:title>CONCLUSIONS</jats:title><jats:p>In this updated interim analysis, inhaled budesonide reduced time to recovery by a median of 3 days in people with COVID-19 with risk factors for adverse outcomes. Once 28 day follow up is complete for all participants randomized to budesonide, final analyses of time to recovery and hospitalization/death will be published. (Funded by the National Institute of Health Research/ United Kingdom Research Innovation [MC_PC_19079]; PRINCIPLE ISRCTN number, <jats:underline>ISRCTN86534580</jats:underline>.)</jats:p></jats:sec>",2021-04-12
137,10.1101/2021.03.02.21252750,17,medRxiv,Infectious Diseases (except HIV/AIDS),True,SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection,"[{'ORCID': 'http://orcid.org/0000-0002-3192-7840', 'authenticated-orcid': False, 'given': 'Manish C.', 'family': 'Choudhary', 'sequence': 'first', 'affiliation': []}, {'given': 'Charles R.', 'family': 'Crain', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xueting', 'family': 'Qiu', 'sequence': 'additional', 'affiliation': []}, {'given': 'William', 'family': 'Hanage', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jonathan Z.', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Both SARS-CoV-2 reinfection and persistent infection have been reported, but sequence characteristics in these scenarios have not been described. We assessed published cases of SARS-CoV-2 reinfection and persistence, characterizing the hallmarks of reinfecting sequences and the rate of viral evolution in persistent infection.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>A systematic review of PubMed was conducted to identify cases of SARS-CoV-2 reinfection and persistence with available sequences. Nucleotide and amino acid changes in the reinfecting sequence were compared to both the initial and contemporaneous community variants. Time-measured phylogenetic reconstruction was performed to compare intra-host viral evolution in persistent SARS-CoV-2 to community-driven evolution.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Twenty reinfection and nine persistent infection cases were identified. Reports of reinfection cases spanned a broad distribution of ages, baseline health status, reinfection severity, and occurred as early as 1.5 months or &gt;8 months after the initial infection. The reinfecting viral sequences had a median of 17.5 nucleotide changes with enrichment in the ORF8 and N genes. The number of changes did not differ by the severity of reinfection and reinfecting variants were similar to the contemporaneous sequences circulating in the community. Patients with persistent COVID-19 demonstrated more rapid accumulation of sequence changes than seen with community-driven evolution with continued evolution during convalescent plasma or monoclonal antibody treatment.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Reinfecting SARS-CoV-2 viral genomes largely mirror contemporaneous circulating sequences in that geographic region, while persistent COVID-19 has been largely described in immunosuppressed individuals and is associated with accelerated viral evolution.</jats:p></jats:sec><jats:sec><jats:title>Summary</jats:title><jats:p>Reinfecting SARS-CoV-2 viral genomes largely mirror contemporaneous circulating sequences in that geographic region, while persistent COVID-19 has been largely described in immunosuppressed individuals and is associated with accelerated viral evolution.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>This study was funded in part by the NIH grant 106701.</jats:p></jats:sec><jats:sec><jats:title>Disclosures</jats:title><jats:p>Dr. Li has consulted for Abbvie.</jats:p></jats:sec>",2021-03-03
138,10.1101/2021.04.21.21255862,17,medRxiv,Health Informatics,False,A Generalizable Data Assembly Algorithm for Infectious Disease Outbreaks,"[{'given': 'Maimuna S.', 'family': 'Majumder', 'sequence': 'first', 'affiliation': []}, {'given': 'Sherri', 'family': 'Rose', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background &amp; Objective</jats:title><jats:p>During infectious disease outbreaks, health agencies often share text-based information about cases and deaths. This information is usually text-based and rarely machine-readable, thus creating challenges for outbreak researchers. Here, we introduce a generalizable data assembly algorithm that automatically curates text-based, outbreak-related information and demonstrate its performance across three outbreaks.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>After developing an algorithm with regular expressions, we automatically curated data from health agencies via three information sources: formal reports, email newsletters, and Twitter. A validation data set was also curated manually for each outbreak.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>When compared against the validation data sets, the overall cumulative missingness and misidentification of the algorithmically curated data were ≤2% and ≤1%, respectively, for all three outbreaks.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Within the context of outbreak research, our work successfully addresses the need for generalizable tools that can transform text-based information into machine-readable data across varied information sources and infectious diseases.</jats:p></jats:sec>",2021-04-27
139,10.1101/2020.04.28.065714,17,bioRxiv,Bioinformatics,False,Reference-based QUantification Of gene Dispensability (QUOD),"[{'ORCID': 'http://orcid.org/0000-0002-4022-8531', 'authenticated-orcid': False, 'given': 'Katharina', 'family': 'Sielemann', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7635-3473', 'authenticated-orcid': False, 'given': 'Bernd', 'family': 'Weisshaar', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3321-7471', 'authenticated-orcid': False, 'given': 'Boas', 'family': 'Pucker', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Dispensability of genes in a phylogenetic lineage, e.g. a species, genus, or higher-level clade, is gaining relevance as most genome sequencing projects move to a pangenome level. Most analyses classify genes as core genes, which are present in all investigated individual genomes, and dispensable genes, which only occur in a single or a few investigated genomes. The binary classification as ‘core’ or ‘dispensable’ is often based on arbitrary cutoffs of presence/absence in the analysed genomes. Even when extended to ‘conditionally dispensable’, this concept still requires the assignment of genes to distinct groups.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Here, we present a new method which overcomes this distinct classification by quantifying gene dispensability and present a dedicated tool for reference-based QUantification Of gene Dispensability (QUOD). As a proof of concept, sequence data of 966 <jats:italic>Arabidopsis thaliana</jats:italic> accessions (Ath-966) were processed to calculate a gene-specific dispensability score for each gene based on normalised coverage in read mappings. We validated this score by comparison of highly conserved Benchmarking Universal Single Copy Orthologs (BUSCOs) to all other genes. The average scores of BUSCOs were significantly lower than the scores of non-BUSCOs. Analysis of variation demonstrated lower variation values between replicates of a single accession than between iteratively, randomly selected accessions from the whole dataset Ath-966. Functional investigations revealed defense and antimicrobial response genes among the genes with high-dispensability scores.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Instead of classifying a gene as core or dispensable, QUOD assigns a dispensability score to each gene. Hence, QUOD facilitates the identification of candidate dispensable genes, associated with high dispensability scores, which often underlie lineage-specific adaptation to varying environmental conditions.</jats:p></jats:sec>",2020-04-29
140,10.1101/2020.07.02.185223,17,bioRxiv,Evolutionary Biology,False,Optimal evolutionary decision-making to store immune memory,"[{'given': 'Oskar H', 'family': 'Schnaack', 'sequence': 'first', 'affiliation': []}, {'given': 'Armita', 'family': 'Nourmohammad', 'sequence': 'additional', 'affiliation': []}]","<jats:p>The adaptive immune system provides a diverse set of molecules that can mount specific responses against a multitude of pathogens. Memory is a key feature of adaptive immunity, which allows organisms to respond more readily upon re-infections. However, differentiation of memory cells is still one of the least understood cell fate decisions. Here, we introduce a mathematical framework to characterize optimal strategies to store memory to maximize the utility of immune response over an organism’s lifetime. We show that memory production should be actively regulated to balance between affinity and cross-reactivity of immune receptors for an effective protection against evolving pathogens. Moreover, we predict that specificity of memory should depend on the organism’s lifespan, and shorter-lived organisms with fewer pathogenic encounters should store more cross-reactive memory. Our framework provides a baseline to gauge the efficacy of immune memory in light of an organism’s coevolutionary history with pathogens.</jats:p>",2020-07-03
141,10.1101/2021.04.27.441645,17,bioRxiv,Biophysics,False,Molecular mechanism of proton-coupled ligand translocation by the bacterial efflux pump EmrE,"[{'given': 'Jakub', 'family': 'Jurasz', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3639-6935', 'authenticated-orcid': False, 'given': 'Jacek', 'family': 'Czub', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6795-7515', 'authenticated-orcid': False, 'given': 'Maciej', 'family': 'Bagiński', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4990-8629', 'authenticated-orcid': False, 'given': 'Miłosz', 'family': 'Wieczór', 'sequence': 'additional', 'affiliation': []}]","<jats:title>A<jats:sc>bstract</jats:sc></jats:title><jats:p>The current surge in bacterial multi-drug resistance (MDR) is one of the largest challenges to public health, threatening to render ineffective many therapies we rely on for treatment of serious infections. Understanding different factors that contribute to MDR is hence crucial from the global “one health” perspective. In this contribution, we focus on the prototypical broad-selectivity proton-coupled antiporter EmrE, one of the smallest known ligand transporters that confers resistance to aromatic cations in a number of clinically relevant species. As an asymmetric homodimer undergoing an “alternating access” protomer-swap conformational change, it serves as a model for the mechanistic understanding of more complex drug transporters. Here, we present a free energy and solvent accessibility analysis that indicates the presence of two complementary ligand translocation pathways that remain operative in a broad range of conditions. Our simulations show a previously undescribed desolvated apo state and anticorrelated accessibility in the ligand-bound state, explaining on a structural level why EmrE does not disrupt the pH gradient through futile proton transfer. By comparing the behavior of a number of model charged and/or aromatic ligands, we also explain the origin of selectivity of EmrE towards a broad class of aromatic cations. Finally, we explore unbiased pathways of ligand entry and exit to identify correlated structural changes implicated in ligand binding and release, as well as characterize key intermediates of occupancy changes.</jats:p>",2021-04-27
142,10.1101/2020.11.02.365700,17,bioRxiv,Evolutionary Biology,False,"The evolution of latitudinal ranges in reef-associated fishes: heritability, limits, and inverse Rapoport's rule","[{'ORCID': 'http://orcid.org/0000-0002-2949-4871', 'authenticated-orcid': False, 'given': 'Marcio R.', 'family': 'Pie', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9709-6154', 'authenticated-orcid': False, 'given': 'Raquel', 'family': 'Divieso', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1884-6157', 'authenticated-orcid': False, 'given': 'Fernanda de Souza', 'family': 'Caron', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7970-4024', 'authenticated-orcid': False, 'given': 'Alexandre', 'family': 'Siqueira', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4568-2362', 'authenticated-orcid': False, 'given': 'Diego', 'family': 'Barneche', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6995-6524', 'authenticated-orcid': False, 'given': 'Osmar', 'family': 'Luiz', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Aim: Variation in the size and position of geographical ranges is a key variable that underlies most biogeographical patterns. However, relatively little is known in terms of general principles driving their evolution, particularly in the marine realm. In this study we explore several fundamental properties regarding the evolution of reef fish latitudinal ranges, namely the degree of similarity in range size between ancestor and descendant lineages (i.e. phylogenetic signal); the evolution of range limits; and the latitudinal distribution of range sizes, particularly with respect to Rapoport's rule. Location: Global. Taxon: Reef-associated fishes. Methods: We integrate data on the latitudinal distribution and evolutionary history of 5,071 reef fish species with phylogenetic comparative methods to assess the level of phylogenetic signal in latitudinal range size, low- and high-latitude limits, and range midpoints, and to estimate rates of evolution of those traits. Finally, we test whether latitudinal ranges become smaller near the equator, as predicted by Rapoport's rule, using phylogenetic generalized least squares. Results: There were varying levels of phylogenetic signal in latitudinal range size, low- and high-latitude limits, and range midpoints. Despite these differences, latitudinal midpoints were consistently shown to have the highest phylogenetic signal among all measured geographic features. Interestingly, the position of high-latitude limits in general evolved at substantially faster rates than their low-latitude counterparts. Finally, we confirm for the first time the existence of an inverse Rapoport's rule in reef-associated fishes using phylogenetic comparative methods. Indeed, mean latitudinal range size of tropical species is nearly twice the size of their temperate counterparts (2067+-1431 km vs. 1168+-725 km, respectively). Main conclusions: We uncovered several congruent patterns in phylogenetic signal and rates of evolution of latitudinal ranges, despite vastly disparate biogeographical distributions and ecological differences between the studied fish lineages. Such broad congruence across different taxa and oceans, as well as with previous data from terrestrial environments, suggests that the observed patterns might represent general principles governing geographical range evolution.</jats:p>",2020-11-04
143,10.1101/2021.04.22.441012,17,bioRxiv,Neuroscience,False,Flexible use of memory by food-caching birds in a laboratory behavioral paradigm,"[{'given': 'Marissa C.', 'family': 'Applegate', 'sequence': 'first', 'affiliation': []}, {'given': 'Dmitriy', 'family': 'Aronov', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary</jats:title><jats:p>Memory is used by animals to influence navigational decisions, and neural activity in memory-related brain regions correlates to spatial variables. However, navigation is a rich behavior that contains a mix of memory-guided and memory-independent strategies. Disentangling the contribution of these strategies to navigation is therefore critical for understanding how memory influences behavioral output. To address this issue, we studied the natural spatial behavior of the chickadee, a food-caching bird. These birds hide food items at concealed, scattered locations and retrieve their caches later in time. We designed an apparatus that allows chickadees to cache and retrieve food while navigating in a laboratory arena. This apparatus enabled detailed, automated, and high-throughput tracking of key behavioral variables – including caches, retrievals, and investigations of cache sites. We built probabilistic models to fit these behavioral data using a combination of various mnemonic and non-mnemonic factors. We find that chickadees use some navigational strategies that are independent of cache memories, including opportunistic foraging and spatial biases. They combine these strategies with spatially precise and long-lasting memories of which sites contain caches and which sites they have previously checked and found to be empty. These memories are used in a context-dependent manner. During caching, chickadees avoid sites that already contain food. During retrieval, they are instead attracted to such occupied sites. These results show that a single memory can be used flexibly by a chickadee to achieve at least two unrelated behavioral goals. Our apparatus enables studying this flexibility in a tractable spatial paradigm.</jats:p>",2021-04-23
144,10.1101/2021.04.28.441797,17,bioRxiv,Microbiology,True,Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.,"[{'ORCID': 'http://orcid.org/0000-0002-1260-2493', 'authenticated-orcid': False, 'given': 'Raveen', 'family': 'Rathnasinghe', 'sequence': 'first', 'affiliation': []}, {'given': 'Mirella', 'family': 'Salvatore', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hongyong', 'family': 'Zheng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sonia', 'family': 'Jangra', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Kehrer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ignacio', 'family': 'Mena', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael', 'family': 'Schotsaert', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomus', 'family': 'Muster', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peter', 'family': 'Palese', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adolfo', 'family': 'Garcia-Sastre', 'sequence': 'additional', 'affiliation': []}]","<jats:p>The influenza A non-structural protein 1 (NS1) is known for its ability to hinder the synthesis of type I interferon (IFN) during viral infection. Influenza viruses lacking NS1 (ΔNS1) are under clinical development as live attenuated human influenza virus vaccines and induce potent influenza virus-specific humoral and cellular adaptive immune responses. Attenuation of ΔNS1 influenza viruses is due to their high IFN inducing properties, that limit their replication in vivo.  This study demonstrates that pre-treatment with a ΔNS1 virus results in an immediate antiviral state which prevents subsequent replication of homologous and heterologous viruses, preventing disease from virus respiratory pathogens, including SARS-CoV-2. Our studies suggest that ΔNS1 influenza viruses could be used for the prophylaxis of influenza, SARS-CoV-2 and other human respiratory viral infections, and that an influenza virus vaccine based on ΔNS1 live attenuated viruses would confer broad protection against influenza virus infection from the moment of administration, first by non-specific innate immune induction, followed by specific adaptive immunity.</jats:p>",2021-04-28
145,10.1101/2021.04.14.439877,17,bioRxiv,Neuroscience,False,The Instability of Functional Connectomes Across the First Year of Life,"[{'given': 'Alexander J.', 'family': 'Dufford', 'sequence': 'first', 'affiliation': []}, {'given': 'Stephanie', 'family': 'Noble', 'sequence': 'additional', 'affiliation': []}, {'given': 'Siyuan', 'family': 'Gao', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dustin', 'family': 'Scheinost', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The uniqueness and stability of the adolescent and adult functional connectome has been demonstrated to be high (80–95% identification) using connectome-based identification (ID) or “fingerprinting”. However, it is unclear to what extent individuals exhibit similar distinctiveness and stability in infancy, a developmental period of rapid and unparalleled brain development. In this study, we examined connectome-based ID rates within and across the first year of life using a longitudinal infant dataset at 1 month and 9 months of age. We also calculated the test–retest reliability of individual connections across the first year of life using the intraclass correlation coefficient (ICC). Overall, we found substantially lower infant ID rates than have been reported in adult and adolescent populations. Within-session ID rates were moderate and significant (ID = 48.94–70.83%). Between-session ID rates were very low and not significant, with task-to-task connectomes resulting in the highest between-session ID rate (ID = 26.6%). Similarly, average edge-level test-retest reliability was higher within-session than between-session (mean within-session ICC = 0.17, mean between-session ICC = 0.10). These findings suggest a lack of uniqueness and stability in functional connectomes across the first year of life consistent with the unparalleled changes in brain functional organization during this critical period.</jats:p>",2021-04-14
146,10.1101/2021.04.26.441371,16,bioRxiv,Cancer Biology,False,Therapeutic targeting of SLC6A8 creatine transporter inhibits KRAS mutant and wildtype colon cancer and modulates human creatine levels,"[{'ORCID': 'http://orcid.org/0000-0003-0607-0467', 'authenticated-orcid': False, 'given': 'Isabel', 'family': 'Kurth', 'sequence': 'first', 'affiliation': []}, {'given': 'Norihiro', 'family': 'Yamaguchi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Celia', 'family': 'Andreu-Agullo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Helen S.', 'family': 'Tian', 'sequence': 'additional', 'affiliation': []}, {'given': 'Subhasree', 'family': 'Sridhar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shugaku', 'family': 'Takeda', 'sequence': 'additional', 'affiliation': []}, {'given': 'Foster C.', 'family': 'Gonsalves', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jia Min', 'family': 'Loo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Afsar', 'family': 'Barlas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katia', 'family': 'Manova-Todorova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robert', 'family': 'Busby', 'sequence': 'additional', 'affiliation': []}, {'given': 'Johanna C.', 'family': 'Bendell', 'sequence': 'additional', 'affiliation': []}, {'given': 'James', 'family': 'Strauss', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marwan', 'family': 'Fakih', 'sequence': 'additional', 'affiliation': []}, {'given': 'Autumn J.', 'family': 'McRee', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew E.', 'family': 'Hendifar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lee S.', 'family': 'Rosen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrea', 'family': 'Cercek', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robert', 'family': 'Wasserman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Scott L.', 'family': 'Spector', 'sequence': 'additional', 'affiliation': []}, {'given': 'Syed', 'family': 'Raza', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5013-0466', 'authenticated-orcid': False, 'given': 'Masoud F.', 'family': 'Tavazoie', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4966-9018', 'authenticated-orcid': False, 'given': 'Sohail F.', 'family': 'Tavazoie', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Colorectal cancer (CRC) is a leading cause of cancer mortality. Creatine metabolism was previously shown to critically regulate colon cancer progression. We report that RGX-202, an oral small-molecule SLC6A8 creatine transporter inhibitor, robustly inhibits creatine import in vitro and in vivo, reduces intracellular phosphocreatine and ATP levels and induces tumor cell apoptosis in CRC. RGX-202 suppressed tumor growth across KRAS wild-type and KRAS mutant xenograft, syngeneic and patient-derived xenograft colorectal cancers. Anti-tumor efficacy correlated with tumoral expression of creatine kinase B. Combining RGX-202 with 5- fluorouracil or the DHODH inhibitor leflunomide caused regressions of multiple colorectal xenograft and PDX tumors of distinct mutational backgrounds. RGX-202 also perturbed creatine metabolism in metastatic CRC patients enrolled in a Phase-1 trial, mirroring pharmacodynamic effects on creatine metabolism observed in mice. This is, to our knowledge, the first demonstration of pre-clinical and human pharmacodynamic activity for creatine metabolism targeting in oncology, revealing a critical target for CRC.</jats:p>",2021-04-26
147,10.1101/2020.12.22.20248753,16,medRxiv,Infectious Diseases (except HIV/AIDS),True,Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: the ACHIEVE open-label trial,"[{'given': 'Konstantinos', 'family': 'Tsiakos', 'sequence': 'first', 'affiliation': []}, {'given': 'Antonios', 'family': 'Tsakiris', 'sequence': 'additional', 'affiliation': []}, {'given': 'Georgios', 'family': 'Tsibris', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pantazis', 'family': 'Voutsinas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Periklis', 'family': 'Panagopoulos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria', 'family': 'Kosmidou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vasileios', 'family': 'Petrakis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Areti', 'family': 'Gravvani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Theologia', 'family': 'Gkavogianni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eleftherios', 'family': 'Klouras', 'sequence': 'additional', 'affiliation': []}, {'given': 'Konstantina', 'family': 'Katrini', 'sequence': 'additional', 'affiliation': []}, {'given': 'Panagiotis', 'family': 'Koufargyris', 'sequence': 'additional', 'affiliation': []}, {'given': 'Iro', 'family': 'Rapti', 'sequence': 'additional', 'affiliation': []}, {'given': 'Athanassios', 'family': 'Karageorgos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Emmanouil', 'family': 'Vrentzos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christina', 'family': 'Damoulari', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vagia', 'family': 'Zarkada', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chrysanthi', 'family': 'Sidiropoulou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sofia', 'family': 'Artemi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anastasios', 'family': 'Ioannidis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Androniki', 'family': 'Papapostolou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Evangelos', 'family': 'Michelakis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria', 'family': 'Georgiopoulou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dimitra-Melia', 'family': 'Myrodia', 'sequence': 'additional', 'affiliation': []}, {'given': 'Panteleimon', 'family': 'Tsiamalos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Konstantinos', 'family': 'Syrigos', 'sequence': 'additional', 'affiliation': []}, {'given': 'George', 'family': 'Chrysos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Nitsotolis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Haralampos', 'family': 'Milionis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Garyphallia', 'family': 'Poulakou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Evangelos J.', 'family': 'Giamarellos-Bourboulis', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>To study the efficacy of oral clarithromycin in moderate COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>An open-label non-randomized trial in 90 patients with COVID-19 of moderate severity was conducted between May and October 2020. The primary endpoint was defined at the end-of-treatment (EOT) as no need for hospital re-admission and no progression into lower respiratory tract infection (LRTI) for patients with upper respiratory tract infection; and as at least 50% decrease of the respiratory symptoms score the without progression into severe respiratory failure (SRF) for patients with LRTI. Viral load, biomarkers, the function of mononuclear cells, and safety were assessed.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The primary endpoint was attained in 86.7% of patients treated with clarithromycin (95% CIs 78.1-92.2%); this was 91.7% and 81.4% among patients starting clarithromycin the first 5 days from symptoms onset or later (odds ratio after multivariate analysis 6.62; p: 0.030). The responses were better for patients infected by non-B1.1 variants. Clarithromycin use was associated with decreases in circulating C-reactive protein, tumour necrosis factor-alpha and interleukin (IL)-6; by increase of Th1 to Th2 mononuclear responses; and by suppression of SARS-CoV-2 viral load. No safety concerns were reported.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Early clarithromycin treatment provides most of clinical improvement in moderate COVID-19 (<jats:bold>Trial Registration:</jats:bold> ClinicalTrials.gov, <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""clintrialgov"" xlink:href=""NCT04398004"">NCT04398004</jats:ext-link>)</jats:p></jats:sec>",2020-12-26
148,10.1101/2020.12.15.20248267,16,medRxiv,Psychiatry and Clinical Psychology,False,Clinician perspectives on what constitutes good practice in community services for people with Complex Emotional Needs: A qualitative thematic meta-synthesis,"[{'ORCID': 'http://orcid.org/0000-0002-1115-5185', 'authenticated-orcid': False, 'given': 'Jordan', 'family': 'Troup', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6865-3425', 'authenticated-orcid': False, 'given': 'Billie', 'family': 'Lever-Taylor', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4905-4168', 'authenticated-orcid': False, 'given': 'Luke', 'family': 'Sheridan Rains', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eva', 'family': 'Broeckelmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jessica', 'family': 'Russell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tamar', 'family': 'Jeynes', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0864-5607', 'authenticated-orcid': False, 'given': 'Chris', 'family': 'Cooper', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3881-2018', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Steare', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zainab', 'family': 'Dedat', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shirley', 'family': 'McNicholas', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8704-0379', 'authenticated-orcid': False, 'given': 'Sian', 'family': 'Oram', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2724-4326', 'authenticated-orcid': False, 'given': 'Oliver', 'family': 'Dale', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2219-1384', 'authenticated-orcid': False, 'given': 'Sonia', 'family': 'Johnson', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Introduction 
The need to improve the quality of community mental health services for people with Complex Emotional Needs (CEN) is recognised internationally and has become a renewed policy priority in England. Such improvement requires positive engagement from clinicians across the service system, and their perspectives on achieving good practice need to be understood. 

Aim
To synthesise qualitative evidence on clinician perspectives on what constitutes good practice, and what helps or prevents it being achieved, in community mental health services for people with CEN.

Methods
Six bibliographic databases were searched for studies published since 2003 and supplementary citation tracking was conducted. Studies that used any recognised qualitative method and reported clinician experiences and perspectives on community-based mental health services for adults with CEN were eligible for this review, including generic and specialist settings. Meta-synthesis was used to generate and synthesise over-arching themes across included studies. 

Results
Twenty-nine papers were eligible for inclusion. Six over-arching themes were identified: 1. The use and misuse of diagnosis; 2. The patient journey into services: nowhere to go; 3. Therapeutic relationships: connection and distance; 4. The nature of treatment: not doing too much or too little; 5. Managing safety issues and crises: being measured and proactive; 6. Clinician and wider service needs: whose needs are they anyway? The overall quality of the evidence was moderate.

Discussion
Through summarising the literature on clinician perspectives on good practice for people with CEN, over-arching priorities were identified on which there appears to be substantial consensus. In their focus on needs such as for a long-term perspective on treatment journeys, high quality and consistent therapeutic relationships, and a balanced approach to safety, clinician priorities are mainly congruent with those found in studies on service user views. They also identify clinician needs that should be met for good care to be provided, including for supervision, joint working and organisational support.</jats:p>",2020-12-16
149,10.1101/2021.04.15.440019,16,bioRxiv,Ecology,False,Eliminating Animal Agriculture Would Negate 56 Percent of Anthropogenic Greenhouse Gas Emissions Through 2100,"[{'ORCID': 'http://orcid.org/0000-0002-7528-738X', 'authenticated-orcid': False, 'given': 'Michael B.', 'family': 'Eisen', 'sequence': 'first', 'affiliation': []}, {'given': 'Patrick O.', 'family': 'Brown', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>We used public data on greenhouse-gas emissions and land use to evaluate the potential impact of eliminating animal agriculture on atmospheric greenhouse gas levels, and global warming potential. We first updated estimates of carbon dioxide, methane, and nitrous oxide emissions from livestock and livestock feed production. We used these data, along with recent estimates of the atmospheric carbon dioxide that could be converted by photosynthesis into perennial biomass on land currently engaged in animal agriculture, to develop models of net anthropogenic emissions under food-system scenarios ranging from “business as usual” to the complete elimination of animal agriculture. We then used simple simulations to project atmospheric levels of these three gases through the end of the century under each scenario. Using cumulative differences in radiative forcing as a measure of the impact of different diets, we found that a gradual transition over the next 15 years to a plant-only diet would have the same effect through the rest of the century as an annual reduction of 28 Gt of CO<jats:sub>2</jats:sub> emissions. This would effectively negate 56 percent of global emissions at the current rate of 50 Gt CO<jats:sub>2</jats:sub>eq per year, with a net negation of 2,200 gigatonnes of CO<jats:sub>2</jats:sub> emissions by the year 2100. The climate benefits would accrue rapidly - most in the first few decades, effectively pausing greenhouse-gas accumulation for 30 years. These results establish the magnitude and the timescale of the positive climate impact that would accrue from eliminating, or significantly reducing, the emissions and land footprints of animal agriculture. How to orchestrate the dietary and agricultural shifts needed to accomplish this in a way that maximizes the beneficial environmental, public health, food security, economic and social consequences and minimizes potential harms should therefore be at the center of climate policy discussions.</jats:p>",2021-04-15
150,10.1101/2021.04.27.441449,16,bioRxiv,Microbiology,False,Endophytic microbiome variation at the level of a single plant seed,"[{'given': 'AF', 'family': 'Bintarti', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6505-5617', 'authenticated-orcid': False, 'given': 'A', 'family': 'Sulesky-Grieb', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1532-6826', 'authenticated-orcid': False, 'given': 'N', 'family': 'Stopnisek', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7189-3067', 'authenticated-orcid': False, 'given': 'A', 'family': 'Shade', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Like other plant compartments, the seed harbors a microbiome. The members of the seed microbiome are the first to colonize a germinating seedling, and they initiate the trajectory of microbiome assembly for the next plant generation. Therefore, the members of the seed microbiome are important for the dynamics of plant microbiome assembly and the vertical transmission of potentially beneficial symbionts. However, it remains challenging to assess the microbiome at the individual seed level (and, therefore, for the future individual plant) due to low endophytic microbial biomass, seed exudates that can select for particular members, and high plant and plastid contamination of resulting reads. Here, we report a protocol for extracting metagenomic DNA from an individual seed (common bean, <jats:italic>Phaseolus vulgaris</jats:italic> L.) with minimal disruption of host tissue, which we expect to be generalizable to other medium-and large-seed plant species. We applied this protocol to quantify the 16S rRNA V4 and ITS2 amplicon composition and variability for individual seeds harvested from replicate common bean plants grown under standard, controlled conditions to maintain health. Using metagenomic DNA extractions from individual seeds, we compared seed-to-seed, pod-to-pod, and plant-to-plant microbiomes, and found highest microbiome variability at the plant level. This suggests that several seeds from the same plant could be pooled for microbiome assessment, given experimental designs that apply treatments at the maternal plant level. This study adds protocols and insights to the growing toolkit of approaches to understand the plant-microbiome engagements that support the health of agricultural and environmental ecosystems.</jats:p>",2021-04-27
151,10.1101/2021.02.28.21250921,15,medRxiv,Epidemiology,True,SARS-CoV-2 infection in households with and without young children: Nationwide cohort study,"[{'ORCID': 'http://orcid.org/0000-0002-7634-8455', 'authenticated-orcid': False, 'given': 'Anders', 'family': 'Husby', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2858-1746', 'authenticated-orcid': False, 'given': 'Giulia', 'family': 'Corn', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6286-5999', 'authenticated-orcid': False, 'given': 'Tyra Grove', 'family': 'Krause', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Infections with seasonally spreading human coronaviruses (HCoVs) are common among young children during winter months in the northern hemisphere, with immunological response lasting around a year. However, it is not clear whether recent household exposure to HCoVs reduces the risk of SARS-CoV-2 infection.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>In a nationwide cohort study we followed all adults in Denmark aged 18 to 60 years from February 27 to November 15, 2020. Hazard ratios of SARS-CoV-2 infection by number of young children aged ten months to five years living in the household were estimated using Cox regression adjusted for adult age, gender, and other potential confounders. In sensitivity analyses we investigated the effect of age of children in the household, number of children living outside of the household, and number of other adult household-members.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Among 449,915 adults in Denmark living in households with young children, 5,761 were tested positive for SARS-CoV-2, while among 2,629,821 adults without young children in their household, 33,788 were tested positive for SARS-CoV-2 (adjusted hazard ratio, 1.05; 95% confidence interval, 1.02 to 1.09). Sensitivity analyses of age of children in the household, number of children living outside of the household, and number of additional adult household members found increasing number of children, and especially increasing number of older children, to substantially increase the risk of SARS-CoV-2 infection.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Living in a household with young children was not associated with decreased risk of SARS-CoV-2 infection, thereby suggesting no strong preventive effect of recent exposure to HCoVs against SARS-CoV-2 infection.</jats:p></jats:sec>",2021-03-02
152,10.1101/2021.04.19.21255720,15,medRxiv,Infectious Diseases (except HIV/AIDS),True,SARS-CoV-2 natural antibody response persists up to 12 months in a nationwide study from the Faroe Islands,"[{'ORCID': 'http://orcid.org/0000-0001-9404-8440', 'authenticated-orcid': False, 'given': 'Maria Skaalum', 'family': 'Petersen', 'sequence': 'first', 'affiliation': []}, {'given': 'Cecilie Bo', 'family': 'Hansen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marnar Fríðheim', 'family': 'Kristiansen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jógvan Páll', 'family': 'Fjallsbak', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sólrun', 'family': 'Larsen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jóhanna Ljósá', 'family': 'Hansen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ida', 'family': 'Jarlhelt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Pérez-Alós', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bjarni', 'family': 'á Steig', 'sequence': 'additional', 'affiliation': []}, {'given': 'Debes Hammershaimb', 'family': 'Christiansen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lars Fodgaard', 'family': 'Møller', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marin', 'family': 'Strøm', 'sequence': 'additional', 'affiliation': []}, {'given': 'Guðrið', 'family': 'Andorsdóttir', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shahin', 'family': 'Gaini', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pál', 'family': 'Weihe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peter', 'family': 'Garred', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Only a few studies have assessed the long-term duration of the humoral immune response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</jats:p><jats:p>In this nationwide longitudinal study from the Faroe Islands with close to full participation of all individuals on the Islands with PCR confirmed COVID-19 during the two waves of infections in the spring and autumn 2020 (n=172 &amp; n=233), samples were drawn at three longitudinal time points (3, 7 and 12 months and 1, 3 and 7 months after disease onset, respectively).</jats:p><jats:p>Serum was analyzed with a direct quantitative IgG antibody binding ELISA to detect anti–SARS-CoV-2 spike RBD antibodies and a commercially available qualitative sandwich RBD ELISA kit measuring total antibody binding.</jats:p><jats:p>The seropositive rate in the convalescent individuals was above 95 % at all sampling time points for both assays. There was an overall decline in IgG titers over time in both waves (p &lt; 0.001). Pairwise comparison showed that IgG declined significantly from the first sample until approximately 7 months in both waves (p &lt; 0.001). After that, the antibody level still declined significantly (p &lt; 0.001), but decelerated with an altered slope remaining fairly stable from 7 months to 12 months after infection. Interestingly, the IgG titers followed a U-shaped curve with higher antibody levels among the oldest (67+) and the youngest (0– 17) age groups compared to intermediate groups (p &lt; 0.001).</jats:p><jats:p>Our results indicate that COVID-19 convalescent individuals are likely to be protected from reinfection at least 12 months after symptom onset and maybe even longer. We believe our results can add to the understanding of natural immunity and the expected durability of SARS-CoV-2 vaccine immune responses.</jats:p>",2021-04-22
153,10.1101/2021.04.21.21255878,15,medRxiv,Health Policy,True,Addressing racial/ethnic disparities in the COVID-19 vaccination campaign,"[{'ORCID': 'http://orcid.org/0000-0001-7276-4876', 'authenticated-orcid': False, 'given': 'Marissa B.', 'family': 'Reitsma', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4007-5192', 'authenticated-orcid': False, 'given': 'Jeremy D.', 'family': 'Goldhaber-Fiebert', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joshua A.', 'family': 'Salomon', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>As of April 19, all adults aged 16 years and older are eligible for COVID-19 vaccination. Unequal vaccination rates across racial/ethnic groups may compound existing disparities in cases, hospitalizations, and deaths among Black, Indigenous, and Hispanic communities.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>From state websites, we extracted shares of people receiving ≥1 vaccine dose, stratified by age and separately by race/ethnicity, through March 31, 2021. Combining these data with demographic data from the American Community Survey, we estimated relative uptake rates by race/ethnicity within each state as the observed share of vaccinations for a racial/ethnic group, divided by the expected share if uptake across racial/ethnic groups within each age group were proportional to population size, an approach that allowed us to control for historical age-based eligibility. We modeled vaccination scale-up within each census tract in a state under three scenarios: 1) a scenario in which unequal uptake rates persist, 2) a scenario in which uptake rates are equalized across race/ethnicity groups over six weeks, and 3) a scenario in which uptake is equalized and states employ place-based allocation strategies that prioritizes disadvantaged census tracts.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>White adults received a disproportionate share of vaccinations compared to Black and Hispanic adults through March 31, 2021. Across states, relative uptake rates, adjusted for eligible population size, were a median 1.3 (IQR, 1.2-1.4) times higher for White compared to Black adults, and a median 1.4 (IQR, 1.2-1.8) times higher for White compared to Hispanic adults. Projecting vaccination coverage under persistence of current disparities in uptake, we found that Black and Hispanic populations would reach 75% coverage among adults almost one month later than White populations. In alternative scenarios, we found that interventions to equalize uptake rates across racial/ethnic groups could narrow but not erase these gaps, and that geographic targeting of vaccine doses to disadvantaged communities may be needed to produce a more equitable convergence of coverage by July.</jats:p></jats:sec><jats:sec><jats:title>Discussion</jats:title><jats:p>Interventions are urgently needed to eliminate disparities in COVID-19 vaccination rates. Eliminating access barriers and increasing vaccine confidence among marginalized populations can narrow gaps in coverage. Combining these interventions with place-based allocation strategies can accelerate vaccination in disadvantaged communities, who have borne a disproportionate burden from COVID-19.</jats:p></jats:sec>",2021-04-23
154,10.1101/2021.04.27.21255985,15,medRxiv,Respiratory Medicine,False,Music and Dance in respiratory disease management in Uganda: A qualitative study of patient and healthcare professional perspectives,"[{'ORCID': 'http://orcid.org/0000-0001-9614-3580', 'authenticated-orcid': False, 'given': 'Keir EJ', 'family': 'Philip', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8733-1379', 'authenticated-orcid': False, 'given': 'Lucy L', 'family': 'Cartwright', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6927-5040', 'authenticated-orcid': False, 'given': 'Debra', 'family': 'Westlake', 'sequence': 'additional', 'affiliation': []}, {'given': 'Grace', 'family': 'Nyakoojo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ivan', 'family': 'Kimuli', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2023-2840', 'authenticated-orcid': False, 'given': 'Bruce', 'family': 'Kirenga', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7376-4648', 'authenticated-orcid': False, 'given': 'Evelyn A', 'family': 'Brakema', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4678-6574', 'authenticated-orcid': False, 'given': 'Mark W', 'family': 'Orme', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6952-334X', 'authenticated-orcid': False, 'given': 'Daisy', 'family': 'Fancourt', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3235-0454', 'authenticated-orcid': False, 'given': 'Nicholas S', 'family': 'Hopkinson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5463-2981', 'authenticated-orcid': False, 'given': 'Rupert', 'family': 'Jones', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4622-191X', 'authenticated-orcid': False, 'given': 'Winceslaus', 'family': 'Katagira', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Introduction</jats:title><jats:p>Music and dance are increasingly used as adjunctive arts-in-health interventions in high-income settings, with a growing body of research suggesting biopsychosocial benefits. Such low-cost, low-resource interventions may have application in low-resource settings such as Uganda. However, research on perceptions of patients and healthcare professionals regarding such approaches is lacking.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We delivered taster music and dance for chronic respiratory disease (CRD) sessions to patients and healthcare professionals. We then conducted an exploratory qualitative study, using thematic analysis of semi-structured interviews with the healthcare professionals and patients regarding i) the role of music and dance in Ugandan life and ii) the perceived acceptability and feasibility of using music and dance in CRD management in Uganda.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Eleven patients with long-term respiratory conditions and eight healthcare professionals were interviewed after selection by purposeful convenience sampling. Four key themes were identified from (interview) analysis: Music and dance: 1) were central components of daily life; 2) had an established role supporting health and wellbeing; 3) had strong therapeutic potential in respiratory disease management; 4) the importance of modulating demographic considerations of culture and religion, and age.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Music and dance are central to life in Uganda, with established roles supporting health and wellbeing. These roles could be built on in the development of music and dance interventions as adjuncts to established components of CRD disease management like pulmonary rehabilitation. Through consideration of key contextual factors, and co-development and adaptation of interventions, such approaches are likely to be well received.</jats:p></jats:sec><jats:sec><jats:title>Summary Box: Key Questions</jats:title><jats:sec><jats:title>What is already known?</jats:title><jats:p>Music and dance are increasingly being used as adjunctive components of CRD management in high resource settings, with a growing body of research suggesting such approaches are effective, well-received, and can be delivered at low cost. However, the perceptions of patients and healthcare professionals about potential application of such approaches in low-resource settings, such as Uganda, is not known.</jats:p></jats:sec><jats:sec><jats:title>What are the new findings?</jats:title><jats:p>Music and dance have central roles in the social, religious and cultural life in Uganda, including a clear view that participation supports both collective and individual health and wellbeing. In this study, both healthcare professionals and patients saw great potential for the use of music and dance as interventions for people with CRD, and highlighted important factors for consideration for successful implementation.</jats:p></jats:sec><jats:sec><jats:title>What do the new findings imply?</jats:title><jats:p>Music and dance interventions for people with long-term respiratory conditions in Uganda are likely to be accepted with enthusiasm due to the existing role of such activities in daily life. Delivery is likely to be feasible, but interventions would need to be co-developed with patients, their family members, and healthcare professionals, considering a number of key factors. Suggested approaches to address these considerations are provided. More generally, this study highlights how genuine co-design processes can provide valuable insights into health intervention development.</jats:p></jats:sec></jats:sec>",2021-04-28
155,10.1101/2021.02.28.433234,15,bioRxiv,Bioinformatics,False,ksrates: positioning whole-genome duplications relative to speciation events in KS distributions,"[{'ORCID': 'http://orcid.org/0000-0003-4390-6534', 'authenticated-orcid': False, 'given': 'Cecilia', 'family': 'Sensalari', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5341-136X', 'authenticated-orcid': False, 'given': 'Steven', 'family': 'Maere', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rolf', 'family': 'Lohaus', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Summary: We present <jats:italic>ksrates</jats:italic>, a user-friendly command-line tool to position ancient whole-genome duplication (WGD) events with respect to speciation events in a phylogeny by comparing paralog and ortholog <jats:italic>K</jats:italic><jats:sub>S</jats:sub> distributions derived from genomic or transcriptomic sequences, while adjusting for substitution rate differences among the lineages involved. Availability and implementation: <jats:italic>ksrates</jats:italic> is implemented in Python 3 and as a Nextflow pipeline. The source code, Singularity and Docker containers, documentation and tutorial are available via https://github.com/VIB-PSB/ksrates.</jats:p>",2021-03-01
156,10.1101/2020.12.21.423721,15,bioRxiv,Cell Biology,True,The SARS-CoV-2 spike protein disrupts the cooperative function of human cardiac pericytes - endothelial cells through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease,"[{'ORCID': 'http://orcid.org/0000-0003-4801-8480', 'authenticated-orcid': False, 'given': 'Elisa', 'family': 'Avolio', 'sequence': 'first', 'affiliation': []}, {'given': 'Monica', 'family': 'Gamez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kapil', 'family': 'Gupta', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rebecca', 'family': 'Foster', 'sequence': 'additional', 'affiliation': []}, {'given': 'Imre', 'family': 'Berger', 'sequence': 'additional', 'affiliation': []}, {'given': 'Massimo', 'family': 'Caputo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew', 'family': 'Davidson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Darryl', 'family': 'Hill', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paolo', 'family': 'Madeddu', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Severe coronavirus disease 2019 (COVID-19) manifests as a life-threatening microvascular syndrome. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses primarily the capsid spike (S) protein to engage with its receptors and infect host cells. To date, it is still not known if the S protein alone, without the other viral elements, is able to trigger vascular cell signalling and provoke cell dysfunction.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We investigated the effects of the recombinant, stabilised S protein on primary human cardiac pericytes (PCs) signalling and function. Endpoints included cell viability, proliferation, migration, cooperation with endothelial cells (ECs) in angiogenesis assays, and release of pro-inflammatory cytokines. Adopting a blocking strategy against the S protein receptors ACE2 and CD147, we explored which receptor mediates the S protein signalling in PCs.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>We show, for the first time, that the recombinant S protein alone elicits functional alterations in cardiac PCs. This was documented as: (1) increased migration, (2) reduced ability to support EC network formation on Matrigel, (3) secretion of pro-inflammatory molecules typically involved in the <jats:italic>cytokine storm</jats:italic>, and (4) production of pro-apoptotic factors responsible for EC death. Furthermore, the S protein stimulates the phosphorylation/activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) through the CD147 receptor, but not ACE2, in cardiac PCs. Accordingly, the neutralization of CD147, using a blocking antibody, prevented the activation of ERK1/2 and partially rescued the PC function in the presence of the S protein.</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>Our findings suggest the new, intriguing hypothesis that the S protein may elicit vascular cell dysfunction, potentially amplifying, or perpetuating, the damage caused by the whole coronavirus. This mechanism may have clinical and therapeutic implication.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>Elizabeth Blackwell Institute (EBI) Rapid Response COVID-19 award.</jats:p></jats:sec><jats:sec><jats:title>Research in context</jats:title><jats:sec><jats:title>Evidence before this study</jats:title><jats:p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses primarily the capsid spike (S) protein to engage with its receptors and infect host cells. Co-receptors and host cell proteases may also be involved. Angiotensin-converting enzyme 2 (ACE2) is the well-recognized entry receptor used by the virus in respiratory epithelial cells; it is also abundantly expressed in the human heart. Alongside ACE2, CD147 has recently emerged as a novel receptor for SARS-CoV-2. Yet, it is not clear if SARS-CoV-2 triggers adverse responses in cardiac vascular mural cells. Likewise, no investigation was devoted to verifying if the recombinant S protein alone can mimic the whole virus signalling.</jats:p></jats:sec><jats:sec><jats:title>Added value of this study</jats:title><jats:p>This study provides the first evidence that the recombinant S protein alone, without the other viral elements, is capable of eliciting cellular signalling in human cardiac pericytes, thereby inducing cell dysfunction. In addition, this study proposes CD147 as the leading receptor mediating S protein signalling in cardiac pericytes.</jats:p></jats:sec><jats:sec><jats:title>Implications of all the available evidence</jats:title><jats:p>These reports imply that fragments of the S protein might be able to elicit vascular cell dysfunction. Blocking the CD147 receptor may help protect the vasculature not only from infection, but also from the collateral damage caused by the S protein.</jats:p></jats:sec></jats:sec>",2020-12-21
157,10.1101/2021.01.08.20248932,15,medRxiv,Infectious Diseases (except HIV/AIDS),True,"Efficacy of propolis as an adjunct treatment for hospitalized COVID-19 patients: a randomized, controlled clinical trial","[{'ORCID': 'http://orcid.org/0000-0002-6808-0540', 'authenticated-orcid': False, 'given': 'Marcelo Augusto', 'family': 'Duarte Silveira', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2131-9988', 'authenticated-orcid': False, 'given': 'David', 'family': 'De Jong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Erica Batista', 'family': 'dos Santos Galvão', 'sequence': 'additional', 'affiliation': []}, {'given': 'Juliana Caldas', 'family': 'Ribeiro', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thiago Cerqueira', 'family': 'Silva', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5719-1301', 'authenticated-orcid': False, 'given': 'Andresa Aparecida', 'family': 'Berretta', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thais Chaves', 'family': 'Amorim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raissa Lanna Araújo', 'family': 'San Martin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luis Filipe Miranda', 'family': 'Rebelo da Conceição', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marcel Miranda', 'family': 'Dantas Gomes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maurício Brito', 'family': 'Teixeira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sergio Pinto', 'family': 'de Souza', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marcele Helena Celestino', 'family': 'Alves dos Santos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Márcio', 'family': 'de Oliveira Silva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Monique', 'family': 'Lírio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lis', 'family': 'Moreno', 'sequence': 'additional', 'affiliation': []}, {'given': 'Julio Cezar', 'family': 'Miranda Sampaio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Renata', 'family': 'Mendonça', 'sequence': 'additional', 'affiliation': []}, {'given': 'Silviana Salles', 'family': 'Ultchak', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fabio Santos', 'family': 'Amorim', 'sequence': 'additional', 'affiliation': []}, {'given': 'João Gabriel', 'family': 'Rosa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paulo Benigno', 'family': 'Pena Batista', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9992-4507', 'authenticated-orcid': False, 'given': 'Suzete Nascimento Farias', 'family': 'da Guarda', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana Verena Almeida', 'family': 'Mendes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rogerio da Hora', 'family': 'Passos', 'sequence': 'additional', 'affiliation': []}, {'name': 'for the BeeCovid Team', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Among candidate treatment options for COVID-19, propolis, produced by honey bees from bioactive plant exudates, has shown potential against viral targets and has demonstrated immunoregulatory properties. We conducted a randomized, controlled, open-label, single center trial, with a standardized propolis product (EPP-AF) on hospitalized adult COVID-19 patients. Patients received standard care plus propolis at an oral dose of 400mg/day (n=40) or 800mg/day (n=42) for seven days, or standard care alone (n=42). Standard care included all necessary interventions, as determined by the attending physician. The primary end point was the time to clinical improvement defined as the length of hospital stay or oxygen therapy dependency. Secondary outcomes included acute kidney injury and need for intensive care or vasoactive drugs. Time in the hospital after intervention was significantly shortened in both propolis groups compared to the controls; median 7 days with 400mg/day and 6 days with 800mg/day, versus 12 days for standard care alone. Propolis did not significantly affect the need for oxygen supplementation. With the higher dose, significantly fewer patients developed acute kidney injury than in the controls (2 versus 10 of 42 patients). Propolis as an adjunct treatment was safe and reduced hospitalization time. The registration number for this clinical trial is: <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""clintrialgov"" xlink:href=""NCT04480593"">NCT04480593</jats:ext-link> (20/07/2020).</jats:p>",2021-01-09
158,10.1101/2021.03.25.21254296,15,medRxiv,Infectious Diseases (except HIV/AIDS),True,"A Simple, Home-Therapy Algorithm to Prevent Hospitalization for COVID-19 Patients: A Retrospective Observational Matched-Cohort Study","[{'given': 'Fredy', 'family': 'Suter', 'sequence': 'first', 'affiliation': []}, {'given': 'Elena', 'family': 'Consolaro', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stefania', 'family': 'Pedroni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chiara', 'family': 'Moroni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elena', 'family': 'Pastò', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria Vittoria', 'family': 'Paganini', 'sequence': 'additional', 'affiliation': []}, {'given': 'Grazia', 'family': 'Pravettoni', 'sequence': 'additional', 'affiliation': []}, {'given': 'Umberto', 'family': 'Cantarelli', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nadia', 'family': 'Rubis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Norberto', 'family': 'Perico', 'sequence': 'additional', 'affiliation': []}, {'given': 'Annalisa', 'family': 'Perna', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tobia', 'family': 'Peracchi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Piero', 'family': 'Ruggenenti', 'sequence': 'additional', 'affiliation': []}, {'given': 'Giuseppe', 'family': 'Remuzzi', 'sequence': 'additional', 'affiliation': []}]","<jats:title>S<jats:sc>ummary</jats:sc></jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Effective home treatment algorithms implemented based on a pathophysiologic and pharmacologic rationale to accelerate recovery and prevent hospitalisation of patients with early coronavirus disease 2019 (COVID-19) would have major implications for patients and health system.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>This academic, matched-cohort study compared outcomes of 90 consecutive consenting patients with mild COVID-19 treated at home by their family physicians between October 2020 and January 2021, according to the proposed recommendation algorithm, with outcomes for 90 age-, sex-, and comorbidities-matched patients who received other therapeutic regimens. Primary outcome was time to resolution of major symptoms. Secondary outcomes included prevention of hospitalisation. Analyses were by intention-to-treat.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>All patients achieved complete remission. The median [IQR] time to resolution of major symptoms was 18 [14-23] days in the ‘recommended’ schedule cohort and 14 [7-30] days in the matched ‘control’ cohort (p=0·033). Other symptoms persisted in a lower percentage of patients in the ‘recommended’ than in the ‘control’ cohort (23·3% versus 73·3%, respectively, p&lt;0·0001) and for a shorter period (p=0·0107). Two patients in the ‘recommended’ cohort were hospitalised compared to 13 (14·4%) controls (Log-rank test, p=0·0038). The prevention algorithm reduced the days and cumulative costs of hospitalisation by &gt;90% (from 481 to 44 days and from €296.000 to €28.000, respectively. 1.2 patients had to be treated to prevent one hospitalisation event.</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>Implementation of an early home treatment algorithm failed to accelerate recovery from major symptoms of COVID 19, but almost eliminated the risk of hospitalisation and related treatment costs.</jats:p></jats:sec><jats:sec id=""s1""><jats:title>R<jats:sc>esearch in</jats:sc> C<jats:sc>ontext</jats:sc></jats:title><jats:sec id=""s1a""><jats:title>Evidence before this study</jats:title><jats:p>We searched PubMed and the Cochrane Library for peer-reviewed articles published in any language up to March 19, 2021, using the search terms “2019-nCoV” or “SARS-CoV-2” or “COVID-19” and “early” or “outpatient” or “treatment” or “home”. Our search did not identify any randomised clinical trials or observational studies that assessed the effectiveness of treatment regimens targeting early, mild symptoms of COVID-19 in the outpatient setting.</jats:p></jats:sec><jats:sec id=""s1b""><jats:title>Added value of this study</jats:title><jats:p>In this fully academic, observational matched-cohort study, we found that early home treatment of 90 consecutive patients with mild COVID-19 by their family physicians according to the proposed recommendation algorithm, designed based on a pathophysiologic and pharmacologic rationale, required few more days to achieve resolution of major symptoms including fever, dyspnea, musculoskeletal pain, headache and cough compared to 90 age-, sex-, and comorbidities-matched patients who received other therapeutic regimens (primary outcome). Nonetheless, it is noteworthy that the home treatment of COVID-19 patients according to the proposed recommendation algorithm significantly reduced the risk of hospitalization compared to the other treatments in the ‘control’ cohort. Days of hospitalization and related treatment costs were reduced by over 90% in the ‘recommended’ cohort as compared to ‘control’ cohort. Just 1.2 patients needed to be treated according to the recommendation algorithm to prevent one hospitalization event. We also found that symptoms such as anosmia and ageusia/dysgeusia were less persistent and lasted a shorter time in the ‘recommendation’ than in the ‘control’ cohort.</jats:p></jats:sec><jats:sec id=""s1c""><jats:title>Implications of the available evidence</jats:title><jats:p>The finding that the implementation of the proposed simple treatment algorithm during the initial, mild phase of COVID-19 has the potential to prevent disease progression, potentially limiting the need for hospital admission, may have major implications for patients and health care providers. Indeed, preventing hospitalisations due to the worsening of COVID-19 will not only save lives, but will also contribute to remarkably reduced treatment costs and to streamlining health care systems that are overburdened by the effects of the pandemic. However, time to hospitalization was a secondary outcome of the study and the possibility of a casual finding cannot be definitely excluded. Thus, the observed reduction in patients hospitalizations should be considered as an hypothesis generating finding that could provide a robust background for a prospective trial primarily aimed to test treatment effect on this outcome.</jats:p></jats:sec></jats:sec>",2021-03-26
159,10.1101/2020.12.18.422878,15,bioRxiv,Biophysics,False,"Biomimetic, smart and multivalent ligands for G-quadruplex isolation and bioorthogonal imaging","[{'given': 'Francesco Rota', 'family': 'Sperti', 'sequence': 'first', 'affiliation': []}, {'given': 'Thibaut', 'family': 'Charbonnier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pauline', 'family': 'Lejault', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joanna', 'family': 'Zell', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3051-2029', 'authenticated-orcid': False, 'given': 'Claire', 'family': 'Bernhard', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5802-4131', 'authenticated-orcid': False, 'given': 'Ibai E.', 'family': 'Valverde', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3056-9295', 'authenticated-orcid': False, 'given': 'David', 'family': 'Monchaud', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>G-quadruplexes (G4s) continue to gather wide attention in the field of chemical biology as their prevalence in the human genome and transcriptome strongly suggests that they may play key regulatory roles in cell biology. G4-specific, cell-permeable small molecules (G4-ligands) innovately permit the interrogation of cellular circuitries in order to assess to what extent G4s influence cell fate and functions. Here, we report on multivalent, biomimetic G4-ligands referred to as TASQs that enable both the isolation and visualization of G4s in human cells. Two biotinylated TASQs, <jats:bold>BioTASQ</jats:bold> and <jats:bold>BioCyTASQ</jats:bold>, are indeed efficient molecular tools to fish out G4s of mixtures of nucleic acids through simple affinity capture protocols and to image G4s in cells <jats:italic>via</jats:italic> a biotin/avidin pretargeted imaging system first applied here to G4s, found to be a reliable alternative to <jats:italic>in situ</jats:italic> click chemistry.</jats:p><jats:sec><jats:title>Abstract Figure</jats:title><jats:fig id=""ufig1"" position=""float"" fig-type=""figure"" orientation=""portrait""><jats:graphic xmlns:xlink=""http://www.w3.org/1999/xlink"" xlink:href=""422878v1_ufig1"" position=""float"" orientation=""portrait"" /></jats:fig></jats:sec>",2020-12-18
160,10.1101/2020.07.16.207845,14,bioRxiv,Bioinformatics,False,Incorporating genome-based phylogeny and functional similarity into diversity assessments helps to resolve a global collection of human gut metagenomes,"[{'ORCID': 'http://orcid.org/0000-0002-7424-5276', 'authenticated-orcid': False, 'given': 'Nicholas D', 'family': 'Youngblut', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7369-992X', 'authenticated-orcid': False, 'given': 'Jacobo', 'family': 'de la Cuesta-Zuluaga', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9087-1672', 'authenticated-orcid': False, 'given': 'Ruth E', 'family': 'Ley', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Tree-based diversity measures incorporate phylogenetic or functional relatedness into comparisons of microbial communities. This can improve the identification of explanatory factors compared to tree-agnostic diversity measures. However, applying tree-based diversity measures to metagenome data is more challenging than for single-locus sequencing (e.g., 16S rRNA gene). The Genome Taxonomy Database (GTDB) provides a genome-based reference database that can be used for species-level metagenome profiling, and a multi-locus phylogeny of all genomes that can be employed for diversity calculations. This approach also allows for functional diversity measures based on genomic content or traits inferred from it. Still, it is unclear how metagenome-based assessments of microbiome diversity benefit from incorporating phylogeny or function into measures of diversity. We assessed this by measuring phylogeny-based, function-based, and tree-agnostic diversity measures from a large, global collection of human gut metagenomes composed of 33 studies and 3348 samples. We found tree-based measures to explain phenotypic variation (e.g., westernization, disease status, and gender) better or on par with tree-agnostic measures. Ecophylogenetic and functional diversity measures provided unique insight into how microbiome diversity was partitioned by phenotype. Tree-based measures greatly improved machine learning model performance for predicting westernization, disease status, and gender, relative to models trained solely on tree-agnostic measures. Notably, ecophylogenetic and functional diversity measures were generally the most important features for predictive performance. Our findings illustrate the usefulness of tree- and function-based measures for metagenomic assessments of microbial diversity - a fundamental component of microbiome science.</jats:p>",2020-07-17
161,10.1101/2021.04.28.441780,14,bioRxiv,Microbiology,False,Suboptimal proteome allocation during changing environments constrains bacterial response and growth recovery,"[{'ORCID': 'http://orcid.org/0000-0002-7547-8565', 'authenticated-orcid': False, 'given': 'Rohan', 'family': 'Balakrishnan', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1837-6842', 'authenticated-orcid': False, 'given': 'Terence', 'family': 'Hwa', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2328-5152', 'authenticated-orcid': False, 'given': 'Jonas', 'family': 'Cremer', 'sequence': 'additional', 'affiliation': []}]","<jats:p>To sustain growth in fluctuating environments microbial organisms must respond appropriately. The response generally requires the synthesis of novel proteins, but this synthesis can be impeded due to the depletion of biosynthetic precursors when growth conditions vary. Microbes must thus devise effective response strategies to manage depleting precursors. To better understand these strategies, we here investigate the active response of Escherichia coli to changes in nutrient conditions, connecting transient gene-expression behavior to growth phenotypes. By synthetically modifying the gene expression during changing growth conditions, we show how the competition by genes for the limited protein synthesis capacity constrains the cellular response. Despite this constraint, cells substantially express genes that are not required, severely slowing down the response. These findings highlight that cells do not optimize growth and recovery in every encountered environment but rather exhibit hardwired response strategies that may have evolved to promote growth in their native environment and include the regulation of multiple genes. The constraint and the suboptimality of the cellular response uncovered in this study provides a conceptual framework relevant for many research applications, from the prediction of evolution and adaptation to the improvement of gene circuits in biotechnology.</jats:p>",2021-04-28
162,10.1101/2021.04.24.441228,14,bioRxiv,Immunology,True,A synthetic peptide CTL vaccine targeting nucleocapsid confers protection from SARS-CoV-2 challenge in rhesus macaques,"[{'ORCID': 'http://orcid.org/0000-0003-4806-8242', 'authenticated-orcid': False, 'given': 'Paul E.', 'family': 'Harris', 'sequence': 'first', 'affiliation': []}, {'given': 'Trevor', 'family': 'Brasel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher', 'family': 'Massey', 'sequence': 'additional', 'affiliation': []}, {'given': 'C. V.', 'family': 'Herst', 'sequence': 'additional', 'affiliation': []}, {'given': 'Scott', 'family': 'Burkholz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Peter', 'family': 'Lloyd', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tikoes', 'family': 'Blankenberg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas M.', 'family': 'Bey', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard', 'family': 'Carback', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Hodge', 'sequence': 'additional', 'affiliation': []}, {'given': 'Serban', 'family': 'Ciotlos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lu', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jason E.', 'family': 'Comer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Reid', 'family': 'Rubsamen', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Persistent transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has given rise to a COVID-19 pandemic. Several vaccines, evoking protective spike antibody responses, conceived in 2020, are being deployed in mass public health vaccination programs. Recent data suggests, however, that as sequence variation in the spike genome accumulates, some vaccines may lose efficacy.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Using a macaque model of SARS-CoV-2 infection, we tested the efficacy of a peptide-based vaccine targeting MHC Class I epitopes on the SARS-CoV-2 nucleocapsid protein. We administered biodegradable microspheres with synthetic peptides and adjuvants to rhesus macaques. Unvaccinated control and vaccinated macaques were challenged with 1 x 10<jats:sup>8</jats:sup> TCID<jats:sub>50</jats:sub> units of SARS-CoV-2, followed by assessment of clinical symptoms, viral load, chest radiographs, sampling of peripheral blood and bronchoalveolar lavage (BAL) fluid for downstream analysis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Vaccinated animals were free of pneumonia-like infiltrates characteristic of SARS-CoV-2 infection and presented with lower viral loads relative to controls. Gene expression in cells collected from BAL samples of vaccinated macaques revealed a unique signature associated with enhanced development of adaptive immune responses relative to control macaques.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>We demonstrate that a room temperature stable peptide vaccine based on known immunogenic HLA Class I bound CTL epitopes from the nucleocapsid protein can provide protection against SARS-CoV-2 infection in non-human primates.</jats:p></jats:sec><jats:sec><jats:title>Graphical Abstract</jats:title><jats:fig id=""ufig1"" position=""float"" orientation=""portrait"" fig-type=""figure""><jats:graphic xmlns:xlink=""http://www.w3.org/1999/xlink"" xlink:href=""441228v1_ufig1"" position=""float"" orientation=""portrait"" /></jats:fig></jats:sec>",2021-04-26
163,10.1101/2020.08.24.265702,14,bioRxiv,Bioinformatics,False,Gene set enrichment analysis for genome-wide DNA methylation data,"[{'ORCID': 'http://orcid.org/0000-0002-9458-3061', 'authenticated-orcid': False, 'given': 'Jovana', 'family': 'Maksimovic', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9788-5690', 'authenticated-orcid': False, 'given': 'Alicia', 'family': 'Oshlack', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1711-7454', 'authenticated-orcid': False, 'given': 'Belinda', 'family': 'Phipson', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>DNA methylation is one of the most commonly studied epigenetic marks, due to its role in disease and development. Illumina methylation arrays have been extensively used to measure methylation across the human genome. Methylation array analysis has primarily focused on preprocessing, normalisation and identification of differentially methylated CpGs and regions. GOmeth and GOregion are new methods for performing unbiased gene set testing following differential methylation analysis. Benchmarking analyses demonstrate GOmeth outperforms other approaches and GOregion is the first method for gene set testing of differentially methylated regions. Both methods are publicly available in the <jats:italic>missMethyl</jats:italic> Bioconductor R package.</jats:p>",2020-08-25
164,10.1101/2021.04.23.441106,14,bioRxiv,Synthetic Biology,False,Versioning Biological Cells for Trustworthy Cell Engineering,"[{'ORCID': 'http://orcid.org/0000-0003-2198-4558', 'authenticated-orcid': False, 'given': 'Jonathan', 'family': 'Tellechea-Luzardo', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2835-4241', 'authenticated-orcid': False, 'given': 'Leanne', 'family': 'Hobbs', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6648-1634', 'authenticated-orcid': False, 'given': 'Elena', 'family': 'Velázquez', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6380-6744', 'authenticated-orcid': False, 'given': 'Lenka', 'family': 'Pelechova', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8998-5234', 'authenticated-orcid': False, 'given': 'Simon', 'family': 'Woods', 'sequence': 'additional', 'affiliation': []}, {'given': 'Victor', 'family': 'de Lorenzo', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2651-4320', 'authenticated-orcid': False, 'given': 'Natalio', 'family': 'Krasnogor', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p><jats:italic>“Full-stack”</jats:italic> biotechnology platforms for cell line (re)programming are on the horizon, due mostly to (a) advances in gene synthesis and editing techniques as well as (b) the growing integration with informatics, the internet of things and automation. These emerging platforms will accelerate the production and consumption of biological products. Hence, transparency, traceability and -ultimately-trustworthiness is required -from cradle to grave- for engineered cell lines and their engineering processes. We report here the first version control system for cell engineering that integrates a new cloud-based version control software for cell lines’ digital footprint with molecular barcoding of living samples. We argue that version control for cell engineering marks a significant step towards more open, reproducible, easier to trace and share, and more trustworthy engineering biology.</jats:p><jats:sec><jats:title>One Sentence Summary</jats:title><jats:p>We demonstrate a transparent and open way of engineering and sharing cell lines.</jats:p></jats:sec>",2021-04-23
165,10.1101/596718,14,bioRxiv,Genomics,False,Influence of neighboring small sequence variants on functional impact prediction,"[{'ORCID': 'http://orcid.org/0000-0003-3996-6817', 'authenticated-orcid': False, 'given': 'Jan-Simon', 'family': 'Baasner', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7674-0385', 'authenticated-orcid': False, 'given': 'Dakota', 'family': 'Howard', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3321-7471', 'authenticated-orcid': False, 'given': 'Boas', 'family': 'Pucker', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Once a suitable reference sequence is generated, genomic differences within a species are often assessed by re-sequencing. Variant calling processes can reveal all differences between two strains, accessions, genotypes, or individuals. These variants can be enriched with predictions about their functional implications based on available structural annotations i.e. gene models. Although these functional impact predictions on a per variant basis are often accurate, some challenging cases require the simultaneous incorporation of multiple adjacent variants into this prediction process. Examples are neighboring variants which modify each others’ functional impact. Neighborhood-Aware Variant Impact Predictor (NAVIP) considers all variants within a given protein coding sequence when predicting the functional consequences. As a proof of concept, variants between the <jats:italic>Arabidopsis thaliana</jats:italic> accessions Columbia-0 and Niederzenz-1 were annotated. NAVIP is freely available on github: <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""uri"" xlink:href=""https://github.com/bpucker/NAVIP"">https://github.com/bpucker/NAVIP</jats:ext-link>.</jats:p>",2019-04-04
166,10.1101/2021.03.10.21252820,14,medRxiv,Genetic and Genomic Medicine,True,Mapping the human genetic architecture of COVID-19 by worldwide meta-analysis,"[{'name': 'The COVID-19 Host Genetics Initiative', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8147-240X', 'authenticated-orcid': False, 'given': 'Andrea', 'family': 'Ganna', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>The genetic makeup of an individual contributes to susceptibility and response to viral infection. While environmental, clinical and social factors play a role in exposure to SARS-CoV-2 and COVID-19 disease severity, host genetics may also be important. Identifying host-specific genetic factors indicate biological mechanisms of therapeutic relevance and clarify causal relationships of modifiable environmental risk factors for SARS-CoV-2 infection and outcomes. We formed a global network of researchers to investigate the role of human genetics in SARS-COV-2 infection and COVID-19 severity. We describe the results of three genome-wide association meta-analyses comprising 49,562 COVID-19 patients from 46 studies across 19 countries worldwide. We reported 15 genome-wide significant loci that are associated with SARS-CoV-2 infection or severe manifestations of COVID-19. Several of these loci correspond to previously documented associations to lung or autoimmune and inflammatory diseases. They also represent potentially actionable mechanisms in response to infection. We further identified smoking and body mass index as causal risk factors for severe COVID-19. The identification of novel host genetic factors associated with COVID-19, with unprecedented speed, was enabled by prioritization of shared resources and analytical frameworks. This working model of international collaboration a blue-print for future genetic discoveries in the event of pandemics or for any complex human disease.</jats:p>",2021-03-12
167,10.1101/2020.12.09.20246207,14,medRxiv,Public and Global Health,True,"Social and racial inequalities in COVID-19 risk of hospitalisation and death across São Paulo state, Brazil","[{'ORCID': 'http://orcid.org/0000-0002-1183-126X', 'authenticated-orcid': False, 'given': 'Sabrina L', 'family': 'Li', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2125-7465', 'authenticated-orcid': False, 'given': 'Rafael H M', 'family': 'Pereira', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3907-423X', 'authenticated-orcid': False, 'suffix': 'Jr', 'given': 'Carlos A', 'family': 'Prete', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1824-7653', 'authenticated-orcid': False, 'given': 'Alexander E', 'family': 'Zarebski', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3754-5755', 'authenticated-orcid': False, 'given': 'Lucas', 'family': 'Emanuel', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9340-030X', 'authenticated-orcid': False, 'given': 'Pedro JH', 'family': 'Alves', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2358-3221', 'authenticated-orcid': False, 'given': 'Pedro S', 'family': 'Peixoto', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6104-7297', 'authenticated-orcid': False, 'given': 'Carlos KV', 'family': 'Braga', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3585-8683', 'authenticated-orcid': False, 'given': 'Andreza A', 'family': 'de Souza Santos', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0025-8293', 'authenticated-orcid': False, 'given': 'William M', 'family': 'de Souza', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6796-4547', 'authenticated-orcid': False, 'given': 'Rogerio J', 'family': 'Barbosa', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9009-9301', 'authenticated-orcid': False, 'given': 'Lewis F', 'family': 'Buss', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3090-4575', 'authenticated-orcid': False, 'suffix': 'Jr', 'given': 'Alfredo', 'family': 'Mendrone', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8490-4634', 'authenticated-orcid': False, 'given': 'Cesar', 'family': 'de Almeida-Neto', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4190-0238', 'authenticated-orcid': False, 'given': 'Suzete C', 'family': 'Ferreira', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7580-4597', 'authenticated-orcid': False, 'given': 'Nanci A', 'family': 'Salles', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2914-6535', 'authenticated-orcid': False, 'given': 'Izabel', 'family': 'Marcilio', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9386-725X', 'authenticated-orcid': False, 'given': 'Chieh-Hsi', 'family': 'Wu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0625-0265', 'authenticated-orcid': False, 'given': 'Nelson', 'family': 'Gouveia', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0543-4735', 'authenticated-orcid': False, 'given': 'Vitor H', 'family': 'Nascimento', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2623-5126', 'authenticated-orcid': False, 'given': 'Ester C', 'family': 'Sabino', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9747-8822', 'authenticated-orcid': False, 'given': 'Nuno R', 'family': 'Faria', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7829-1272', 'authenticated-orcid': False, 'given': 'Jane P', 'family': 'Messina', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Summary</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Little evidence exists on the differential health effects of COVID-19 on disadvantaged population groups. Here we characterise the differential risk of hospitalisation and death in São Paulo state, Brazil and show how vulnerability to COVID-19 is shaped by socioeconomic inequalities.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We conducted a cross-sectional study using hospitalised severe acute respiratory infections (SARI) notified from March to August 2020, in the<jats:italic>Sistema de Monitoramento Inteligente de São Paulo</jats:italic>(SIMI-SP) database. We examined the risk of hospitalisation and death by race and socioeconomic status using multiple datasets for individual-level and spatio-temporal analyses. We explained these inequalities according to differences in daily mobility from mobile phone data, teleworking behaviour, and comorbidities.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Throughout the study period, patients living in the 40% poorest areas were more likely to die when compared to patients living in the 5% wealthiest areas (OR: 1·60, 95% CI: 1·48 – 1·74) and were more likely to be hospitalised between April and July, 2020 (OR: 1·08, 95% CI: 1·04 – 1·12). Black and<jats:italic>Pardo</jats:italic>individuals were more likely to be hospitalised when compared to White individuals (OR: 1·37, 95% CI: 1·32 – 1·41; OR: 1·23, 95% CI: 1·21 – 1·25, respectively), and were more likely to die (OR: 1·14, 95% CI: 1·07 – 1·21; 1·09, 95% CI: 1·05 – 1·13, respectively).</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>Low-income and Black and<jats:italic>Pardo</jats:italic>communities are more likely to die with COVID-19. This is associated with differential access to healthcare, adherence to social distancing, and the higher prevalence of comorbidities.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>This project was supported by a Medical Research Council-São Paulo Research Foundation (FAPESP) CADDE partnership award (MR/S0195/1 and FAPESP 18/14389-0) (<jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""uri"" xlink:href=""http://caddecentre.org/"">http://caddecentre.org/</jats:ext-link>). This work received funding from the U.K. Medical Research Council under a concordat with the U.K. Department for International Development.</jats:p></jats:sec>",2020-12-12
168,10.1101/2020.12.29.20248977,13,medRxiv,Public and Global Health,True,"The second COVID-19 emergency status declaration for Japan: effects as of February 7, 2021","[{'given': 'Junko', 'family': 'Kurita', 'sequence': 'first', 'affiliation': []}, {'given': 'Tamie', 'family': 'Sugawara', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yasushi', 'family': 'Ohkusa', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>On January 7, 2021, a second state of emergency was declared in Japan. Object: We evaluated effects of the second emergency status declaration and those of other countermeasures, climate conditions, and mobility through January 21, 2021, when two weeks had passed since the state was activated, as assessed on February 7, 2021.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>We regressed the effective reproduction number R(<jats:italic>t</jats:italic>) on temperature, humidity, mobility, and countermeasures such as the two emergency status declarations and GTTC.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Estimation results indicate that the second emergency status declaration after GTTC significantly reduced infectiousness as well as the first declaration, controlling for climate condition and mobility. Temperature was found to exert a significant negative effect, although it was not significant if humidity was added as an explanatory variable.</jats:p></jats:sec><jats:sec><jats:title>Discussion and Conclusion</jats:title><jats:p>Results demonstrate that the second emergency status significantly reduced infectiousness.</jats:p></jats:sec><jats:sec><jats:title>ICMJE Statement</jats:title><jats:p>Contributors JK was responsible for the coordination of the study and responsible for the data setting. YO developed the model and TS illustrated the results. All authors contributed to the writing of the final manuscript.</jats:p></jats:sec>",2021-01-04
169,10.1101/2020.11.18.387282,13,bioRxiv,Neuroscience,False,Only the fastest corticospinal fibers contribute to beta corticomuscular coherence,"[{'given': 'J.', 'family': 'Ibáñez', 'sequence': 'first', 'affiliation': []}, {'given': 'A.', 'family': 'Del Vecchio', 'sequence': 'additional', 'affiliation': []}, {'given': 'J. C.', 'family': 'Rothwell', 'sequence': 'additional', 'affiliation': []}, {'given': 'S. N.', 'family': 'Baker', 'sequence': 'additional', 'affiliation': []}, {'given': 'D.', 'family': 'Farina', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>A common way to study human corticospinal transmission is with transcranial magnetic stimulation. However, this is biased to activity in the fastest conducting axons. It is unclear whether conclusions obtained in this context are representative of volitional activity in mild-to-moderate contractions. A possible alternative to overcome this limitation is to study the corticospinal transmission of endogenously generated brain activity. Here we study the transmission speeds of cortical beta rhythms travelling to the muscles during steady contractions. To do this, we introduce new methods to improve delay estimates in the corticomuscular transmission of beta rhythms, and which we validate both in simulations and experimentally. Applying these approaches to experimental data from humans, we show that corticomuscular beta transmission delays are only 1-2ms longer than expected from the fastest corticospinal pathway. Simulations using realistic distributions of the conduction velocities for descending axons projecting to lower motoneurons suggest two scenarios that can explain these results: either a very small fraction of only the fastest corticospinal axons selectively transmit beta activity, or else the entire pool does. The implications that these two scenarios have for our understanding of corticomuscular interactions are discussed in the final part of this manuscript.</jats:p><jats:sec><jats:title>SIGNIFICANCE</jats:title><jats:p>We present and validate an improved methodology to measure the delay in the transmission of cortical beta activity to tonically active muscles. The estimated corticomuscular beta transmission delays which this yields are remarkably similar to those expected from transmission in the fastest corticospinal axons. A simulation of beta transmission along a pool of corticospinal axons using a realistic distribution of fiber diameters suggests two possible mechanisms by which fast corticomuscular transmission is achieved: either a very small fraction of descending axons transmits beta activity to the muscles or, alternatively, the entire population does and natural cancellation of slow channels occurs due to the distribution of axon diameters in the corticospinal tract.</jats:p></jats:sec>",2020-11-20
170,10.1101/2020.03.05.975441,13,bioRxiv,Synthetic Biology,False,High throughput functional variant screens via in-vivo production of single-stranded DNA,"[{'ORCID': 'http://orcid.org/0000-0001-5047-2207', 'authenticated-orcid': False, 'given': 'Max G.', 'family': 'Schubert', 'sequence': 'first', 'affiliation': []}, {'given': 'Daniel B.', 'family': 'Goodman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Timothy M.', 'family': 'Wannier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Divjot', 'family': 'Kaur', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fahim', 'family': 'Farzadfard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Timothy K.', 'family': 'Lu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Seth L.', 'family': 'Shipman', 'sequence': 'additional', 'affiliation': []}, {'given': 'George M.', 'family': 'Church', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Tremendous genetic variation exists in nature, but our ability to create and characterize individual genetic variants remains far more limited in scale. Likewise, engineering proteins and phenotypes requires the introduction of synthetic variants, but design of variants outpaces experimental measurement of variant effect. Here, we optimize efficient and continuous generation of precise genomic edits in <jats:italic>Escherichia coli</jats:italic>, via in-vivo production of single-stranded DNA by the targeted reverse-transcription activity of retrons. Greater than 90% editing efficiency can be obtained using this method, enabling multiplexed applications. We introduce Retron Library Recombineering (RLR), a system for high-throughput screens of variants, wherein the association of introduced edits with their retron elements enables a targeted deep sequencing phenotypic output. We use RLR for pooled, quantitative phenotyping of synthesized variants, characterizing antibiotic resistance alleles. We also perform RLR using sheared genomic DNA of an evolved bacterium, experimentally querying millions of sequences for antibiotic resistance variants. In doing so, we demonstrate that RLR is uniquely suited to utilize non-designed sources of variation. Pooled experiments using ssDNA produced in vivo thus present new avenues for exploring variation, both designed and not, across the entire genome.</jats:p>",2020-03-06
171,10.1101/2021.04.27.441707,13,bioRxiv,Microbiology,True,Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant,"[{'given': 'Soo-Young', 'family': 'Lee', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4237-4740', 'authenticated-orcid': False, 'given': 'Dong-Kyun', 'family': 'Ryu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0872-0147', 'authenticated-orcid': False, 'given': 'Young Ki', 'family': 'Choi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Penny', 'family': 'Moore', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carel A van', 'family': 'Baalen', 'sequence': 'additional', 'affiliation': []}, {'given': 'rina', 'family': 'song', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aloys SL', 'family': 'Tijsma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thandeka', 'family': 'Gwete-Moyo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Minsoo', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Young-Il', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cheolmin', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jong-In', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ki-Sung', 'family': 'Kwon', 'sequence': 'additional', 'affiliation': []}]","<jats:p>The global circulation of newly emerging variants of SARS-CoV-2 is a new threat to public health due to their increased transmissibility and immune evasion. Moreover, currently available vaccines and therapeutic antibodies were shown to be less effective against new variants, in particular, the South African (SA) variant, termed 501Y.V2 or B.1.351. To assess the efficacy of the CT-P59 monoclonal antibody against the SA variant, we sought to perform as in vitro binding and neutralization assays, and in vivo animal studies. CT-P59 neutralized B.1.1.7 variant to a similar extent as to wild type virus. CT-P59 showed reduced binding affinity against a RBD (receptor binding domain) triple mutant containing mutations defining B.1.351 (K417N/E484K/N501Y) also showed reduced potency against the SA variant in live virus and pseudovirus neutralization assay systems. However, in vivo ferret challenge studies demonstrated that a therapeutic dosage of CT-P59 was able to decrease B.1.351 viral load in the upper and lower respiratory tracts, comparable to that observed for the wild type virus. Overall, although CT-P59 showed reduced in vitro neutralizing activity against the SA variant, sufficient antiviral effect in B.1.351-infected animals was confirmed with a clinical dosage of CT-P59, suggesting that CT-P59 has therapeutic potential for COVID-19 patients infected with SA variant.</jats:p>",2021-04-28
172,10.1101/2021.04.26.441450,13,bioRxiv,Bioinformatics,False,Toward comprehensive functional analysis of gene lists weighted by gene essentiality scores,"[{'given': 'Rui', 'family': 'Fan', 'sequence': 'first', 'affiliation': []}, {'given': 'Qinghua', 'family': 'Cui', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Gene functional enrichment analysis represents one of the most popular bioinformatics methods for annotating the pathways and function categories of a given gene list. Current algorithms for enrichment computation such as Fisher’s exact test and hypergeometric test totally depend on the category count numbers of the gene list and one gene set. In this case, whatever the genes are, they were treated equally. However, actually genes show different scores in their essentiality in a gene list and in a gene set. It is thus hypothesized that the essentiality scores could be important and should be considered in gene functional analysis. For this purpose, here we proposed WEAT (<jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""uri"" xlink:href=""https://www.cuilab.cn/weat/"">https://www.cuilab.cn/weat/</jats:ext-link>), a weighted gene set enrichment algorithm and online tool by weighting genes using essentiality scores. We confirmed the usefulness of WEAT using two case studies, the functional analysis of one aging-related gene list and one gene list involved in Lung Squamous Cell Carcinoma (LUSC). Finally, we believe that the WEAT method and tool could provide more possibilities for further exploring the functions of given gene lists.</jats:p>",2021-04-27
173,10.1101/2021.04.28.440978,13,bioRxiv,Neuroscience,False,Human interictal epileptiform discharges are traveling waves reflecting ictal self-organization,"[{'ORCID': 'http://orcid.org/0000-0003-4323-4643', 'authenticated-orcid': False, 'given': 'Elliot H', 'family': 'Smith', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4851-3676', 'authenticated-orcid': False, 'given': 'Jyun-You', 'family': 'Liou', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8172-3152', 'authenticated-orcid': False, 'given': 'Edward M', 'family': 'Merricks', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tyler S', 'family': 'Davis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kyle', 'family': 'Thomson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6702-7596', 'authenticated-orcid': False, 'given': 'Bradley', 'family': 'Greger', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul A', 'family': 'House', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8592-7539', 'authenticated-orcid': False, 'given': 'Ronald', 'family': 'Emerson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robert R', 'family': 'Goodman', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9695-3564', 'authenticated-orcid': False, 'suffix': 'Jr.', 'given': 'Guy M', 'family': 'McKhann', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8770-8965', 'authenticated-orcid': False, 'given': 'Sameer A', 'family': 'Sheth', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4485-7933', 'authenticated-orcid': False, 'given': 'Catherine A', 'family': 'Schevon', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8843-5468', 'authenticated-orcid': False, 'given': 'John D', 'family': 'Rolston', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Interictal epileptiform discharges (IEDs), also known as interictal spikes, are large intermittent electrophysiological events observed between seizures in patients with epilepsy. While seizures are infrequent and unpredictable, IEDs are far more common, often occurring several times per minute. Yet despite the abundance of IEDs, it remains unknown how they relate to seizures. To better understand this relationship, we examined multi-day recordings of 96-channel microelectrode arrays implanted in human epilepsy patients. These recordings (spanning single cell action potentials to population field potentials) allowed us to study the microscale spatiotemporal organization of over 45,000 IEDs across 10 participants from 2 surgical centers. These recordings showed that the majority of IEDs propagate across neocortex as traveling waves. While all of these traveling wave distributions exhibited a predominant, consistent direction, the majority also exhibited a second, auxiliary, direction. Clustering the IED distributions revealed that their predominant and auxiliary distributions were antipodal, mimicking the spatial microstructure of seizure discharges (SDs) that we have previously reported. We thus compared spatial features of IED sub-distributions to those for SDs, showing a correspondence between ictal and interictal spatial properties in participants whose microelectrode arrays were recruited into the seizure from adjacent cortical tissue. These results reveal fundamental relationships between IEDs and seizures and suggest how IEDs could be used to infer spatial features of seizures.</jats:p>",2021-04-29
174,10.1101/2021.03.24.21254046,13,medRxiv,Infectious Diseases (except HIV/AIDS),True,Sudden rise in COVID-19 case fatality among young and middle-aged adults in the south of Brazil after identification of the novel B.1.1.28.1 (P.1) SARS-CoV-2 strain: analysis of data from the state of Parana,"[{'given': 'Maria Helena Santos', 'family': 'de Oliveira', 'sequence': 'first', 'affiliation': []}, {'given': 'Giuseppe', 'family': 'Lippi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Brandon Michael', 'family': 'Henry', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Brazil is currently suffering a deadly surge of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, which has been attributed to the spread of a new strain known as P.1 (B.1.1.28.1). In this investigation, we analyzed coronavirus disease 2019 (COVID-19) public health data from Parana, the largest state in southern half of Brazil, between September 1, 2020 and March 17, 2021, to evaluate recent trends in case fatality rates in different age groups. A total of 553,518 cases of SARS-CoV-2, 8,853 currently registered as fatal, were finally included in our analysis. All age groups showed either decline or stabilization of the case fatality rates (CFRs) between September 2020 and January 2021. In February 2021, an increase in CFR for almost all age groups could be instead observed. All groups above 20 years of age showed statistically significant increases in CFR when diagnosed in February 2021 as opposed to January 2021. Patients aged 20-29 years experienced a tripling of their CFR, from 0.04% to 0.13%, while those aged 30-39, 40-49, 50-59 experienced approximate CFR doubling. Individuals between 20 and 29 years of age whose diagnosis was made in February 2021 had an over 3-fold higher risk of death compared to those diagnosed in January 2021 (Risk Ratio (RR): 3.15 [95%CI: 1.52-6.53], p&lt;0.01), while those aged 30-39, 40-49, 50-59 years experienced 93% (1.93 [95%CI:1.31-2.85], p&lt;0.01), 110% (RR: 2.10 [95%CI:1.62-2.72], p&lt;0.01), and 80% (RR: 1.80 [95%CI:1.50-2.16], p&lt;0.01) increases in risk of death, respectively. Notably, the observed CFR increase coincided with the second consecutive month of declining number of diagnosed SARS-CoV-2 cases. Taken together, these preliminary findings suggest significant increases in CFR in young and middle-aged adults after identification of a novel SARS-CoV-2 strain circulating in Brazil, and this should raise public health alarms, including the need for more aggressive local and regional public health interventions and faster vaccination.</jats:p>",2021-03-26
175,10.1101/2021.04.28.441243,13,bioRxiv,Ecology,False,Capturing site-to-site variability through Hierarchical Bayesian calibration of a process-based dynamic vegetation model,"[{'ORCID': 'http://orcid.org/0000-0001-8236-303X', 'authenticated-orcid': False, 'given': 'Istem', 'family': 'Fer', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4022-5979', 'authenticated-orcid': False, 'given': 'Alexey N.', 'family': 'Shiklomanov', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8431-0879', 'authenticated-orcid': False, 'given': 'Kimberly A.', 'family': 'Novick', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1227-7731', 'authenticated-orcid': False, 'given': 'Christopher M.', 'family': 'Gough', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1433-5173', 'authenticated-orcid': False, 'given': 'M. Altaf', 'family': 'Arain', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0761-9458', 'authenticated-orcid': False, 'given': 'Jiquan', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0399-5221', 'authenticated-orcid': False, 'given': 'Bailey', 'family': 'Murphy', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5226-6041', 'authenticated-orcid': False, 'given': 'Ankur R.', 'family': 'Desai', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2324-2518', 'authenticated-orcid': False, 'given': 'Michael C.', 'family': 'Dietze', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Process-based ecosystem models help us understand and predict ecosystem processes, but using them has long involved a difficult choice between performing data- and labor-intensive site-level calibrations or relying on general parameters that may not reflect local conditions. Hierarchical Bayesian (HB) calibration provides a third option that frees modelers from assuming model parameters to be completely generic or completely site-specific and allows a formal distinction between prediction at known calibration sites and out-of-sample prediction to new sites. Here, we compare calibrations of a process-based dynamic vegetation model to eddy-covariance data across 12 temperate deciduous Ameriflux sites fit using either site-specific, joint cross-site, or HB approaches. To be able to apply HB to computationally demanding process-based models we introduce a novel emulator-based HB calibration tool, which we make available through the PEcAn community cyberinfrastructure. Using these calibrations to make predictions at held-out tower sites, we show that the joint cross-site calibration is falsely over-confident due to more information fed into the calibration. By showing which parameters show high site-to-site variability, HB calibration also formally gives us a structure that can detect which process representations are missing from the models and prioritize errors based on the magnitude of the associated uncertainty. For example, in our case-study we were able to identify large site-to-site variability in the parameters associated with the temperature responses of respiration and photosynthesis, associated with a lack of thermal acclimation and adaptation in the model. Moving forward, HB approaches present important new opportunities for statistical modeling of the spatiotemporal variability in modeled parameters and processes that yields both new insights and improved predictions.</jats:p>",2021-04-29
176,10.1101/2021.01.04.425178,13,bioRxiv,Evolutionary Biology,False,A mutational hotspot that determines highly repeatable evolution can be built and broken by silent genetic changes,"[{'ORCID': 'http://orcid.org/0000-0002-3608-538X', 'authenticated-orcid': False, 'given': 'James S.', 'family': 'Horton', 'sequence': 'first', 'affiliation': []}, {'given': 'Louise M.', 'family': 'Flanagan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Robert W.', 'family': 'Jackson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8253-2697', 'authenticated-orcid': False, 'given': 'Nicholas K.', 'family': 'Priest', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5274-7806', 'authenticated-orcid': False, 'given': 'Tiffany B.', 'family': 'Taylor', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Mutational hotspots can determine evolutionary outcomes and make evolution repeatable. Hotspots are products of multiple evolutionary forces including mutation rate heterogeneity, but this variable is often hard to identify. In this work we reveal that a powerfully deterministic genetic hotspot can be built and broken by a handful of silent mutations. We observed this when studying homologous immotile variants of the bacteria <jats:italic>Pseudomonas fluorescens</jats:italic>, AR2 and Pf0-2x. AR2 resurrects motility through highly repeatable <jats:italic>de novo</jats:italic> mutation of the same nucleotide in &gt;95% lines in minimal media (<jats:italic>ntrB</jats:italic> A289C). Pf0-2x, however, evolves via a number of mutations meaning the two strains diverge significantly during adaptation. We determined that this evolutionary disparity was owed to just 6 synonymous variations within the <jats:italic>ntrB</jats:italic> locus, which we demonstrated by swapping the sites and observing that we were able to both break (&gt;95% to 0% in AR2) and build (0% to 80% in Pf0-2x) a powerfully deterministic mutational hotspot. Our work reveals a fundamental role for silent genetic variation in determining adaptive outcomes.</jats:p>",2021-01-04
177,10.1101/2020.05.13.20101253,13,medRxiv,Infectious Diseases (except HIV/AIDS),True,The infection fatality rate of COVID-19 inferred from seroprevalence data,"[{'given': 'John P.A.', 'family': 'Ioannidis', 'sequence': 'first', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>To estimate the infection fatality rate of coronavirus disease 2019 (COVID-19) from data of seroprevalence studies.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Population studies with sample size of at least 500 and published as peer-reviewed papers or preprints as of July 11, 2020 were retrieved from PubMed, preprint servers, and communications with experts. Studies on blood donors were included, but studies on healthcare workers were excluded. The studies were assessed for design features and seroprevalence estimates. Infection fatality rate was estimated from each study dividing the number of COVID-19 deaths at a relevant time point by the number of estimated people infected in each relevant region. Correction was also attempted accounting for the types of antibodies assessed. Secondarily, results from national studies were also examined from preliminary press releases and reports whenever a country had no other data presented in full papers of preprints.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>36 studies (43 estimates) were identified with usable data to enter into calculations and another 7 preliminary national estimates were also considered for a total of 50 estimates. Seroprevalence estimates ranged from 0.222% to 47%. Infection fatality rates ranged from 0.00% to 1.63% and corrected values ranged from 0.00% to 1.31%. Across 32 different locations, the median infection fatality rate was 0.27% (corrected 0.24%). Most studies were done in pandemic epicenters with high death tolls. Median corrected IFR was 0.10% in locations with COVID-19 population mortality rate less than the global average (&lt;73 deaths per million as of July 12, 2020), 0.27% in locations with 73-500 COVID-19 deaths per million, and 0.90% in locations exceeding 500 COVID-19 deaths per million. Among people &lt;70 years old, infection fatality rates ranged from 0.00% to 0.57% with median of 0.05% across the different locations (corrected median of 0.04%).</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The infection fatality rate of COVID-19 can vary substantially across different locations and this may reflect differences in population age structure and case-mix of infected and deceased patients as well as multiple other factors. Estimates of infection fatality rates inferred from seroprevalence studies tend to be much lower than original speculations made in the early days of the pandemic.</jats:p></jats:sec>",2020-05-19
178,10.1101/2020.05.11.20098491,13,medRxiv,Epidemiology,False,The roles of stewardship and socioeconomic status in geographic variation in antibiotic prescribing: an observational study,"[{'given': 'Stephen M', 'family': 'Kissler', 'sequence': 'first', 'affiliation': []}, {'given': 'R Monina', 'family': 'Klevens', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael L', 'family': 'Barnett', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5646-1314', 'authenticated-orcid': False, 'given': 'Yonatan H', 'family': 'Grad', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Importance</jats:title><jats:p>Reducing geographic disparities in antibiotic prescribing is a central public health priority to combat antibiotic resistance, but the drivers of this variation have been unclear.</jats:p></jats:sec><jats:sec><jats:title>Objective</jats:title><jats:p>To measure how differences in outpatient visit rates per 1,000 individuals (‘observed disease’) and in antibiotic prescribing rates per outpatient visit (‘stewardship’) each contributed to a gap in monthly antibiotic prescriptions per 1,000 individuals in Boston <jats:italic>vs</jats:italic>. the rest of Massachusetts, and to identify spatial correlates of the medical conditions that contributed most to the gap.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>We conducted an observational study of medical insurance claims collected between January 2011 and September 2015.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>Outpatient visits in Massachusetts.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>5,028,609 Massachusetts residents under the age of 65 with at least one full month of primary medical insurance during the study period.</jats:p></jats:sec><jats:sec><jats:title>Exposures</jats:title><jats:p>Residence in Boston <jats:italic>vs</jats:italic>. the rest of Massachusetts.</jats:p></jats:sec><jats:sec><jats:title>Main outcomes</jats:title><jats:p>(1) The proportion of the gap in antibiotic prescribing rate between Boston and the rest of Massachusetts attributable to observed disease <jats:italic>vs</jats:italic>. stewardship for 20 medical conditions previously associated with antibiotic prescribing; and (2) geographic correlations between childhood vaccination, air pollution, density of children, and social deprivation index with the medical conditions that best explain the gap in prescribing.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The average monthly antibiotic prescribing rate per 1,000 individuals in Boston was 51.8 (IQR 43.4, 57.5) <jats:italic>vs</jats:italic>. 65.2 (IQR 54.8, 74.5) in the rest of Massachusetts. Geographic differences in outpatient visit rates accounted for 56.0% of the gap in antibiotic prescribing between Boston and the rest of the state, while differences in stewardship accounted for just 19.8% of the gap. Geographic differences in outpatient visit rates for sinusitis, pharyngitis, and suppurative otitis media accounted for 43.3% of the gap in prescribing between Boston and the rest of Massachusetts. Social deprivation index best explains the geographic variation in outpatient visit rates for respiratory illness, with fewer visits in census tracts with higher social deprivation index.</jats:p></jats:sec><jats:sec><jats:title>Conclusions and relevance</jats:title><jats:p>Interventions aimed at reducing geographic disparities in antibiotic prescribing should target the drivers of outpatient visits for respiratory illness and should account for possible under-utilization of health services in areas with the lowest antibiotic consumption. Our findings challenge the conventional wisdom that prescribing practices are the main driver of geographic disparities in antibiotic use.</jats:p></jats:sec>",2020-05-14
179,10.1101/2020.12.30.424757,12,bioRxiv,Cancer Biology,False,A persistent invasive phenotype in post-hypoxic tumor cells is revealed by novel fate-mapping and computational modeling,"[{'ORCID': 'http://orcid.org/0000-0002-5876-2644', 'authenticated-orcid': False, 'given': 'Heber L.', 'family': 'Rocha', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4889-5144', 'authenticated-orcid': False, 'given': 'Inês', 'family': 'Godet', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4547-1220', 'authenticated-orcid': False, 'given': 'Furkan', 'family': 'Kurtoglu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0142-0387', 'authenticated-orcid': False, 'given': 'John', 'family': 'Metzcar', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9445-7113', 'authenticated-orcid': False, 'given': 'Kali', 'family': 'Konstantinopoulos', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2527-465X', 'authenticated-orcid': False, 'given': 'Soumitra', 'family': 'Bhoyar', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3984-9338', 'authenticated-orcid': False, 'given': 'Daniele M.', 'family': 'Gilkes', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9925-0151', 'authenticated-orcid': False, 'given': 'Paul', 'family': 'Macklin', 'sequence': 'additional', 'affiliation': []}]","<jats:title>SUMMARY</jats:title><jats:p>Hypoxia is a critical factor in solid tumors that has been associated with cancer progression and aggressiveness. We recently developed a hypoxia-fate mapping system that allowed the tracing of post-hypoxic cells within a tumor for the first time. This novel approach, based on an oxygen-dependent fluorescent switch, made the investigation of the post-hypoxic phenotype possible. The system allowed us to measure key biological features such as oxygen distribution, cell proliferation and migration. Using this data, we developed a computational model to investigate the motility and phenotypic persistence of hypoxic and post-hypoxic cells during tumor progression. The behavior of hypoxic and post-hypoxic cells was defined by phenotypic persistence time, cell movement bias and the fraction of cells that respond to an enhanced migratory stimulus. Our studies revealed that post-hypoxic cells have an enhanced persistent migratory phenotype that promotes the formation of invasive structures (“plumes”) expanding towards the oxygenated tumor regions. This work combined advanced cell tracking and imaging techniques with mathematical modeling, and revealed for the first time that a persistent invasive migratory phenotype that develops under hypoxic conditions enhances their escape into non-hypoxic tumor regions to invade the surrounding tissue.</jats:p>",2021-01-01
180,10.1101/2021.03.22.436441,12,bioRxiv,Immunology,True,Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals,"[{'given': 'Carmen', 'family': 'Camara', 'sequence': 'first', 'affiliation': []}, {'given': 'Daniel', 'family': 'Lozano-Ojalvo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eduardo', 'family': 'Lopez-Granados', 'sequence': 'additional', 'affiliation': []}, {'given': 'Estela', 'family': 'Paz-Artal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marjorie', 'family': 'Pion', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rafael', 'family': 'Correa-Rocha', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alberto', 'family': 'Ortiz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marcos', 'family': 'Lopez-Hoyos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marta Erro', 'family': 'Iribarren', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jose', 'family': 'Portoles', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pilar', 'family': 'Portoles', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mayte', 'family': 'Perez-Olmeda', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jesus', 'family': 'Oteo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cecilia', 'family': 'Berin', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7764-5307', 'authenticated-orcid': False, 'given': 'Ernesto', 'family': 'Guccione', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2942-0485', 'authenticated-orcid': False, 'given': 'Antonio', 'family': 'Bertoletti', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7037-1681', 'authenticated-orcid': False, 'given': 'Jordi', 'family': 'Ochando', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The rapid development and deployment of mRNA-based vaccines against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) led to the design of accelerated vaccination schedules that have been extremely effective in naïve individuals. While a two-dose immunization regimen with the BNT162b2 vaccine has been demonstrated to provide a 95% efficacy in naïve individuals, the effects of the second vaccine dose in individuals who have previously recovered from natural SARS-CoV-2 infection has been questioned. Here we characterized SARS-CoV-2 spike-specific humoral and cellular immunity in naïve and previously infected individuals during full BNT162b2 vaccination. Our results demonstrate that the second dose increases both the humoral and cellular immunity in naïve individuals. On the contrary, the second BNT162b2 vaccine dose results in a reduction of cellular immunity in COVID-19 recovered individuals, which suggests that a second dose, according to the current standard regimen of vaccination, may be not necessary in individuals previously infected with SARS-CoV-2.</jats:p>",2021-03-22
181,10.1101/2020.10.30.20222729,12,medRxiv,Psychiatry and Clinical Psychology,False,Service user experiences of community services for Complex Emotional Needs: A qualitative thematic synthesis,"[{'ORCID': 'http://orcid.org/0000-0003-4905-4168', 'authenticated-orcid': False, 'given': 'Luke Sheridan', 'family': 'Rains', 'sequence': 'first', 'affiliation': []}, {'given': 'Athena', 'family': 'Echave', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jessica', 'family': 'Rees', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hannah Rachel', 'family': 'Scott', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6865-3425', 'authenticated-orcid': False, 'given': 'Billie', 'family': 'Lever-Taylor', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eva', 'family': 'Broeckelmann', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3881-2018', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Steare', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6521-3101', 'authenticated-orcid': False, 'given': 'Phoebe', 'family': 'Barnett', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chris', 'family': 'Cooper', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tamar', 'family': 'Jeynes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jessica', 'family': 'Russell', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8704-0379', 'authenticated-orcid': False, 'given': 'Sian', 'family': 'Oram', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1072-6182', 'authenticated-orcid': False, 'given': 'Sarah', 'family': 'Rowe', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2219-1384', 'authenticated-orcid': False, 'given': 'Sonia', 'family': 'Johnson', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>There is a recognised need to develop clear service models and pathways to provide high quality care in the community for people with complex emotional needs, who may have been given a “personality disorder” diagnosis. Services should be informed by the views of people with these experiences.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>To systematically review and synthesise qualitative studies on service user experiences of community mental health care for Complex Emotional Needs.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We searched six bibliographic databases for papers published since 2003. We included peer reviewed studies reporting data on service user experiences and views about good care from community-based mental health services for adults with CEN, including generic mental health services and specialist “personality disorder” services. Studies using any qualitative method were included and thematic synthesis used to identify over-arching themes.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Forty-seven papers were included. Main themes were: 1) The need for a long-term perspective on treatment journeys; 2) The need for individualised and holistic care; 3) Large variations in accessibility and quality of mental health services; 4) The centrality of therapeutic relationships; 5) Impacts of ‘personality disorder’ diagnosis. Themes tended to recur across studies from different countries and years.</jats:p></jats:sec><jats:sec><jats:title>Discussion</jats:title><jats:p>Recurrent major themes included wanting support that is individualised and holistic, provides continuity over long journeys towards recovery, and that is delivered by empathetic and well-informed clinicians who are hopeful but realistic about the prospects of treatment. Care that met these simple and clearly stated priorities tended to be restricted to often limited periods of treatment by specialist “personality disorder” services: generic and primary care services were often reported as far from adequate. There is an urgent need to co-design and test strategies for improving long-term support and treatment care for people with “personality disorders” throughout the mental health care system.</jats:p></jats:sec>",2020-11-03
182,10.1101/2021.04.23.441067,12,bioRxiv,Neuroscience,False,Differential impact of acute and chronic stress on CA1 spatial coding and gamma oscillations,"[{'given': 'Anupratap', 'family': 'Tomar', 'sequence': 'first', 'affiliation': []}, {'given': 'Denis', 'family': 'Polygalov', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1243-5189', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'McHugh', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Chronic and acute stress differentially affect behaviour, as well as the structural integrity of the hippocampus, a key brain region involved in cognition and memory. However, it remains unclear if and how the facilitatory effects of acute stress on hippocampal information coding are disrupted as the stress becomes chronic. To examine this, we compared the impact of acute and chronic stress on neural activity in the CA1 subregion of male mice subjected to a chronic immobilization stress paradigm. We observed that following first exposure to stress (acute stress), the spatial information encoded in the hippocampus sharpened and the neurons became increasingly tuned to the underlying theta oscillation in the local field potential (LFP). However, following repeated exposure to same stress (chronic stress), spatial tuning was poorer and the power of both the slow-gamma (30-50 Hz) and fast-gamma (55-90 Hz) oscillations, which correlate with excitatory inputs into the region, decreased. These results support the idea that acute and chronic stress differentially affect neural computations carried out by hippocampal circuits and suggest that acute stress may improve cognitive processing.</jats:p>",2021-04-23
183,10.1101/2020.07.22.20160341,12,medRxiv,Health Policy,True,Effects of non-pharmaceutical interventions on COVID-19: A Tale of Three Models,"[{'given': 'Vincent', 'family': 'Chin', 'sequence': 'first', 'affiliation': []}, {'given': 'John P.A.', 'family': 'Ioannidis', 'sequence': 'additional', 'affiliation': []}, {'given': 'Martin A.', 'family': 'Tanner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sally', 'family': 'Cripps', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>In this paper, we compare the inference regarding the effectiveness of the various non-pharmaceutical interventions (NPIs) for COVID-19 obtained from three SIR models, all developed by the Imperial College COVID-19 Response Team. One model was applied to European countries and published in <jats:italic>Nature</jats:italic><jats:sup>1</jats:sup> (model 1), concluding that complete lockdown was by far the most effective measure, responsible for 80% of the reduction in <jats:italic>R<jats:sub>t</jats:sub></jats:italic>, and 3 million deaths were avoided in the examined countries. The Imperial College team applied a different model to the USA states<jats:sup>2</jats:sup> (model 2), and in response to our original submission, the Imperial team has proposed in a referee report a third model which is a hybrid of the first two models (model 3). We demonstrate that inference is highly nonrobust to model specification. In particular, inference regarding the relative effectiveness of NPIs changes substantially with the model and decision makers who are unaware of, or ignore, model uncertainty are underestimating the risk attached to any decisions based on that model. Our primary observation is that by applying to European countries the model that the Imperial College team used for the USA states (model 2), complete lockdown has no or little effect, since it was introduced typically at a point when <jats:italic>R<jats:sub>t</jats:sub></jats:italic> was already very low. Moreover, using several state-of-the-art metrics for Bayesian model comparison, we demonstrate that model 2 (when applied to the European data) is better supported by the data than the model published in Nature<jats:sup>1</jats:sup>. In particular, serious doubt is cast on the conclusions in Flaxman et al.<jats:sup>1</jats:sup>, whether we examine the data up to May 5th (as in Flaxman et al.<jats:sup>1</jats:sup>) or beyond the point when NPIs began to be lifted. Only by objectively considering a wide variety of models in a statistically principled manner, can one begin to address the effectiveness of NPIs such as lockdown. The approach outlined in this paper provides one such path.</jats:p>",2020-07-27
184,10.1101/2021.04.12.439490,12,bioRxiv,Cancer Biology,False,"Design, Synthesis and Evaluation of WD-repeat containing protein 5 (WDR5) degraders","[{'given': 'Anja', 'family': 'Dölle', 'sequence': 'first', 'affiliation': []}, {'given': 'Bikash', 'family': 'Adhikari', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andreas', 'family': 'Krämer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Janik', 'family': 'Weckesser', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicola', 'family': 'Berner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lena-Marie', 'family': 'Berger', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mathias', 'family': 'Diebold', 'sequence': 'additional', 'affiliation': []}, {'given': 'Magdalena M.', 'family': 'Szewczyk', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dalia', 'family': 'Barsyte-Lovejoy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cheryl H.', 'family': 'Arrowsmith', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jakob', 'family': 'Gebel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Frank', 'family': 'Löhr', 'sequence': 'additional', 'affiliation': []}, {'given': 'Volker', 'family': 'Dötsch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Martin', 'family': 'Eilers', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stephanie', 'family': 'Heinzlmeir', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bernhard', 'family': 'Küster', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christoph', 'family': 'Sotriffer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elmar', 'family': 'Wolf', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stefan', 'family': 'Knapp', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Histone H3K4 methylation serves as post-translational hallmark of actively transcribed genes and is introduced by histone methyltransferases (HMT) and its regulatory scaffolding proteins. One of these is the WD-repeat containing protein 5 (WDR5) that has also been associated with controlling long non-coding RNAs and transcription factors including MYC. The wide influence of dysfunctional HMTs complexes and the typically upregulated MYC levels in diverse tumor types suggested WDR5 as an attractive drug target. Indeed, protein-protein interface inhibitors for two protein interaction interfaces on WDR5 have been developed. While such compounds only inhibit a subset of WDR5 interactions, chemically induced proteasomal degradation of WDR5 might represent an elegant way to target all oncogenic function. This study presents the design, synthesis and evaluation of two diverse WDR5 degrader series based on two WIN site binding scaffolds and shows that linker nature and length strongly influence degradation efficacy.</jats:p>",2021-04-12
185,10.1101/2020.11.22.393231,12,bioRxiv,Genomics,False,Uncovering transposable element variants and their potential adaptive impact in urban populations of the malaria vector Anopheles coluzzii,"[{'given': 'Carlos', 'family': 'Vargas-Chavez', 'sequence': 'first', 'affiliation': []}, {'given': 'Neil Michel', 'family': 'Longo Pendy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sandrine E.', 'family': 'Nsango', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Aguilera', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4726-580X', 'authenticated-orcid': False, 'given': 'Diego', 'family': 'Ayala', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9824-027X', 'authenticated-orcid': False, 'given': 'Josefa', 'family': 'González', 'sequence': 'additional', 'affiliation': []}]","<jats:title>A<jats:sc>bstract</jats:sc></jats:title><jats:sec><jats:title>Background</jats:title><jats:p><jats:italic>Anopheles coluzzii</jats:italic> is one of the primary vectors of human malaria in sub-Saharan Africa. Recently, it has colonized the main cities of Central Africa threatening vector control programs. The adaptation of <jats:italic>An. coluzzii</jats:italic> to urban environments is partly due to an increased tolerance to organic pollution and insecticides. While some of the molecular mechanisms for ecological adaptation, including chromosome rearrangements and introgressions, are known, the role of transposable elements (TEs) in the adaptive processes of this species has not been studied yet. To assess the role of TEs in rapid urban adaptation, the first step is to accurately annotate TE insertions in the genomes of natural populations collected in urban settings.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>We sequenced using long-reads six <jats:italic>An. coluzzii</jats:italic> genomes from natural breeding sites in two major Central Africa cities. We <jats:italic>de novo</jats:italic> annotated the complete set of TEs in these genomes and in an additional high-quality <jats:italic>An. coluzzii</jats:italic> genome available and identified 64 previously undescribed TE families. TEs were non-randomly distributed throughout the genome with significant differences in the number of insertions of several superfamilies across the studied genomes. We identified seven putatively active families with insertions near genes with functions related to vectorial capacity. Moreover, we identified several TE insertions providing promoter and transcription factor binding sites to insecticide resistance and immune-related genes.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The analysis of multiple genomes sequenced using long-read technologies allowed us to generate the most comprehensive TE annotations in this species to date. We identified several TE insertions that could potentially impact both genome architecture and the regulation of functionally relevant genes in <jats:italic>An. coluzzii</jats:italic>. These results provide a basis for future studies of the impact of TEs on the biology of <jats:italic>An. coluzzii</jats:italic>.</jats:p></jats:sec>",2020-11-22
186,10.1101/2021.04.07.21254965,12,medRxiv,Rehabilitation Medicine and Physical Therapy,False,Does one exercise a day make the knee stronger and keep surgery away? A randomized dose-response trial of home-based knee-extensor exercise in patients eligible for knee replacement (the QUADX-1 trial),"[{'ORCID': 'http://orcid.org/0000-0003-2020-8792', 'authenticated-orcid': False, 'given': 'Rasmus Skov', 'family': 'Husted', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0132-8182', 'authenticated-orcid': False, 'given': 'Anders', 'family': 'Troelsen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Henrik', 'family': 'Husted', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7629-168X', 'authenticated-orcid': False, 'given': 'Birk', 'family': 'Grønfeldt', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9102-4515', 'authenticated-orcid': False, 'given': 'Kristian', 'family': 'Thorborg', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7356-6481', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Kallemose', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1173-0335', 'authenticated-orcid': False, 'given': 'Michael Skovdal', 'family': 'Rathleff', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6884-1971', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Bandholm', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Objectives</jats:title><jats:p>To firstly investigate the efficacy of three different dosages of home-based, knee-extensor strength exercise on isometric knee-extensor strength in patients eligible for knee replacement due to severe knee osteoarthritis, and secondly, the influence of exercise on symptoms, physical function and decision on surgery.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Randomized dose-response trial.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>Primary and secondary care.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>One-hundred and forty patients eligible for knee replacement were included. Eligibility for surgery was assessed by an orthopedic surgeon specialized in knee arthroplasty.</jats:p></jats:sec><jats:sec><jats:title>Interventions</jats:title><jats:p>Patients were randomized to three groups; 2, 4 or 6 home-based knee-extensor exercise-sessions per week (group 2, 4 and 6 respectively) for 12 weeks (N=47/group). Exercise instruction was given by a trained physiotherapist.</jats:p></jats:sec><jats:sec><jats:title>Main outcome measures</jats:title><jats:p>The primary outcome was isometric knee-extensor strength. Secondary outcomes were Oxford Knee Score, Knee Osteoarthritis Outcome Score, average knee pain last week (0-10 numeric rating scale), 6-minute walk test, stair climbing test, exercise adherence and “need for surgery”. The primary endpoint was after 12 weeks of exercise (before surgery) and the secondary after surgery. Outcome assessors and patients were blinded to allocation.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>After 12 weeks of exercise, data were available for 117 patients (N=39/group). Isometric knee-extensor strength increased in all groups but intention-to-treat analysis showed no difference between the three groups in change from baseline to after 12 weeks of exercise in isometric knee-extensor muscle strength: Group 2 vs. 4 (0.009 Nm/kg [95% CI -0.15 to 0.17], P=0.913), group 2 vs. 6 (-0.03 Nm/kg [95% CI -0.18 to 0.13], P=0.725) and group 4 vs. 6 (-0.04 Nm/kg [95% CI -0.20 to 0.13], P=0.668). For the secondary outcomes a significant difference before surgery was found between group 2 and group 6 for Oxford Knee Score (4.2 [95% CI 0.6 to 7.8], P=0.02) and average knee pain last week (NRS 0-10) (-1.1 [95% -2.2 to -0.1], P=0.03) in favour of group 2. No other differences were observed before and after surgery. After the 12- week exercise intervention, 38 (32.5%) patients wanted surgery and 79 (67.5%) postponed surgery. This was independent of exercise dosage.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Knee-extensor strength increased with both 2, 4 and 6 exercise sessions per week but none of the prescribed exercise dosages were superior to the others for the primary outcome isometric knee-extensor strength after 12 weeks. Two home-based knee-extensor exercise sessions a week seems superior to six for patient-reported outcomes, and across exercise dosages, only one in three patients decided to have surgery after the coordinated home-based exercise intervention.</jats:p></jats:sec><jats:sec><jats:title>Trial registration</jats:title><jats:p>ClinicalTrials.gov identifier: <jats:underline>NCT02931058</jats:underline>, pre-registered October 10<jats:sup>th</jats:sup>, 2016. Protocol PubMed (PMID: <jats:underline>29347947</jats:underline>).</jats:p></jats:sec><jats:sec><jats:title>What is already known on this topic</jats:title><jats:p>Clinical guidelines recommend exercise therapy targeting the knee-extensor muscles in patients eligible for knee replacement before surgery is considered.</jats:p><jats:p>Exercise therapy may reduce knee osteoarthritis symptoms and impact the decision on surgery, but the dose-response relationship is not described.</jats:p><jats:p>Exercise therapy is typically delivered as supervised programs requiring physical attendance at fixed times and often require self-payment, which may be a barrier for some patients.</jats:p></jats:sec><jats:sec><jats:title>What this study adds</jats:title><jats:p>Knee-extensor strength increased with 2, 4 and 6 exercise sessions per week, but none of the prescribed exercise dosages were superior to the others after 12 weeks – indicating no dose-response relationship.</jats:p><jats:p>Two in three patients eligible for knee replacement decided to postpone knee replacement surgery after 12 weeks of home-based exercise with <jats:italic>one</jats:italic> simple exercise.</jats:p><jats:p>This study successfully employed a model of coordinated care where the patients’ decision on surgical treatment was re-evaluated based on symptom changes following simple home-based exercise therapy. These findings suggest using a model of coordinated non-surgical and surgical care to improve the decision on surgery for patients eligible for knee replacement.</jats:p></jats:sec>",2021-04-07
187,10.1101/2021.04.27.441665,12,bioRxiv,Neuroscience,False,The medial orbitofrontal cortex - basolateral amygdala circuit regulates the influence of reward cues on adaptive behavior and choice,"[{'given': 'Nina T.', 'family': 'Lichtenberg', 'sequence': 'first', 'affiliation': []}, {'given': 'Linnea', 'family': 'Sepe-Forrest', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zachary T.', 'family': 'Pennington', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexander C.', 'family': 'Lamparelli', 'sequence': 'additional', 'affiliation': []}, {'given': 'Venuz Y.', 'family': 'Greenfield', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kate M.', 'family': 'Wassum', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Adaptive reward-related decision making requires accurate prospective consideration of the current availability and desirability of potential rewarding options. Often this information must be inferred based on the presence of predictive environmental events. The basolateral amygdala (BLA) and medial orbitofrontal cortex (mOFC) are two key nodes in the circuitry supporting such outcome guided behavior, but very little is known about the function of direct connections between these regions. Here, in male rats, we first anatomically confirmed the existence of bidirectional, direct projections between the mOFC and BLA and found that BLA projections to mOFC are distinct from those to lateral OFC (lOFC). Next, using pathway-specific chemogenetic inhibition and the outcome-selective Pavlovian-to-instrumental transfer and devaluation tests, we interrogated the function of the bidirectional mOFC→BLA connections in reward-directed behavior. We found evidence that the mOFC→BLA pathway mediates the use of environmental cues to predict which reward is available, information needed to infer which action to choose, and how desirable that reward is to ensure adaptive cue responses. By contrast, the BLA→mOFC pathway is not needed to use cues to know which reward is available but is needed to use the current desirability of that reward to infer how advantageous it would be to respond to the cue. These functions differ from those we previously identified for the lOFC-BLA circuit. Collectively, these data reveal the mOFC-BLA circuit as critical for the cue-dependent reward outcome expectations that influence adaptive behavior and decision making.</jats:p><jats:sec><jats:title>SIGNIFICANCE STATEMENT</jats:title><jats:p>To make good decisions we evaluate how advantageous a particular course of action would be. This requires understanding what rewarding events might be available and how desirable those events are currently. Such prospective considerations are critical for adaptive decision making but are disrupted in many psychiatric diseases. Here we reveal that direct connections between the medial orbitofrontal cortex and basolateral amygdala mediate these functions. These findings are especially important in light of evidence of dysfunction in this circuit in substance use disorder and mental illnesses marked by poor decision making.</jats:p></jats:sec>",2021-04-27
188,10.1101/2021.04.16.439809,12,bioRxiv,Neuroscience,False,A Cryptochrome adopts distinct moon- and sunlight states and functions as moonlight interpreter in monthly oscillator entrainment,"[{'given': 'Birgit', 'family': 'Poehn', 'sequence': 'first', 'affiliation': []}, {'given': 'Shruthi', 'family': 'Krishnan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Martin', 'family': 'Zurl', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aida', 'family': 'Coric', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dunja', 'family': 'Rokvic', 'sequence': 'additional', 'affiliation': []}, {'given': 'Enrique', 'family': 'Arboleda', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lukas', 'family': 'Orel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Florian', 'family': 'Raible', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eva', 'family': 'Wolf', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8038-1741', 'authenticated-orcid': False, 'given': 'Kristin', 'family': 'Tessmar-Raible', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Measuring time by the moon’s monthly cycles is a wide-spread phenomenon and crucial for successful reproduction in countless marine organisms. In several species, such as the mass-spawning bristle worm <jats:italic>Platynereis dumerilii</jats:italic>, an endogenous monthly oscillator synchronizes reproduction to specific days. Classical work showed that this oscillator is set by full moon. But how do organisms recognize this specific moon phase?</jats:p><jats:p>We uncover L-Cry’s involvement: photoreduction and recovery kinetics of its co-factor FAD differ strongly when purified L-Cry is exposed to naturalistic moonlight, naturalistic sunlight, or their different successions. L-Cry’s sun-versus moonlight states correlate with distinct sub-cellular localizations, indicating differential signalling. These properties enable a discrimination between sun- and moonlight, as well as moonlight duration as a moon phase indicator.</jats:p><jats:p>Consistently, <jats:italic>l-cry</jats:italic> mutants re-entrain their circalunar phase less well than wild-type to naturalistic moonlight. But under artificially strong nocturnal light, <jats:italic>l-cry</jats:italic> mutants re-entrain faster than wildtype, suggesting that L-Cry at least partly blocks “wrong” light from impacting on this oscillator. Our work provides a new level of functional understanding of moon-regulated biological processes.</jats:p>",2021-04-18
189,10.1101/2021.04.26.441388,12,bioRxiv,Systems Biology,False,Integrative biology defines novel biomarkers of resistance to strongylid infection in horses,"[{'ORCID': 'http://orcid.org/0000-0002-4032-139X', 'authenticated-orcid': False, 'given': 'Guillaume', 'family': 'Sallé', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6389-0712', 'authenticated-orcid': False, 'given': 'Cécile', 'family': 'Canlet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jacques', 'family': 'Cortet', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christine', 'family': 'Koch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joshua', 'family': 'Malsa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fabrice', 'family': 'Reigner', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9315-007X', 'authenticated-orcid': False, 'given': 'Mickaël', 'family': 'Riou', 'sequence': 'additional', 'affiliation': []}, {'given': 'Noémie', 'family': 'Perrot', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6916-6418', 'authenticated-orcid': False, 'given': 'Alexandra', 'family': 'Blanchard', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8001-6314', 'authenticated-orcid': False, 'given': 'Nuria', 'family': 'Mach', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The widespread failure of anthelmintic drugs against nematodes of veterinary interest requires novel control strategies. Selective treatment of the most susceptible individuals could reduce drug selection pressure but requires appropriate biomarkers of the intrinsic susceptibility potential. To date, this has been missing in livestock species. Here, we selected Welsh ponies with divergent intrinsic susceptibility to cyathostomin infection and found that their potential was sustained across a 10-year time window. Using this unique set of individuals, we monitored variations in their blood cell populations, plasma metabolites and faecal microbiota over a grazing season to isolate core differences between their respective responses under worm-free or natural infection conditions. Our analyses identified the concomitant rise in plasmatic phenylalanine level and faecal <jats:italic>Prevotella</jats:italic> abundance and the reduction in circulating monocyte counts as biomarkers of the need for drug treatment. This biological signal was replicated in other independent populations. We also unravelled an immunometabolic network encompassing plasmatic beta-hydroxybutyrate level, short-chain fatty acid producing bacteria and circulating neutrophils that forms the discriminant baseline between susceptible and resistant individuals. Altogether our observations open new perspectives on the susceptibility of equids to cyathostomin infection and leave scope for both new biomarkers of infection and nutritional intervention.</jats:p>",2021-04-27
190,10.1101/2021.04.27.441587,12,bioRxiv,Biophysics,False,A nanoscale reciprocating rotary mechanism with coordinated mobility control,"[{'ORCID': 'http://orcid.org/0000-0001-9185-3954', 'authenticated-orcid': False, 'given': 'Eva', 'family': 'Bertosin', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9927-1502', 'authenticated-orcid': False, 'given': 'Christopher M.', 'family': 'Maffeo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Thomas', 'family': 'Drexler', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7805-906X', 'authenticated-orcid': False, 'given': 'Maximilian N.', 'family': 'Honemann', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6042-8442', 'authenticated-orcid': False, 'given': 'Aleksei', 'family': 'Aksimentiev', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1270-3662', 'authenticated-orcid': False, 'given': 'Hendrik', 'family': 'Dietz', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Biological molecular motors transform chemical energy into mechanical work by coupling a cycle of catalytic reactions to large scale structural transitions. Mechanical deformation can be surprisingly efficient in realizing such coupling, as demonstrated by the celebrated example of F<jats:sub>1</jats:sub>F<jats:sub>o</jats:sub> ATP synthase. Here, we describe a synthetic molecular mechanism that transforms a rotary motion of an asymmetric camshaft into reciprocating large-scale transitions in the structure of the surrounding stator orchestrated by mechanical deformation. We designed the mechanism using DNA origami, characterized the structure of the components and the entire mechanism using cryo-electron microscopy, and examined the mechanism’s dynamic behavior using single-particle fluorescence microscopy and molecular dynamics simulations. The data indicates that, while the camshaft can rotate inside the stator by diffusion, mechanical deformation of the stator makes the camshaft pause at a set of preferred orientations. By changing the mechanical stiffness of the stator, we could accelerate or suppress the Brownian rotation within the mechanism, thereby demonstrating an allosteric coupling between the movement of the camshaft and of the stator, and the ability to tailor the free energy landscape that governs the rotary motion. Our mechanism provides a framework for the manufacture of artificial nanomachines that, just like the man-made machines in the macroscopic world, function because of coordinated movements of their components.</jats:p>",2021-04-27
191,10.1101/2021.04.27.441586,12,bioRxiv,Cell Biology,False,"Kinase activity of TBK1 is required for its binding to STING, but not for its recruitment to the Golgi","[{'given': 'Haruka', 'family': 'Kemmoku', 'sequence': 'first', 'affiliation': []}, {'given': 'Yoshihiko', 'family': 'Kuchitsu', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9806-910X', 'authenticated-orcid': False, 'given': 'Kojiro', 'family': 'Mukai', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0464-6370', 'authenticated-orcid': False, 'given': 'Tomohiko', 'family': 'Taguchi', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Stimulator of interferon genes (STING) is an innate immune protein for DNA pathogens. In response to the emergence of DNA in the cytosol, STING relocates from the endoplasmic reticulum (ER) to the Golgi and induces the type I interferon response through cytosolic TANK-binding kinase 1 (TBK1). The molecular mechanism underlying TBK1 activation by STING remains poorly understood. Here we report a cell system by which STING and TBK1 are simultaneously monitored. The system utilizes STING/TBK1-double knockout (KO) cells, fluorescent protein-tagged TBK1 and STING, and super-resolution microscopy. After STING stimulation, TBK1 is directly recruited to the trans-Golgi network (TGN), not to the other parts of the Golgi. The recruitment of TBK1 does not require its kinase activity. C-terminal STING variants (ΔC9 and L373A), in which the TBK1-STING binding interface is mutated or deleted, induce the recruitment of TBK1. These results indicate that the kinase activity of TBK1 or the C-terminal motif of STING is not required for its recruitment to TGN, but rather for the formation of the stable STING signalling complex at TGN.</jats:p>",2021-04-27
192,10.1101/2021.03.03.21251066,12,medRxiv,Infectious Diseases (except HIV/AIDS),True,Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination,"[{'given': 'Lisa', 'family': 'Müller', 'sequence': 'first', 'affiliation': []}, {'given': 'Marcel', 'family': 'Andrée', 'sequence': 'additional', 'affiliation': []}, {'given': 'Wiebke', 'family': 'Moskorz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ingo', 'family': 'Drexler', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lara', 'family': 'Walotka', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ramona', 'family': 'Grothmann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Johannes', 'family': 'Ptok', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jonas', 'family': 'Hillebrandt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anastasia', 'family': 'Ritchie', 'sequence': 'additional', 'affiliation': []}, {'given': 'Denise', 'family': 'Rabl', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philipp Niklas', 'family': 'Ostermann', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rebekka', 'family': 'Robitzsch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sandra', 'family': 'Hauka', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andreas', 'family': 'Walker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher', 'family': 'Menne', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ralf', 'family': 'Grutza', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jörg', 'family': 'Timm', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ortwin', 'family': 'Adams', 'sequence': 'additional', 'affiliation': []}, {'given': 'Heiner', 'family': 'Schaal', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The SARS-CoV-2 pandemic has led to the development of various vaccines. Real-life data on immune responses elicited in the most vulnerable group of vaccinees over 80 years old is still underrepresented despite the prioritization of the elderly in vaccination campaigns.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We conducted a cohort study with two age groups, young vaccinees below the age of 60 and elderly vaccinees over the age of 80, to compare their antibody responses to the first and second dose of the BNT162b2 COVID-19 vaccination.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>While the majority of participants in both groups produced specific IgG antibody titers against SARS-CoV-2 spike protein, titers were significantly lower in elderly participants. Although the increment of antibody levels after the second immunization was higher in elderly participants, the absolute mean titer of this group remained lower than the &lt;60 group. After the second vaccination, 31.3 % of the elderly had no detectable neutralizing antibodies in contrast to the younger group, in which only 2.2% had no detectable neutralizing antibodies.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Our data suggests that lower frequencies of neutralizing antibodies after BNT162b2 vaccination in the elderly population may require earlier revaccination to ensure strong immunity and protection against infection.</jats:p></jats:sec>",2021-03-05
193,10.1101/2021.01.27.21250604,12,medRxiv,Epidemiology,True,The World Mortality Dataset: Tracking excess mortality across countries during the COVID-19 pandemic,"[{'given': 'Ariel', 'family': 'Karlinsky', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5639-7209', 'authenticated-orcid': False, 'given': 'Dmitry', 'family': 'Kobak', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Comparing the impact of the COVID-19 pandemic between countries or across time is difficult because the reported numbers of cases and deaths can be strongly affected by testing capacity and reporting policy. Excess mortality, defined as the increase in all-cause mortality relative to the expected mortality, is widely considered as a more objective indicator of the COVID-19 death toll. However, there has been no central, frequently-updated repository of the all-cause mortality data across countries. To fill this gap, we have collected weekly, monthly, or quarterly all-cause mortality data from 89 countries and territories, openly available as the regularly-updated World Mortality Dataset. We used this dataset to compute the excess mortality in each country during the COVID-19 pandemic. We found that in the worst-affected countries the annual mortality increased by over 50%, while in several other countries it decreased by over 5%, presumably due to lockdown measures decreasing the non-COVID mortality. Moreover, we found that while some countries have been reporting the COVID-19 deaths very accurately, many countries have been underreporting their COVID-19 deaths by an order of magnitude or more. Averaging across the entire dataset suggests that the world’s COVID-19 death toll may be at least 1.6 times higher than the reported number of deaths.</jats:p>",2021-01-29
194,10.1101/2021.01.26.21250420,11,medRxiv,Infectious Diseases (except HIV/AIDS),True,Outcomes of Ivermectin in the treatment of COVID-19: a systematic review and meta-analysis,"[{'given': 'Alex', 'family': 'Castañeda-Sabogal', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3904-7514', 'authenticated-orcid': False, 'given': 'Diego', 'family': 'Chambergo-Michilot', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4664-2856', 'authenticated-orcid': False, 'given': 'Carlos J.', 'family': 'Toro-Huamanchumo', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7261-7702', 'authenticated-orcid': False, 'given': 'Christian', 'family': 'Silva-Rengifo', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2768-9712', 'authenticated-orcid': False, 'given': 'José', 'family': 'Gonzales-Zamora', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2896-1407', 'authenticated-orcid': False, 'given': 'Joshuan J.', 'family': 'Barboza', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>To assess the outcomes of ivermectin in ambulatory and hospitalized patients with COVID-19.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Five databases and websites for preprints were searched until January 2021 for randomized controlled trials (RCTs) and retrospective cohorts assessing ivermectin versus control in ambulatory and hospitalized participants. The primary outcome was overall mortality. Secondary outcome was recovered patients. For meta-analysis, random-effects and inverse variance meta-analyses with logarithmic transformation were performed. ROBINS-I for cohort studies, and the Cochrane Risk of Bias 2.0 tool for trials were used. The strength of evidence was assessed using GRADE.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>After the selection, twelve studies (five retrospective cohort studies, six randomized clinical trials and one case series), were included. In total, 7412 participants were reported, the mean age was 47.5 (SD 9.5) years, and 4283 (58%) were male. Ivermectin was not associated with reduced mortality (logRR: 0.89, 95% CI 0.09 to 1.70, p = 0.04, I<jats:sup>2</jats:sup>= 84.7%), or reduced patient recovery (logRR 5.52, 95% CI -24.36 to 35.4, p = 0.51, I<jats:sup>2</jats:sup>= 92.6%). All studies had a high risk of bias, and showed a very low certainty of the evidence.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>There insufficient certainty and quality of evidence to recommend the use of ivermectin to prevent or treat ambulatory or hospitalized patients with COVID-19.</jats:p></jats:sec>",2021-01-27
195,10.1101/2021.04.27.441656,11,bioRxiv,Cancer Biology,False,Immune microenvironment subtypes and association with tumor cell mutations and antigen expression in follicular lymphoma.,"[{'given': 'Guangchun', 'family': 'Han', 'sequence': 'first', 'affiliation': []}, {'given': 'Qing', 'family': 'Deng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Enyu', 'family': 'Dai', 'sequence': 'additional', 'affiliation': []}, {'given': 'Minghao', 'family': 'Dang', 'sequence': 'additional', 'affiliation': []}, {'given': 'John', 'family': 'Ma', 'sequence': 'additional', 'affiliation': []}, {'given': 'Haopeng', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Olga', 'family': 'Kudryashova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mark', 'family': 'Meerson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sergey', 'family': 'Isaev', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nikita', 'family': 'Kotlov', 'sequence': 'additional', 'affiliation': []}, {'given': 'Krystle', 'family': 'Nomie', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aleksander', 'family': 'Bagaev', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simrit', 'family': 'Parmar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Frederick', 'family': 'Hagemeister', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sairah', 'family': 'Ahmed', 'sequence': 'additional', 'affiliation': []}, {'given': 'Swami', 'family': 'Iyer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Filepe', 'family': 'Samaniego', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raphael', 'family': 'Steiner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luis', 'family': 'Fayad', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hun', 'family': 'Lee', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nathan', 'family': 'Fowler', 'sequence': 'additional', 'affiliation': []}, {'given': 'Francisco', 'family': 'Vega', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher', 'family': 'Flowers', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paolo', 'family': 'Strati', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jason', 'family': 'Westin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sattva', 'family': 'Neelapu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Loretta', 'family': 'Nastoupil', 'sequence': 'additional', 'affiliation': []}, {'given': 'Linghua', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6309-9472', 'authenticated-orcid': False, 'given': 'Michael R', 'family': 'Green', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Follicular lymphoma (FL) is a B-cell lymphoma with a complex tumor microenvironment that is rich in non-malignant immune cells. We applied single-cell RNA-sequencing to characterize the diverse tumor and immune cell populations of FL and identified major phenotypic subsets of FL T-cells including a novel cytotoxic CD4 T-cell population. Their relative proportions of T-cells defined four major FL subtypes, characterized by differential representation or relative depletion of distinct T-cell subsets. By integrating exome sequencing, we observed that somatic mutations are associated with, but not definitive for, reduced antigen presentation on FL cells. In turn, expression of MHC class II genes by FL cells was associated with significant differences in the proportions and targetable immunophenotypic characteristics. This provides a classification framework of the FL microenvironment, their association with FL genotypes and antigen presentation, and informs different potential immunotherapeutic strategies based upon tumor cell MHC class II expression.</jats:p>",2021-04-28
196,10.1101/2020.01.31.928960,11,bioRxiv,Molecular Biology,False,Widespread divergent transcription from prokaryotic promoters,"[{'given': 'Emily', 'family': 'Warman', 'sequence': 'first', 'affiliation': []}, {'given': 'David', 'family': 'Forrest', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joseph T.', 'family': 'Wade', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3375-5154', 'authenticated-orcid': False, 'given': 'David C.', 'family': 'Grainger', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Promoters are DNA sequences that stimulate the initiation of transcription. In all prokaryotes, promoters are believed to drive transcription in a single direction. Here we show that prokaryotic promoters are frequently bidirectional and drive divergent transcription. Mechanistically, this occurs because key promoter elements have inherent symmetry and often coincide on opposite DNA strands. Reciprocal stimulation between divergent transcription start sites also contributes. Horizontally acquired DNA is enriched for bidirectional promoters suggesting that they represent an early step in prokaryotic promoter evolution.</jats:p>",2020-02-02
197,10.1101/2020.04.17.047480,11,bioRxiv,Microbiology,True,Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity,"[{'ORCID': 'http://orcid.org/0000-0002-9005-3979', 'authenticated-orcid': False, 'given': 'Collin D.', 'family': 'Heer', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0516-814X', 'authenticated-orcid': False, 'given': 'Daniel J.', 'family': 'Sanderson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0451-6066', 'authenticated-orcid': False, 'given': 'Lynden S.', 'family': 'Voth', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8435-9042', 'authenticated-orcid': False, 'given': 'Yousef M.O.', 'family': 'Alhammad', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4593-4096', 'authenticated-orcid': False, 'given': 'Mark S.', 'family': 'Schmidt', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5941-4094', 'authenticated-orcid': False, 'given': 'Samuel A.J.', 'family': 'Trammell', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-4213-2354', 'authenticated-orcid': False, 'given': 'Stanley', 'family': 'Perlman', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael S.', 'family': 'Cohen', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1560-1573', 'authenticated-orcid': False, 'given': 'Anthony R.', 'family': 'Fehr', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4955-3226', 'authenticated-orcid': False, 'given': 'Charles', 'family': 'Brenner', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:p>Poly-ADP-ribose polymerase (PARP) superfamily members covalently link either a single ADP-ribose (ADPR) or a chain of ADPR units to proteins using nicotinamide adenine dinucleotide (NAD) as the source of ADPR. While the well-known poly-ADP-ribosylating (PARylating) PARPs primarily function in the DNA damage response, many non-canonical mono-ADP-ribosylating (MARylating) PARPs are associated with cellular antiviral responses. We recently demonstrated robust upregulation of several PARPs following infection with Murine Hepatitis Virus (MHV), a model coronavirus. Here we show that SARS-CoV-2 infection strikingly upregulates MARylating PARPs and induces the expression of genes encoding enzymes for salvage NAD synthesis from nicotinamide (NAM) and nicotinamide riboside (NR), while downregulating other NAD biosynthetic pathways. We show that overexpression of PARP10 is sufficient to depress cellular NAD and that the activities of the transcriptionally induced enzymes PARP7, PARP10, PARP12 and PARP14 are limited by cellular NAD and can be enhanced by pharmacological activation of NAD synthesis. We further demonstrate that infection with MHV induces a severe attack on host cell NAD<jats:sup>+</jats:sup>and NADP<jats:sup>+</jats:sup>. Finally, we show that NAMPT activation, NAM and NR dramatically decrease the replication of an MHV virus that is sensitive to PARP activity. These data suggest that the antiviral activities of noncanonical PARP isozyme activities are limited by the availability of NAD, and that nutritional and pharmacological interventions to enhance NAD levels may boost innate immunity to coronaviruses.</jats:p>",2020-04-18
198,10.1101/2021.04.07.21255081,11,medRxiv,Infectious Diseases (except HIV/AIDS),True,Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study,"[{'given': 'Matt D.T.', 'family': 'Hitchings', 'sequence': 'first', 'affiliation': []}, {'given': 'Otavio T.', 'family': 'Ranzani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mario Sergio', 'family': 'Scaramuzzini Torres', 'sequence': 'additional', 'affiliation': []}, {'given': 'Silvano Barbosa', 'family': 'de Oliveira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Maria', 'family': 'Almiron', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rodrigo', 'family': 'Said', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ryan', 'family': 'Borg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Wade L.', 'family': 'Schulz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Roberto Dias', 'family': 'de Oliveira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patricia Vieira', 'family': 'da Silva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel Barros', 'family': 'de Castro', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vanderson', 'family': 'de Souza Sampaio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bernardino', 'family': 'Cláudio de Albuquerque', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tatyana Costa', 'family': 'Amorim Ramos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Shadia Hussami', 'family': 'Hauache Fraxe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cristiano Fernandes', 'family': 'da Costa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Felipe Gomes', 'family': 'Naveca', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andre M.', 'family': 'Siqueira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Wildo Navegantes', 'family': 'de Araújo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jason R.', 'family': 'Andrews', 'sequence': 'additional', 'affiliation': []}, {'given': 'Derek A.T.', 'family': 'Cummings', 'sequence': 'additional', 'affiliation': []}, {'given': 'Albert I.', 'family': 'Ko', 'sequence': 'additional', 'affiliation': []}, {'given': 'Julio', 'family': 'Croda', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant P.1 emerged in the city of Manaus in late 2020 during a large resurgence of coronavirus disease (COVID-19), and has spread throughout Brazil. The effectiveness of vaccines in settings with widespread P.1 transmission has not been reported.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We performed a matched test-negative case-control study to estimate the effectiveness of an inactivated vaccine, CoronaVac, in healthcare workers (HCWs) in Manaus, where P.1 accounted for 75% of genotyped SARS-CoV-2 samples at the peak of its epidemic. Information from electronic surveillance databases was used to select cases of RT-PCR-confirmed SARS-CoV-2 infection and matched test-negative controls from 19 January, 2021 to 25 March, 2021. We used conditional logistic regression to estimate the effectiveness in reducing the odds of primary and secondary outcomes of, respectively, symptomatic and any SARS-CoV-2 infection.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Among 53,176 HCWs, 46,884 (88%) received at least one dose of CoronaVac and 2,656 (5%) underwent RT-PCR testing from 19 January, 2021 to 25 March, 2021. Of 2,797 RT-PCR tests, 776 (28%) were positive. 393 and 135 case-control pairs with and without, respectively, symptomatic illness were selected for the matched analyses. Vaccination with at least one dose was associated with a 0.50-fold reduction (adjusted vaccine effectiveness, 49.6%; 95% CI, 11.3 - 71.4) in the odds of symptomatic SARS-CoV-2 infection during the period 14 days or more after receiving the first dose. Estimated vaccine effectiveness of at least one dose against any SARS-CoV-2 infection was 35.1% (95% CI, −6.6 - 60.5) in the same time period.</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>Administration of at least one dose of CoronaVac showed effectiveness against symptomatic SARS-CoV-2 infection in the setting of epidemic P.1 transmission, underscoring the need to increase vaccination efforts in response to the spread of this variant in Brazil and globally.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>Pan American Health Organization; Fundação Oswaldo Cruz (Fiocruz); Municipal Health Secretary of Manaus</jats:p></jats:sec>",2021-04-07
199,10.1101/2021.04.23.441127,11,bioRxiv,Cell Biology,False,Precursor types predict the stability of neuronal branches,"[{'ORCID': 'http://orcid.org/0000-0002-8601-5638', 'authenticated-orcid': False, 'given': 'Joachim', 'family': 'Fuchs', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7873-8687', 'authenticated-orcid': False, 'given': 'Britta J.', 'family': 'Eickholt', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Branches are critical for neuron function, generating the morphological complexity required for functional networks. They emerge from different, well-described, cytoskeletal precursor structures that elongate to branches. While branches are thought to be maintained by shared cytoskeletal regulators, our data from mouse hippocampal neurons indicate that the precursor structures trigger alternative branch maintenance mechanisms with differing stabilities. While branches originating from lamellipodia or growth cone splitting events collapse soon after formation, branches emerging from filopodia persist. Furthermore, compared to other developing neurites, axons stabilise all branches and preferentially initiate branches from filopodia. These differences explain the decreased stability of branches we observe in neurons lacking the plasma membrane protein phospholipid phosphatase related protein 3 (PLPPR3/PRG2). Rather than altering branch stability directly, PLPPR3 boosts a ‘filopodia branch program’ on axons, thereby indirectly initiating more long-lived branches. We propose that studies on branching should distinguish overall stabilising effects from effects on precursor types, ideally using multifactorial statistical models as exemplified in this study.</jats:p>",2021-04-23
200,10.1101/2021.03.18.435942,11,bioRxiv,Genomics,False,Sequence determinants of human gene regulatory elements,"[{'ORCID': 'http://orcid.org/0000-0001-6576-5440', 'authenticated-orcid': False, 'given': 'Biswajyoti', 'family': 'Sahu', 'sequence': 'first', 'affiliation': []}, {'given': 'Tuomo', 'family': 'Hartonen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Päivi', 'family': 'Pihlajamaa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bei', 'family': 'Wei', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kashyap', 'family': 'Dave', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fangjie', 'family': 'Zhu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eevi', 'family': 'Kaasinen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Katja', 'family': 'Lidschreiber', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michael', 'family': 'Lidschreiber', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3295-8729', 'authenticated-orcid': False, 'given': 'Carsten O.', 'family': 'Daub', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patrick', 'family': 'Cramer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Teemu', 'family': 'Kivioja', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6851-9912', 'authenticated-orcid': False, 'given': 'Jussi', 'family': 'Taipale', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>DNA determines where and when genes are expressed, but the full set of sequence determinants that control gene expression is not known. To obtain a global and unbiased view of the relative importance of different sequence determinants in gene expression, we measured transcriptional activity of DNA sequences that are in aggregate ∼100 times longer than the human genome in three different cell types. We show that enhancers can be classified to three main types: classical enhancers<jats:sup>1</jats:sup>, closed chromatin enhancers and chromatin-dependent enhancers, which act via different mechanisms and differ in motif content. Transcription factors (TFs) act generally in an additive manner with weak grammar, with classical enhancers increasing expression from promoters by a mechanism that does not involve specific TF-TF interactions. Few TFs are strongly active in a cell, with most activities similar between cell types. Chromatin-dependent enhancers are enriched in forkhead motifs, whereas classical enhancers contain motifs for TFs with strong transactivator domains such as ETS and bZIP; these motifs are also found at transcription start site (TSS)-proximal positions. However, some TFs, such as NRF1 only activate transcription when placed close to the TSS, and others such as YY1 display positional preference with respect to the TSS. TFs can thus be classified into four non-exclusive subtypes based on their transcriptional activity: chromatin opening, enhancing, promoting and TSS determining factors – consistent with the view that the binding motif is the only atomic unit of gene expression.</jats:p>",2021-03-18
201,10.1101/2021.03.19.436138,11,bioRxiv,Cell Biology,False,Intraflagellar transport trains can turn around without the ciliary tip complex,"[{'ORCID': 'http://orcid.org/0000-0003-3772-6318', 'authenticated-orcid': False, 'given': 'Adrian Pascal', 'family': 'Nievergelt', 'sequence': 'first', 'affiliation': []}, {'given': 'Ilia', 'family': 'Zykov', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dennis', 'family': 'Diener', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6953-8915', 'authenticated-orcid': False, 'given': 'Tim-Oliver', 'family': 'Buchholz', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9556-2097', 'authenticated-orcid': False, 'given': 'Markus', 'family': 'Delling', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0750-8515', 'authenticated-orcid': False, 'given': 'Stefan', 'family': 'Diez', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8499-5812', 'authenticated-orcid': False, 'given': 'Florian', 'family': 'Jug', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ludĕk', 'family': 'S̆tĕpánek', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2295-9568', 'authenticated-orcid': False, 'given': 'Gaia', 'family': 'Pigino', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Cilia and flagella are microtubule doublet based organelles found across the eukaryotic tree of life. Their very high aspect ratio and crowded interior are unfavourable to diffusive transport for their assembly and maintenance. Instead, a highly dynamic system of intraflagellar transport (IFT) trains moves rapidly up and down the cilium. However, the mechanism of how these trains turn around upon reaching the ciliary tip has remained elusive. It has been hypothesized that there exists a dedicated calcium-dependent protein-based machinery at the ciliary tip to mediate this conversion. In this work, we use physical and chemical methods to manipulate IFT in the cilia of the unicellular green alga <jats:italic>Chlamydomonas reinhardtii</jats:italic> to show that no such stationary tip-machinery is required for IFT turnaround. Instead, we demonstrate that the conversion from anterograde to retrograde IFT trains is a calcium independent intrinsic ability of the IFT system.</jats:p>",2021-03-19
202,10.1101/2021.02.07.21251281,11,medRxiv,Infectious Diseases (except HIV/AIDS),True,Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients,"[{'given': 'Eduardo', 'family': 'Cervantes-Alvarez', 'sequence': 'first', 'affiliation': []}, {'given': 'Nathaly Limon-de la', 'family': 'Rosa', 'sequence': 'additional', 'affiliation': []}, {'given': 'Moisés', 'family': 'Salgado-de la Mora', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paola', 'family': 'Valdez-Sandoval', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mildred', 'family': 'Palacios-Jiménez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fátima', 'family': 'Rodriguez-Alvarez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Brenda I.', 'family': 'Vera-Maldonado', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eduardo', 'family': 'Aguirre-Aguilar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Juan Manuel', 'family': 'Escobar-Valderrama', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jorge', 'family': 'Alanis-Mendizabal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Osvely', 'family': 'Méndez-Guerrero', 'sequence': 'additional', 'affiliation': []}, {'given': 'Farid', 'family': 'Tejeda-Dominguez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jiram', 'family': 'Torres-Ruíz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Diana', 'family': 'Gómez-Martín', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kathryn L', 'family': 'Colborn', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Kershenobich', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christene A', 'family': 'Huang', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0118-4676', 'authenticated-orcid': False, 'given': 'Nalu', 'family': 'Navarro-Alvarez', 'sequence': 'additional', 'affiliation': []}]","<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>BACKGROUND</jats:title><jats:p>Prognostic biomarkers are needed to identify patients at high-risk for severe COVID-19. Galectin-3 is known to drive neutrophil infiltration and release of pro-inflammatory cytokines contributing to airway inflammation.</jats:p></jats:sec><jats:sec><jats:title>METHODS</jats:title><jats:p>In this prospective cohort, we assessed galectin-3 levels in 156 hospitalized patients with confirmed COVID-19. COVID-19 patients were diagnosed as either <jats:italic>critical</jats:italic> (&gt;50% lung damage) or <jats:italic>moderate</jats:italic> (&lt;50% of lung damage) based on computerized tomography. Patients who required invasive mechanical ventilation (IMV) and/or died during hospitalization were categorized as having a <jats:italic>severe outcome</jats:italic>, and a <jats:italic>non-severe outcome</jats:italic> if they were discharged and none of the former occurred.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>Elevated serum galectin-3 was significantly higher in critical patients compared to moderate ones (35.91 ± 19.37 ng/mL vs. 25 ± 14.85 ng/mL, p&lt;0.0001). Patients who progressed to a <jats:italic>severe outcome</jats:italic> including IMV and/or in-hospital death, presented higher galectin-3 levels (41.17 ng/mL [IQR 29.71 – 52.25] vs. 23.76 ng/mL [IQR 15.78 – 33.97] compared to those of a non-severe outcome, p&lt;0.0001). Galectin-3 discriminated well between those with severe and non-severe outcome, with an AUC of 0.75 (95% CI 0.67 – 0.84, p&lt;0.0001) and was found to be an independent predictor of severe outcome regardless of the percentage of lung involvement. Additionally, the combination of galectin-3, CRP and albumin, significantly improved its individual predicting ability with an AUC 0.84 (95% CI 0.77 – 0.91, p&lt;0.0001).</jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p>Circulating galectin-3 levels can be used to predict severe outcomes in COVID-19 patients, including the requirement of mechanical ventilation and/or death, regardless of the initial severity of the disease.</jats:p></jats:sec>",2021-02-09
203,10.1101/2021.04.27.441542,11,bioRxiv,Plant Biology,False,The Boundary-Expressed EPIDERMAL PATTERNING FACTOR-LIKE2 Gene Encoding a Signaling Peptide Promotes Cotyledon Growth during Arabidopsis thaliana Embryogenesis,"[{'given': 'Rina', 'family': 'Fujihara', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4123-6154', 'authenticated-orcid': False, 'given': 'Naoyuki', 'family': 'Uchida', 'sequence': 'additional', 'affiliation': []}, {'given': 'Toshiaki', 'family': 'Tameshige', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6565-7132', 'authenticated-orcid': False, 'given': 'Nozomi', 'family': 'Kawamoto', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yugo', 'family': 'Hotokezaka', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1379-3930', 'authenticated-orcid': False, 'given': 'Takumi', 'family': 'Higaki', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1317-7716', 'authenticated-orcid': False, 'given': 'Ruediger', 'family': 'Simon', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6168-427X', 'authenticated-orcid': False, 'given': 'Keiko U', 'family': 'Torii', 'sequence': 'additional', 'affiliation': []}, {'given': 'Masao', 'family': 'Tasaka', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-9000-7502', 'authenticated-orcid': False, 'given': 'Mitsuhiro', 'family': 'Aida', 'sequence': 'additional', 'affiliation': []}]","<jats:p>The shoot organ boundaries have important roles in plant growth and morphogenesis. It has been reported that a gene encoding a cysteine-rich secreted peptide of the EPIDERMAL PATTERNING FACTOR-LIKE (EPFL) family, <jats:italic>EPFL2</jats:italic>, is expressed in the boundary domain between the two cotyledon primordia of Arabidopsis thaliana embryo. However, its developmental functions remain unknown. This study aimed to analyze the role of <jats:italic>EPFL2</jats:italic> during embryogenesis. We found that cotyledon growth was reduced in its loss-of-function mutants, and this phenotype was associated with the reduction of auxin response peaks at the tips of the primordia. The reduced cotyledon size of the mutant embryo recovered in germinating seedlings, indicating the presence of a factor that acted redundantly with <jats:italic>EPFL2</jats:italic> to promote cotyledon growth in late embryogenesis. Our analysis indicates that the boundary domain between the cotyledon primordia acts as a signaling center that organizes auxin response peaks and promotes cotyledon growth.</jats:p>",2021-04-28
204,10.1101/2021.03.12.21253448,11,medRxiv,Epidemiology,True,SARS-CoV-2 infection and risk of clinical sequelae during the post-acute phase: a retrospective cohort study,"[{'ORCID': 'http://orcid.org/0000-0002-4148-2881', 'authenticated-orcid': False, 'given': 'Sarah E.', 'family': 'Daugherty', 'sequence': 'first', 'affiliation': []}, {'given': 'Yinglong', 'family': 'Guo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kevin', 'family': 'Heath', 'sequence': 'additional', 'affiliation': []}, {'given': 'Micah C.', 'family': 'Dasmariñas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Karol Giuseppe', 'family': 'Jubilo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jirapat', 'family': 'Samranvedhya', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marc', 'family': 'Lipsitch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ken', 'family': 'Cohen', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>Clinical sequelae have not been well characterized during the post-acute phase of SARS-CoV-2 among adults 18 to 65 years old, and this study sought to fill that gap by evaluating excess risk and relative hazards for developing incident clinical sequelae during the post-acute phase.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Retrospective cohort study including three propensity-matched groups.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>This study merged three data sources from a large United States health plan: a large national administrative claims database, an outpatient lab testing database, and an inpatient hospital admissions database.</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>Individuals 18 to 65 years old with continuous health plan enrollment from January 2019 to date of SARS-CoV-2 diagnosis. Three comparator groups were identified and propensity-score matched to individuals infected with SARS-CoV-2: a 2020 comparator group, a historical 2019 comparator group and a historical comparator group with viral lower respiratory tract illness (vLRTI).</jats:p></jats:sec><jats:sec><jats:title>Main outcome measures</jats:title><jats:p>Over 50 clinical sequelae during the post-acute phase (index date + 21 days) were ascertained using ICD-10 codes. Excess risk due to SARS-CoV-2 during the 4 months following the acute phase of illness and hazard ratios with 95% Bonferroni-corrected confidence intervals were calculated.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>This study found 14% of adults ≤65 years of age who were infected with SARS-CoV-2 (n=193113) had at least one new clinical sequelae that required medical attention during the post-acute phase of illness. When considering risk for specific sequelae attributable to SARS-Cov-2 infection during the post-acute phase, clinical outcomes including chronic respiratory failure, cardiac arrythmia, hypercoagulability, encephalopathy, peripheral neuropathy, amnesia (memory difficulty), diabetes, liver test abnormalities, myocarditis, anxiety and fatigue were significantly elevated compared to the three propensity-matched comparator groups (2020, 2019, vLRTI). Significant risk differences due to SARS-CoV-2 infection ranged from 0.02 to 2.26 per 100 people and hazard ratios ranged from 1.24 to 25.65 when compared to the 2020 comparator group.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Our results confirm excess risk for developing clinical sequelae due to SARS-CoV-2 during the post-acute phase, including specific types of sequelae less commonly seen among other viral illnesses. Although individuals who were older, had pre-existing conditions, and were hospitalized due to COVID-19 were at greatest excess risk, younger adults (≤50 years), adults who did not have pre-existing conditions or adults who were not hospitalized due to COVID-19 were still at elevated risk for developing new clinical sequelae. The elevated risk for incident sequelae during the post-acute phase is relevant for healthcare planning.</jats:p></jats:sec><jats:sec><jats:title>Summary Box</jats:title><jats:sec><jats:title>What is already known on this topic</jats:title><jats:p>Small observational studies and case reports of hospitalized patients have shown some COVID-19 survivors suffer from short- and long-term sequelae. Few studies have characterized the excess risk of clinical sequelae attributable to SARS-CoV-2 during the post-acute phase among adults ≤65 years of age in a large generalizable sample.</jats:p></jats:sec><jats:sec><jats:title>What this study adds</jats:title><jats:p>This study found 14% of individuals ≤65 years of age who were infected with SARS-CoV-2 (n=193113) had a diagnosis of at least one new sequelae that required medical attention during the post-acute phase of illness. Elevated risk for specific clinical sequelae during the post-acute phase of illness was noted across a range of organ systems including cardiovascular, neurologic, kidney, respiratory, and mental health complications. The risk for incident sequelae increases with age, pre-existing conditions, and hospitalization for COVID-19; however, even among adults ≤ 50 years of age and individuals without pre-existing conditions or hospitalization due to COVID-19, risk for some clinical sequelae is still elevated. These results indicate where additional diagnostic follow-up, rehabilitation, and symptom management may be warranted among younger adults with milder infection.</jats:p></jats:sec></jats:sec>",2021-03-12
205,10.1101/2021.04.15.440089,10,bioRxiv,Immunology,True,Substantial Differences in SARS-CoV-2 Antibody Responses Elicited by Natural Infection and mRNA Vaccination,"[{'given': 'Rafael', 'family': 'Assis', 'sequence': 'first', 'affiliation': []}, {'given': 'Aarti', 'family': 'Jain', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rie', 'family': 'Nakajima', 'sequence': 'additional', 'affiliation': []}, {'given': 'Al', 'family': 'Jasinskas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Saahir', 'family': 'Kahn', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anton', 'family': 'Palma', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5352-7338', 'authenticated-orcid': False, 'given': 'Daniel M.', 'family': 'Parker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Anthony', 'family': 'Chau', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amanda', 'family': 'Leung', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christina', 'family': 'Grabar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fjolla', 'family': 'Muqolli', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ghali', 'family': 'Khalil', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jessica Colin', 'family': 'Escobar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jenny', 'family': 'Ventura', 'sequence': 'additional', 'affiliation': []}, {'given': 'D. Huw', 'family': 'Davies', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bruce', 'family': 'Albala', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bernadette', 'family': 'Boden-Albala', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sebastian', 'family': 'Schubl', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philip L.', 'family': 'Felgner', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>We analyzed data from two ongoing serologic surveys, a longitudinal cohort of health care workers (HCW) from the University of California Irvine Medical Center (Orange County, CA, USA), collected from May and December 2020 through March 2021, and a cross sectional county-wide study in July 2020 (actOC; Orange County, CA) and a more focused community study in the city of Santa Ana (Santa Ana Cares; Orange County, CA, USA), collected in December 2020 - in order to compare the antibody responses to SARS-CoV-2 natural infection and vaccination. In addition, we serially tested 9 volunteers at multiple time points to analyze the time course of vaccine-induced antibody response in more detail. In May 2020, 1060 HCW were enrolled and had finger stick samples collected. Finger stick samples were again collected in December 2020, before vaccination, as well as January, February and March 2021 during vaccination campaign. A total of 8,729 finger stick blood specimens were probed and analyzed for IgG and IgM antibodies using a coronavirus antigen microarray (COVAM).The microarray contained 10 SARS-CoV-2 antigens including nucleocapid protein (NP) and several varying fragments of the spike protein, as well as 4 SARS, 3 MERS, 12 Common CoV, and 8 Influenza antigens.Based on a random forest based prediction algorithm, between May and December, prior to vaccine rollout, we observed that seropositivity in the HCW cohort increased from 4.5% to 13%. An intensive vaccination campaign with mRNA vaccines was initiated on December 16, 2020 and 6,724 healthcare workers were vaccinated within 3 weeks. The observed seropositivity of the HCW specimens taken in the last week of January 2021 jumped to 78%, and by the last week in February it reached 93%, and peaked at 98% seropositive in March. The antibody profile induced by natural exposure differed from the profile induced after mRNA vaccination. Messenger RNA vaccines induced elevated antibody (Ab) reactivity levels against the Receptor Binding Domain (RBD) domain of SARS-CoV-2 spike, and cross-reactive responses against SARS and MERS RBD domains. Nucleocapsid protein (NP), which is an immunodominant antigen induced after natural exposure, is not present in the vaccine and can be used as a biomarker of past exposure. The results show that naturally-exposed individuals mount a stronger anti-spike response upon vaccination than individuals that were not previously exposed. Longitudinal specimens taken at approximately weekly intervals from 9 individuals show variation in the response to the mRNA vaccine, with some showing a vigorous response to the first dose (prime) and others requiring a subsequent dose (boost) to reach high anti-SARS-CoV-2 levels. Antibody titers determined by serial dilution of the specimens were used to accurately compare antibody levels in these samples. mRNA vaccinees after the boost have higher Ab titers (up to 10 times higher) than convalescent plasmas from donors who recovered from natural infection. The results of this study exemplify the time course and outcomes expected from similar mRNA mass vaccination campaigns conducted in other institutions.</jats:p>",2021-04-19
206,10.1101/2021.02.11.21249258,10,medRxiv,Infectious Diseases (except HIV/AIDS),True,"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial","[{'name': 'RECOVERY Collaborative Group', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9822-1586', 'authenticated-orcid': False, 'given': 'Peter W', 'family': 'Horby', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4050-6191', 'authenticated-orcid': False, 'given': 'Guilherme', 'family': 'Pessoa-Amorim', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4100-2163', 'authenticated-orcid': False, 'given': 'Leon', 'family': 'Peto', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher E', 'family': 'Brightling', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rahuldeb', 'family': 'Sarkar', 'sequence': 'additional', 'affiliation': []}, {'given': 'Koshy', 'family': 'Thomas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vandana', 'family': 'Jeebun', 'sequence': 'additional', 'affiliation': []}, {'given': 'Abdul', 'family': 'Ashish', 'sequence': 'additional', 'affiliation': []}, {'given': 'Redmond', 'family': 'Tully', 'sequence': 'additional', 'affiliation': []}, {'given': 'David', 'family': 'Chadwick', 'sequence': 'additional', 'affiliation': []}, {'given': 'Muhammad', 'family': 'Sharafat', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard', 'family': 'Stewart', 'sequence': 'additional', 'affiliation': []}, {'given': 'Banu', 'family': 'Rudran', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5258-793X', 'authenticated-orcid': False, 'given': 'J Kenneth', 'family': 'Baillie', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8962-5642', 'authenticated-orcid': False, 'given': 'Maya H', 'family': 'Buch', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6219-3379', 'authenticated-orcid': False, 'given': 'Lucy C', 'family': 'Chappell', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7843-6280', 'authenticated-orcid': False, 'given': 'Jeremy N', 'family': 'Day', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3410-7642', 'authenticated-orcid': False, 'given': 'Saul N', 'family': 'Furst', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1096-188X', 'authenticated-orcid': False, 'given': 'Thomas', 'family': 'Jaki', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6506-2689', 'authenticated-orcid': False, 'given': 'Katie', 'family': 'Jeffery', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5500-2247', 'authenticated-orcid': False, 'given': 'Edmund', 'family': 'Juszczak', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7694-3051', 'authenticated-orcid': False, 'given': 'Wei Shen', 'family': 'Lim', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0450-1606', 'authenticated-orcid': False, 'given': 'Alan', 'family': 'Montgomery', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5523-511X', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Mumford', 'sequence': 'additional', 'affiliation': []}, {'given': 'Kathryn', 'family': 'Rowan', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2858-2087', 'authenticated-orcid': False, 'given': 'Guy', 'family': 'Thwaites', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0562-3963', 'authenticated-orcid': False, 'given': 'Marion', 'family': 'Mafham', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1179-0023', 'authenticated-orcid': False, 'given': 'Richard', 'family': 'Haynes', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-6646-827X', 'authenticated-orcid': False, 'given': 'Martin J', 'family': 'Landray', 'sequence': 'additional', 'affiliation': []}]","<jats:title>SUMMARY</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Tocilizumab is a monoclonal antibody that binds to the receptor for interleukin (IL)-6, reducing inflammation, and is commonly used to treat rheumatoid arthritis. We evaluated the safety and efficacy of tocilizumab in adult patients admitted to hospital with COVID-19 with evidence of both hypoxia and systemic inflammation.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation &lt;92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein [CRP] ≥75 mg/L) were eligible for randomisation to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg to 800 mg (depending on weight) given intravenously. A second dose could be given 12 to 24 hours later if the patient’s condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and <jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""uri"" xlink:href=""http://clinicaltrials.gov"">clinicaltrials.gov</jats:ext-link> (<jats:ext-link xmlns:xlink=""http://www.w3.org/1999/xlink"" ext-link-type=""clintrialgov"" xlink:href=""NCT04381936"">NCT04381936</jats:ext-link>).</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Between 23 April 2020 and 24 January 2021, 4116 adults were included in the assessment of tocilizumab, including 562 (14%) patients receiving invasive mechanical ventilation, 1686 (41%) receiving non-invasive respiratory support, and 1868 (45%) receiving no respiratory support other than oxygen. Median CRP was 143 [IQR 107-204] mg/L and 3385 (82%) patients were receiving systemic corticosteroids at randomisation. Overall, 596 (29%) of the 2022 patients allocated tocilizumab and 694 (33%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0·86; 95% confidence interval [CI] 0·77-0·96; p=0·007). Consistent results were seen in all pre-specified subgroups of patients. In particular, a clear mortality benefit was seen in those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital alive within 28 days (54% vs. 47%; rate ratio 1·22; 95% CI 1·12-1·34; p&lt;0·0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (33% vs. 38%; risk ratio 0·85; 95% CI 0·78-0·93; p=0·0005).</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the level of respiratory support and were additional to the benefits of systemic corticosteroids.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>UK Research and Innovation (Medical Research Council) and National Institute of Health Research (Grant ref: MC_PC_19056).</jats:p></jats:sec>",2021-02-11
207,10.1101/2021.03.31.21254687,10,medRxiv,Infectious Diseases (except HIV/AIDS),True,"SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission","[{'given': 'Lennard YW', 'family': 'Lee', 'sequence': 'first', 'affiliation': []}, {'given': 'Stefan', 'family': 'Rozmanowski', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthew', 'family': 'Pang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andre', 'family': 'Charlett', 'sequence': 'additional', 'affiliation': []}, {'given': 'Charlotte', 'family': 'Anderson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gareth J', 'family': 'Hughes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthew', 'family': 'Barnard', 'sequence': 'additional', 'affiliation': []}, {'given': 'Leon', 'family': 'Peto', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard', 'family': 'Vipond', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alex', 'family': 'Sienkiewicz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Susan', 'family': 'Hopkins', 'sequence': 'additional', 'affiliation': []}, {'given': 'John', 'family': 'Bell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Derrick W', 'family': 'Crook', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nick', 'family': 'Gent', 'sequence': 'additional', 'affiliation': []}, {'given': 'A Sarah', 'family': 'Walker', 'sequence': 'additional', 'affiliation': []}, {'given': 'Tim EA', 'family': 'Peto', 'sequence': 'additional', 'affiliation': []}, {'given': 'David W', 'family': 'Eyre', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>How SARS-CoV-2 infectivity varies with viral load is incompletely understood. Whether rapid point-of-care antigen lateral flow devices (LFDs) detect most potential transmission sources despite imperfect sensitivity is unknown.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We combined SARS-CoV-2 testing and contact tracing data from England between 01-September-2020 and 28-February-2021. We used multivariable logistic regression to investigate relationships between PCR-confirmed infection in contacts of community-diagnosed cases and index case viral load, S gene target failure (proxy for B.1.1.7 infection), demographics, SARS-CoV-2 incidence, social deprivation, and contact event type. We used LFD performance to simulate the proportion of cases with a PCR-positive contact expected to be detected using one of four LFDs.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>231,498/2,474,066 (9%) contacts of 1,064,004 index cases tested PCR-positive. PCR-positive results in contacts independently increased with higher case viral loads (lower Ct values) e.g., 11.7%(95%CI 11.5-12.0%) at Ct=15 and 4.5%(4.4-4.6%) at Ct=30. B.1.1.7 infection increased PCR-positive results by ∼50%, (e.g. 1.55-fold, 95%CI 1.49-1.61, at Ct=20). PCR-positive results were most common in household contacts (at Ct=20.1, 8.7%[95%CI 8.6-8.9%]), followed by household visitors (7.1%[6.8-7.3%]), contacts at events/activities (5.2%[4.9-5.4%]), work/education (4.6%[4.4-4.8%]), and least common after outdoor contact (2.9%[2.3-3.8%]). Contacts of children were the least likely to test positive, particularly following contact outdoors or at work/education. The most and least sensitive LFDs would detect 89.5%(89.4-89.6%) and 83.0%(82.8-83.1%) of cases with PCR-positive contacts respectively.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>SARS-CoV-2 infectivity varies by case viral load, contact event type, and age. Those with high viral loads are the most infectious. B.1.1.7 increased transmission by ∼50%. The best performing LFDs detect most infectious cases.</jats:p></jats:sec><jats:sec><jats:title>Key points</jats:title><jats:p>In 2,474,066 contacts of 1,064,004 SARS-CoV-2 cases, PCR-positive tests in contacts increased with higher index case viral loads, the B.1.1.7 variant and household contact. Children were less infectious. Lateral flow devices can detect 83.0-89.5% of infections leading to onward transmission.</jats:p></jats:sec>",2021-04-05
208,10.1101/2021.03.26.21254391,10,medRxiv,Infectious Diseases (except HIV/AIDS),True,Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study),"[{'ORCID': 'http://orcid.org/0000-0001-9791-122X', 'authenticated-orcid': False, 'given': 'Madhumita', 'family': 'Shrotri', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3982-642X', 'authenticated-orcid': False, 'given': 'Maria', 'family': 'Krutikov', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9526-0045', 'authenticated-orcid': False, 'given': 'Tom', 'family': 'Palmer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rebecca', 'family': 'Giddings', 'sequence': 'additional', 'affiliation': []}, {'given': 'Borscha', 'family': 'Azmi', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2485-8354', 'authenticated-orcid': False, 'given': 'Sathyavani', 'family': 'Subbarao', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christopher', 'family': 'Fuller', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aidan', 'family': 'Irwin-Singer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel', 'family': 'Davies', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0655-232X', 'authenticated-orcid': False, 'given': 'Gokhan', 'family': 'Tut', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jamie Lopez', 'family': 'Bernal', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paul', 'family': 'Moss', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3549-6232', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Hayward', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-8968-5963', 'authenticated-orcid': False, 'given': 'Andrew', 'family': 'Copas', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1713-2555', 'authenticated-orcid': False, 'given': 'Laura', 'family': 'Shallcross', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The effectiveness of SARS-CoV-2 vaccines in frail older adults living in Long-Term Care Facilities (LTCFs) is uncertain. We estimated protective effects of the first dose of ChAdOx1 and BNT162b2 vaccines against infection in this population.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Cohort study comparing vaccinated and unvaccinated LTCF residents in England, undergoing routine asymptomatic testing (8 December 2020 - 15 March 2021). We estimated the relative hazard of PCR-positive infection using Cox proportional hazards regression, adjusting for age, sex, prior infection, local SARS-CoV-2 incidence, LTCF bed capacity, and clustering by LTCF.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Of 10,412 residents (median age 86 years) from 310 LTCFs, 9,160 were vaccinated with either ChAdOx1 (6,138; 67%) or BNT162b2 (3,022; 33%) vaccines. A total of 670,628 person days and 1,335 PCR-positive infections were included. Adjusted hazard ratios (aHRs) for PCR-positive infection relative to unvaccinated residents declined from 28 days following the first vaccine dose to 0·44 (0·24, 0·81) at 28-34 days and 0·38 (0·19, 0·77) at 35-48 days. Similar effect sizes were seen for ChAdOx1 (aHR 0·32 [0·15-0·66] and BNT162b2 (aHR 0·35 [0·17, 0·71]) vaccines at 35-48 days. Mean PCR cycle threshold values were higher, implying lower infectivity, for infections ≥28 days post-vaccination compared with those prior to vaccination (31·3 vs 26·6, p&lt;0·001).</jats:p></jats:sec><jats:sec><jats:title>Interpretation</jats:title><jats:p>The first dose of BNT162b2 and ChAdOx1 vaccines was associated with substantially reduced SARS-CoV-2 infection risk in LTCF residents from 4 weeks to at least 7 weeks.</jats:p></jats:sec><jats:sec><jats:title>Funding</jats:title><jats:p>UK Government Department of Health and Social Care.</jats:p></jats:sec><jats:sec><jats:title>Research in Context</jats:title><jats:sec><jats:title>Evidence before this study</jats:title><jats:p>We conducted a systematic search for studies which evaluated SARS-CoV-2 vaccine effectiveness in residents of long-term care facilities (LTCFs) published between 01/01/2020 and 11/03/2021. We used variations of search terms for “COVID-19” AND “vaccine effectiveness” OR “vaccine efficacy” AND “care homes” OR “long term care facilities” OR “older people” on Ovid MEDLINE and MedRxiv. We identified one pre-print article regarding LTCFs in Denmark, which reported that a single dose of BNT162b was ineffective against SARS-CoV-2 infection in residents, however, participants received the second vaccine dose 24 days following the first dose on average, which is likely to be too soon to capture the protective effects of a single vaccine dose. Additionally, we identified two pre-print reports of studies evaluating vaccine effectiveness against symptomatic infection and hospitalisation amongst older adults in the community. The first of these found 81% vaccine effectiveness against COVID-19-related hospitalisation at 28-34 days following a single dose of BNT162b or ChAdOx1 in ≥80-year-olds. The second of these found vaccine effectiveness against symptomatic infection of 60% at 28-34 days and 73% at 35+ days following a single dose of ChAdOx1 in ≥70-year-olds. No studies were identified that focused on the effectiveness of a single vaccine dose against infection amongst LTCF residents at more than 4 weeks post-vaccination, a particularly important question in the context of the UK policy decision to extend the dose interval beyond 3 weeks.</jats:p></jats:sec><jats:sec><jats:title>Added value of this study</jats:title><jats:p>We conducted a prospective cohort study of 10,412 residents aged ≥65 years, from 310 LTCFs across England, to investigate the protective effect of the first dose of the ChAdOx1 and BNT162b vaccines against SARS-CoV-2 infection in frail older adults. We retrieved results from routine monthly PCR testing, as well as outbreak and clinical testing for SARS-CoV-2, thereby capturing data on asymptomatic as well as symptomatic infections, which we linked to vaccination records. We estimated vaccine effectiveness to be 56% (19-76%) at 28-34 days, and 62% (23-81%) at 35-48 days following a single dose of ChAdOx1 or BNT162. Our findings suggest that the risk of SARS-CoV-2 infection is substantially reduced from 28 days following the first dose of either vaccine and that this effect is maintained for at least 7 weeks, with similar protection offered by both vaccine types. We also found that PCR cycle threshold (Ct) values, which are negatively associated with the ability to isolate virus, were significantly higher in infections occurring at ≥ 28days post vaccination compared to those occurring in the unvaccinated period, suggesting that vaccination may reduce onward transmission of SARS-CoV-2 in breakthrough infections. To the best of our knowledge, our findings constitute the first real-world evidence on vaccine effectiveness against infection for ChAdOx1, in any age group. We can also infer that both vaccines are effective against the B.1.1.7 variant, because our analysis period coincided with the rapid emergence of B.1.1.7 in England during the second wave of the pandemic.</jats:p></jats:sec><jats:sec><jats:title>Implications of all the available evidence</jats:title><jats:p>Our findings add to the growing body of evidence on the protective effect of the BNT162b vaccines in residents of LTCFs and demonstrate the effectiveness of ChAdOx1 in this vulnerable population. Evaluating single-dose vaccine efficacy has become increasingly important in light of extended dosing intervals that have been implemented in order to maximise vaccine coverage across high-risk groups. Further work is required to evaluate the effectiveness of the first vaccine dose after 8-12 weeks, as well as following the second dose, and to evaluate the long-term impact of vaccination on SARS-CoV-2 infection, transmission and mortality in LTCFs. This will inform policy decisions regarding the ongoing need for disease control measures in LTCF such as visitor restrictions, which continue to have a detrimental impact on the wellbeing of residents, their relatives, and staff.</jats:p><jats:p>Supplementary material attached.</jats:p></jats:sec></jats:sec>",2021-03-26
209,10.1101/2021.02.23.432474,10,bioRxiv,Neuroscience,True,SARS-CoV-2 causes brain inflammation and induces Lewy body formation in macaques,"[{'given': 'Ingrid H.C.H.M.', 'family': 'Philippens', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5330-2617', 'authenticated-orcid': False, 'given': 'Kinga P.', 'family': 'Böszörményi', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jacqueline A.', 'family': 'Wubben', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zahra C.', 'family': 'Fagrouch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nikki', 'family': 'van Driel', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amber Q.', 'family': 'Mayenburg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Diana', 'family': 'Lozovagia', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eva', 'family': 'Roos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bernadette', 'family': 'Schurink', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marianna', 'family': 'Bugiani', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ronald E.', 'family': 'Bontrop', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jinte', 'family': 'Middeldorp', 'sequence': 'additional', 'affiliation': []}, {'given': 'Willy M.', 'family': 'Bogers', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lioe-Fee', 'family': 'de Geus-Oei', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jan A.M.', 'family': 'Langermans', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marieke A.', 'family': 'Stammes', 'sequence': 'additional', 'affiliation': []}, {'given': 'Babs E.', 'family': 'Verstrepen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ernst J.', 'family': 'Verschoor', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>SARS-CoV-2 may cause acute respiratory disease, but the infection can also initiate neurological symptoms. Here we show that SARS-CoV-2 infection causes brain inflammation in the macaque model. An increased metabolic activity in the pituitary gland of two macaques was observed by longitudinal positron emission tomography-computed tomography (PET-CT). Post-mortem analysis demonstrated infiltration of T-cells and activated microglia in the brain, and viral RNA was detected in brain tissues from one animal. We observed Lewy bodies in brains of all rhesus macaques. These data emphasize the virus’ capability to induce neuropathology in this nonhuman primate model for SARS-CoV-2 infection. As in humans Lewy body formation is an indication for the development of Parkinson’s disease, this data represents a warning for potential long-term neurological effects after SARS-CoV-2 infection.</jats:p><jats:sec><jats:title>One-Sentence Summar</jats:title><jats:p>SARS-CoV-2 causes brain inflammation and Lewy bodies, a hallmark for Parkinson, after an asymptomatic infection in macaques.</jats:p></jats:sec>",2021-02-23
210,10.1101/2020.12.16.423022,10,bioRxiv,Systems Biology,False,Comprehensive prediction of robust synthetic lethality between paralog pairs in cancer cell lines,"[{'given': 'Barbara De', 'family': 'Kegel', 'sequence': 'first', 'affiliation': []}, {'given': 'Niall', 'family': 'Quinn', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicola A.', 'family': 'Thompson', 'sequence': 'additional', 'affiliation': []}, {'given': 'David J.', 'family': 'Adams', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2750-9854', 'authenticated-orcid': False, 'given': 'Colm J.', 'family': 'Ryan', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Pairs of paralogs may share common functionality and hence display synthetic lethal interactions. As the majority of human genes have an identifiable paralog, exploiting synthetic lethality between paralogs may be a broadly applicable approach for targeting gene loss in cancer. However only a biased subset of human paralog pairs has been tested for synthetic lethality to date. Here, by analysing genome-wide CRISPR screens and molecular profiles of over 700 cancer cell lines, we identify features predictive of synthetic lethality between paralogs, including shared protein-protein interactions and evolutionary conservation. We develop a machine-learning classifier based on these features to predict which paralog pairs are most likely to be synthetic lethal and to explain why. We show that our classifier accurately predicts the results of combinatorial CRISPR screens in cancer cell lines and furthermore can distinguish pairs that are synthetic lethal in multiple cell lines from those that are cell-line specific.</jats:p>",2020-12-16
211,10.1101/2020.12.24.20248802,10,medRxiv,Infectious Diseases (except HIV/AIDS),True,Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact,"[{'given': 'Hannah E.', 'family': 'Davis', 'sequence': 'first', 'affiliation': []}, {'given': 'Gina S.', 'family': 'Assaf', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lisa', 'family': 'McCorkell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hannah', 'family': 'Wei', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-1500-3277', 'authenticated-orcid': False, 'given': 'Ryan J.', 'family': 'Low', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-9117-764X', 'authenticated-orcid': False, 'given': 'Yochai', 'family': 'Re’em', 'sequence': 'additional', 'affiliation': []}, {'given': 'Signe', 'family': 'Redfield', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-7868-3855', 'authenticated-orcid': False, 'given': 'Jared P.', 'family': 'Austin', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-5711-0903', 'authenticated-orcid': False, 'given': 'Athena', 'family': 'Akrami', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Growing evidence shows that a significant number of patients with COVID-19 experience prolonged symptoms, known as Long COVID. Few systematic studies exist which investigate this population, and hence, relatively little is known about the range in symptom makeup and severity, expected clinical course, impact on daily functioning, and expected return to baseline health. In this study, we analysed responses from 3,762 participants with confirmed (diagnostic/antibody positive; 1,020) or suspected (diagnostic/antibody negative or untested; 2,742) COVID-19, from 56 countries, with illness duration of at least 28 days. 3608 (96%) reported symptoms beyond 90 days. Prevalence of 205 symptoms in 10 organ systems was estimated in this cohort, with 66 symptoms traced over seven months. Except for loss of smell and taste, the prevalence and trajectory of all symptoms were similar between groups with confirmed and suspected COVID-19. Respondents experienced an average of 14.5 symptoms in an average of 9.08 organ systems. Three clusters of symptoms were identified based on their prevalence over time. The most likely early symptoms were fatigue, dry cough, shortness of breath, headaches, muscle aches, chest tightness, and sore throat. The most frequent symptoms reported after month 6 were fatigue, post-exertional malaise, and cognitive dysfunction. Majority (&gt;85%) experienced relapses, with exercise, physical or mental activity, and stress as the main triggers. 1,700 (45.2%) reported requiring a reduced work schedule compared to pre-illness and 839 (22.3%) were not working at the time of survey due to their health conditions.</jats:p><jats:sec><jats:title>Significance Statement</jats:title><jats:p>Results from our international online survey of 3,762 individuals with suspected or confirmed COVID-19 illness suggest that Long COVID is composed of heterogeneous post-acute infection sequelae that often affect multiple organ systems, with impact on functioning and quality of life ranging from mild to severe. This study represents the largest collection of symptoms identified in the Long COVID population to date, and is the first to quantify individual symptom trajectory over time, for 7 months. Three clusters of symptoms were quantified, each with different morphologies over time. The clusters of symptoms that persist longest include a combination of the neurological/cognitive and systemic symptoms. The reduced work capacity because of cognitive dysfunction, in addition to other debilitating symptoms, translated into the loss of hours, jobs, and ability to work relative to pre-illness levels.</jats:p></jats:sec><jats:sec><jats:title>Structured Abstract</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>To characterize the symptom profile and time course in patients with Long COVID, along with the impact on daily life, work, and return to baseline health.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>International web-based survey of suspected and confirmed COVID-19 cases with illness lasting over 28 days and onset prior to June 2020.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>Survey distribution via online COVID-19 support groups and social media</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>3,762 respondents from 56 countries completed the survey. 1166 (31.0%) were 40-49 years old, 937 (25.0%) were 50-59 years old, 905 (24.1%) were 30-39 years old, 277 (7.4%) were 18-29 years old, and 477 (12.7%) were above 60 years old. 2961 (78.9%) were women, 718 (19.1%) were men, and 63 (1.7%) were nonbinary. 317 (8.4%) reported being hospitalized. 1020 (27.1%) reported receiving a laboratory-confirmed diagnosis of COVID-19. 3608 (96%) reported symptoms beyond 90 days.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Prevalence of 205 symptoms in 10 organ systems was estimated in this cohort, with 66 symptoms traced over seven months. Except for loss of smell and taste, the prevalence and trajectory of all other symptoms are similar between confirmed (diagnostic/antibody positive) and suspected groups (diagnostic/antibody negative or untested). Respondents experienced symptoms in an average of 9.08 (95% confidence interval 9.04 to 9.13) organ systems. The most frequent symptoms reported after month 6 were: <jats:bold>fatigue</jats:bold> (77.7%, 74.9% to 80.3%), <jats:bold>post-exertional malaise</jats:bold> (72.2%, 69.3% to 75.0%), and <jats:bold>cognitive dysfunction</jats:bold> (55.4%, 52.4% to 58.8%). These three symptoms were also the three most commonly reported overall. In those who recovered in less than 90 days, the average number of symptoms peaked at week 2 (11.4, 9.4 to 13.6), and in those who did not recover in 90 days, the average number of symptoms peaked at month 2 (17.2, 16.5 to 17.8). Respondents with symptoms over 6 months experienced an average of 13.8 (12.7 to 14.9) symptoms in month 7. 85.9% (84.8% to 87.0%) experienced relapses, with exercise, physical or mental activity, and stress as the main triggers. 86.7% (85.6% to 92.5%) of unrecovered respondents were experiencing fatigue at the time of survey, compared to 44.7% (38.5% to 50.5%) of recovered respondents. 45.2% (42.9% to 47.2%) reported requiring a reduced work schedule compared to pre-illness and 22.3% (20.5% to 24.3%) were not working at the time of survey due to their health conditions.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Patients with Long COVID report prolonged multisystem involvement and significant disability. Most had not returned to previous levels of work by 6 months. Many patients are not recovered by 7 months, and continue to experience significant symptom burden.</jats:p></jats:sec></jats:sec>",2020-12-26
212,10.1101/2021.03.01.433367,10,bioRxiv,Animal Behavior and Cognition,False,The perception of odor pleasantness is shared across cultures,"[{'ORCID': 'http://orcid.org/0000-0003-2282-5903', 'authenticated-orcid': False, 'given': 'Artin', 'family': 'Arshamian', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2940-3378', 'authenticated-orcid': False, 'given': 'Richard C.', 'family': 'Gerkin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicole', 'family': 'Kruspe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ewelina', 'family': 'Wnuk', 'sequence': 'additional', 'affiliation': []}, {'given': 'Simeon', 'family': 'Floyd', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carolyn', 'family': 'O’Meara', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gabriela Garrido', 'family': 'Rodriguez', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-3529-8981', 'authenticated-orcid': False, 'given': 'Johan N.', 'family': 'Lundström', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5056-4598', 'authenticated-orcid': False, 'given': 'Joel D.', 'family': 'Mainland', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-0132-216X', 'authenticated-orcid': False, 'given': 'Asifa', 'family': 'Majid', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Human sensory experience varies across the globe. Nonetheless, all humans share sensory systems with a common anatomical blueprint. In olfaction, it is unknown to what degree sensory perception, in particular the perception of odor pleasantness, is dictated by universal biological principles versus sculpted by culture. To address this issue, we asked 235 individuals from 9 diverse non-western cultures to rank the hedonic value of monomolecular odorants. We observed substantial global consistency, with molecular identity explaining 41% of the variance in individual pleasantness rankings, while culture explained only 6%. These rankings were predicted by the physicochemical properties of out-of-sample molecules and out-of-sample pleasantness ratings given by a separate group of industrialized western urbanites, indicating human olfactory perception is strongly constrained by universal principles.</jats:p>",2021-03-02
213,10.1101/2020.11.18.20230599,10,medRxiv,Infectious Diseases (except HIV/AIDS),True,"Remdesivir induced viral RNA and subgenomic RNA suppression, and evolution of viral variants in SARS-CoV-2 infected patients","[{'given': 'Florencia A.T.', 'family': 'Boshier', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-4792-5903', 'authenticated-orcid': False, 'given': 'Juanita', 'family': 'Pang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Justin', 'family': 'Penner', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joseph', 'family': 'Hughes', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2999-3870', 'authenticated-orcid': False, 'given': 'Matthew', 'family': 'Parker', 'sequence': 'additional', 'affiliation': []}, {'given': 'James', 'family': 'Shepherd', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nele', 'family': 'Alders', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alasdair', 'family': 'Bamford', 'sequence': 'additional', 'affiliation': []}, {'given': 'Louis', 'family': 'Grandjean', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stephanie', 'family': 'Grunewald', 'sequence': 'additional', 'affiliation': []}, {'given': 'James', 'family': 'Hatcher', 'sequence': 'additional', 'affiliation': []}, {'given': 'Timothy', 'family': 'Best', 'sequence': 'additional', 'affiliation': []}, {'given': 'Caroline', 'family': 'Dalton', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patricia Dyal', 'family': 'Bynoe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Claire', 'family': 'Frauenfelder', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jutta', 'family': 'Köeglmeier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Phoebe', 'family': 'Myerson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sunando', 'family': 'Roy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rachel', 'family': 'Williams', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-1482-0889', 'authenticated-orcid': False, 'given': 'Emma C', 'family': 'Thomson', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6498-9212', 'authenticated-orcid': False, 'given': 'Thushan I', 'family': 'de Silva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Richard A.', 'family': 'Goldstein', 'sequence': 'additional', 'affiliation': []}, {'given': 'Judith', 'family': 'Breuer', 'sequence': 'additional', 'affiliation': []}, {'name': 'The COVID-19 Genomics UK (COG-UK) consortium', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>While changes in SARS-CoV-2 viral load over time have been documented, detailed information on the impact of remdesivir and how it might alter intra-host viral evolution is limited. Sequential viral loads and deep sequencing of SARS-CoV-2 recovered from the upper respiratory tract of hospitalised children revealed that remdesivir treatment suppressed viral RNA levels in one patient but not in a second infected with an identical strain. Evidence of drug resistance to explain this difference was not found. Reduced levels of subgenomic (sg) RNA during treatment of the second patient, suggest an additional effect of remdesivir on viral replication that is independent of viral RNA levels. Haplotype reconstruction uncovered persistent SARS-CoV-2 variant genotypes in four patients. We conclude that these are likely to have arisen from within-host evolution, and not co-transmission, although superinfection cannot be excluded in one case. Sample-to-sample heterogeneity in the abundances of variant genotypes is best explained by the presence of discrete viral populations in the lung with incomplete population sampling in diagnostic swabs. Such compartmentalisation is well described in serious lung infections caused by influenza and <jats:italic>Mycobacterium tuberculosis</jats:italic> and has been associated with poor drug penetration, suboptimal treatment and drug resistance. Our data provide evidence that remdesivir is able to suppress SARS-CoV-2 replication <jats:italic>in vivo</jats:italic> but that its efficacy may be compromised by factors reducing penetration into the lung. Based on data from influenza and <jats:italic>Mycobacterium tuberculosis</jats:italic> lung infections we conclude that early use of remdesivir combined with other agents should now be evaluated.</jats:p><jats:sec><jats:title>Summary Sentence</jats:title><jats:p>Deep sequencing of longitudinal samples from SARS-CoV-2 infected paediatric patients identifies evidence of remdesivir-associated inhibition of viral replication <jats:italic>in vivo</jats:italic> and uncovers evidence of within host evolution of distinct viral genotypes.</jats:p></jats:sec>",2020-11-20
214,10.1101/2020.09.12.20192922,10,medRxiv,Genetic and Genomic Medicine,False,Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia,"[{'name': 'The Schizophrenia Working Group of the Psychiatric Genomics Consortium', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-3622-835X', 'authenticated-orcid': False, 'given': 'Stephan', 'family': 'Ripke', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-6980-4053', 'authenticated-orcid': False, 'given': 'James TR', 'family': 'Walters', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0001-7073-2379', 'authenticated-orcid': False, 'given': 'Michael C', 'family': 'O’Donovan', 'sequence': 'additional', 'affiliation': []}]","<jats:title>SUMMARY</jats:title><jats:p>Schizophrenia is a psychiatric disorder whose pathophysiology is largely unknown. It has a heritability of 60-80%, much of which is attributable to common risk alleles, suggesting genome-wide association studies can inform our understanding of aetiology<jats:sup>1</jats:sup>. Here, in 69,369 people with schizophrenia and 236,642 controls, we report common variant associations at 270 distinct loci. Using fine-mapping and functional genomic data, we prioritise 19 genes based on protein-coding or UTR variation, and 130 genes in total as likely to explain these associations. Fine-mapped candidates were enriched for genes associated with rare disruptive coding variants in people with schizophrenia, including the glutamate receptor subunit <jats:italic>GRIN2A</jats:italic> and transcription factor <jats:italic>SP4</jats:italic>, and were also enriched for genes implicated by such variants in autism and developmental disorder. Associations were concentrated in genes expressed in CNS neurons, both excitatory and inhibitory, but not other tissues or cell types, and implicated fundamental processes related to neuronal function, particularly synaptic organisation, differentiation and transmission. We identify biological processes of pathophysiological relevance to schizophrenia, show convergence of common and rare variant associations in schizophrenia and neurodevelopmental disorders, and provide a rich resource of priority genes and variants to advance mechanistic studies.</jats:p>",2020-09-13
215,10.1101/2021.04.27.21256140,10,medRxiv,Epidemiology,True,Predicting daily COVID-19 case rates from SARS-CoV-2 RNA concentrations across a diversity of wastewater catchments,"[{'given': 'Alessandro', 'family': 'Zulli', 'sequence': 'first', 'affiliation': []}, {'given': 'Annabelle', 'family': 'Pan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stephen M.', 'family': 'Bart', 'sequence': 'additional', 'affiliation': []}, {'given': 'Forrest W.', 'family': 'Crawford', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-8722-7667', 'authenticated-orcid': False, 'given': 'Edward H.', 'family': 'Kaplan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthew', 'family': 'Cartter', 'sequence': 'additional', 'affiliation': []}, {'given': 'Albert I.', 'family': 'Ko', 'sequence': 'additional', 'affiliation': []}, {'given': 'Duncan', 'family': 'Cozens', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marcela', 'family': 'Sanchez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Doug E.', 'family': 'Brackney', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jordan', 'family': 'Peccia', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>We assessed the relationship between municipality COVID-19 case rates and SARS-CoV-2 concentrations in the primary sludge of corresponding wastewater treatment facilities. Over 1,000 daily primary sludge samples were collected from six wastewater treatment facilities with catchments serving 18 cities and towns in the State of Connecticut, USA. Samples were analyzed for SARS-CoV-2 RNA concentrations during a six-month time period that overlapped with fall 2020 and winter 2021 COVID-19 outbreaks in each municipality. We fit a single regression model to estimate reported case rates in the six municipalities from SARS-CoV-2 RNA concentrations collected daily from corresponding wastewater treatment facilities. Results demonstrate the ability of SARS-CoV-2 RNA concentrations in primary sludge to estimate COVID-19 reported case rates across treatment facilities and wastewater catchments, with coverage probabilities ranging from 0.94 to 0.96. Leave-one-out cross validation suggests that the model can be broadly applied to wastewater catchments that range in more than one order of magnitude in population served. Estimation of case rates from wastewater data can be useful in locations with limited testing availability or testing disparities, or delays in individual COVID-19 testing programs.</jats:p>",2021-04-27
216,10.1101/2021.04.26.441407,10,bioRxiv,Developmental Biology,False,Guidance by followers ensures long-range coordination of cell migration through α-Catenin mechanoperception,"[{'given': 'Arthur', 'family': 'Boutillon', 'sequence': 'first', 'affiliation': []}, {'given': 'Diego', 'family': 'Jahn', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sebastián', 'family': 'González-Tirado', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jörn', 'family': 'Starruß', 'sequence': 'additional', 'affiliation': []}, {'given': 'Lutz', 'family': 'Brusch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Nicolas B.', 'family': 'David', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>Morphogenesis, wound healing and some cancer metastases depend upon migration of cell collectives that need to be guided to their destination as well as coordinated with other cell movements. During zebrafish gastrulation, extension of the embryonic axis is led by the mesendodermal polster that migrates towards the animal pole, followed by axial mesoderm that is undergoing convergence and extension. We here investigate how polster cells are guided towards the animal pole. Using a combination of precise laser ablations, advanced transplantations and functional as well as silico approaches, we establish that the directional information guiding polster cells is mechanical, and is provided by the anteriorward migration of the following cells. This information is detected by cell-cell contact through E-Cadherin/α-Catenin mechanotransduction and propagates from cell to cell over the whole tissue. Such guidance of migrating cells by followers ensures long-range coordination of movements and developmental robustness.</jats:p>",2021-04-27
217,10.1101/2021.04.27.441637,10,bioRxiv,Evolutionary Biology,False,The nature of intraspecific genome size variation in taxonomically complex eyebrights,"[{'ORCID': 'http://orcid.org/0000-0003-3700-2942', 'authenticated-orcid': False, 'given': 'Hannes', 'family': 'Becher', 'sequence': 'first', 'affiliation': []}, {'given': 'Robyn F', 'family': 'Powell', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0003-2561-516X', 'authenticated-orcid': False, 'given': 'Max R', 'family': 'Brown', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chris', 'family': 'Metherell', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jaume', 'family': 'Pellicer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ilia J', 'family': 'Leitch', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alex D', 'family': 'Twyford', 'sequence': 'additional', 'affiliation': []}]","<jats:p>Genome size (GS) is a key trait related to morphology, life history, and evolvability. Although GS is, by definition, affected by presence/absence variants (PAVs), which are ubiquitous in population sequencing studies, GS is often treated as an intrinsic property of a species. Here, we studied intra- and interspecific GS variation in taxonomically complex British eyebrights (Euphrasia).

We generated GS data for 192 individuals of diploid and tetraploid Euphrasia and analysed GS variation in relation to ploidy, taxonomy, population affiliation, and geography. We further compared the genomic repeat content of 30 samples.

We found considerable genuine intraspecific GS variation, and observed isolation-by-distance for GS in outcrossing diploids. Tetraploid Euphrasia showed contrasting patterns, with GS increasing with latitude in outcrossing Euphrasia arctica, but little GS variation in the highly selfing Euphrasia micrantha. Interspecific differences in GS genomic repeat percentages were small. 

We show the utility of treating GS as the outcome of polygenic variation. Like other types of genetic variation, such as single nucleotide polymorphisms, GS variation may be increased through hybridisation and population subdivision. In addition to selection on associated traits, GS is predicted to be affected indirectly by selection due to pleiotropy of the underlying PAVs.</jats:p>",2021-04-28
218,10.1101/2021.04.24.441269,10,bioRxiv,Cell Biology,False,Egalitarian feeds forward to Staufen to inhibit Dynein during mRNP transport,"[{'ORCID': 'http://orcid.org/0000-0002-6527-637X', 'authenticated-orcid': False, 'given': 'Imre', 'family': 'Gáspár', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-2692-6122', 'authenticated-orcid': False, 'given': 'Ly Jane', 'family': 'Phea', 'sequence': 'additional', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-5061-4620', 'authenticated-orcid': False, 'given': 'Anne', 'family': 'Ephrussi', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>The regulated recruitment and activity of motor proteins is crucial for intracellular transport of cargoes, including ribonucleoprotein complexes (RNP). Here we show that regulation of mRNP transport by the minus end-directed dynein motor complex in the <jats:italic>Drosophila</jats:italic> germline relies on the interplay of two double-stranded RNA binding proteins, Staufen and the dynein adaptor Egalitarian. Our quantitative <jats:italic>in situ</jats:italic> analysis shows that, in the nurse cells, Egalitarian associates with <jats:italic>bicoid, oskar</jats:italic> and <jats:italic>staufen</jats:italic> mRNAs, which consequently enrich in the oocyte. This results in ooplasmic accumulation of Staufen and its recruitment to the transcripts. We demonstrate that Staufen levels scale proportionately with RNA content in <jats:italic>oskar</jats:italic> mRNPs, and to a lesser extent in <jats:italic>bicoid</jats:italic> mRNPs. We show that enhanced recruitment of Staufen to <jats:italic>oskar</jats:italic> mRNPs results in dissociation of Egalitarian and a reduction in minus end-directed transport, although dynein remains associated with the RNPs. The downregulation of dynein activity prevents anterior accumulation of <jats:italic>oskar</jats:italic> mRNA, whose transport to the posterior is essential for localized production of Oskar protein. Our observations identify a feed-forward loop, whereby <jats:italic>staufen</jats:italic> mRNA localization and protein accumulation in the oocyte enable motor switching, promoting <jats:italic>oskar</jats:italic> mRNA localization to the posterior pole.</jats:p>",2021-04-25
219,10.1101/2020.04.16.20068528,10,medRxiv,Infectious Diseases (except HIV/AIDS),True,Cholesterol Metabolism—Impacts on SARS-CoV-2 Infection Prognosis,"[{'given': 'Yumeng', 'family': 'Peng', 'sequence': 'first', 'affiliation': []}, {'ORCID': 'http://orcid.org/0000-0002-0698-4077', 'authenticated-orcid': False, 'given': 'Luming', 'family': 'Wan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chen', 'family': 'Fan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pingping', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaolin', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jin', 'family': 'Sun', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yanhong', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Qiulin', 'family': 'Yan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jing', 'family': 'Gong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Huan', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaopan', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Huilong', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yufei', 'family': 'Wang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yulong', 'family': 'Zong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Feng', 'family': 'Yin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Xiaoli', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hui', 'family': 'Zhong', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yuan', 'family': 'Cao', 'sequence': 'additional', 'affiliation': []}, {'given': 'Congwen', 'family': 'Wei', 'sequence': 'additional', 'affiliation': []}]","<jats:title>Abstract</jats:title><jats:p>In this study, we specifically addressed the connection between the SARS-CoV-2 virus with host cholesterol metabolism. Plasma lipid profile was measured in 861 COVID-19 patients classified as mild (n=215), moderate (n=364), severe (n=217) or critical (n=65) and 1108 age- and sex-matched healthy individuals. We showed that the levels of both TG and HDL-C were significantly lower in patients with severe disease than in patients with moderate or mild disease. After successful treatment, cholesterol metabolism was reestablished in patients with SARS-CoV-2 infection. The serum concentrations of TC and HDL-C can be used as indicators of disease severity and prognosis in COVID-19 patients.</jats:p>",2020-04-22
